{ "name": "Peptide and GLP-1 recruiting study locations", "description": "Sponsor-registered study locations for identity-checked peptide and GLP-1 trials, grouped by NCT record and exact place while preserving repeated rows and conflicting site statuses.", "author": "HealthspanLedger", "edition": "2026.08", "version": "91ffc6bcafe5", "page": "https://healthspanledger.com/trials", "citeAs": "HealthspanLedger. Peptide and GLP-1 recruiting study locations. Edition 2026.08 (version 91ffc6bcafe5). Derived from ClinicalTrials.gov API v2, US National Library of Medicine, retrieved 2026-08-23. Licensed CC BY 4.0. https://healthspanledger.com/trials", "license": { "url": "https://creativecommons.org/licenses/by/4.0/", "name": "Creative Commons Attribution 4.0 International (CC BY 4.0)" }, "source": { "name": "ClinicalTrials.gov API v2, US National Library of Medicine", "url": "https://clinicaltrials.gov/data-api/api", "retrieved": "2026-08-23", "publisherLastUpdated": null, "license": "https://www.usa.gov/publicdomain/label/1.0/", "licenseName": "US Government work, public domain" }, "arrangement": "The underlying records are United States government work and carry no copyright. How this table selects, joins, labels and bounds them is ours, and that work is licensed CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/): reuse it, including commercially, and credit HealthspanLedger with a link to the page it came from.", "temporalCoverage": "2026-08-23", "measurementTechnique": "Starts with identity-checked studies marked recruiting in HealthspanLedger's compound pipeline, fetches each exact NCT record, strips contact and investigator fields, and groups repeated source locations by NCT id plus normalized facility, city, state or region, postal code, country and coordinates. A site is recruiting only when its complete source-status set is exactly RECRUITING.", "readThisFirst": [ "One row is one NCT identifier plus one exact normalized location tuple. It is not one unique physical facility across the corpus.", "A site marked recruiting in the registry is not proof of an open slot or of anybody's eligibility.", "Sponsors submit and update these records. The National Library of Medicine does not independently verify enrollment availability.", "Conflicting source statuses are preserved and registered_as_recruiting is false for those rows.", "Contact names, investigator names, phone numbers and email addresses are not retained." ], "rows": [ { "compound_slugs": "semaglutide", "nct_id": "NCT07779343", "study_title": "OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme", "lead_sponsor": "University of Health Sciences, Algeria", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Department of Medicine, , Mother and Child Hospital of the Army (MCHA), Algiers University Hospital, Algiers, Algeria.", "city": "Algiers", "state_or_region": null, "postal_code": "16000", "country": "Algeria", "latitude": 36.73225, "longitude": 3.08746, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07779343" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Italiano de Buenos Aires", "city": "ABB", "state_or_region": null, "postal_code": "C1199ABB", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Buenos Aires Macula S.A.", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1061AAE", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Buenos Aires Macula S.A.", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1061AAE", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Centro de Investigaciones Metabólicas (CINME)", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1056ABI", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Centro de Investigaciones Metabólicas (CINME)", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1056ABI", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Metabólicas (CINME)", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1056ABI", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Metabolicas (CINME)", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1056ABJ", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Metabolicas (CINME)", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1056ABJ", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1425AGC", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1425AGC", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1425AGC", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1425AGC", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Centro Médico Viamonte", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1120AAC", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Médico Viamonte", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1120AAC", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Cicemo Srl", "city": "Buenos Aires", "state_or_region": null, "postal_code": "1424", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cicemo Srl", "city": "Buenos Aires", "state_or_region": null, "postal_code": "1424", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CIPREC", "city": "Buenos Aires", "state_or_region": null, "postal_code": "1061", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CIPREC", "city": "Buenos Aires", "state_or_region": null, "postal_code": "1061", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CIPREC", "city": "Buenos Aires", "state_or_region": null, "postal_code": "1061", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "DOM Centro de Reumatología", "city": "Buenos Aires", "state_or_region": null, "postal_code": "1111", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Fundación Respirar", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1426ABP", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fundación Respirar", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1426ABP", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Glenny Corp - Centro Medico Saavedra", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1430CKE", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Glenny Corp - Centro Medico Saavedra", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1430CKE", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Glenny Corp. S.A.", "city": "Buenos Aires", "state_or_region": null, "postal_code": "1430", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Italiano de Buenos Aires", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1199ABB", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital Sirio Libanes", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1419", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IDIM - Instituto de Diagnostico e Investigaciones Metabolicas", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1012AAR", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IDIM - Instituto de Diagnostico e Investigaciones Metabolicas", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1012AAR", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Investigaciones Medicas Imoba Srl", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1056ABH", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Kynet Recoleta", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1119ACU", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mautalen Salud e Investigación", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1128AAF", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mautalen- Salud e Investigacion", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1128AAF", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "OMI- Organización Médica de Investigación", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1015", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Buenos Aires", "state_or_region": null, "postal_code": "C1425AGC", "country": "Argentina", "latitude": -34.61315, "longitude": -58.37723, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CEDIC Centro de Investigación Clínica", "city": "CABA", "state_or_region": null, "postal_code": "C1060ABA", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centro Médico Viamonte SRL", "city": "CABA", "state_or_region": null, "postal_code": "C1120AAC", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CIPREC Arenales", "city": "CABA", "state_or_region": null, "postal_code": "C1061AAS.", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "CABA", "state_or_region": null, "postal_code": "C1120AAC", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Caba", "state_or_region": null, "postal_code": "C1128AAF", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Centro de Investigaciones Metabólicas", "city": "City of Buenos Aires", "state_or_region": null, "postal_code": "C1056ABI", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General de Agudos Dr. J. M. Ramos Mejia", "city": "Ciudad Autonoma Buenos Aires", "state_or_region": null, "postal_code": "C1221ADC", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General de Agudos Dr. J. M. Ramos Mejia", "city": "Ciudad Autonoma Buenos Aires", "state_or_region": null, "postal_code": "C1221ADC", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Instituto Centenario", "city": "Ciudad de Buenos Aires", "state_or_region": null, "postal_code": "C1204AAD", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Ciudad de Buenos Aires", "state_or_region": null, "postal_code": "C1094AAD", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Investigaciones Clínicas Córdoba", "city": "Córdoba", "state_or_region": null, "postal_code": "5000", "country": "Argentina", "latitude": -31.40648, "longitude": -64.18853, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Instituto de Cardiología de Corrientes", "city": "Corrientes", "state_or_region": null, "postal_code": "W3400AMY", "country": "Argentina", "latitude": -27.46784, "longitude": -58.8344, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Clínicas Baigorria", "city": "Granadero Baigorria", "state_or_region": null, "postal_code": "2152", "country": "Argentina", "latitude": -32.85683, "longitude": -60.71754, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Instituto de Investigaciones Clinicas Mar Del Plata", "city": "Mar del Plata", "state_or_region": null, "postal_code": "B7600FZN", "country": "Argentina", "latitude": -38.00042, "longitude": -57.5562, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Investigaciones Clínicas Mar del Plata", "city": "Mar del Plata", "state_or_region": null, "postal_code": "B7600FZO", "country": "Argentina", "latitude": -38.00042, "longitude": -57.5562, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Austral", "city": "Pilar", "state_or_region": null, "postal_code": "B1629ODT", "country": "Argentina", "latitude": -34.45867, "longitude": -58.91398, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Austral", "city": "Pilar", "state_or_region": null, "postal_code": "B1629ODT", "country": "Argentina", "latitude": -34.45867, "longitude": -58.91398, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "DIM Clinica Privada", "city": "Ramos Mejía", "state_or_region": null, "postal_code": "1704", "country": "Argentina", "latitude": -34.6551, "longitude": -58.55318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "DIM Clinica Privada", "city": "Ramos Mejía", "state_or_region": null, "postal_code": "1704", "country": "Argentina", "latitude": -34.6551, "longitude": -58.55318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "DIM Clínica Privada", "city": "Ramos Mejía", "state_or_region": null, "postal_code": "B1704ETD", "country": "Argentina", "latitude": -34.6551, "longitude": -58.55318, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "DIM Clínica Privada", "city": "Ramos Mejía", "state_or_region": null, "postal_code": "B1704ETD", "country": "Argentina", "latitude": -34.6551, "longitude": -58.55318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "INECO Neurociencias Oroño", "city": "Rosario", "state_or_region": null, "postal_code": "2000", "country": "Argentina", "latitude": -32.94682, "longitude": -60.63932, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Investigaciones Clinicas Rosario", "city": "Rosario", "state_or_region": null, "postal_code": "S2000CVD", "country": "Argentina", "latitude": -32.94682, "longitude": -60.63932, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Rosario", "state_or_region": null, "postal_code": "S2000CVD", "country": "Argentina", "latitude": -32.94682, "longitude": -60.63932, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital El Cruce", "city": "San Juan Bautista", "state_or_region": null, "postal_code": "B1888", "country": "Argentina", "latitude": -34.80896, "longitude": -58.27623, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital El Cruce", "city": "San Juan Bautista", "state_or_region": null, "postal_code": "B1888", "country": "Argentina", "latitude": -34.80896, "longitude": -58.27623, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Centro de Investigaciones Médicas Tucuman", "city": "SAN M. de Tucuman", "state_or_region": null, "postal_code": "T4000AXL", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "San Nicolás", "state_or_region": null, "postal_code": "B2900DMH", "country": "Argentina", "latitude": -31.43628, "longitude": -64.45288, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "San Vicente", "state_or_region": null, "postal_code": "5006", "country": "Argentina", "latitude": -35.0249, "longitude": -58.42409, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CEDIR - Centro de diagnóstico y rehabilitación Santa Fe", "city": "Santa Fe", "state_or_region": null, "postal_code": "S3000FSO", "country": "Argentina", "latitude": -31.64881, "longitude": -60.70868, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Diagnóstico y Rehabilitación (CEDIR)", "city": "Santa Fe", "state_or_region": null, "postal_code": "3000", "country": "Argentina", "latitude": -31.64881, "longitude": -60.70868, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sanatorio Norte", "city": "Santiago del Estero", "state_or_region": null, "postal_code": "G4200", "country": "Argentina", "latitude": -27.80047, "longitude": -64.26285, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CEMEDIC", "city": "CABA", "state_or_region": "Buenos Aires", "postal_code": "C1440CFD", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centro de Investigaciones Metabólicas", "city": "Capital Federal", "state_or_region": "Buenos Aires", "postal_code": "C1056ABI", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centro Médico Arsema", "city": "Ciudad Autónoma de Buenos Aires", "state_or_region": "Buenos Aires", "postal_code": "C1427", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CICEMO- Consultorio (Av Directorio)", "city": "Ciudad Autónoma de Buenos Aires", "state_or_region": "Buenos Aires", "postal_code": "C1424CIQ", "country": "Argentina", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Centro Médico CIMEL", "city": "Lanús Este", "state_or_region": "Buenos Aires", "postal_code": "B1824KAJ", "country": "Argentina", "latitude": -34.71416, "longitude": -58.37431, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Renalida", "city": "Mar del Plata", "state_or_region": "Buenos Aires", "postal_code": "B7600", "country": "Argentina", "latitude": -38.00042, "longitude": -57.5562, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centro de Investigación C.I.C.E 9 de Julio - Sanatorio 9 de Julio", "city": "San Miguel de Tucumán", "state_or_region": "Tucumán Province", "postal_code": "T4000DPX", "country": "Argentina", "latitude": -26.81601, "longitude": -65.21051, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Flinders Medical Centre", "city": "Adelaide", "state_or_region": null, "postal_code": "5042", "country": "Australia", "latitude": -34.92866, "longitude": 138.59863, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Nightingale Research", "city": "Adelaide", "state_or_region": null, "postal_code": "5000", "country": "Australia", "latitude": -34.92866, "longitude": 138.59863, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nightingale Research", "city": "Adelaide", "state_or_region": null, "postal_code": "5000", "country": "Australia", "latitude": -34.92866, "longitude": 138.59863, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Botany", "state_or_region": null, "postal_code": "2019", "country": "Australia", "latitude": -33.94599, "longitude": 151.19591, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Box Hill Hospital", "city": "Box Hill", "state_or_region": null, "postal_code": "3128", "country": "Australia", "latitude": -37.81887, "longitude": 145.12545, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Core Research Group", "city": "Brisbane", "state_or_region": null, "postal_code": "4064", "country": "Australia", "latitude": -27.46794, "longitude": 153.02809, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gallipoli Medical Research Ltd", "city": "Brisbane", "state_or_region": null, "postal_code": "4120", "country": "Australia", "latitude": -27.46794, "longitude": 153.02809, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mater Misericordiae Limited", "city": "Brisbane", "state_or_region": null, "postal_code": "4101", "country": "Australia", "latitude": -27.46794, "longitude": 153.02809, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Brisbane and Women's Hospital", "city": "Brisbane", "state_or_region": null, "postal_code": "4029", "country": "Australia", "latitude": -27.46794, "longitude": 153.02809, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Genesis Research Services", "city": "Broadmeadow", "state_or_region": null, "postal_code": "2292", "country": "Australia", "latitude": -32.92371, "longitude": 151.72849, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06700538", "study_title": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "lead_sponsor": "Arrowhead Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Research Site 6", "city": "Charlestown", "state_or_region": null, "postal_code": null, "country": "Australia", "latitude": -32.96828, "longitude": 151.69318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06700538" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Cornerstone Dermatology", "city": "Coorparoo", "state_or_region": null, "postal_code": "4151", "country": "Australia", "latitude": -27.49325, "longitude": 153.05826, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "East Toowoomba", "state_or_region": null, "postal_code": "4350", "country": "Australia", "latitude": -27.57086, "longitude": 151.97422, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Fitzroy", "state_or_region": null, "postal_code": "3065", "country": "Australia", "latitude": -37.79839, "longitude": 144.97833, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Barwon Health", "city": "Geelong", "state_or_region": null, "postal_code": "3220", "country": "Australia", "latitude": -38.14711, "longitude": 144.36069, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Heidelberg Heights", "state_or_region": null, "postal_code": "3081", "country": "Australia", "latitude": -37.74313, "longitude": 145.05695, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Austin Health", "city": "Heidelberg", "state_or_region": null, "postal_code": "3084", "country": "Australia", "latitude": -37.75, "longitude": 145.06667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ipswich Hospital", "city": "Ipswich", "state_or_region": null, "postal_code": "4305", "country": "Australia", "latitude": -27.62343, "longitude": 152.76067, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Kingswood", "state_or_region": null, "postal_code": "2747", "country": "Australia", "latitude": -33.75614, "longitude": 150.72346, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Melbourne", "state_or_region": null, "postal_code": "3004", "country": "Australia", "latitude": -37.814, "longitude": 144.96332, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fiona Stanley Hospital", "city": "Murdoch", "state_or_region": null, "postal_code": "6150", "country": "Australia", "latitude": -32.06987, "longitude": 115.83757, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hunter Medical Research Institute", "city": "Newcastle", "state_or_region": null, "postal_code": "2305", "country": "Australia", "latitude": -32.92953, "longitude": 151.7801, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "TrialsWest - Osborne Park", "city": "Osborne Park", "state_or_region": null, "postal_code": "6017", "country": "Australia", "latitude": -31.90066, "longitude": 115.81083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Parkville", "state_or_region": null, "postal_code": "3050", "country": "Australia", "latitude": -37.78333, "longitude": 144.95, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Royal Melbourne Hospital", "city": "Parkville", "state_or_region": null, "postal_code": "3050", "country": "Australia", "latitude": -37.78333, "longitude": 144.95, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Perth Children's Hospital", "city": "Perth", "state_or_region": null, "postal_code": "6009", "country": "Australia", "latitude": -31.95224, "longitude": 115.8614, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gold Coast University Hospital", "city": "Southport", "state_or_region": null, "postal_code": "4215", "country": "Australia", "latitude": -27.96724, "longitude": 153.39796, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "St Leonards", "state_or_region": null, "postal_code": "2065", "country": "Australia", "latitude": -33.82344, "longitude": 151.19836, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06700538", "study_title": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "lead_sponsor": "Arrowhead Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Research Site 7", "city": "Sydney", "state_or_region": null, "postal_code": null, "country": "Australia", "latitude": -33.86785, "longitude": 151.20732, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06700538" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "University of Sydney - Charles Perkins Centre", "city": "Sydney", "state_or_region": null, "postal_code": "2006", "country": "Australia", "latitude": -33.86785, "longitude": 151.20732, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Westmead Hospital", "city": "Westmead", "state_or_region": null, "postal_code": "2145", "country": "Australia", "latitude": -33.80383, "longitude": 150.98768, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Bruce", "state_or_region": "Australian Capital Territory", "postal_code": "2617", "country": "Australia", "latitude": -35.24405, "longitude": 149.09083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Blacktown", "state_or_region": "New South Wales", "postal_code": "2148", "country": "Australia", "latitude": -33.76667, "longitude": 150.91667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sydney Clinical Trials", "city": "Campbelltown", "state_or_region": "New South Wales", "postal_code": "2560", "country": "Australia", "latitude": -34.06667, "longitude": 150.81667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Prince Alfred Hospital", "city": "Camperdown", "state_or_region": "New South Wales", "postal_code": "2050", "country": "Australia", "latitude": -33.88965, "longitude": 151.17642, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Castle Hill Medical Centre", "city": "Castle Hill", "state_or_region": "New South Wales", "postal_code": "2154", "country": "Australia", "latitude": -33.73333, "longitude": 151, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Castle Hill Medical Centre", "city": "Castle Hill", "state_or_region": "New South Wales", "postal_code": "2154", "country": "Australia", "latitude": -33.73333, "longitude": 151, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Novatrials", "city": "Charlestown", "state_or_region": "New South Wales", "postal_code": "2290", "country": "Australia", "latitude": -32.96828, "longitude": 151.69318, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Concord Repatriation General Hospital", "city": "Concord", "state_or_region": "New South Wales", "postal_code": "2139", "country": "Australia", "latitude": -33.84722, "longitude": 151.10381, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Concord Repatriation General Hospital", "city": "Concord", "state_or_region": "New South Wales", "postal_code": "2139", "country": "Australia", "latitude": -33.84722, "longitude": 151.10381, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Gosford Renal Research", "city": "Gosford", "state_or_region": "New South Wales", "postal_code": "2250", "country": "Australia", "latitude": -33.4244, "longitude": 151.34399, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Gosford Renal Research", "city": "Gosford", "state_or_region": "New South Wales", "postal_code": "2250", "country": "Australia", "latitude": -33.4244, "longitude": 151.34399, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Kanwal", "state_or_region": "New South Wales", "postal_code": "2259", "country": "Australia", "latitude": -33.253, "longitude": 151.4911, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nepean Hospital", "city": "Kingswood", "state_or_region": "New South Wales", "postal_code": "2747", "country": "Australia", "latitude": -33.75614, "longitude": 150.72346, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nepean Hospital", "city": "Kingswood", "state_or_region": "New South Wales", "postal_code": "2747", "country": "Australia", "latitude": -33.75614, "longitude": 150.72346, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Liverpool Hospital", "city": "Liverpool", "state_or_region": "New South Wales", "postal_code": "2170", "country": "Australia", "latitude": -33.91938, "longitude": 150.92588, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Liverpool Hospital", "city": "Liverpool", "state_or_region": "New South Wales", "postal_code": "2170", "country": "Australia", "latitude": -33.91938, "longitude": 150.92588, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sydney Cardiometabolic Centre", "city": "Liverpool", "state_or_region": "New South Wales", "postal_code": "2170", "country": "Australia", "latitude": -33.91938, "longitude": 150.92588, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hunter Diabetes Centre", "city": "Merewether", "state_or_region": "New South Wales", "postal_code": "2291", "country": "Australia", "latitude": -32.94801, "longitude": 151.74325, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Hunter Medical Research Institute - Endocrinology and Diabetes", "city": "New Lambton Heights", "state_or_region": "New South Wales", "postal_code": "2305", "country": "Australia", "latitude": -32.92466, "longitude": 151.69364, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Roger Chih Yu Chen", "city": "Sydney", "state_or_region": "New South Wales", "postal_code": "2148", "country": "Australia", "latitude": -33.86785, "longitude": 151.20732, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06820281", "study_title": "Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes", "lead_sponsor": "Victor Chang Cardiac Research Institute", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Victor Chang Cardiac Research Institute", "city": "Sydney", "state_or_region": "New South Wales", "postal_code": "2010", "country": "Australia", "latitude": -33.86785, "longitude": 151.20732, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06820281" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "The Children's Hospital at Westmead - Clinical Research Centre", "city": "Westmead", "state_or_region": "New South Wales", "postal_code": "2145", "country": "Australia", "latitude": -33.80383, "longitude": 150.98768, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Westmead Hospital", "city": "Westmead", "state_or_region": "New South Wales", "postal_code": "2145", "country": "Australia", "latitude": -33.80383, "longitude": 150.98768, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Westmead Hospital", "city": "Westmead", "state_or_region": "New South Wales", "postal_code": "2145", "country": "Australia", "latitude": -33.80383, "longitude": 150.98768, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sunshine Coast University Hospital", "city": "Birtinya", "state_or_region": "Queensland", "postal_code": "4575", "country": "Australia", "latitude": -26.74322, "longitude": 153.11913, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "University of Sunshine Coast - Vitality Village", "city": "Birtinya", "state_or_region": "Queensland", "postal_code": "4575", "country": "Australia", "latitude": -26.74322, "longitude": 153.11913, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Heart of Australia", "city": "Chelmer", "state_or_region": "Queensland", "postal_code": "4068", "country": "Australia", "latitude": -27.51326, "longitude": 152.97524, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Herston", "state_or_region": "Queensland", "postal_code": "4006", "country": "Australia", "latitude": -27.44453, "longitude": 153.01852, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Logan Hospital", "city": "Meadowbrook", "state_or_region": "Queensland", "postal_code": "4131", "country": "Australia", "latitude": -27.66401, "longitude": 153.14465, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Morayfield", "state_or_region": "Queensland", "postal_code": "4506", "country": "Australia", "latitude": -27.10876, "longitude": 152.94907, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "South Brisbane", "state_or_region": "Queensland", "postal_code": "4101", "country": "Australia", "latitude": -27.48034, "longitude": 153.02049, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Queensland Children's Hospital", "city": "South Brisbane", "state_or_region": "Queensland", "postal_code": "4101", "country": "Australia", "latitude": -27.48034, "longitude": 153.02049, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "University of Sunshine Coast - South Brisbane", "city": "South Brisbane", "state_or_region": "Queensland", "postal_code": "4101", "country": "Australia", "latitude": -27.48034, "longitude": 153.02049, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Royal Adelaide Hospital - Cardiology Department", "city": "Adelaide", "state_or_region": "South Australia", "postal_code": "5000", "country": "Australia", "latitude": -34.92866, "longitude": 138.59863, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern Adelaide Diabetes & Endocrine services", "city": "Oaklands Park", "state_or_region": "South Australia", "postal_code": "5046", "country": "Australia", "latitude": -35.00671, "longitude": 138.54457, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Emeritus Research Melbourne", "city": "Camberwell", "state_or_region": "Victoria", "postal_code": "3124", "country": "Australia", "latitude": -37.84205, "longitude": 145.0694, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Camberwell", "state_or_region": "Victoria", "postal_code": "3124", "country": "Australia", "latitude": -37.84205, "longitude": 145.0694, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Monash Health", "city": "Clayton", "state_or_region": "Victoria", "postal_code": "3168", "country": "Australia", "latitude": -37.91667, "longitude": 145.11667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Monash Health", "city": "Clayton", "state_or_region": "Victoria", "postal_code": "3168", "country": "Australia", "latitude": -37.91667, "longitude": 145.11667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06191848", "study_title": "Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)", "lead_sponsor": "University of Melbourne", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-04-30", "facility": "St Vincents Hospital Melbourne", "city": "Fitzroy", "state_or_region": "Victoria", "postal_code": "3065", "country": "Australia", "latitude": -37.79839, "longitude": 144.97833, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06191848" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Austin Health", "city": "Heidelberg", "state_or_region": "Victoria", "postal_code": "3084", "country": "Australia", "latitude": -37.75, "longitude": 145.06667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Austin Health", "city": "Heidelberg", "state_or_region": "Victoria", "postal_code": "3084", "country": "Australia", "latitude": -37.75, "longitude": 145.06667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06191848", "study_title": "Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)", "lead_sponsor": "University of Melbourne", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-04-30", "facility": "Austin Health-Repatriation Hospital", "city": "Melbourne", "state_or_region": "Victoria", "postal_code": "3084", "country": "Australia", "latitude": -37.814, "longitude": 144.96332, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06191848" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Baker Heart and Diabetes Institute", "city": "Melbourne", "state_or_region": "Victoria", "postal_code": "3004", "country": "Australia", "latitude": -37.814, "longitude": 144.96332, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Baker Heart and Diabetes Institute", "city": "Melbourne", "state_or_region": "Victoria", "postal_code": "3004", "country": "Australia", "latitude": -37.814, "longitude": 144.96332, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06191848", "study_title": "Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)", "lead_sponsor": "University of Melbourne", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-04-30", "facility": "Eastern Health", "city": "Melbourne", "state_or_region": "Victoria", "postal_code": "3128", "country": "Australia", "latitude": -37.814, "longitude": 144.96332, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06191848" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07245771", "study_title": "Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity", "lead_sponsor": "Ikaria Bioscience Pty Ltd", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-24", "facility": "Nucleus Network Pty Ltd", "city": "Melbourne", "state_or_region": "Victoria", "postal_code": "3004", "country": "Australia", "latitude": -37.814, "longitude": 144.96332, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07245771" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06191848", "study_title": "Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)", "lead_sponsor": "University of Melbourne", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-04-30", "facility": "Western Health", "city": "Melbourne", "state_or_region": "Victoria", "postal_code": "3011", "country": "Australia", "latitude": -37.814, "longitude": 144.96332, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06191848" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Melbourne Hospital", "city": "Parkville", "state_or_region": "Victoria", "postal_code": "3050", "country": "Australia", "latitude": -37.78333, "longitude": 144.95, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Melbourne Hospital", "city": "Parkville", "state_or_region": "Victoria", "postal_code": "3050", "country": "Australia", "latitude": -37.78333, "longitude": 144.95, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Melbourne Renal Research Group", "city": "Reservoir", "state_or_region": "Victoria", "postal_code": "3073", "country": "Australia", "latitude": -37.71667, "longitude": 145, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Sunshine Hospital - Western Centre for Health Research and Education", "city": "St Albans", "state_or_region": "Victoria", "postal_code": "3021", "country": "Australia", "latitude": -37.74496, "longitude": 144.80049, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Perth Children's Hospital", "city": "Nedlands", "state_or_region": "Western Australia", "postal_code": "6009", "country": "Australia", "latitude": -31.98184, "longitude": 115.8073, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Perth Hospital", "city": "Perth", "state_or_region": "Western Australia", "postal_code": "6000", "country": "Australia", "latitude": -31.95224, "longitude": 115.8614, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Perth Hospital", "city": "Perth", "state_or_region": "Western Australia", "postal_code": "6000", "country": "Australia", "latitude": -31.95224, "longitude": 115.8614, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical University of Graz", "city": "Graz", "state_or_region": null, "postal_code": "8036", "country": "Austria", "latitude": 47.06733, "longitude": 15.44197, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical University of Graz", "city": "Graz", "state_or_region": null, "postal_code": "8036", "country": "Austria", "latitude": 47.06733, "longitude": 15.44197, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medical University of Graz", "city": "Graz", "state_or_region": null, "postal_code": "8036", "country": "Austria", "latitude": 47.06733, "longitude": 15.44197, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universität Graz", "city": "Graz", "state_or_region": null, "postal_code": "8036", "country": "Austria", "latitude": 47.06733, "longitude": 15.44197, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universität Graz", "city": "Graz", "state_or_region": null, "postal_code": "8036", "country": "Austria", "latitude": 47.06733, "longitude": 15.44197, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universität Graz", "city": "Graz", "state_or_region": null, "postal_code": "8036", "country": "Austria", "latitude": 47.06733, "longitude": 15.44197, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universitaet Innsbruck", "city": "Innsbruck", "state_or_region": null, "postal_code": "6020", "country": "Austria", "latitude": 47.26266, "longitude": 11.39454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universitaet Innsbruck", "city": "Innsbruck", "state_or_region": null, "postal_code": "6020", "country": "Austria", "latitude": 47.26266, "longitude": 11.39454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Universitätsklinik Kinder-Jugendheilkunde Innsbruck", "city": "Innsbruck", "state_or_region": null, "postal_code": "6020", "country": "Austria", "latitude": 47.26266, "longitude": 11.39454, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ordensklinikum Linz GmbH", "city": "Linz", "state_or_region": null, "postal_code": "4010", "country": "Austria", "latitude": 48.30639, "longitude": 14.28611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ordensklinikum Linz GmbH", "city": "Linz", "state_or_region": null, "postal_code": "4010", "country": "Austria", "latitude": 48.30639, "longitude": 14.28611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Ordination Winhofer-Stöckl", "city": "Mattersburg", "state_or_region": null, "postal_code": "7210", "country": "Austria", "latitude": 47.73333, "longitude": 16.4, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Fließer-Görzer [Ordination]", "city": "Saint Stefan", "state_or_region": null, "postal_code": "8511", "country": "Austria", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uniklinikum Salzburg", "city": "Salzburg", "state_or_region": null, "postal_code": "5020", "country": "Austria", "latitude": 47.79941, "longitude": 13.04399, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Universitätsklinik für Kinder und Jugendheilkunde Haus E", "city": "Salzburg", "state_or_region": null, "postal_code": "5020", "country": "Austria", "latitude": 47.79941, "longitude": 13.04399, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Itariu [Ordination]", "city": "Vienna", "state_or_region": null, "postal_code": "1180", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Klinik Hietzing 3. Med. Abt.", "city": "Vienna", "state_or_region": null, "postal_code": "1130", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinik Hietzing", "city": "Vienna", "state_or_region": null, "postal_code": "1130", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinik Hietzing", "city": "Vienna", "state_or_region": null, "postal_code": "1130", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinik Landstrasse", "city": "Vienna", "state_or_region": null, "postal_code": "1030", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinik Landstraße", "city": "Vienna", "state_or_region": null, "postal_code": "1030", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Klinik Landstraße", "city": "Vienna", "state_or_region": null, "postal_code": "1030", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical University of Vienna", "city": "Vienna", "state_or_region": null, "postal_code": "1090", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical University of Vienna", "city": "Vienna", "state_or_region": null, "postal_code": "1090", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universität Wien", "city": "Vienna", "state_or_region": null, "postal_code": "1090", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universität Wien", "city": "Vienna", "state_or_region": null, "postal_code": "1090", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Universität Wien", "city": "Vienna", "state_or_region": null, "postal_code": "1090", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Ordination Dr. Günter Sokol", "city": "Vienna", "state_or_region": null, "postal_code": "1120", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Universitätsklinikum AKH Wien", "city": "Vienna", "state_or_region": null, "postal_code": "1090", "country": "Austria", "latitude": 48.20849, "longitude": 16.37208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinikum Wels - Grieskirchen GmbH", "city": "Wels", "state_or_region": null, "postal_code": "4600", "country": "Austria", "latitude": 48.16667, "longitude": 14.03333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinikum Wels - Grieskirchen GmbH", "city": "Wels", "state_or_region": null, "postal_code": "4600", "country": "Austria", "latitude": 48.16667, "longitude": 14.03333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Landesklinikum Wiener Neustadt", "city": "Wiener Neustadt", "state_or_region": null, "postal_code": "2700", "country": "Austria", "latitude": 47.80485, "longitude": 16.23196, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06896981", "study_title": "Semaglutide in Women With Polycystic Ovary Syndrome and Obesity", "lead_sponsor": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-04-02", "facility": "Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University", "city": "Dhaka", "state_or_region": "Dhaka Division", "postal_code": "1000", "country": "Bangladesh", "latitude": 23.7104, "longitude": 90.40744, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06896981" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZORG Campus Aalst-Moorselbaan", "city": "Aalst", "state_or_region": null, "postal_code": "9300", "country": "Belgium", "latitude": 50.93604, "longitude": 4.0355, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZORG Campus Aalst-Moorselbaan", "city": "Aalst", "state_or_region": null, "postal_code": "9300", "country": "Belgium", "latitude": 50.93604, "longitude": 4.0355, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "AZORG", "city": "Aalst", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.93604, "longitude": 4.0355, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Anima Research Center", "city": "Alken", "state_or_region": null, "postal_code": "3570", "country": "Belgium", "latitude": 50.87553, "longitude": 5.30558, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Anima Research Center", "city": "Alken", "state_or_region": null, "postal_code": "3570", "country": "Belgium", "latitude": 50.87553, "longitude": 5.30558, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "UZA", "city": "Antwerp", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 51.22047, "longitude": 4.40026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "ZAS", "city": "Antwerp", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 51.22047, "longitude": 4.40026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Imelda", "city": "Bonheiden", "state_or_region": null, "postal_code": "2820", "country": "Belgium", "latitude": 51.02261, "longitude": 4.54714, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "AZ St Jan Brugge", "city": "Bruges", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 51.20892, "longitude": 3.22424, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire Brugmann", "city": "Brussels", "state_or_region": null, "postal_code": "1020", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cliniques Universitaires Saint-Luc", "city": "Brussels", "state_or_region": null, "postal_code": "1200", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cliniques universitaires Saint-Luc", "city": "Brussels", "state_or_region": null, "postal_code": "1200", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Cliniques universitaires Saint-Luc", "city": "Brussels", "state_or_region": null, "postal_code": "1200", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "Erasme", "city": "Brussels", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopital Erasme", "city": "Brussels", "state_or_region": null, "postal_code": "1070", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopital Erasme", "city": "Brussels", "state_or_region": null, "postal_code": "1070", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Université Libre de Bruxelles - Hôpital Erasme", "city": "Brussels", "state_or_region": null, "postal_code": "1070", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Université Libre de Bruxelles - Hôpital Erasme", "city": "Brussels", "state_or_region": null, "postal_code": "1070", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Université Libre de Bruxelles - Hôpital Erasme", "city": "Brussels", "state_or_region": null, "postal_code": "1070", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "UZ Brussel - Universitair Ziekenhuis Brussel", "city": "Brussels", "state_or_region": null, "postal_code": "1090", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "UZ Brussel - Universitair Ziekenhuis Brussel", "city": "Brussels", "state_or_region": null, "postal_code": "1090", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "UZ Brussel", "city": "Brussels", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UZ Brussel", "city": "Brussels", "state_or_region": null, "postal_code": "1090", "country": "Belgium", "latitude": 50.85045, "longitude": 4.34878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Antwerp University Hospital", "city": "Edegem", "state_or_region": null, "postal_code": "2650", "country": "Belgium", "latitude": 51.15662, "longitude": 4.44504, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitair Ziekenhuis Antwerpen", "city": "Edegem", "state_or_region": null, "postal_code": "2650", "country": "Belgium", "latitude": 51.15662, "longitude": 4.44504, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitair Ziekenhuis Antwerpen", "city": "Edegem", "state_or_region": null, "postal_code": "2650", "country": "Belgium", "latitude": 51.15662, "longitude": 4.44504, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "UZA - Universitair Ziekenhuis Antwerpen", "city": "Edegem", "state_or_region": null, "postal_code": "2650", "country": "Belgium", "latitude": 51.15662, "longitude": 4.44504, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ziekenhuis Oost-Limburg", "city": "Genk", "state_or_region": null, "postal_code": "3600", "country": "Belgium", "latitude": 50.965, "longitude": 5.50082, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ziekenhuis Oost-Limburg", "city": "Genk", "state_or_region": null, "postal_code": "3600", "country": "Belgium", "latitude": 50.965, "longitude": 5.50082, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZ Maria Middelares", "city": "Ghent", "state_or_region": null, "postal_code": "9000", "country": "Belgium", "latitude": 51.05, "longitude": 3.71667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitair Ziekenhuis Gent", "city": "Ghent", "state_or_region": null, "postal_code": "9000", "country": "Belgium", "latitude": 51.05, "longitude": 3.71667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Universitair Ziekenhuis Gent", "city": "Ghent", "state_or_region": null, "postal_code": "9000", "country": "Belgium", "latitude": 51.05, "longitude": 3.71667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UZ Gent", "city": "Ghent", "state_or_region": null, "postal_code": "9000", "country": "Belgium", "latitude": 51.05, "longitude": 3.71667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "Jan Yperman", "city": "Ieper", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.85114, "longitude": 2.88569, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "KORMONT", "city": "Kluisbergen", "state_or_region": null, "postal_code": "9690", "country": "Belgium", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "KORMONT", "city": "Kluisbergen", "state_or_region": null, "postal_code": "9690", "country": "Belgium", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZ Groeninge Campus Kennedylaan", "city": "Kortrijk", "state_or_region": null, "postal_code": "8500", "country": "Belgium", "latitude": 50.82803, "longitude": 3.26487, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZ Groeninge Campus Kennedylaan", "city": "Kortrijk", "state_or_region": null, "postal_code": "8500", "country": "Belgium", "latitude": 50.82803, "longitude": 3.26487, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZ Groeninge Campus Kennedylaan", "city": "Kortrijk", "state_or_region": null, "postal_code": "8500", "country": "Belgium", "latitude": 50.82803, "longitude": 3.26487, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "AZ Groeninge Kortrijk", "city": "Kortrijk", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.82803, "longitude": 3.26487, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CHU Tivoli", "city": "La Louvière", "state_or_region": null, "postal_code": "7100", "country": "Belgium", "latitude": 50.48657, "longitude": 4.18785, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "UZ Leuven", "city": "Leuven", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.87959, "longitude": 4.70093, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UZ Leuven", "city": "Leuven", "state_or_region": null, "postal_code": "3000", "country": "Belgium", "latitude": 50.87959, "longitude": 4.70093, "site_statuses": "SUSPENDED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UZ Leuven", "city": "Leuven", "state_or_region": null, "postal_code": "3000", "country": "Belgium", "latitude": 50.87959, "longitude": 4.70093, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UZ Leuven", "city": "Leuven", "state_or_region": null, "postal_code": "3000", "country": "Belgium", "latitude": 50.87959, "longitude": 4.70093, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman", "city": "Liège", "state_or_region": null, "postal_code": "4000", "country": "Belgium", "latitude": 50.63373, "longitude": 5.56749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman", "city": "Liège", "state_or_region": null, "postal_code": "4000", "country": "Belgium", "latitude": 50.63373, "longitude": 5.56749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Liège", "city": "Liège", "state_or_region": null, "postal_code": "4000", "country": "Belgium", "latitude": 50.63373, "longitude": 5.56749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Liège", "city": "Liège", "state_or_region": null, "postal_code": "4000", "country": "Belgium", "latitude": 50.63373, "longitude": 5.56749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "CHU de Liège", "city": "Liège", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.63373, "longitude": 5.56749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Chc Montlégia", "city": "Liège", "state_or_region": null, "postal_code": "4000", "country": "Belgium", "latitude": 50.63373, "longitude": 5.56749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Chc Montlégia", "city": "Liège", "state_or_region": null, "postal_code": "4000", "country": "Belgium", "latitude": 50.63373, "longitude": 5.56749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "MECLINAS", "city": "Mechelen", "state_or_region": null, "postal_code": "2800", "country": "Belgium", "latitude": 51.02574, "longitude": 4.47762, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "Centre Hospitalier Mouscron", "city": "Mouscron", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 50.74497, "longitude": 3.20639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinique Saint-Luc Bouge", "city": "Namur", "state_or_region": null, "postal_code": "5004", "country": "Belgium", "latitude": 50.4669, "longitude": 4.86746, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZ Oostende vzw", "city": "Ostend", "state_or_region": null, "postal_code": "8400", "country": "Belgium", "latitude": 51.21551, "longitude": 2.927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "AZ Delta - Roeselare", "city": "Roeselare", "state_or_region": null, "postal_code": "8800", "country": "Belgium", "latitude": 50.94653, "longitude": 3.12269, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZ Delta vzw", "city": "Roeselare", "state_or_region": null, "postal_code": "8800", "country": "Belgium", "latitude": 50.94653, "longitude": 3.12269, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AZ Delta", "city": "Roeselare", "state_or_region": null, "postal_code": "8800", "country": "Belgium", "latitude": 50.94653, "longitude": 3.12269, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "Vitaz", "city": "Sint-Niklaas", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 51.16509, "longitude": 4.1437, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "VITAZ", "city": "Sint-Niklaas", "state_or_region": null, "postal_code": "B-9100", "country": "Belgium", "latitude": 51.16509, "longitude": 4.1437, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05569772", "study_title": "Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes", "lead_sponsor": "Universitaire Ziekenhuizen KU Leuven", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-07-07", "facility": "AZ Turnhout", "city": "Turnhout", "state_or_region": null, "postal_code": null, "country": "Belgium", "latitude": 51.32254, "longitude": 4.94471, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05569772" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "KORMONT", "city": "Zwalm", "state_or_region": null, "postal_code": "9630", "country": "Belgium", "latitude": 50.87848, "longitude": 3.726, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NewData Clinical Research - Aracaju", "city": "Aracaju", "state_or_region": null, "postal_code": "49075-000", "country": "Brazil", "latitude": -10.91111, "longitude": -37.07167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NewData Clinical Research - Aracaju", "city": "Aracaju", "state_or_region": null, "postal_code": "49075-000", "country": "Brazil", "latitude": -10.91111, "longitude": -37.07167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NewData Clinical Research - Aracaju", "city": "Aracaju", "state_or_region": null, "postal_code": "49075-000", "country": "Brazil", "latitude": -10.91111, "longitude": -37.07167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Federal do Rio de Janeiro", "city": "Barra", "state_or_region": null, "postal_code": "21941-617", "country": "Brazil", "latitude": -11.08944, "longitude": -43.14167, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Federal do Rio de Janeiro", "city": "Barra", "state_or_region": null, "postal_code": "21941-617", "country": "Brazil", "latitude": -11.08944, "longitude": -43.14167, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fundação Pio XII - Hospital de Câncer de Barretos", "city": "Barretos", "state_or_region": null, "postal_code": "14784400", "country": "Brazil", "latitude": -20.55722, "longitude": -48.56778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitário João de Barros Barreto", "city": "Belém", "state_or_region": null, "postal_code": "66073-000", "country": "Brazil", "latitude": -1.45583, "longitude": -48.50444, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitário João de Barros Barreto", "city": "Belém", "state_or_region": null, "postal_code": "66073-005", "country": "Brazil", "latitude": -1.45583, "longitude": -48.50444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitário João de Barros Barreto", "city": "Belém", "state_or_region": null, "postal_code": "66073-005", "country": "Brazil", "latitude": -1.45583, "longitude": -48.50444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital das Clinicas da Universidade Federal de Minas Gerais (HC-UFMG)", "city": "Belo Horizonte", "state_or_region": null, "postal_code": "30130-100", "country": "Brazil", "latitude": -19.92083, "longitude": -43.93778, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital das Clinicas da Universidade Federal de Minas Gerais (HC-UFMG)", "city": "Belo Horizonte", "state_or_region": null, "postal_code": "30130-100", "country": "Brazil", "latitude": -19.92083, "longitude": -43.93778, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NUPEC - Cardio", "city": "Belo Horizonte", "state_or_region": null, "postal_code": "30220-140", "country": "Brazil", "latitude": -19.92083, "longitude": -43.93778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Faculdade de Medicina da UNESP", "city": "Botucatu", "state_or_region": null, "postal_code": "18618-686", "country": "Brazil", "latitude": -22.88583, "longitude": -48.445, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Estadual Paulista 'Julio De Mesquita Filho'", "city": "Botucatu", "state_or_region": null, "postal_code": "18618-970", "country": "Brazil", "latitude": -22.88583, "longitude": -48.445, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Estadual Paulista 'Julio De Mesquita Filho'", "city": "Botucatu", "state_or_region": null, "postal_code": "18618-970", "country": "Brazil", "latitude": -22.88583, "longitude": -48.445, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Pesquisa Clinica do Brasil", "city": "Brasília", "state_or_region": null, "postal_code": "71625-175", "country": "Brazil", "latitude": -15.77972, "longitude": -47.92972, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chronos Pesquisa Clínica", "city": "Brasília", "state_or_region": null, "postal_code": "72145-450", "country": "Brazil", "latitude": -15.77972, "longitude": -47.92972, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "L2IP - Instituto de Pesquisas Clínicas", "city": "Brasília", "state_or_region": null, "postal_code": "70200730", "country": "Brazil", "latitude": -15.77972, "longitude": -47.92972, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "L2IP - Instituto de Pesquisas Clínicas", "city": "Brasília", "state_or_region": null, "postal_code": "70200730", "country": "Brazil", "latitude": -15.77972, "longitude": -47.92972, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Brasília", "state_or_region": null, "postal_code": "71625-009", "country": "Brazil", "latitude": -15.77972, "longitude": -47.92972, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Pesquisa clinica de Campinas", "city": "Campinas", "state_or_region": null, "postal_code": "13060-080", "country": "Brazil", "latitude": -22.90556, "longitude": -47.06083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Loema Instituto de Pesquisa Clinica", "city": "Campinas", "state_or_region": null, "postal_code": "13092-133", "country": "Brazil", "latitude": -22.90556, "longitude": -47.06083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Loema Instituto de Pesquisa Clinica", "city": "Campinas", "state_or_region": null, "postal_code": "13092-133", "country": "Brazil", "latitude": -22.90556, "longitude": -47.06083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Campinas", "state_or_region": null, "postal_code": "13060-904", "country": "Brazil", "latitude": -22.90556, "longitude": -47.06083, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fundação Universidade de Caxias do Sul (FUCS)", "city": "Caxias do Sul", "state_or_region": null, "postal_code": "95070-560", "country": "Brazil", "latitude": -29.16806, "longitude": -51.17944, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fundação Universidade de Caxias do Sul (FUCS)", "city": "Caxias do Sul", "state_or_region": null, "postal_code": "95070-560", "country": "Brazil", "latitude": -29.16806, "longitude": -51.17944, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital das Clínicas da Faculdade de Medicina da USP", "city": "Cerqueira César", "state_or_region": null, "postal_code": "05403-000", "country": "Brazil", "latitude": -23.03556, "longitude": -49.16611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital das Clínicas da Faculdade de Medicina da USP", "city": "Cerqueira César", "state_or_region": null, "postal_code": "05403-000", "country": "Brazil", "latitude": -23.03556, "longitude": -49.16611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Digestivo de Curitiba", "city": "Curitiba", "state_or_region": null, "postal_code": "80430-180", "country": "Brazil", "latitude": -25.42778, "longitude": -49.27306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Digestivo de Curitiba", "city": "Curitiba", "state_or_region": null, "postal_code": "80430-180", "country": "Brazil", "latitude": -25.42778, "longitude": -49.27306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cline Research Center", "city": "Curitiba", "state_or_region": null, "postal_code": "80030-480", "country": "Brazil", "latitude": -25.42778, "longitude": -49.27306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Curitiba", "state_or_region": null, "postal_code": "80030-480", "country": "Brazil", "latitude": -25.42778, "longitude": -49.27306, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Walter Cantidio", "city": "Fortaleza", "state_or_region": null, "postal_code": "60430-270", "country": "Brazil", "latitude": -3.71722, "longitude": -38.54306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Federal de Goias", "city": "Goiânia", "state_or_region": null, "postal_code": "74605-020", "country": "Brazil", "latitude": -16.67861, "longitude": -49.25389, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Galileo Medical Research", "city": "Juiz de Fora", "state_or_region": null, "postal_code": "36033-318", "country": "Brazil", "latitude": -21.76417, "longitude": -43.35028, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Galileo Medical Research", "city": "Juiz de Fora", "state_or_region": null, "postal_code": "36033-318", "country": "Brazil", "latitude": -21.76417, "longitude": -43.35028, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Pesquisa Clinica do Brasil", "city": "Lago Sul", "state_or_region": null, "postal_code": "71625-175", "country": "Brazil", "latitude": -15.84577, "longitude": -47.88369, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Brasilia", "city": "Lago Sul", "state_or_region": null, "postal_code": "71635580", "country": "Brazil", "latitude": -15.84577, "longitude": -47.88369, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Natal", "state_or_region": null, "postal_code": "59020-035", "country": "Brazil", "latitude": -5.795, "longitude": -35.20944, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHN - Complexo Hospitalar de Niterói", "city": "Niterói", "state_or_region": null, "postal_code": "24020-096", "country": "Brazil", "latitude": -22.88333, "longitude": -43.10361, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Clinicas de Porto Alegre", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90035-903", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Clinicas de Porto Alegre", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90035-903", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Clinicas de Porto Alegre", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90035-903", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Moinhos de Vento", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90560032", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospitalar Moinhos de Vento", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90035-001", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospitalar Moinhos de Vento", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90035-001", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMV Pesquisa Cardiologica - Porto Alegre - Rua Orfanotrofio", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90840-440", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90630-165", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Federal do Rio Grande do Sul", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90035-903", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Federal do Rio Grande do Sul", "city": "Porto Alegre", "state_or_region": null, "postal_code": "90035-903", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto do Fígado e Tranplantes de Pernambuco", "city": "Recife", "state_or_region": null, "postal_code": "50100-130", "country": "Brazil", "latitude": -8.05389, "longitude": -34.88111, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Clínicas de Ribeirão Preto", "city": "Ribeirão Preto", "state_or_region": null, "postal_code": "14051-140", "country": "Brazil", "latitude": -21.1775, "longitude": -47.81028, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Clínicas de Ribeirão Preto", "city": "Ribeirão Preto", "state_or_region": null, "postal_code": "14051-140", "country": "Brazil", "latitude": -21.1775, "longitude": -47.81028, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IBPClin - Instituto Brasil de Pesquisa Clínica", "city": "Rio de Janeiro", "state_or_region": null, "postal_code": "20241-180", "country": "Brazil", "latitude": -22.90642, "longitude": -43.18223, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ruschel Medicina e Pesquisa Clínica", "city": "Rio de Janeiro", "state_or_region": null, "postal_code": "22270-060", "country": "Brazil", "latitude": -22.90642, "longitude": -43.18223, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universidade Federal do Rio de Janeiro", "city": "Rio de Janeiro", "state_or_region": null, "postal_code": "21941-913", "country": "Brazil", "latitude": -22.90642, "longitude": -43.18223, "site_statuses": "SUSPENDED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CLIAGEN Clínica de Atenção em Gastroenterologia, Especialidades e Nutrição", "city": "Salvador", "state_or_region": null, "postal_code": "41500-300", "country": "Brazil", "latitude": -12.97563, "longitude": -38.49096, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CLIAGEN Clínica de Atenção em Gastroenterologia, Especialidades e Nutrição", "city": "Salvador", "state_or_region": null, "postal_code": "41500-300", "country": "Brazil", "latitude": -12.97563, "longitude": -38.49096, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inovace Pesquisa Clínica", "city": "Salvador", "state_or_region": null, "postal_code": "41820-000", "country": "Brazil", "latitude": -12.97563, "longitude": -38.49096, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pesquisare Saude", "city": "Santo André", "state_or_region": null, "postal_code": "09080-110", "country": "Brazil", "latitude": -23.66389, "longitude": -46.53833, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pesquisare Saude", "city": "Santo André", "state_or_region": null, "postal_code": "09080-110", "country": "Brazil", "latitude": -23.66389, "longitude": -46.53833, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Multidisciplinar de Estudos Clinicos", "city": "São Bernardo do Campo", "state_or_region": null, "postal_code": "09715-090", "country": "Brazil", "latitude": -23.69389, "longitude": -46.565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Base", "city": "São José do Rio Preto", "state_or_region": null, "postal_code": "15090-000", "country": "Brazil", "latitude": -20.81972, "longitude": -49.37944, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Base", "city": "São José do Rio Preto", "state_or_region": null, "postal_code": "15090-000", "country": "Brazil", "latitude": -20.81972, "longitude": -49.37944, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "São José dos Campos", "state_or_region": null, "postal_code": "12243-280", "country": "Brazil", "latitude": -23.17944, "longitude": -45.88694, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CEPIC - Centro Paulista de Investigação Clínica", "city": "São Paulo", "state_or_region": null, "postal_code": "04266-010", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CEPIC - Centro Paulista de Investigação Clínica", "city": "São Paulo", "state_or_region": null, "postal_code": "04266-010", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clínica Hepatogastro JK", "city": "São Paulo", "state_or_region": null, "postal_code": "04543-011", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clínica Hepatogastro JK", "city": "São Paulo", "state_or_region": null, "postal_code": "04543-011", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clínica Hepatogastro JK", "city": "São Paulo", "state_or_region": null, "postal_code": "04543-011", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CPHosp Medicina, Ensino e Pesquisa (CPQuali)", "city": "São Paulo", "state_or_region": null, "postal_code": "01228-000", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CPQuali Pesquisa Clínica", "city": "São Paulo", "state_or_region": null, "postal_code": "01228-000", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CPQuali Pesquisa Clínica", "city": "São Paulo", "state_or_region": null, "postal_code": "01228-000", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital das Clinicas FMUSP", "city": "São Paulo", "state_or_region": null, "postal_code": "05403-000", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital do Rim e Hipertensao Fundacao Oswaldo Ramos", "city": "São Paulo", "state_or_region": null, "postal_code": "04038-002", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "São Paulo", "state_or_region": null, "postal_code": "04012-180", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rocco E Nazato Servicos Medicos LTDA", "city": "São Paulo", "state_or_region": null, "postal_code": "04077-020", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rocco E Nazato Servicos Medicos LTDA", "city": "São Paulo", "state_or_region": null, "postal_code": "04077-020", "country": "Brazil", "latitude": -23.5475, "longitude": -46.63611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CEDOES", "city": "Vitória", "state_or_region": null, "postal_code": "29055450", "country": "Brazil", "latitude": -20.31944, "longitude": -40.33778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CEDOES", "city": "Vitória", "state_or_region": null, "postal_code": "29055450", "country": "Brazil", "latitude": -20.31944, "longitude": -40.33778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CEDOES", "city": "Vitória", "state_or_region": null, "postal_code": "29055450", "country": "Brazil", "latitude": -20.31944, "longitude": -40.33778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Integral Pesquisa e Ensino", "city": "Votuporanga", "state_or_region": null, "postal_code": "15500-269", "country": "Brazil", "latitude": -20.42278, "longitude": -49.97278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Integral Pesquisa e Ensino", "city": "Votuporanga", "state_or_region": null, "postal_code": "15500-269", "country": "Brazil", "latitude": -20.42278, "longitude": -49.97278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Centro de Diabetes Curitiba", "city": "Curitiba", "state_or_region": "Paraná", "postal_code": "80810-040", "country": "Brazil", "latitude": -25.42778, "longitude": -49.27306, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Instituto Pró-Renal Brasil", "city": "Curitiba", "state_or_region": "Paraná", "postal_code": "80440-020", "country": "Brazil", "latitude": -25.42778, "longitude": -49.27306, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Quanta Diagnóstico Nuclear / Medicina Nuclear Alto da XV", "city": "Curitiba", "state_or_region": "Paraná", "postal_code": "80045-110", "country": "Brazil", "latitude": -25.42778, "longitude": -49.27306, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Irmandade da Santa Casa de Misericórdia de Porto Alegre", "city": "Porto Alegre", "state_or_region": "Rio Grande do Sul", "postal_code": "90020-090", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Núcleo de Pesquisa Clínica do Rio Grande do Sul Ltda.", "city": "Porto Alegre", "state_or_region": "Rio Grande do Sul", "postal_code": "90430-001", "country": "Brazil", "latitude": -30.03283, "longitude": -51.23019, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "SRH - Zdrave EAD", "city": "Bankya", "state_or_region": null, "postal_code": "1320", "country": "Bulgaria", "latitude": 42.86328, "longitude": 22.68034, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "MC For Life EOOD", "city": "Burgas", "state_or_region": null, "postal_code": "8000", "country": "Bulgaria", "latitude": 42.50651, "longitude": 27.46886, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MHAT Sv. Ivan Rilski EOOD", "city": "Gorna Oryahovitsa", "state_or_region": null, "postal_code": "5100", "country": "Bulgaria", "latitude": 43.12778, "longitude": 25.70167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MHAT Sv. Ivan Rilski EOOD", "city": "Gorna Oryahovitsa", "state_or_region": null, "postal_code": "5100", "country": "Bulgaria", "latitude": 43.12778, "longitude": 25.70167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital \"St. Ivan Rilski\"", "city": "Gorna Oryahovitsa", "state_or_region": null, "postal_code": "5100", "country": "Bulgaria", "latitude": 43.12778, "longitude": 25.70167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital \"St. Ivan Rilski\"", "city": "Gorna Oryahovitsa", "state_or_region": null, "postal_code": "5100", "country": "Bulgaria", "latitude": 43.12778, "longitude": 25.70167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "AIPSMC - DiMed EOOD", "city": "Haskovo", "state_or_region": null, "postal_code": "6300", "country": "Bulgaria", "latitude": 41.93415, "longitude": 25.55557, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "MC Kazanlak EOOD", "city": "Kazanlak", "state_or_region": null, "postal_code": "6100", "country": "Bulgaria", "latitude": 42.61667, "longitude": 25.4, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Medical centre Zdrave 1 OOD", "city": "Kozloduy", "state_or_region": null, "postal_code": "3320", "country": "Bulgaria", "latitude": 43.77691, "longitude": 23.73001, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medical center Medi City 21 OOD", "city": "Kyustendil", "state_or_region": null, "postal_code": "2500", "country": "Bulgaria", "latitude": 42.28314, "longitude": 22.69224, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Medical Center Zdrave Lom EOOD", "city": "Lom", "state_or_region": null, "postal_code": "3600", "country": "Bulgaria", "latitude": 43.8317, "longitude": 23.23793, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Montana", "state_or_region": null, "postal_code": "3400", "country": "Bulgaria", "latitude": 43.41285, "longitude": 23.22174, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Multi-profile Hospital For Active Treatment-Uni Hospital Ltd.", "city": "Panagyurishte", "state_or_region": null, "postal_code": "4500", "country": "Bulgaria", "latitude": 42.49518, "longitude": 24.19021, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Multi-profile Hospital For Active Treatment-Uni Hospital Ltd.", "city": "Panagyurishte", "state_or_region": null, "postal_code": "4500", "country": "Bulgaria", "latitude": 42.49518, "longitude": 24.19021, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "IPMC - Dr. Elizabeta Dimitrova", "city": "Petrich", "state_or_region": null, "postal_code": "2850", "country": "Bulgaria", "latitude": 41.39365, "longitude": 23.20012, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "OCSOMCE - Dr. Albena Dinkova EOOD", "city": "Pleven", "state_or_region": null, "postal_code": "5800", "country": "Bulgaria", "latitude": 43.41791, "longitude": 24.61666, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Saint Marina Hospital", "city": "Pleven", "state_or_region": null, "postal_code": "5800", "country": "Bulgaria", "latitude": 43.41791, "longitude": 24.61666, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "AIPSMCEMDID - Dr. Georgi Levterov EOOD", "city": "Plovdiv", "state_or_region": null, "postal_code": "4000", "country": "Bulgaria", "latitude": 42.15387, "longitude": 24.75001, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "DCC Sveti Georgi EOOD", "city": "Plovdiv", "state_or_region": null, "postal_code": "4002", "country": "Bulgaria", "latitude": 42.15387, "longitude": 24.75001, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Plovdiv", "state_or_region": null, "postal_code": "4001", "country": "Bulgaria", "latitude": 42.15387, "longitude": 24.75001, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "UMHAT Sveti Georgi EAD, Plovdiv, Clinic of Pediatrics", "city": "Plovdiv", "state_or_region": null, "postal_code": "4001", "country": "Bulgaria", "latitude": 42.15387, "longitude": 24.75001, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "MHAT Hadzhi Dimitar OOD", "city": "Sliven", "state_or_region": null, "postal_code": "8800", "country": "Bulgaria", "latitude": 42.68607, "longitude": 26.32558, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Nader Yabrudi - ASMPVBE Individual practice", "city": "Smolyan", "state_or_region": null, "postal_code": "4700", "country": "Bulgaria", "latitude": 41.57439, "longitude": 24.71204, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Acibadem City Clinic Tokuda University Hospital EAD", "city": "Sofia", "state_or_region": null, "postal_code": "1407", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Acibadem City Clinic Tokuda University Hospital EAD", "city": "Sofia", "state_or_region": null, "postal_code": "1407", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "DCC Neoklinik EAD", "city": "Sofia", "state_or_region": null, "postal_code": "1408", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "DCC XX - Sofia EOOD, Endocrinology", "city": "Sofia", "state_or_region": null, "postal_code": "1618", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "DCC XXV Sofia EOOD, Endocrinology Consulting room", "city": "Sofia", "state_or_region": null, "postal_code": "1712", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diagnostic Consultative Center Alexandrovska", "city": "Sofia", "state_or_region": null, "postal_code": "1431", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diagnostic Consultative Center Alexandrovska", "city": "Sofia", "state_or_region": null, "postal_code": "1431", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hipocrat 9 - Dr. Rumyana Boykova - Draganova - AISPEMD EOOD", "city": "Sofia", "state_or_region": null, "postal_code": "1463", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Sofia", "state_or_region": null, "postal_code": "1606", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Sofia", "state_or_region": null, "postal_code": "1616", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "MC Diamedical - 2013 OOD, Sofia", "city": "Sofia", "state_or_region": null, "postal_code": "1618", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Medical center Children's Health EOOD", "city": "Sofia", "state_or_region": null, "postal_code": "1618", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Medical Centre Acad. Iv. Penchev EOOD", "city": "Sofia", "state_or_region": null, "postal_code": "1431", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "ACTIVE_NOT_RECRUITING; COMPLETED", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medical Centre Medical Arts Medico-dental centre", "city": "Sofia", "state_or_region": null, "postal_code": "1618", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Military Academy MHAT Sofia", "city": "Sofia", "state_or_region": null, "postal_code": "1606", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Military Academy MHAT Sofia", "city": "Sofia", "state_or_region": null, "postal_code": "1606", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sofia", "state_or_region": null, "postal_code": "1407", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sofia", "state_or_region": null, "postal_code": "1618", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sofia", "state_or_region": null, "postal_code": "1700", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "SHATPD - Prof. Ivan Mitev EAD, Pediatric Endocrinology and Metabolic Diseases", "city": "Sofia", "state_or_region": null, "postal_code": "1606", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "UMHAT Sofiamed EAD", "city": "Sofia", "state_or_region": null, "postal_code": "1750", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "UMHAT Sveta Anna Sofia AD, Second Clinic of Internal Diseases", "city": "Sofia", "state_or_region": null, "postal_code": "1750", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UMHATEM 'N.I. Pirogov'", "city": "Sofia", "state_or_region": null, "postal_code": "1606", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Multiprofile Hospital for Active Treatment St. Ivan Rilski EAD", "city": "Sofia", "state_or_region": null, "postal_code": "1431", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Multiprofile Hospital for Active Treatment St. Ivan Rilski EAD", "city": "Sofia", "state_or_region": null, "postal_code": "1431", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "USHATE Akad. Ivan Penchev EAD, Second Clinic of Endocrinology", "city": "Sofia", "state_or_region": null, "postal_code": "1431", "country": "Bulgaria", "latitude": 42.69751, "longitude": 23.32415, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Center New Rehabilitation Center EOOD", "city": "Stara Zagora", "state_or_region": null, "postal_code": "6001", "country": "Bulgaria", "latitude": 42.43205, "longitude": 25.64262, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Center New Rehabilitation Center EOOD", "city": "Stara Zagora", "state_or_region": null, "postal_code": "6001", "country": "Bulgaria", "latitude": 42.43205, "longitude": 25.64262, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "UMHAT Prof. Dr. Stoyan Kirkovich AD", "city": "Stara Zagora", "state_or_region": null, "postal_code": "6003", "country": "Bulgaria", "latitude": 42.43205, "longitude": 25.64262, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "AIPSMC Dr. Evelina Zlatanova EOOD", "city": "Varna", "state_or_region": null, "postal_code": "9010", "country": "Bulgaria", "latitude": 43.21912, "longitude": 27.91024, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "UMHAT Sveta Marina EAD, Clinic of Internal Diseases", "city": "Varna", "state_or_region": null, "postal_code": "9010", "country": "Bulgaria", "latitude": 43.21912, "longitude": 27.91024, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "UMHAT Sveta Marina EAD, First Pediatric Clinic", "city": "Varna", "state_or_region": null, "postal_code": "9010", "country": "Bulgaria", "latitude": 43.21912, "longitude": 27.91024, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "MC Nevromedics EOOD, Internal Diseases", "city": "Veliko Tarnovo", "state_or_region": null, "postal_code": "5005", "country": "Bulgaria", "latitude": 43.08124, "longitude": 25.62904, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Center - Arcus Medical", "city": "Veliko Tarnovo", "state_or_region": null, "postal_code": "5002", "country": "Bulgaria", "latitude": 43.08124, "longitude": 25.62904, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "DCC 1 Velingrad EOOD", "city": "Velingrad", "state_or_region": null, "postal_code": "4600", "country": "Bulgaria", "latitude": 42.02754, "longitude": 23.99155, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Yambol", "state_or_region": null, "postal_code": "8600", "country": "Bulgaria", "latitude": 42.48243, "longitude": 26.50006, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Pleven", "state_or_region": "Pleven Province", "postal_code": "5800", "country": "Bulgaria", "latitude": 43.41791, "longitude": 24.61666, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Plovdiv", "state_or_region": "Plovdiv Province", "postal_code": "4000", "country": "Bulgaria", "latitude": 42.15387, "longitude": 24.75001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Sofia", "state_or_region": "Sofia", "postal_code": "1606", "country": "Bulgaria", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Sofia", "state_or_region": "Sofia", "postal_code": "1618", "country": "Bulgaria", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Heritage Medical Research Clinic", "city": "Calgary", "state_or_region": null, "postal_code": "T2N 4Z6", "country": "Canada", "latitude": 51.05011, "longitude": -114.08529, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ecogene-21", "city": "Chicoutimi", "state_or_region": null, "postal_code": "G7H 7K9", "country": "Canada", "latitude": 48.41963, "longitude": -71.06369, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology and internal medicine research institute", "city": "Edmonton", "state_or_region": null, "postal_code": "T5R 1W2", "country": "Canada", "latitude": 53.55014, "longitude": -113.46871, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Of Alberta Hospital", "city": "Edmonton", "state_or_region": null, "postal_code": "T6G 2C8", "country": "Canada", "latitude": 53.55014, "longitude": -113.46871, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Wells Research Group", "city": "Edmonton", "state_or_region": null, "postal_code": "T5L 4G4", "country": "Canada", "latitude": 53.55014, "longitude": -113.46871, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "QEII Health Sciences Centre - Victoria General Site", "city": "Halifax", "state_or_region": null, "postal_code": "B3H 2Y9", "country": "Canada", "latitude": 44.64269, "longitude": -63.57688, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Premier Clinical Trial Network", "city": "Hamilton", "state_or_region": null, "postal_code": "L8L5G4", "country": "Canada", "latitude": 43.25011, "longitude": -79.84963, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Winterberry Research Inc.", "city": "Hamilton", "state_or_region": null, "postal_code": "L8J 0B6", "country": "Canada", "latitude": 43.25011, "longitude": -79.84963, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "London Digestive Disease Institute", "city": "London", "state_or_region": null, "postal_code": "N6K 1M6", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "London Digestive Disease Institute", "city": "London", "state_or_region": null, "postal_code": "N6K 1M6", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "London Health Sciences Centre", "city": "London", "state_or_region": null, "postal_code": "N6A 5W9", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "London Health Sciences Centre", "city": "London", "state_or_region": null, "postal_code": "N6A 5W9", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital - London Health Sciences Centre", "city": "London", "state_or_region": null, "postal_code": "N6A 5A5", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinique IMD", "city": "Montreal", "state_or_region": null, "postal_code": "H3H 1E8", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinique IMD", "city": "Montreal", "state_or_region": null, "postal_code": "H3H 1E8", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07463846", "study_title": "A Study to Evaluate ALN-2232 in Participants With Obesity", "lead_sponsor": "Alnylam Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Clinical Trial Site", "city": "Mount Royal", "state_or_region": null, "postal_code": "H3P 3P1", "country": "Canada", "latitude": 45.51675, "longitude": -73.64918, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07463846" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Private Practice - Dr. Stephane M. Gauthier", "city": "North Bay", "state_or_region": null, "postal_code": "P1B 2H3", "country": "Canada", "latitude": 46.3168, "longitude": -79.46633, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Ottawa Hospital - General Campus", "city": "Ottawa", "state_or_region": null, "postal_code": "K1H 8L6", "country": "Canada", "latitude": 45.41117, "longitude": -75.69812, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Ottawa Hospital - General Campus", "city": "Ottawa", "state_or_region": null, "postal_code": "K1H 8L6", "country": "Canada", "latitude": 45.41117, "longitude": -75.69812, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Alpha Recherche Clinique - Lebourgneuf", "city": "Québec", "state_or_region": null, "postal_code": "G2J 0C4", "country": "Canada", "latitude": 46.81228, "longitude": -71.21454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diex Recherche Québec", "city": "Québec", "state_or_region": null, "postal_code": "G1N 4V3", "country": "Canada", "latitude": 46.81228, "longitude": -71.21454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diex Recherche Québec", "city": "Québec", "state_or_region": null, "postal_code": "G1N 4V3", "country": "Canada", "latitude": 46.81228, "longitude": -71.21454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diex Recherche Quebec", "city": "Québec", "state_or_region": null, "postal_code": "G1V 4T3", "country": "Canada", "latitude": 46.81228, "longitude": -71.21454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Diex Recherche Quebec", "city": "Québec", "state_or_region": null, "postal_code": "G1V 4T3", "country": "Canada", "latitude": 46.81228, "longitude": -71.21454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Recherche Clinique Sigma Inc.", "city": "Québec", "state_or_region": null, "postal_code": "G1G 5X1", "country": "Canada", "latitude": 46.81228, "longitude": -71.21454, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Bluewater Clinical Research Group Inc.", "city": "Sarnia", "state_or_region": null, "postal_code": "N7T 4X3", "country": "Canada", "latitude": 42.97866, "longitude": -82.40407, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research of Ontario", "city": "Toronto", "state_or_region": null, "postal_code": "M1S 4T7", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "St. Joseph's Health Centre", "city": "Toronto", "state_or_region": null, "postal_code": "M6R 1B5", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Toronto General Hospital", "city": "Toronto", "state_or_region": null, "postal_code": "M5G 2C4", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diex Recherche Inc. Division Trois-Rivieres", "city": "Trois-Rivières", "state_or_region": null, "postal_code": "G9A 4P3", "country": "Canada", "latitude": 46.34515, "longitude": -72.5477, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "(G.I.R.I.) GI Research Institute Foundation", "city": "Vancouver", "state_or_region": null, "postal_code": "V5Z 2K5", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "(G.I.R.I.) GI Research Institute Foundation", "city": "Vancouver", "state_or_region": null, "postal_code": "V5Z 2K5", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "(G.I.R.I.) GI Research Institute Foundation", "city": "Vancouver", "state_or_region": null, "postal_code": "V5Z 2K5", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vancouver General Hospital", "city": "Vancouver", "state_or_region": null, "postal_code": "V5Z 1M9", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vancouver General Hospital", "city": "Vancouver", "state_or_region": null, "postal_code": "V5Z 1M9", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vancouver General Hospital", "city": "Vancouver", "state_or_region": null, "postal_code": "V5Z 1M9", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Health Sciences Centre Winnipeg", "city": "Winnipeg", "state_or_region": null, "postal_code": "R3A 1R9", "country": "Canada", "latitude": 49.8844, "longitude": -97.14704, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "C-Health Partners", "city": "Calgary", "state_or_region": "Alberta", "postal_code": "T2V 4J2", "country": "Canada", "latitude": 51.05011, "longitude": -114.08529, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "ss-31", "nct_id": "NCT07531251", "study_title": "Clinical Trial in Patients With Barth Syndrome- 4TAZPower", "lead_sponsor": "Stealth BioTherapeutics Inc.", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-13", "facility": "Metabolics and Genetics in Canada (MAGIC)", "city": "Calgary", "state_or_region": "Alberta", "postal_code": null, "country": "Canada", "latitude": 51.05011, "longitude": -114.08529, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07531251" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Calgary", "city": "Calgary", "state_or_region": "Alberta", "postal_code": "T2N 4N1", "country": "Canada", "latitude": 51.05011, "longitude": -114.08529, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Calgary", "city": "Calgary", "state_or_region": "Alberta", "postal_code": "T2N 4N1", "country": "Canada", "latitude": 51.05011, "longitude": -114.08529, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Kelowna Health and Memory Centre Ltd.", "city": "Kelowna", "state_or_region": "British Columbia", "postal_code": "V1Y 5A8", "country": "Canada", "latitude": 49.88307, "longitude": -119.48568, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medical Arts Health Research Group_Kelowna", "city": "Kelowna", "state_or_region": "British Columbia", "postal_code": "V1Y4N7", "country": "Canada", "latitude": 49.88307, "longitude": -119.48568, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fraser Clinical Trials", "city": "New Westminster", "state_or_region": "British Columbia", "postal_code": "V3L 3W4", "country": "Canada", "latitude": 49.20678, "longitude": -122.91092, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hilltop Medical Clinic", "city": "Surrey", "state_or_region": "British Columbia", "postal_code": "V4A 0C1", "country": "Canada", "latitude": 49.10635, "longitude": -122.82509, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Ocean West Research Clinic", "city": "Surrey", "state_or_region": "British Columbia", "postal_code": "V3Z 2N6", "country": "Canada", "latitude": 49.10635, "longitude": -122.82509, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pacific Gastroenterology Associates", "city": "Vancouver", "state_or_region": "British Columbia", "postal_code": "V6Z 2K5", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Vancouver", "state_or_region": "British Columbia", "postal_code": "V5Y 3W2", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of British Columbia", "city": "Vancouver", "state_or_region": "British Columbia", "postal_code": "V5Z 1M9", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of British Columbia", "city": "Vancouver", "state_or_region": "British Columbia", "postal_code": "V5Z 1M9", "country": "Canada", "latitude": 49.24966, "longitude": -123.11934, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Dr. M.B. Jones Inc", "city": "Victoria", "state_or_region": "British Columbia", "postal_code": "V8V 4A1", "country": "Canada", "latitude": 48.4359, "longitude": -123.35155, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "G.A. Research Associates Ltd.", "city": "Moncton", "state_or_region": "New Brunswick", "postal_code": "E1G 1A7", "country": "Canada", "latitude": 46.09454, "longitude": -64.7965, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Viable Clinical Research", "city": "Bridgewater", "state_or_region": "Nova Scotia", "postal_code": "B4N 3N2", "country": "Canada", "latitude": 44.37856, "longitude": -64.51882, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Viable Clinical Research", "city": "Bridgewater", "state_or_region": "Nova Scotia", "postal_code": "B4N 3N2", "country": "Canada", "latitude": 44.37856, "longitude": -64.51882, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Nova Scotia Hlth Halifax", "city": "Halifax", "state_or_region": "Nova Scotia", "postal_code": "B3H1V7", "country": "Canada", "latitude": 44.64269, "longitude": -63.57688, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Care Access Cape Breton", "city": "Sydney", "state_or_region": "Nova Scotia", "postal_code": "B1M 0A1", "country": "Canada", "latitude": 46.1351, "longitude": -60.1831, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centricity Research (Brampton)", "city": "Brampton", "state_or_region": "Ontario", "postal_code": "L6S 0C6", "country": "Canada", "latitude": 43.68341, "longitude": -79.76633, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centricity Research Brampton Endocrinology", "city": "Brampton", "state_or_region": "Ontario", "postal_code": "L6S 0C6", "country": "Canada", "latitude": 43.68341, "longitude": -79.76633, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centricity Research (Vaughan)", "city": "Concord", "state_or_region": "Ontario", "postal_code": "L4K 4M2", "country": "Canada", "latitude": 43.80011, "longitude": -79.48291, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Apex Trials", "city": "Guelph", "state_or_region": "Ontario", "postal_code": "N1G 0B4", "country": "Canada", "latitude": 43.54594, "longitude": -80.25599, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Guelph", "state_or_region": "Ontario", "postal_code": "N1H 1B1", "country": "Canada", "latitude": 43.54594, "longitude": -80.25599, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hamilton Medical Research Group", "city": "Hamilton", "state_or_region": "Ontario", "postal_code": "L8L 5G4", "country": "Canada", "latitude": 43.25011, "longitude": -79.84963, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06908694", "study_title": "Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy", "lead_sponsor": "Hamilton Health Sciences Corporation", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-07-29", "facility": "Juravinski Cancer Centre", "city": "Hamilton", "state_or_region": "Ontario", "postal_code": "L8V1C3", "country": "Canada", "latitude": 43.25011, "longitude": -79.84963, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06908694" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06852391", "study_title": "JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity", "lead_sponsor": "McMaster University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-14", "facility": "McMaster University", "city": "Hamilton", "state_or_region": "Ontario", "postal_code": "L8S 4L8", "country": "Canada", "latitude": 43.25011, "longitude": -79.84963, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06852391" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Premier Clinical Trial Research Network (PCTRN)", "city": "Hamilton", "state_or_region": "Ontario", "postal_code": "L8L 5G4", "country": "Canada", "latitude": 43.25011, "longitude": -79.84963, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Wharton Medical Clinic Clinical Trials (Hamilton)", "city": "Hamilton", "state_or_region": "Ontario", "postal_code": "L8L 5G8", "country": "Canada", "latitude": 43.25011, "longitude": -79.84963, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07195994", "study_title": "A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes", "lead_sponsor": "QuickSilver Scientific", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-16", "facility": "KGK Science Inc.", "city": "London", "state_or_region": "Ontario", "postal_code": "N6B3L1", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07195994" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06396416", "study_title": "Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2", "lead_sponsor": "Western University, Canada", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-29", "facility": "London Health Sciences Centre", "city": "London", "state_or_region": "Ontario", "postal_code": "N6A 5A5", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06396416" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Milestone Research", "city": "London", "state_or_region": "Ontario", "postal_code": "N5W 6A2", "country": "Canada", "latitude": 42.98339, "longitude": -81.23304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centricity Research (Nepean)", "city": "Nepean", "state_or_region": "Ontario", "postal_code": "K2J 0V2", "country": "Canada", "latitude": 45.33619, "longitude": -75.7225, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07059377", "study_title": "Semaglutide for Smoking Cessation in Patients With Diabetes", "lead_sponsor": "Ottawa Heart Institute Research Corporation", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-11", "facility": "University of Ottawa Heart Institute", "city": "Ottawa", "state_or_region": "Ontario", "postal_code": "K1Y 4W7", "country": "Canada", "latitude": 45.41117, "longitude": -75.69812, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07059377" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Bluewater Clin Res Group Inc", "city": "Sarnia", "state_or_region": "Ontario", "postal_code": "N7T 4X3", "country": "Canada", "latitude": 42.97866, "longitude": -82.40407, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sarnia", "state_or_region": "Ontario", "postal_code": "N7T 4X3", "country": "Canada", "latitude": 42.97866, "longitude": -82.40407, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Scarborough Village", "state_or_region": "Ontario", "postal_code": "M1R 0B1", "country": "Canada", "latitude": 43.73899, "longitude": -79.22124, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Stouffville", "state_or_region": "Ontario", "postal_code": "L4A1H2", "country": "Canada", "latitude": 43.96682, "longitude": -79.2496, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Albion Finch Medical Centre", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M9V 4B4", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Diabetes Heart Research Centre", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M6G 1M2", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diabetes Heart Research Centre", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M6G 1M2", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07294950", "study_title": "Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination", "lead_sponsor": "Mount Sinai Hospital, Canada", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-10", "last_update_post_date": "2026-02-11", "facility": "Leadership Sinai Centre for Diabetes", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M5T 3L9", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07294950" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M4G3E8", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M6G 1M2", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M9V 4B4", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05822609", "study_title": "Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes", "lead_sponsor": "University of Washington", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-06-02", "facility": "Toronto General Hospital, University Health Network", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M5G2N2", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05822609" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05938712", "study_title": "The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients", "lead_sponsor": "University Health Network, Toronto", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-05-01", "facility": "Toronto General Hospital", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M5G 2N2", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05938712" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Toronto Liver Centre", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M6H 3M1", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Toronto Liver Centre", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M6H 3M1", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07017270", "study_title": "Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis", "lead_sponsor": "Unity Health Toronto", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-06-26", "facility": "Unity Health Toronto", "city": "Toronto", "state_or_region": "Ontario", "postal_code": "M5B1W8", "country": "Canada", "latitude": 43.70643, "longitude": -79.39864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 2, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07017270" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Applied Medical Informatics Research Inc.", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4A 3T2", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier de l'Universite de Montreal (CHUM)", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H2X 1R9", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centre Medical Acadie", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4N 2W2", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Endocrinologie Oasis Inc", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4J 1E3", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07284511", "study_title": "A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar", "lead_sponsor": "McGill University Health Centre/Research Institute of the McGill University Health Centre", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-27", "facility": "Hygea Medical Clinic", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4A 3T2", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284511" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07284511", "study_title": "A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar", "lead_sponsor": "McGill University Health Centre/Research Institute of the McGill University Health Centre", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-27", "facility": "Institut de Recherches Cliniques de Montréal", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H2W 1R7", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07284511" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "McGill University Health Centre (MUHC)", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H3H 2R9", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "McGill University Health Centre (MUHC)", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H3H 2R9", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07284511", "study_title": "A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar", "lead_sponsor": "McGill University Health Centre/Research Institute of the McGill University Health Centre", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-27", "facility": "McGill University Health Centre", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4A 3J1", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07284511" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06387199", "study_title": "Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide", "lead_sponsor": "McGill University Health Centre/Research Institute of the McGill University Health Centre", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-18", "facility": "Research Institute of the McGill University Health Centre", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4A 3J1", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06387199" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06894784", "study_title": "A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes", "lead_sponsor": "McGill University Health Centre/Research Institute of the McGill University Health Centre", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-03-30", "facility": "Research Institute of the McGill University Health Centre", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4A 3J1", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06894784" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Montreal", "state_or_region": "Quebec", "postal_code": "H4N 2W2", "country": "Canada", "latitude": 45.50884, "longitude": -73.58781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centricity Res Pointe-Claire", "city": "Pointe-Claire", "state_or_region": "Quebec", "postal_code": "H9R 4S3", "country": "Canada", "latitude": 45.44868, "longitude": -73.81669, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Saint-Charles-Borromée", "state_or_region": "Quebec", "postal_code": "J6E 2B4", "country": "Canada", "latitude": 46.05007, "longitude": -73.46586, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre de Médecine Métabolique de Lanaudière", "city": "Terrebonne", "state_or_region": "Quebec", "postal_code": "J6X 4P7", "country": "Canada", "latitude": 45.70004, "longitude": -73.64732, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07317115", "study_title": "Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes", "lead_sponsor": "GT Metabolic Solutions, Inc.", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-19", "facility": "Westmount Surgical Center", "city": "Westmount", "state_or_region": "Quebec", "postal_code": "H3Z 2P9", "country": "Canada", "latitude": 45.48341, "longitude": -73.59918, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07317115" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Edificio Fleming", "city": "La Serena", "state_or_region": null, "postal_code": "1710209", "country": "Chile", "latitude": -29.90591, "longitude": -71.25014, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Edificio Fleming", "city": "La Serena", "state_or_region": null, "postal_code": "1710209", "country": "Chile", "latitude": -29.90591, "longitude": -71.25014, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Medicas UC", "city": "Santiago", "state_or_region": null, "postal_code": "8330024", "country": "Chile", "latitude": -33.45694, "longitude": -70.64827, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Medicas UC", "city": "Santiago", "state_or_region": null, "postal_code": "8330024", "country": "Chile", "latitude": -33.45694, "longitude": -70.64827, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Clinicas Viña del Mar", "city": "Viña del Mar", "state_or_region": null, "postal_code": "2540488", "country": "Chile", "latitude": -33.02457, "longitude": -71.55183, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigaciones Clinicas Viña del Mar", "city": "Viña del Mar", "state_or_region": null, "postal_code": "2540488", "country": "Chile", "latitude": -33.02457, "longitude": -71.55183, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "Beijing Anzhen Hospital Capital Medical University", "city": "Beijing", "state_or_region": null, "postal_code": "10029", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Ditan Hospital Capital Medical University", "city": "Beijing", "state_or_region": null, "postal_code": "100015", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Ditan Hospital Capital Medical University", "city": "Beijing", "state_or_region": null, "postal_code": "100015", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Ditan Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100015", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Friendship Hospital Affiliate of Capital University", "city": "Beijing", "state_or_region": null, "postal_code": "100050", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Friendship Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100050", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Friendship Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100050", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "liraglutide", "nct_id": "NCT06742710", "study_title": "Liraglutide Treatment in Obese Infertile PCOS Women", "lead_sponsor": "Peking University Third Hospital", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-05-29", "facility": "Beijing Obstetrics and Gynecology Hospital", "city": "Beijing", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06742710" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Tsinghua Changgung Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "102218", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Tsinghua Changgung Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "102218", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "state_or_region": null, "postal_code": "100069", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Youan Hospital, Capital Medical University", "city": "Beijing", "state_or_region": null, "postal_code": "100069", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Beijing Youan Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100069", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07150975", "study_title": "Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects", "lead_sponsor": "Gan & Lee Pharmaceuticals.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-08", "last_update_post_date": "2025-11-25", "facility": "Beijing", "city": "Beijing", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07150975" }, { "compound_slugs": "mazdutide; semaglutide; tirzepatide", "nct_id": "NCT07633639", "study_title": "GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity", "lead_sponsor": "China-Japan Friendship Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-06-08", "facility": "China-Japan Friendship Hospital", "city": "Beijing", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07633639" }, { "compound_slugs": "liraglutide", "nct_id": "NCT06742710", "study_title": "Liraglutide Treatment in Obese Infertile PCOS Women", "lead_sponsor": "Peking University Third Hospital", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-05-29", "facility": "Haidian District Maternal and Child Health Care Hospital", "city": "Beijing", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06742710" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07036172", "study_title": "Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients", "lead_sponsor": "Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-06", "last_update_post_date": "2025-06-25", "facility": "Peking University People's Hospital", "city": "Beijing", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07036172" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Peking University People's Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100034", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Peking University People's Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100044", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Peking University People's Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100044", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "mazdutide", "nct_id": "NCT06931028", "study_title": "A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-06", "last_update_post_date": "2025-06-29", "facility": "Peking University Third Hospital", "city": "Beijing", "state_or_region": null, "postal_code": "100191", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06931028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Hospital of Jilin University", "city": "Changchun", "state_or_region": null, "postal_code": "130021", "country": "China", "latitude": 43.88, "longitude": 125.32278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Hospital of Jilin University", "city": "Changchun", "state_or_region": null, "postal_code": "130021", "country": "China", "latitude": 43.88, "longitude": 125.32278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University)", "city": "Changsha", "state_or_region": null, "postal_code": "410005", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University)", "city": "Changsha", "state_or_region": null, "postal_code": "410005", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hunan Provincial People's Hospital", "city": "Changsha", "state_or_region": null, "postal_code": "410005", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Changsha", "state_or_region": null, "postal_code": "410013", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Changsha", "state_or_region": null, "postal_code": "410015", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Second Xiangya Hospital of Central South University", "city": "Changsha", "state_or_region": null, "postal_code": "410011", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Xiangya Hospital Central South University", "city": "Changsha", "state_or_region": null, "postal_code": "410008", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Xiangya Hospital, Central South University", "city": "Changsha", "state_or_region": null, "postal_code": "410008", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Changzhou Third People's Hospital", "city": "Changzhou Shi", "state_or_region": null, "postal_code": "214442", "country": "China", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Changzhou Third People's Hospital", "city": "Changzhou Shi", "state_or_region": null, "postal_code": "214442", "country": "China", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sichuan Provincial People's Hospital", "city": "Chengdu", "state_or_region": null, "postal_code": "610072", "country": "China", "latitude": 30.66667, "longitude": 104.06667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "West China Hospital, Sichuan University", "city": "Chengdu", "state_or_region": null, "postal_code": "610041", "country": "China", "latitude": 30.66667, "longitude": 104.06667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "West China Hospital, Sichuan University", "city": "Chengdu", "state_or_region": null, "postal_code": "610041", "country": "China", "latitude": 30.66667, "longitude": 104.06667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "2nd Affiliated Hospital Chongqing Medical University", "city": "Chongqing", "state_or_region": null, "postal_code": "400010", "country": "China", "latitude": 29.56026, "longitude": 106.55771, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chongqing Three Gorges Central Hospital", "city": "Chongqing", "state_or_region": null, "postal_code": "404000", "country": "China", "latitude": 29.56026, "longitude": 106.55771, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chongqing Three Gorges Central Hospital", "city": "Chongqing", "state_or_region": null, "postal_code": "404000", "country": "China", "latitude": 29.56026, "longitude": 106.55771, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First People's Hospital of Foshan", "city": "Foshan", "state_or_region": null, "postal_code": "528000", "country": "China", "latitude": 23.02677, "longitude": 113.13148, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First People's Hospital of Foshan", "city": "Foshan", "state_or_region": null, "postal_code": "528000", "country": "China", "latitude": 23.02677, "longitude": 113.13148, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First People's Hospital of Foshan", "city": "Foshan", "state_or_region": null, "postal_code": "528041", "country": "China", "latitude": 23.02677, "longitude": 113.13148, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fujian Medical University Mengchao Hepatobiliary Hospital (Fuzhou Infectious Disease Hospital)", "city": "Fuzhou", "state_or_region": null, "postal_code": "350025", "country": "China", "latitude": 26.06139, "longitude": 119.30611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fujian Medical University Union Hospital", "city": "Fuzhou", "state_or_region": null, "postal_code": "350025", "country": "China", "latitude": 26.06139, "longitude": 119.30611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "state_or_region": null, "postal_code": "350005", "country": "China", "latitude": 26.06139, "longitude": 119.30611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Fujian Medical University", "city": "Fuzhou", "state_or_region": null, "postal_code": "350005", "country": "China", "latitude": 26.06139, "longitude": 119.30611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital Of Fujian Medical University", "city": "Fuzhou", "state_or_region": null, "postal_code": "350207", "country": "China", "latitude": 26.06139, "longitude": 119.30611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Guangzhou 8th People's Hospital", "city": "Guangzhou", "state_or_region": null, "postal_code": "510060", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Guangzhou Eighth People's Hospital,Guangzhou Medical University", "city": "Guangzhou", "state_or_region": null, "postal_code": "510000", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Guangzhou Eighth People's Hospital,Guangzhou Medical University", "city": "Guangzhou", "state_or_region": null, "postal_code": "510000", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Guangzhou First People's Hospital", "city": "Guangzhou", "state_or_region": null, "postal_code": "510013", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Guangzhou First People's Hospital", "city": "Guangzhou", "state_or_region": null, "postal_code": "510013", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NanFang Hosptial", "city": "Guangzhou", "state_or_region": null, "postal_code": "510515", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NanFang Hosptial", "city": "Guangzhou", "state_or_region": null, "postal_code": "510515", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern Medical University Nanfang Hospital", "city": "Guangzhou", "state_or_region": null, "postal_code": "510515", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "The First Affiliated Hospital of Guangzhou Medical University", "city": "Guangzhou", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital,Sun Yat-sen University", "city": "Guangzhou", "state_or_region": null, "postal_code": "510080", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The third affiliated hospital of Sun Yat-Sen University", "city": "Guangzhou", "state_or_region": null, "postal_code": "510630", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Guizhou Provincial People's Hospital", "city": "Guiyang", "state_or_region": null, "postal_code": "550002", "country": "China", "latitude": 26.58333, "longitude": 106.71667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Guizhou Provincial People's Hospital", "city": "Guiyang", "state_or_region": null, "postal_code": "550002", "country": "China", "latitude": 26.58333, "longitude": 106.71667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Affiliated Hospital of Guizhou Medical University", "city": "Guiyang", "state_or_region": null, "postal_code": "550004", "country": "China", "latitude": 26.58333, "longitude": 106.71667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Affiliated Hospital of Hangzhou Normal University", "city": "Hangzhou", "state_or_region": null, "postal_code": "310015", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "state_or_region": null, "postal_code": "310016", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine", "city": "Hangzhou", "state_or_region": null, "postal_code": "310016", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Affiliated Hospital of Hangzhou Normal University", "city": "Hangzhou", "state_or_region": null, "postal_code": "310015", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Affiliated Hospital of Hangzhou Normal University", "city": "Hangzhou", "state_or_region": null, "postal_code": "310015", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital, Zhejiang University", "city": "Hangzhou", "state_or_region": null, "postal_code": "310003", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital, Zhejiang University", "city": "Hangzhou", "state_or_region": null, "postal_code": "310003", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide; tirzepatide", "nct_id": "NCT07293325", "study_title": "Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-06", "last_update_post_date": "2025-12-19", "facility": "The Second Affiliated Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07293325" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Zhejiang Hospital", "city": "Hangzhou", "state_or_region": null, "postal_code": "310013", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Zhejiang Hospital", "city": "Hangzhou", "state_or_region": null, "postal_code": "310013", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Hefei", "state_or_region": null, "postal_code": "230000", "country": "China", "latitude": 31.86389, "longitude": 117.28083, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Hefei", "state_or_region": null, "postal_code": "230601", "country": "China", "latitude": 31.86389, "longitude": 117.28083, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Huai'an", "state_or_region": null, "postal_code": "223005", "country": "China", "latitude": 33.58861, "longitude": 119.01917, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Hospital of Jiaxing", "city": "Jiaxing", "state_or_region": null, "postal_code": "314001", "country": "China", "latitude": 30.7522, "longitude": 120.75, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Hospital of Jiaxing", "city": "Jiaxing", "state_or_region": null, "postal_code": "314001", "country": "China", "latitude": 30.7522, "longitude": 120.75, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jinhua Central Hospital", "city": "Jinhua", "state_or_region": null, "postal_code": "321000", "country": "China", "latitude": 29.10678, "longitude": 119.64421, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "First People's hospital of Yunann Province", "city": "Kunming", "state_or_region": null, "postal_code": "650032", "country": "China", "latitude": 25.03889, "longitude": 102.71833, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Langfang", "state_or_region": null, "postal_code": "065000", "country": "China", "latitude": 39.52079, "longitude": 116.71471, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Liangyugang", "state_or_region": null, "postal_code": "222002", "country": "China", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Liaocheng People's Hospital", "city": "Liaocheng", "state_or_region": null, "postal_code": "252000", "country": "China", "latitude": 36.45064, "longitude": 116.00247, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Liaocheng People's Hospital", "city": "Liaocheng", "state_or_region": null, "postal_code": "252000", "country": "China", "latitude": 36.45064, "longitude": 116.00247, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Liaocheng People's Hospital", "city": "Liaocheng", "state_or_region": null, "postal_code": "252000", "country": "China", "latitude": 36.45064, "longitude": 116.00247, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Luoyang", "state_or_region": null, "postal_code": "471009", "country": "China", "latitude": 34.67345, "longitude": 112.43684, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Henan University of Science &Technology", "city": "Luoyang", "state_or_region": null, "postal_code": "471003", "country": "China", "latitude": 34.67345, "longitude": 112.43684, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "state_or_region": null, "postal_code": "471003", "country": "China", "latitude": 34.67345, "longitude": 112.43684, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Henan University of Science and Technology", "city": "Luoyang", "state_or_region": null, "postal_code": "471003", "country": "China", "latitude": 34.67345, "longitude": 112.43684, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Affiliated Hospital of Southwest Medical University", "city": "Luzhou", "state_or_region": null, "postal_code": "646000", "country": "China", "latitude": 28.8903, "longitude": 105.42575, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First affiliated hospital of Nanchang University (Xianghu campus)", "city": "Nanchang", "state_or_region": null, "postal_code": "330209", "country": "China", "latitude": 28.68396, "longitude": 115.85306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "state_or_region": null, "postal_code": "330006", "country": "China", "latitude": 28.68396, "longitude": 115.85306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Nanchang University", "city": "Nanchang", "state_or_region": null, "postal_code": "330006", "country": "China", "latitude": 28.68396, "longitude": 115.85306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 28.68396, "longitude": 115.85306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Second Affiliated Hospital of Nanchang University", "city": "Nanchang", "state_or_region": null, "postal_code": "330006", "country": "China", "latitude": 28.68396, "longitude": 115.85306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Second Affiliated Hospital to Nanchang University", "city": "Nanchang", "state_or_region": null, "postal_code": "330006", "country": "China", "latitude": 28.68396, "longitude": 115.85306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Second Affiliated Hospital to Nanchang University", "city": "Nanchang", "state_or_region": null, "postal_code": "330006", "country": "China", "latitude": 28.68396, "longitude": 115.85306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jiangsu Province Hospital", "city": "Nanjing", "state_or_region": null, "postal_code": "210029", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "state_or_region": null, "postal_code": "210008", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nanjing Drum Tower Hospital", "city": "Nanjing", "state_or_region": null, "postal_code": "210008", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nanjing Jiangning Hospital", "city": "Nanjing", "state_or_region": null, "postal_code": "211100", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Nanjing", "state_or_region": null, "postal_code": "2100008", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Second Hospital of Nanjing", "city": "Nanjing", "state_or_region": null, "postal_code": "210003", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Second Hospital of Nanjing", "city": "Nanjing", "state_or_region": null, "postal_code": "210003", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Nanyang", "state_or_region": null, "postal_code": "473009", "country": "China", "latitude": 33.00524, "longitude": 112.54659, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Nanyang Medical College", "city": "Nanyang", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 33.00524, "longitude": 112.54659, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ningbo 2nd Hospital", "city": "Ningbo", "state_or_region": null, "postal_code": "315000", "country": "China", "latitude": 29.87819, "longitude": 121.54945, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ningbo Medical Center", "city": "Ningbo", "state_or_region": null, "postal_code": "315041", "country": "China", "latitude": 29.87819, "longitude": 121.54945, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ningbo Second Hospital", "city": "Ningbo", "state_or_region": null, "postal_code": "315010", "country": "China", "latitude": 29.87819, "longitude": 121.54945, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ningbo Second Hospital", "city": "Ningbo", "state_or_region": null, "postal_code": "315010", "country": "China", "latitude": 29.87819, "longitude": 121.54945, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The first affiliated hospital of Ningbo university", "city": "Ningbo", "state_or_region": null, "postal_code": "315010", "country": "China", "latitude": 29.87819, "longitude": 121.54945, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "General Hospital of Ningxia Medical University", "city": "Ningxia", "state_or_region": null, "postal_code": "750004", "country": "China", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "General Hospital of Ningxia Medical University", "city": "Ningxia", "state_or_region": null, "postal_code": "750004", "country": "China", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Pinggu", "state_or_region": null, "postal_code": "101200", "country": "China", "latitude": 40.14554, "longitude": 117.10949, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pingxiang People's Hospital", "city": "Pingxiang", "state_or_region": null, "postal_code": "337000", "country": "China", "latitude": 27.61672, "longitude": 113.85353, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pingxiang People's Hospital", "city": "Pingxiang", "state_or_region": null, "postal_code": "337000", "country": "China", "latitude": 27.61672, "longitude": 113.85353, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pingxiang People's Hospital", "city": "Pingxiang", "state_or_region": null, "postal_code": "337055", "country": "China", "latitude": 27.61672, "longitude": 113.85353, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Pingxiang", "state_or_region": null, "postal_code": "337055", "country": "China", "latitude": 27.61672, "longitude": 113.85353, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Qingdao Municipal Hospital", "city": "Qingdao", "state_or_region": null, "postal_code": "266001", "country": "China", "latitude": 36.06488, "longitude": 120.38042, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Qingdao Municipal Hospital", "city": "Qingdao", "state_or_region": null, "postal_code": "266001", "country": "China", "latitude": 36.06488, "longitude": 120.38042, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "Department of Endocrinology, Huadong Hospital Affiliated to Fudan University", "city": "Shanghai", "state_or_region": null, "postal_code": "200040", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "state_or_region": null, "postal_code": "200040", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Huashan Hospital, Fudan University", "city": "Shanghai", "state_or_region": null, "postal_code": "200040", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Renji Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "state_or_region": null, "postal_code": "200127", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Renji Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "state_or_region": null, "postal_code": "200127", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Renmin Hospital of Wuhan University", "city": "Shanghai", "state_or_region": null, "postal_code": "430060", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "state_or_region": null, "postal_code": "200025", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "state_or_region": null, "postal_code": "200025", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ruijin Hospital Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "state_or_region": null, "postal_code": "200025", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "Shanghai East Hospital Tongji University", "city": "Shanghai", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shanghai East Hospital", "city": "Shanghai", "state_or_region": null, "postal_code": "200120", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shanghai East Hospital", "city": "Shanghai", "state_or_region": null, "postal_code": "200120", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shanghai General Hospital", "city": "Shanghai", "state_or_region": null, "postal_code": "200080", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shanghai General Hospital", "city": "Shanghai", "state_or_region": null, "postal_code": "200080", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shanghai Public Health Clinical Center", "city": "Shanghai", "state_or_region": null, "postal_code": "201508", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shanghai Public Health Clinical Center", "city": "Shanghai", "state_or_region": null, "postal_code": "201508", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "state_or_region": null, "postal_code": "200092", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07521631", "study_title": "Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes", "lead_sponsor": "Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Zhongshan Hoapital", "city": "Shanghai", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07521631" }, { "compound_slugs": "mazdutide", "nct_id": "NCT06519656", "study_title": "Efficacy of Mazdutide for Treating PCOS", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2024-10", "last_update_post_date": "2024-10-24", "facility": "Zhongshan Hospital Fudan University", "city": "Shanghai", "state_or_region": null, "postal_code": "200032", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06519656" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Zhongshan Hospital,Fudan University", "city": "Shanghai", "state_or_region": null, "postal_code": "200032", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shengjing Hospital of China Medical University", "city": "Shenyang", "state_or_region": null, "postal_code": "110022", "country": "China", "latitude": 41.79222, "longitude": 123.43278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Sixth People's Hospital of Shenyang", "city": "Shenyang", "state_or_region": null, "postal_code": "110006", "country": "China", "latitude": 41.79222, "longitude": 123.43278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Sixth People's Hospital of Shenyang", "city": "Shenyang", "state_or_region": null, "postal_code": "110006", "country": "China", "latitude": 41.79222, "longitude": 123.43278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Peking University Shenzhen Hospital", "city": "Shenzhen", "state_or_region": null, "postal_code": "518036", "country": "China", "latitude": 22.54554, "longitude": 114.0683, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Third People's Hospital of Shenzhen", "city": "Shenzhen", "state_or_region": null, "postal_code": "518112", "country": "China", "latitude": 22.54554, "longitude": 114.0683, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Third People's Hospital of Shenzhen", "city": "Shenzhen", "state_or_region": null, "postal_code": "518112", "country": "China", "latitude": 22.54554, "longitude": 114.0683, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Shijiazhuang", "state_or_region": null, "postal_code": "050000", "country": "China", "latitude": 38.04139, "longitude": 114.47861, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Third Hospital of Hebei Medical University", "city": "Shijiazhuang", "state_or_region": null, "postal_code": "050051", "country": "China", "latitude": 38.04139, "longitude": 114.47861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Fifth People's Hospital of Suzhou", "city": "Suzhou", "state_or_region": null, "postal_code": "215007", "country": "China", "latitude": 31.30408, "longitude": 120.59538, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Fifth People's Hospital of Suzhou", "city": "Suzhou", "state_or_region": null, "postal_code": "215007", "country": "China", "latitude": 31.30408, "longitude": 120.59538, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Tianjin", "state_or_region": null, "postal_code": "300134", "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "TEDA International Cardiovascular Hospital", "city": "Tianjin", "state_or_region": null, "postal_code": null, "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tianjin People' s Hospital", "city": "Tianjin", "state_or_region": null, "postal_code": "300121", "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tianjin Second People's Hospital", "city": "Tianjin", "state_or_region": null, "postal_code": "300192", "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tianjin Second People's Hospital", "city": "Tianjin", "state_or_region": null, "postal_code": "300192", "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tianjin Third Central Hospital", "city": "Tianjin", "state_or_region": null, "postal_code": "300170", "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tianjin Third Central Hospital", "city": "Tianjin", "state_or_region": null, "postal_code": "300170", "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "state_or_region": null, "postal_code": "325000", "country": "China", "latitude": 27.99942, "longitude": 120.66682, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "state_or_region": null, "postal_code": "325000", "country": "China", "latitude": 27.99942, "longitude": 120.66682, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "state_or_region": null, "postal_code": "325000", "country": "China", "latitude": 27.99942, "longitude": 120.66682, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Renmin Hospital of Wuhan University", "city": "Wuhan", "state_or_region": null, "postal_code": "430060", "country": "China", "latitude": 30.58333, "longitude": 114.26667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "state_or_region": null, "postal_code": "430022", "country": "China", "latitude": 30.58333, "longitude": 114.26667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "state_or_region": null, "postal_code": "430022", "country": "China", "latitude": 30.58333, "longitude": 114.26667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Wuxi No. 5 People's Hospital", "city": "Wuxi", "state_or_region": null, "postal_code": "214005", "country": "China", "latitude": 31.56887, "longitude": 120.28857, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "First Affiliated Hospital of Xi'an JiaoTong University", "city": "Xi'an", "state_or_region": null, "postal_code": "710061", "country": "China", "latitude": 34.25833, "longitude": 108.92861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "First Affiliated Hospital of Xi'an JiaoTong University", "city": "Xi'an", "state_or_region": null, "postal_code": "710061", "country": "China", "latitude": 34.25833, "longitude": 108.92861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Second Affiliated Hospital of medical college of Xi'an JiaoTong University", "city": "Xi'an", "state_or_region": null, "postal_code": "710004", "country": "China", "latitude": 34.25833, "longitude": 108.92861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Second Affiliated Hospital of medical college of Xi'an JiaoTong University", "city": "Xi'an", "state_or_region": null, "postal_code": "710004", "country": "China", "latitude": 34.25833, "longitude": 108.92861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The First Affiliated Hospital of Xi'an Jiaotong University", "city": "Xi'an", "state_or_region": null, "postal_code": "710061", "country": "China", "latitude": 34.25833, "longitude": 108.92861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Affiliated Hospital of Xuzhou Medical College", "city": "Xuzhou", "state_or_region": null, "postal_code": "221002", "country": "China", "latitude": 34.20442, "longitude": 117.28386, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yanbian University Hospital", "city": "Yanji", "state_or_region": null, "postal_code": "133000", "country": "China", "latitude": 42.88825, "longitude": 129.50241, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "General Hospital of Ningxia Medical University", "city": "Yinchuan", "state_or_region": null, "postal_code": "750004", "country": "China", "latitude": 38.46806, "longitude": 106.27306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Yueyang", "state_or_region": null, "postal_code": "414000", "country": "China", "latitude": 29.37455, "longitude": 113.09481, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yueyang Central Hospital", "city": "Yueyang", "state_or_region": null, "postal_code": "414000", "country": "China", "latitude": 29.37455, "longitude": 113.09481, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yuncheng Center Hopsital - West Compus", "city": "Yuncheng", "state_or_region": null, "postal_code": "44099", "country": "China", "latitude": 35.02306, "longitude": 110.99278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sixth People's Hospital of Zhengzhou", "city": "Zhengzhou", "state_or_region": null, "postal_code": "450005", "country": "China", "latitude": 34.75778, "longitude": 113.64861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sixth People's Hospital of Zhengzhou", "city": "Zhengzhou", "state_or_region": null, "postal_code": "450005", "country": "China", "latitude": 34.75778, "longitude": 113.64861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Third People's Hospital of Zhenjiang", "city": "Zhenjiang", "state_or_region": null, "postal_code": "212021", "country": "China", "latitude": 32.21086, "longitude": 119.45508, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Third People's Hospital of Zhenjiang", "city": "Zhenjiang", "state_or_region": null, "postal_code": "212021", "country": "China", "latitude": 32.21086, "longitude": 119.45508, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Zhoukou Central Hospital", "city": "Zhoukou", "state_or_region": null, "postal_code": "466000", "country": "China", "latitude": 33.63333, "longitude": 114.63333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "The First Affiliated Hospital of Bengbu Medical College", "city": "Bengbu", "state_or_region": "Anhui", "postal_code": null, "country": "China", "latitude": 32.94083, "longitude": 117.36083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Beijing Children's Hospital, Capital Medical University", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": "100045", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "mazdutide", "nct_id": "NCT06937749", "study_title": "A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-20", "facility": "Beijing Tsinghua Changgung Hospital", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": "100044", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937749" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Capital Center for Children's Health, Capital Medical University", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": "100020", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "mazdutide", "nct_id": "NCT06862908", "study_title": "A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-07", "last_update_post_date": "2025-07-11", "facility": "Fuwai Hospital, CAMS&PUMC", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": "100037", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06862908" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT06598839", "study_title": "Immuno-effect of Tα1 for Stage I NSCLC", "lead_sponsor": "Yousheng Mao", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-09", "last_update_post_date": "2024-09-19", "facility": "National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": "100021", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06598839" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06716216", "study_title": "A Study of BGM0504 in Participants with Type 2 Diabetes", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2024-10", "last_update_post_date": "2025-02-07", "facility": "Peking University People's Hospital", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": "100044", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06716216" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06911203", "study_title": "A Study of BGM0504 in Participants With Obesity", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-01", "last_update_post_date": "2025-10-28", "facility": "Peking University People's Hospital", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": "100044", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06911203" }, { "compound_slugs": "liraglutide", "nct_id": "NCT06742710", "study_title": "Liraglutide Treatment in Obese Infertile PCOS Women", "lead_sponsor": "Peking University Third Hospital", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-05-29", "facility": "Peking University Third Hospital", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": null, "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06742710" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06830343", "study_title": "The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity", "lead_sponsor": "CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-04-06", "facility": "Peking University Third Hospital", "city": "Beijing", "state_or_region": "Beijing Municipality", "postal_code": null, "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06830343" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT06829355", "study_title": "\"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer\"", "lead_sponsor": "Beijing Friendship Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-02", "last_update_post_date": "2025-02-17", "facility": "Beijing Friendship Hospital, Capital Medical University", "city": "Beijing", "state_or_region": "China", "postal_code": "100050", "country": "China", "latitude": 39.9075, "longitude": 116.39723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06829355" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "The Second Affiliated Hospital of Chongqing Medical University", "city": "Chongqing", "state_or_region": "Chongqing Municipality", "postal_code": "400000", "country": "China", "latitude": 29.56026, "longitude": 106.55771, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Fujian Provincial Hospital, Affiliated to Fuzhou University", "city": "Fuzhou", "state_or_region": "Fujian", "postal_code": "350000", "country": "China", "latitude": 26.06139, "longitude": 119.30611, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "The First Affiliated Hospital of Xiamen University", "city": "Xiamen", "state_or_region": "Fujian", "postal_code": "361003", "country": "China", "latitude": 24.47979, "longitude": 118.08187, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "liraglutide", "nct_id": "NCT03087032", "study_title": "Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)", "lead_sponsor": "The First Affiliated Hospital of Xiamen University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-01", "last_update_post_date": "2025-01-13", "facility": "The first afilliated hospital of Xiamen university", "city": "Xiamen", "state_or_region": "Fujian", "postal_code": "361003", "country": "China", "latitude": 24.47979, "longitude": 118.08187, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT03087032" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT06584006", "study_title": "Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors", "lead_sponsor": "The First Affiliated Hospital of Xiamen University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2024-09", "last_update_post_date": "2024-09-19", "facility": "Zhijuan Lin", "city": "Xiamen", "state_or_region": "Fujian", "postal_code": null, "country": "China", "latitude": 24.47979, "longitude": 118.08187, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06584006" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "Guangdong Provincial People's Hospital", "city": "Guangzhou", "state_or_region": "Guangdong", "postal_code": null, "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT07644897", "study_title": "Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma", "lead_sponsor": "Sun Yat-sen University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-12", "facility": "Sun yat-sen uniersity", "city": "Guangzhou", "state_or_region": "Guangdong", "postal_code": "510000", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07644897" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07374328", "study_title": "Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus", "lead_sponsor": "Second Affiliated Hospital of Guangzhou Medical University", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-28", "facility": "The Second Affiliated Hospital, Guangzhou Medical University", "city": "Guangzhou", "state_or_region": "Guangdong", "postal_code": "510260", "country": "China", "latitude": 23.11667, "longitude": 113.25, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07374328" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT07644897", "study_title": "Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma", "lead_sponsor": "Sun Yat-sen University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-12", "facility": "Nanshan hospital", "city": "Shenzhen", "state_or_region": "Guangdong", "postal_code": "518000", "country": "China", "latitude": 22.54554, "longitude": 114.0683, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07644897" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Henan Children's Hospital Zhengzhou Children's Hospital", "city": "Zhengzhou", "state_or_region": "Henan", "postal_code": "450018", "country": "China", "latitude": 34.75778, "longitude": 113.64861, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Union Hospital Tongji Medical College Huazhong University of Science and Technology", "city": "Wuhan", "state_or_region": "Hubei", "postal_code": "430022", "country": "China", "latitude": 30.58333, "longitude": 114.26667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Wuhan Children Hospital", "city": "Wuhan", "state_or_region": "Hubei", "postal_code": "430019", "country": "China", "latitude": 30.58333, "longitude": 114.26667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Zhongnan Hospital of Wuhan University", "city": "Wuhan", "state_or_region": "Hubei", "postal_code": "430000", "country": "China", "latitude": 30.58333, "longitude": 114.26667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "Department of Endocrinology, Xiangya Hospital of Central South University", "city": "Changsha", "state_or_region": "Hunan", "postal_code": "410008", "country": "China", "latitude": 28.19874, "longitude": 112.97087, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "Department of Endocrinology, Changzhou No.2 People's Hospital", "city": "Changzhou", "state_or_region": "Jiangsu", "postal_code": null, "country": "China", "latitude": 31.77359, "longitude": 119.95401, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "Department of Endocrinology, Endocrine and Metabolic Disease Medical Center,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210008", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "Department of Endocrinology, Jiangsu Province Hospital of Traditional Chinese Medicine", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": null, "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210000", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07619989", "study_title": "Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-31", "facility": "Department of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Medical School", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210008", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07619989" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07743983", "study_title": "A Study of BGM0504 in Early T2DM With Obesity", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-08-04", "facility": "Nanjing Drum Tower Hospital（The Affiliated Hospital of Nanjing University Medical School）", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210008", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07743983" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "Nanjing First Hospital Nanjing Medical University", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": null, "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Nanjing First Hospital, Nanjing Medical University", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210000", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT05553093", "study_title": "Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes", "lead_sponsor": "Nanjing First Hospital, Nanjing Medical University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2022-09", "last_update_post_date": "2022-09-23", "facility": "Nanjing First Hospital", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210006", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05553093" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "The First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210029", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06461377", "study_title": "The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy", "lead_sponsor": "The First Affiliated Hospital with Nanjing Medical University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-06", "last_update_post_date": "2024-06-21", "facility": "the First Affiliated Hospital of Nanjing Medical University", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210029", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06461377" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT06461910", "study_title": "Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma", "lead_sponsor": "Zekuan Xu", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-03-03", "facility": "The First Hospital of Nanjing Medical University", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": null, "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06461910" }, { "compound_slugs": "liraglutide", "nct_id": "NCT06361238", "study_title": "Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-20", "facility": "Wenxue liu", "city": "Nanjing", "state_or_region": "Jiangsu", "postal_code": "210000", "country": "China", "latitude": 32.06167, "longitude": 118.77778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06361238" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "The Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University", "city": "Suzhou", "state_or_region": "Jiangsu", "postal_code": "215000", "country": "China", "latitude": 31.30408, "longitude": 120.59538, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "Subei People's Hospital of Jiangsu Province", "city": "Yangzhou", "state_or_region": "Jiangsu", "postal_code": null, "country": "China", "latitude": 32.39722, "longitude": 119.43583, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "The First Bethune Hospital of Jilin University-Pediatric", "city": "Changchun", "state_or_region": "Jilin", "postal_code": "130021", "country": "China", "latitude": 43.88, "longitude": 125.32278, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "The Second Affiliated Hospital of Dalian Medical University", "city": "Dalian", "state_or_region": "Liaoning", "postal_code": null, "country": "China", "latitude": 38.91222, "longitude": 121.60222, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07272343", "study_title": "The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes", "lead_sponsor": "Second Affiliated Hospital of Nanchang University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2026-04-02", "facility": "Minde road No.1", "city": "Jiangxi", "state_or_region": "Nanchang", "postal_code": "330000", "country": "China", "latitude": 33.99934, "longitude": 105.19994, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07272343" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "Qilu Hospital of Shandong University", "city": "Jinan", "state_or_region": "Shandong", "postal_code": null, "country": "China", "latitude": 36.66833, "longitude": 116.99722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Shandong Provincial Hospital-Pediatric", "city": "Jinan", "state_or_region": "Shandong", "postal_code": "250098", "country": "China", "latitude": 36.66833, "longitude": 116.99722, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Children's Hospital of Fudan University", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": "201102", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07083154", "study_title": "GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-05", "facility": "Department of Endocrinology, Shanghai General Hospital", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": "200080", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07083154" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Huadong Hospital, Fudan University", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": "200000", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Renji Hospital, Shanghai Jiao Tong University School of Medicine", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": "200000", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07469800", "study_title": "Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-27", "facility": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": null, "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07469800" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Shanghai Tenth People's Hospital, School of Medicine, Tongji University", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": "200000", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": "200030", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05086614", "study_title": "Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer", "lead_sponsor": "Fudan University", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2021-03", "last_update_post_date": "2021-10-21", "facility": "Zhongshan Hospital, Fudan University", "city": "Shanghai", "state_or_region": "Shanghai Municipality", "postal_code": "200032", "country": "China", "latitude": 31.22222, "longitude": 121.45806, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05086614" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Chengdu Women's and Children's Central Hospital", "city": "Chengdu", "state_or_region": "Sichuan", "postal_code": "610031", "country": "China", "latitude": 30.66667, "longitude": 104.06667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "West China Hospital of Sichuan University", "city": "Chengdu", "state_or_region": "Sichuan", "postal_code": null, "country": "China", "latitude": 30.66667, "longitude": 104.06667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "The Affiliated Hospital of Southwest Medical University", "city": "Luzhou", "state_or_region": "Sichuan", "postal_code": "646000", "country": "China", "latitude": 28.8903, "longitude": 105.42575, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "liraglutide", "nct_id": "NCT07244003", "study_title": "Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control", "lead_sponsor": "Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-24", "facility": "Tianjin Medical University General Hospital", "city": "Tianjin", "state_or_region": "Tianjin Municipality", "postal_code": null, "country": "China", "latitude": 39.14222, "longitude": 117.17667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07244003" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "The Friendship Hospital of Yili Kazak Autonomous Prefecture", "city": "Kazak", "state_or_region": "Xinjiang", "postal_code": null, "country": "China", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "The Seventh Affiliated Hospital of Xinjiang Medical University", "city": "Ürümqi", "state_or_region": "Xinjiang", "postal_code": null, "country": "China", "latitude": 43.80096, "longitude": 87.60046, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT05339529", "study_title": "Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)", "lead_sponsor": "Nanjing Medical University", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-12", "facility": "The First Affiliated Hospital of Kunming Medical University", "city": "Kunming", "state_or_region": "Yunnan", "postal_code": null, "country": "China", "latitude": 25.03889, "longitude": 102.71833, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05339529" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06989177", "study_title": "Probiotic Intervention on Body Weight", "lead_sponsor": "Chinese Academy of Sciences", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-17", "facility": "Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences", "city": "Hangzhou", "state_or_region": "Zhejiang", "postal_code": "310024", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06989177" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07255209", "study_title": "A Study of IBI362 in Chinese Adolescents With Obesity or Overweight", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-08", "facility": "The Children's Hospital, Zhejiang University School of Medicine", "city": "Hangzhou", "state_or_region": "Zhejiang", "postal_code": "310052", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07255209" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06989203", "study_title": "Protein Supplementation Intervention on Body Weight", "lead_sponsor": "Chinese Academy of Sciences", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-17", "facility": "Tongde Hospital of Zhejiang Province", "city": "Hangzhou", "state_or_region": "Zhejiang", "postal_code": "310024", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06989203" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "Zhejiang Provincial People's Hospital", "city": "Hangzhou", "state_or_region": "Zhejiang", "postal_code": "310000", "country": "China", "latitude": 30.29365, "longitude": 120.16142, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05356104", "study_title": "GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)", "lead_sponsor": "Chinese University of Hong Kong", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-05", "facility": "First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "state_or_region": "Zhejiang", "postal_code": null, "country": "China", "latitude": 27.99942, "longitude": 120.66682, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05356104" }, { "compound_slugs": "mazdutide", "nct_id": "NCT07517042", "study_title": "ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management", "lead_sponsor": "Shanghai Zhongshan Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-04-08", "facility": "The First Affiliated Hospital of Wenzhou Medical University", "city": "Wenzhou", "state_or_region": "Zhejiang", "postal_code": "325000", "country": "China", "latitude": 27.99942, "longitude": 120.66682, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07517042" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Fundación Santa Fe de Bogotá", "city": "Bogotá", "state_or_region": null, "postal_code": "110111", "country": "Colombia", "latitude": 4.60971, "longitude": -74.08175, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Servicios de Salud Ips Suramericana S.A.S.", "city": "Medellín", "state_or_region": "Antioquia", "postal_code": "05001", "country": "Colombia", "latitude": 6.245, "longitude": -75.57151, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Opca bolnica Karlovac", "city": "Karlovac", "state_or_region": null, "postal_code": "47000", "country": "Croatia", "latitude": 45.49167, "longitude": 15.55, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Poliklinika SLAVONIJA OSIJEK", "city": "Osijek", "state_or_region": null, "postal_code": "31000", "country": "Croatia", "latitude": 45.55066, "longitude": 18.6942, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Clinical Hospital Centre Rijeka_Pediatric", "city": "Rijeka", "state_or_region": null, "postal_code": "51 000", "country": "Croatia", "latitude": 45.32673, "longitude": 14.44241, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Opca bolnica Varazdin_Endocrinology", "city": "Varaždin", "state_or_region": null, "postal_code": "42 000", "country": "Croatia", "latitude": 46.30444, "longitude": 16.33778, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "KBC \"Sestre Milosrdnice\"", "city": "Zagreb", "state_or_region": null, "postal_code": "10 000", "country": "Croatia", "latitude": 45.81444, "longitude": 15.97798, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Klinika Za Djecje Bolesti Zagreb_Endocrinology", "city": "Zagreb", "state_or_region": null, "postal_code": "10000", "country": "Croatia", "latitude": 45.81444, "longitude": 15.97798, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Poliklinika Solmed", "city": "Zagreb", "state_or_region": null, "postal_code": "10000", "country": "Croatia", "latitude": 45.81444, "longitude": 15.97798, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Fakultní nemocnice U sv. Anny v Brně", "city": "Brno", "state_or_region": null, "postal_code": "656 91", "country": "Czechia", "latitude": 49.19522, "longitude": 16.60796, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SurGal Clinic", "city": "Brno", "state_or_region": null, "postal_code": "602 00", "country": "Czechia", "latitude": 49.19522, "longitude": 16.60796, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SurGal Clinic", "city": "Brno", "state_or_region": null, "postal_code": "602 00", "country": "Czechia", "latitude": 49.19522, "longitude": 16.60796, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Nemocnice Český Krumlov, a.s.", "city": "Český Krumlov", "state_or_region": null, "postal_code": "381 01", "country": "Czechia", "latitude": 48.81091, "longitude": 14.31521, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centrum zdraví Dolní Břežany, a.s.", "city": "Dolní Břežany", "state_or_region": null, "postal_code": "252 41", "country": "Czechia", "latitude": 49.96321, "longitude": 14.4585, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "MUDr. Petr Buček s.r.o.", "city": "Frýdek-Místek", "state_or_region": null, "postal_code": "738 01", "country": "Czechia", "latitude": 49.68333, "longitude": 18.35, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "CTC Hodonin s.r.o.", "city": "Hodonín", "state_or_region": null, "postal_code": "695 01", "country": "Czechia", "latitude": 48.84893, "longitude": 17.13244, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterologie", "city": "Hradec Králové", "state_or_region": null, "postal_code": "500 02", "country": "Czechia", "latitude": 50.20923, "longitude": 15.83277, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterologie", "city": "Hradec Králové", "state_or_region": null, "postal_code": "500 02", "country": "Czechia", "latitude": 50.20923, "longitude": 15.83277, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "KARDIOLOGIE - LIBEREC s.r.o.", "city": "Liberec", "state_or_region": null, "postal_code": "460 01", "country": "Czechia", "latitude": 50.76711, "longitude": 15.05619, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Krajska nemocnice Liberec a.s.", "city": "Liberec", "state_or_region": null, "postal_code": "460 01", "country": "Czechia", "latitude": 50.76711, "longitude": 15.05619, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Krajska nemocnice Liberec a.s.", "city": "Liberec", "state_or_region": null, "postal_code": "460 01", "country": "Czechia", "latitude": 50.76711, "longitude": 15.05619, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Krajská nemocnice Liberec", "city": "Liberec", "state_or_region": null, "postal_code": "460 01", "country": "Czechia", "latitude": 50.76711, "longitude": 15.05619, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Interní a diabetologická ordinace s.r.o.", "city": "Náchod", "state_or_region": null, "postal_code": "54701", "country": "Czechia", "latitude": 50.4167, "longitude": 16.16289, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EndoArt", "city": "Ostrava", "state_or_region": null, "postal_code": "710 00", "country": "Czechia", "latitude": 49.83465, "longitude": 18.28204, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EndoArt", "city": "Ostrava", "state_or_region": null, "postal_code": "710 00", "country": "Czechia", "latitude": 49.83465, "longitude": 18.28204, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fakultni nemocnice Ostrava", "city": "Ostrava", "state_or_region": null, "postal_code": "708 52", "country": "Czechia", "latitude": 49.83465, "longitude": 18.28204, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mestska nemocnice Ostrava", "city": "Ostrava", "state_or_region": null, "postal_code": "728 80", "country": "Czechia", "latitude": 49.83465, "longitude": 18.28204, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Site s.r.o.", "city": "Pilsen", "state_or_region": null, "postal_code": "301 00", "country": "Czechia", "latitude": 49.74747, "longitude": 13.37759, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Site s.r.o.", "city": "Pilsen", "state_or_region": null, "postal_code": "301 00", "country": "Czechia", "latitude": 49.74747, "longitude": 13.37759, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "DIALINE s.r.o.", "city": "Plzeň 3", "state_or_region": null, "postal_code": "301 00", "country": "Czechia", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "DiaVize s.r.o.", "city": "Prague", "state_or_region": null, "postal_code": "140 00", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "ENDOTRIAL s.r.o.", "city": "Prague", "state_or_region": null, "postal_code": "10400", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "EUC Klinika Praha a.s.", "city": "Prague", "state_or_region": null, "postal_code": "150 00", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Fledip s.r.o.", "city": "Prague", "state_or_region": null, "postal_code": "160 00", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Fledip s.r.o.", "city": "Prague", "state_or_region": null, "postal_code": "160 00", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "FNKV-Internal Clinic-Nephrology", "city": "Prague", "state_or_region": null, "postal_code": "100 34", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "General Faculty Hospital, Prague", "city": "Prague", "state_or_region": null, "postal_code": "128 08", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "General Faculty Hospital, Prague", "city": "Prague", "state_or_region": null, "postal_code": "128 08", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "IKEM Klinika nefrologie", "city": "Prague", "state_or_region": null, "postal_code": "140 21", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ISCARE klinické centrum", "city": "Prague", "state_or_region": null, "postal_code": "19000", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ISCARE klinické centrum", "city": "Prague", "state_or_region": null, "postal_code": "19000", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Milan Kvapil s.r.o.", "city": "Prague", "state_or_region": null, "postal_code": "149 00", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ResTrial GastroEndo s.r.o", "city": "Prague", "state_or_region": null, "postal_code": "143 00", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ResTrial GastroEndo s.r.o", "city": "Prague", "state_or_region": null, "postal_code": "143 00", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vseobecna fakultni nemocnice v Praze", "city": "Prague", "state_or_region": null, "postal_code": "12808", "country": "Czechia", "latitude": 50.08804, "longitude": 14.42076, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Internist Care s.r.o.", "city": "Smiřice", "state_or_region": null, "postal_code": "503 03", "country": "Czechia", "latitude": 50.29978, "longitude": 15.86508, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Masarykova Nemocnice V Usti Nad Labem", "city": "Ústí nad Labem", "state_or_region": null, "postal_code": "40113", "country": "Czechia", "latitude": 50.6607, "longitude": 14.03227, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Masarykova Nemocnice V Usti Nad Labem", "city": "Ústí nad Labem", "state_or_region": null, "postal_code": "40113", "country": "Czechia", "latitude": 50.6607, "longitude": 14.03227, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Aalborg Universitetshospital - Børne og Ungeafdelingen", "city": "Aalborg", "state_or_region": null, "postal_code": "9000", "country": "Denmark", "latitude": 57.048, "longitude": 9.9187, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07527195", "study_title": "Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-07", "facility": "Aarhus Universitetshospital, Steno Diabetes Center Aarhus", "city": "Aarhus N", "state_or_region": null, "postal_code": "8200", "country": "Denmark", "latitude": 56.20367, "longitude": 10.17317, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07527195" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Aarhus Universitetshospital, Steno Diabetes Center Aarhus", "city": "Aarhus N", "state_or_region": null, "postal_code": "8200", "country": "Denmark", "latitude": 56.20367, "longitude": 10.17317, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aarhus Universitetshospital, Skejby", "city": "Aarhus", "state_or_region": null, "postal_code": "8200", "country": "Denmark", "latitude": 56.15674, "longitude": 10.21076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aarhus Universitetshospital, Skejby", "city": "Aarhus", "state_or_region": null, "postal_code": "8200", "country": "Denmark", "latitude": 56.15674, "longitude": 10.21076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05630586", "study_title": "Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke", "lead_sponsor": "Aarhus University Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2022-11", "last_update_post_date": "2023-04-25", "facility": "Aarhus University Hospital", "city": "Aarhus", "state_or_region": null, "postal_code": "8000", "country": "Denmark", "latitude": 56.15674, "longitude": 10.21076, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05630586" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06423599", "study_title": "Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure", "lead_sponsor": "Jens D Hove, MD,PHD", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-23", "facility": "Amager and Hvidovre Hospital University of Copenhagen", "city": "Copenhagen", "state_or_region": null, "postal_code": "DK-2650", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06423599" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07581145", "study_title": "Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients", "lead_sponsor": "Ole Lander Svendsen", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-12", "facility": "Copenhagen Wound Healing Center, Bispebjerg University Hospital", "city": "Copenhagen", "state_or_region": null, "postal_code": "2400", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07581145" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05702931", "study_title": "Semaglutide Treatment for Hyperglycaemia After Renal Transplantation", "lead_sponsor": "Rigshospitalet, Denmark", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2025-12-29", "facility": "Department og Nephrology and Endocrinology, Rigshospitalet", "city": "Copenhagen", "state_or_region": null, "postal_code": "2100", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05702931" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Herlev and Gentofte Hospital", "city": "Copenhagen", "state_or_region": null, "postal_code": "2730", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Herlev and Gentofte Hospital", "city": "Copenhagen", "state_or_region": null, "postal_code": "2730", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06082063", "study_title": "Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes", "lead_sponsor": "Steno Diabetes Center Copenhagen", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-01", "last_update_post_date": "2025-01-10", "facility": "Rigshospitalet", "city": "Copenhagen", "state_or_region": null, "postal_code": null, "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06082063" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06606821", "study_title": "The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease", "lead_sponsor": "Tina Vilsbøll", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-05", "last_update_post_date": "2025-05-22", "facility": "Rigshospitalet", "city": "Copenhagen", "state_or_region": null, "postal_code": "2100", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06606821" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rigshospitalet", "city": "Copenhagen", "state_or_region": null, "postal_code": "2100", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rigshospitalet", "city": "Copenhagen", "state_or_region": null, "postal_code": "2100", "country": "Denmark", "latitude": 55.67594, "longitude": 12.56553, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07523633", "study_title": "Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder", "lead_sponsor": "Anders Fink-Jensen, MD, DMSci", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-14", "facility": "Psychiatric Center Copenhagen, Frederiksberg Hospital", "city": "Frederiksberg", "state_or_region": null, "postal_code": "2100", "country": "Denmark", "latitude": 55.67938, "longitude": 12.53463, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07523633" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06606821", "study_title": "The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease", "lead_sponsor": "Tina Vilsbøll", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-05", "last_update_post_date": "2025-05-22", "facility": "Gentofte Hospital", "city": "Gentofte Municipality", "state_or_region": null, "postal_code": "2900", "country": "Denmark", "latitude": 55.74903, "longitude": 12.54601, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06606821" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aalborg Universitetshospital, Syd", "city": "Gistrup", "state_or_region": null, "postal_code": "9260", "country": "Denmark", "latitude": 56.9943, "longitude": 9.99085, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aalborg Universitetshospital, Syd", "city": "Gistrup", "state_or_region": null, "postal_code": "9260", "country": "Denmark", "latitude": 56.9943, "longitude": 9.99085, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06792422", "study_title": "A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma", "lead_sponsor": "Glostrup University Hospital, Copenhagen", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-11", "last_update_post_date": "2025-01-24", "facility": "Department of Ophthalmology, Rigshospitalet", "city": "Glostrup Municipality", "state_or_region": null, "postal_code": "2600", "country": "Denmark", "latitude": 55.6666, "longitude": 12.40377, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06792422" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Gentofte Hospital - Center for Klinisk Metabolisk Forskning", "city": "Hellerup", "state_or_region": null, "postal_code": "2900", "country": "Denmark", "latitude": 55.73204, "longitude": 12.57093, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07239570", "study_title": "A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease", "lead_sponsor": "Peter Rossing", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-20", "facility": "Steno Diabetes Center Copenhagen", "city": "Herlev", "state_or_region": null, "postal_code": null, "country": "Denmark", "latitude": 55.72366, "longitude": 12.43998, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07239570" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06082063", "study_title": "Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes", "lead_sponsor": "Steno Diabetes Center Copenhagen", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-01", "last_update_post_date": "2025-01-10", "facility": "Steno Diabetes Center Copenhagen", "city": "Herlev", "state_or_region": null, "postal_code": "2730", "country": "Denmark", "latitude": 55.72366, "longitude": 12.43998, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06082063" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06606821", "study_title": "The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease", "lead_sponsor": "Tina Vilsbøll", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-05", "last_update_post_date": "2025-05-22", "facility": "Steno Diabetes Center Copenhagen", "city": "Herlev", "state_or_region": null, "postal_code": "2730", "country": "Denmark", "latitude": 55.72366, "longitude": 12.43998, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06606821" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07010432", "study_title": "The Role of the Amylin Analogue Cagrilintide in Bone Metabolism", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2025-07", "last_update_post_date": "2025-07-25", "facility": "Steno Diabetes Center Copenhagen", "city": "Herlev", "state_or_region": null, "postal_code": "2730", "country": "Denmark", "latitude": 55.72366, "longitude": 12.43998, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07010432" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Regionshospitalet Gødstrup, Hjertesygdomme", "city": "Herning", "state_or_region": null, "postal_code": "7400", "country": "Denmark", "latitude": 56.13615, "longitude": 8.97662, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Holbæk Sygehus - Børne- og Ungeafdelingen", "city": "Holbæk", "state_or_region": null, "postal_code": "4300", "country": "Denmark", "latitude": 55.7175, "longitude": 11.71279, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Odense Universitetshospital", "city": "Odense", "state_or_region": null, "postal_code": "5000", "country": "Denmark", "latitude": 55.39594, "longitude": 10.38831, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Odense Universitetshospital", "city": "Odense", "state_or_region": null, "postal_code": "5000", "country": "Denmark", "latitude": 55.39594, "longitude": 10.38831, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vejle Sygehus", "city": "Vejle", "state_or_region": null, "postal_code": "7100", "country": "Denmark", "latitude": 55.70927, "longitude": 9.5357, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vejle Sygehus", "city": "Vejle", "state_or_region": null, "postal_code": "7100", "country": "Denmark", "latitude": 55.70927, "longitude": 9.5357, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06939088", "study_title": "Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder", "lead_sponsor": "Anders Fink-Jensen, MD, DMSci", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-10", "facility": "Department of Psychiatry, Aalborg University Hospital", "city": "Aalborg", "state_or_region": "Denmark", "postal_code": "9000", "country": "Denmark", "latitude": 57.048, "longitude": 9.9187, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06939088" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06939088", "study_title": "Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder", "lead_sponsor": "Anders Fink-Jensen, MD, DMSci", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-10", "facility": "Psychiatric Center Copenhagen, Frederiksberg Hospital", "city": "Frederiksberg", "state_or_region": "Denmark", "postal_code": "2100", "country": "Denmark", "latitude": 55.67938, "longitude": 12.53463, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06939088" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07136714", "study_title": "Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity", "lead_sponsor": "Nordsjaellands Hospital", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-06", "facility": "Mental Health Centre North Zealand", "city": "Hillerød", "state_or_region": "Denmark", "postal_code": "3400", "country": "Denmark", "latitude": 55.92791, "longitude": 12.30081, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07136714" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06762314", "study_title": "Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes", "lead_sponsor": "Mostafa Bahaa", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-13", "facility": "Tanta Unuversity", "city": "Tanta", "state_or_region": null, "postal_code": "31527", "country": "Egypt", "latitude": 30.78847, "longitude": 31.00192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06762314" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Amiens-Picardie", "city": "Amiens", "state_or_region": null, "postal_code": "80054", "country": "France", "latitude": 49.9, "longitude": 2.3, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Amiens-Picardie", "city": "Amiens", "state_or_region": null, "postal_code": "80054", "country": "France", "latitude": 49.9, "longitude": 2.3, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU d'Amiens-Picardie - Hôpital Sud", "city": "Amiens", "state_or_region": null, "postal_code": "80054", "country": "France", "latitude": 49.9, "longitude": 2.3, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire D'Angers", "city": "Angers", "state_or_region": null, "postal_code": "49100", "country": "France", "latitude": 47.47156, "longitude": -0.55202, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire D'Angers", "city": "Angers", "state_or_region": null, "postal_code": "49100", "country": "France", "latitude": 47.47156, "longitude": -0.55202, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Centre Hospitalier Universitaire d'Angers", "city": "Angers", "state_or_region": null, "postal_code": "49933", "country": "France", "latitude": 47.47156, "longitude": -0.55202, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire d'Angers", "city": "Angers", "state_or_region": null, "postal_code": "49933", "country": "France", "latitude": 47.47156, "longitude": -0.55202, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Besançon", "city": "Besançon", "state_or_region": null, "postal_code": "25000", "country": "France", "latitude": 47.24878, "longitude": 6.01815, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CHU ROUEN_HOPITAL DE BOIS GUILLAUME_Service de Nutrition", "city": "Bois-Guillaume", "state_or_region": null, "postal_code": "76230", "country": "France", "latitude": 49.4602, "longitude": 1.12219, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hospices Civils de Lyon - Hopital Louis Pradel", "city": "Bron", "state_or_region": null, "postal_code": "69677", "country": "France", "latitude": 45.73865, "longitude": 4.91303, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Hôpital Privé Saint Martin_Service de chirurgie digestive", "city": "Caen", "state_or_region": null, "postal_code": "14000", "country": "France", "latitude": 49.18585, "longitude": -0.35912, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Beaujon", "city": "Clichy", "state_or_region": null, "postal_code": "92110", "country": "France", "latitude": 48.90018, "longitude": 2.30952, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Beaujon", "city": "Clichy", "state_or_region": null, "postal_code": "92110", "country": "France", "latitude": 48.90018, "longitude": 2.30952, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Beaujon", "city": "Clichy", "state_or_region": null, "postal_code": "92110", "country": "France", "latitude": 48.90018, "longitude": 2.30952, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CENTRE HOSPITALIER DE COLMAR_Endocrinologie/Diabetologie/Centre Nutritionnel", "city": "Colmar", "state_or_region": null, "postal_code": "68024", "country": "France", "latitude": 48.08078, "longitude": 7.35584, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "HOP Dijon-Bourgogne", "city": "Côte-d'Or", "state_or_region": null, "postal_code": "21000", "country": "France", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "HOP Dijon-Bourgogne", "city": "Côte-d'Or", "state_or_region": null, "postal_code": "21000", "country": "France", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopital Henri Mondor", "city": "Créteil", "state_or_region": null, "postal_code": "94000", "country": "France", "latitude": 48.79266, "longitude": 2.46569, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopital Henri Mondor", "city": "Créteil", "state_or_region": null, "postal_code": "94000", "country": "France", "latitude": 48.79266, "longitude": 2.46569, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand", "city": "Dijon", "state_or_region": null, "postal_code": "21079", "country": "France", "latitude": 47.31344, "longitude": 5.01391, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05305794", "study_title": "Effect of Weekly GLP1 Agonist Treatment in \"Double Diabetes\"", "lead_sponsor": "Centre Hospitalier Universitaire Dijon", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2025-12-18", "facility": "Chu Dijon Bourgogne", "city": "Dijon", "state_or_region": null, "postal_code": "21000", "country": "France", "latitude": 47.31344, "longitude": 5.01391, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05305794" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinique des Cèdres", "city": "Échirolles", "state_or_region": null, "postal_code": "38130", "country": "France", "latitude": 45.14603, "longitude": 5.71441, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinique des Cèdres", "city": "Échirolles", "state_or_region": null, "postal_code": "38130", "country": "France", "latitude": 45.14603, "longitude": 5.71441, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHD Vendee", "city": "La Roche-sur-Yon", "state_or_region": null, "postal_code": "85000", "country": "France", "latitude": 46.66974, "longitude": -1.42757, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHD Vendee", "city": "La Roche-sur-Yon", "state_or_region": null, "postal_code": "85000", "country": "France", "latitude": 46.66974, "longitude": -1.42757, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHD Vendee", "city": "La Roche-sur-Yon", "state_or_region": null, "postal_code": "85000", "country": "France", "latitude": 46.66974, "longitude": -1.42757, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier De Versailles", "city": "Le Chesnay", "state_or_region": null, "postal_code": "78150", "country": "France", "latitude": 48.8222, "longitude": 2.12213, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier De Versailles", "city": "Le Chesnay", "state_or_region": null, "postal_code": "78150", "country": "France", "latitude": 48.8222, "longitude": 2.12213, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "LES HOPITAUX DE CHARTRES_HOPITAL LOUIS PASTEUR_Service d'endocrinologie", "city": "Le Coudray", "state_or_region": null, "postal_code": "28630", "country": "France", "latitude": 48.42115, "longitude": 1.50057, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "LES HOPITAUX DE CHARTRES_HOPITAL LOUIS PASTEUR_Service d'endocrinologie", "city": "Le Coudray", "state_or_region": null, "postal_code": "28630", "country": "France", "latitude": 48.42115, "longitude": 1.50057, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre", "city": "Le Kremlin-Bicêtre", "state_or_region": null, "postal_code": "94270", "country": "France", "latitude": 48.81471, "longitude": 2.36073, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre", "city": "Le Kremlin-Bicêtre", "state_or_region": null, "postal_code": "94270", "country": "France", "latitude": 48.81471, "longitude": 2.36073, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopital Claude Huriez - CHU de Lille", "city": "Lille", "state_or_region": null, "postal_code": "59037", "country": "France", "latitude": 50.63391, "longitude": 3.05512, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Claude Huriez", "city": "Lille", "state_or_region": null, "postal_code": "59000", "country": "France", "latitude": 50.63391, "longitude": 3.05512, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Claude Huriez", "city": "Lille", "state_or_region": null, "postal_code": "59000", "country": "France", "latitude": 50.63391, "longitude": 3.05512, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hôpital Jeanne de Flandre", "city": "Lille", "state_or_region": null, "postal_code": "59000", "country": "France", "latitude": 50.63391, "longitude": 3.05512, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Hôpital Privé La Louvière_Service de chirurgie", "city": "Lille", "state_or_region": null, "postal_code": "59800", "country": "France", "latitude": 50.63391, "longitude": 3.05512, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren", "city": "Limoges", "state_or_region": null, "postal_code": "87042", "country": "France", "latitude": 45.83362, "longitude": 1.24759, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopital De La Croix-Rousse", "city": "Lyon", "state_or_region": null, "postal_code": "69004", "country": "France", "latitude": 45.74906, "longitude": 4.84789, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopital De La Croix-Rousse", "city": "Lyon", "state_or_region": null, "postal_code": "69004", "country": "France", "latitude": 45.74906, "longitude": 4.84789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone", "city": "Marseille", "state_or_region": null, "postal_code": "13385", "country": "France", "latitude": 43.29695, "longitude": 5.38107, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chu Saint Eloi", "city": "Montpellier", "state_or_region": null, "postal_code": "34295", "country": "France", "latitude": 43.61093, "longitude": 3.87635, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chu Saint Eloi", "city": "Montpellier", "state_or_region": null, "postal_code": "34295", "country": "France", "latitude": 43.61093, "longitude": 3.87635, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centres Médico Chirurgicaux - Clinique Ambroise Paré", "city": "Neuilly-sur-Seine", "state_or_region": null, "postal_code": "92200", "country": "France", "latitude": 48.8846, "longitude": 2.26965, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centres Médico Chirurgicaux - Clinique Ambroise Paré", "city": "Neuilly-sur-Seine", "state_or_region": null, "postal_code": "92200", "country": "France", "latitude": 48.8846, "longitude": 2.26965, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Nice - Hôpital l'Archet", "city": "Nice", "state_or_region": null, "postal_code": "06200", "country": "France", "latitude": 43.70313, "longitude": 7.26608, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Nice - Hôpital l'Archet", "city": "Nice", "state_or_region": null, "postal_code": "06202", "country": "France", "latitude": 43.70313, "longitude": 7.26608, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Nice - Hôpital l'Archet", "city": "Nice", "state_or_region": null, "postal_code": "06202", "country": "France", "latitude": 43.70313, "longitude": 7.26608, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital de l'Archet", "city": "Nice", "state_or_region": null, "postal_code": "06200", "country": "France", "latitude": 43.70313, "longitude": 7.26608, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital de l'Archet", "city": "Nice", "state_or_region": null, "postal_code": "06200", "country": "France", "latitude": 43.70313, "longitude": 7.26608, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "APHP - LA PITIE SALPETRIERE _ Service de Nutrition", "city": "Paris", "state_or_region": null, "postal_code": "75013", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Assistance Publique - Hopitaux de Paris (AP-HP) - Hopital Robert Debre - Centre Hospitalo Universitaire (C -T", "city": "Paris", "state_or_region": null, "postal_code": "75019", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hôpital Armand Trousseau", "city": "Paris", "state_or_region": null, "postal_code": "75012", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Cochin", "city": "Paris", "state_or_region": null, "postal_code": "75014", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Cochin", "city": "Paris", "state_or_region": null, "postal_code": "75014", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "HOPITAL EUROPEEN GEORGES POMPIDOU_Service de nutrition et diabétologie", "city": "Paris", "state_or_region": null, "postal_code": "75015", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Saint Antoine", "city": "Paris", "state_or_region": null, "postal_code": "75571", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Saint Antoine", "city": "Paris", "state_or_region": null, "postal_code": "75571", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Saint Antoine", "city": "Paris", "state_or_region": null, "postal_code": "75571", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopitaux Universitaires Pitié-Salpétrière", "city": "Paris", "state_or_region": null, "postal_code": "75013", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopitaux Universitaires Pitié-Salpétrière", "city": "Paris", "state_or_region": null, "postal_code": "75013", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pitie Salpetriere University Hospital", "city": "Paris", "state_or_region": null, "postal_code": "75013", "country": "France", "latitude": 48.85341, "longitude": 2.3488, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire De Bordeaux", "city": "Pessac", "state_or_region": null, "postal_code": "33600", "country": "France", "latitude": 44.80565, "longitude": -0.6324, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire De Bordeaux", "city": "Pessac", "state_or_region": null, "postal_code": "33600", "country": "France", "latitude": 44.80565, "longitude": -0.6324, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Bordeaux Haut-Leveque", "city": "Pessac", "state_or_region": null, "postal_code": "33600", "country": "France", "latitude": 44.80565, "longitude": -0.6324, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CHU DE BORDEAUX-HOPITAL HAUT LEVEQUE_Service d'Endocrinologie, Diabétologie et Maladies Métaboliques", "city": "Pessac", "state_or_region": null, "postal_code": "33600", "country": "France", "latitude": 44.80565, "longitude": -0.6324, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Lyon Sud", "city": "Pierre-Bénite", "state_or_region": null, "postal_code": "69494 Cédex", "country": "France", "latitude": 45.70359, "longitude": 4.82424, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Lyon Sud", "city": "Pierre-Bénite", "state_or_region": null, "postal_code": "69495", "country": "France", "latitude": 45.70359, "longitude": 4.82424, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Lyon Sud", "city": "Pierre-Bénite", "state_or_region": null, "postal_code": "69495", "country": "France", "latitude": 45.70359, "longitude": 4.82424, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "HCL-HOPITAL LYON SUD_Service d'Endocrinologie-Diabète-Nutrition", "city": "Pierre-Bénite", "state_or_region": null, "postal_code": "69310", "country": "France", "latitude": 45.70359, "longitude": 4.82424, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou", "city": "Rennes", "state_or_region": null, "postal_code": "35000", "country": "France", "latitude": 48.11109, "longitude": -1.67431, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Charles Nicolle", "city": "Rouen", "state_or_region": null, "postal_code": "76031", "country": "France", "latitude": 49.44313, "longitude": 1.09932, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CHU NANTES - HOPITAL NORD LAENNEC_Service d'Endocrinologie-Diabétologie-Nutrition", "city": "Saint-Herblain", "state_or_region": null, "postal_code": "44800", "country": "France", "latitude": 47.21154, "longitude": -1.651, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Saint Étienne - Hôpital Nord", "city": "Saint-Priest-en-Jarez", "state_or_region": null, "postal_code": "42270", "country": "France", "latitude": 45.4739, "longitude": 4.37678, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centre Hospitalier Universitaire de Saint Étienne - Hôpital Nord", "city": "Saint-Priest-en-Jarez", "state_or_region": null, "postal_code": "42270", "country": "France", "latitude": 45.4739, "longitude": 4.37678, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nouvel Hôpital Civil (NHC)", "city": "Strasbourg", "state_or_region": null, "postal_code": "67091", "country": "France", "latitude": 48.58392, "longitude": 7.74553, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "CHU de Toulouse - Hôpital des Enfants", "city": "Toulouse", "state_or_region": null, "postal_code": "31059", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Rangueil", "city": "Toulouse", "state_or_region": null, "postal_code": "31059", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Rangueil", "city": "Toulouse", "state_or_region": null, "postal_code": "31059", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHU Rangueil", "city": "Toulouse", "state_or_region": null, "postal_code": "31059", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinique Pasteur", "city": "Toulouse", "state_or_region": null, "postal_code": "31076", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinique Pasteur", "city": "Toulouse", "state_or_region": null, "postal_code": "31076", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Rangueil - CHU de Toulouse", "city": "Toulouse", "state_or_region": null, "postal_code": "31059", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hôpital Rangueil - CHU de Toulouse", "city": "Toulouse", "state_or_region": null, "postal_code": "31059", "country": "France", "latitude": 43.60426, "longitude": 1.44367, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CENTRE DE RECHERCHE CLINIQUE PORTES DU SUD_Service d'Endocrinologie-Diabétologie-Maladies Métaboliques", "city": "Vénissieux", "state_or_region": null, "postal_code": "69200", "country": "France", "latitude": 45.69706, "longitude": 4.88593, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "CENTRE DE RECHERCHE CLINIQUE PORTES DU SUD_Service d'Endocrinologie-Diabétologie-Maladies Métaboliques", "city": "Vénissieux", "state_or_region": null, "postal_code": "69200", "country": "France", "latitude": 45.69706, "longitude": 4.88593, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Groupe Hospitalier Mutualiste Les Portes du Sud", "city": "Vénissieux", "state_or_region": null, "postal_code": "69200", "country": "France", "latitude": 45.69706, "longitude": 4.88593, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ltd \"Health\"", "city": "Batumi", "state_or_region": null, "postal_code": "6010", "country": "Georgia", "latitude": 41.64077, "longitude": 41.6306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ltd \"Health\"", "city": "Batumi", "state_or_region": null, "postal_code": "6010", "country": "Georgia", "latitude": 41.64077, "longitude": 41.6306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ISR-GEO Med Res Clin Healthycore", "city": "Tbilisi", "state_or_region": null, "postal_code": "0112", "country": "Georgia", "latitude": 41.69143, "longitude": 44.83412, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ISR-GEO Med Res Clin Healthycore", "city": "Tbilisi", "state_or_region": null, "postal_code": "0112", "country": "Georgia", "latitude": 41.69143, "longitude": 44.83412, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Herz - und Diabeteszentrum Nordrhein - Westfalen, Bad Oeynhausen", "city": "Bad Oeynhausen", "state_or_region": null, "postal_code": "32545", "country": "Germany", "latitude": 52.20699, "longitude": 8.80365, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Herz- und Diabeteszentrum NRW - Bad Oeynhausen", "city": "Bad Oeynhausen", "state_or_region": null, "postal_code": "32545", "country": "Germany", "latitude": 52.20699, "longitude": 8.80365, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bad Oeynhausen", "state_or_region": null, "postal_code": "32545", "country": "Germany", "latitude": 52.20699, "longitude": 8.80365, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charité - Universitätsmedizin Berlin", "city": "Berlin", "state_or_region": null, "postal_code": "13353", "country": "Germany", "latitude": 52.52437, "longitude": 13.41053, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charité - Universitätsmedizin Berlin", "city": "Berlin", "state_or_region": null, "postal_code": "13353", "country": "Germany", "latitude": 52.52437, "longitude": 13.41053, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charité Campus Virchow-Klinikum", "city": "Berlin", "state_or_region": null, "postal_code": "13353", "country": "Germany", "latitude": 52.52437, "longitude": 13.41053, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR", "city": "Berlin", "state_or_region": null, "postal_code": "13597", "country": "Germany", "latitude": 52.52437, "longitude": 13.41053, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07557953", "study_title": "A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-15", "facility": "Parexel International GmbH", "city": "Berlin", "state_or_region": null, "postal_code": "14050", "country": "Germany", "latitude": 52.52437, "longitude": 13.41053, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07557953" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07597018", "study_title": "A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-26", "facility": "Parexel International GmbH", "city": "Berlin", "state_or_region": null, "postal_code": "14050", "country": "Germany", "latitude": 52.52437, "longitude": 13.41053, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07597018" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Berlin", "state_or_region": null, "postal_code": "13597", "country": "Germany", "latitude": 52.52437, "longitude": 13.41053, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "DSP Bochum, Diabetes- und Stoffwechselpraxis", "city": "Bochum", "state_or_region": null, "postal_code": "44869", "country": "Germany", "latitude": 51.48165, "longitude": 7.21648, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH", "city": "Bochum", "state_or_region": null, "postal_code": "44892", "country": "Germany", "latitude": 51.48165, "longitude": 7.21648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH", "city": "Bochum", "state_or_region": null, "postal_code": "44892", "country": "Germany", "latitude": 51.48165, "longitude": 7.21648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07326111", "study_title": "A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese", "lead_sponsor": "University of Bonn", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-01-08", "facility": "University Hospital BG Bergmannsheil Bochum General internal medicine, endocrinology and diabetology, gastroenterology and hepatology", "city": "Bochum", "state_or_region": null, "postal_code": "44789", "country": "Germany", "latitude": 51.48165, "longitude": 7.21648, "site_statuses": "ENROLLING_BY_INVITATION", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07326111" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07326111", "study_title": "A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese", "lead_sponsor": "University of Bonn", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-01-08", "facility": "University Hospital Bonn Division of Endocrinology, Diabetes and Metabolism", "city": "Bonn", "state_or_region": null, "postal_code": "53127", "country": "Germany", "latitude": 50.73438, "longitude": 7.09549, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07326111" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Städtisches Klinikum Brandenburg", "city": "Brandenburg", "state_or_region": null, "postal_code": "14770", "country": "Germany", "latitude": 50.69716, "longitude": 6.14466, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Studiengesellschaft Dres. Könemann/Steinmann GbR", "city": "Bünde", "state_or_region": null, "postal_code": "32257", "country": "Germany", "latitude": 52.19837, "longitude": 8.58644, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Chemnitz", "state_or_region": null, "postal_code": "09116", "country": "Germany", "latitude": 50.8357, "longitude": 12.92922, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Universitaetsklinikum Koeln", "city": "Cologne", "state_or_region": null, "postal_code": "50937", "country": "Germany", "latitude": 50.93333, "longitude": 6.95, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Köln (AöR)", "city": "Cologne", "state_or_region": null, "postal_code": "50937", "country": "Germany", "latitude": 50.93333, "longitude": 6.95, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Köln (AöR)", "city": "Cologne", "state_or_region": null, "postal_code": "50937", "country": "Germany", "latitude": 50.93333, "longitude": 6.95, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Damme", "state_or_region": null, "postal_code": "49401", "country": "Germany", "latitude": 52.52148, "longitude": 8.19766, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Technische Universität Dresden", "city": "Dresden", "state_or_region": null, "postal_code": "01307", "country": "Germany", "latitude": 51.05089, "longitude": 13.73832, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Technische Universität Dresden", "city": "Dresden", "state_or_region": null, "postal_code": "01307", "country": "Germany", "latitude": 51.05089, "longitude": 13.73832, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitaetsklinikum Carl Gustav Carus, Technischen Universitaet Dresden", "city": "Dresden", "state_or_region": null, "postal_code": "01307", "country": "Germany", "latitude": 51.05089, "longitude": 13.73832, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Duisburg", "state_or_region": null, "postal_code": "47051", "country": "Germany", "latitude": 51.43247, "longitude": 6.76516, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Deutsches Diabetes-Zentrum (DDZ)", "city": "Düsseldorf", "state_or_region": null, "postal_code": "40225", "country": "Germany", "latitude": 51.22319, "longitude": 6.77927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Elsterwerda", "state_or_region": null, "postal_code": "04910", "country": "Germany", "latitude": 51.46043, "longitude": 13.52001, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Erlangen", "state_or_region": null, "postal_code": "91054", "country": "Germany", "latitude": 49.59099, "longitude": 11.00783, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Erlangen", "city": "Erlangen", "state_or_region": null, "postal_code": "91054", "country": "Germany", "latitude": 49.59099, "longitude": 11.00783, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "InnoDiab Forschung GmbH", "city": "Essen", "state_or_region": null, "postal_code": "45136", "country": "Germany", "latitude": 51.45657, "longitude": 7.01228, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Essen", "state_or_region": null, "postal_code": "45359", "country": "Germany", "latitude": 51.45657, "longitude": 7.01228, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Falkensee", "state_or_region": null, "postal_code": "14612", "country": "Germany", "latitude": 52.56014, "longitude": 13.0927, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Frankfurt Goethe-Universität", "city": "Frankfurt", "state_or_region": null, "postal_code": "60590", "country": "Germany", "latitude": 49.68333, "longitude": 10.53333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Frankfurt Goethe-Universität", "city": "Frankfurt", "state_or_region": null, "postal_code": "60590", "country": "Germany", "latitude": 49.68333, "longitude": 10.53333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Frankfurt Goethe-Universität", "city": "Frankfurt", "state_or_region": null, "postal_code": "60590", "country": "Germany", "latitude": 49.68333, "longitude": 10.53333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Frankfurt", "city": "Frankfurt", "state_or_region": null, "postal_code": "69590", "country": "Germany", "latitude": 49.68333, "longitude": 10.53333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Frankfurt", "city": "Frankfurt", "state_or_region": null, "postal_code": "69590", "country": "Germany", "latitude": 49.68333, "longitude": 10.53333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Gladbeck", "state_or_region": null, "postal_code": "45968", "country": "Germany", "latitude": 51.57077, "longitude": 6.98593, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Praxiszentrum für Gastroenterologie", "city": "Grevenbroich", "state_or_region": null, "postal_code": "41515", "country": "Germany", "latitude": 51.09102, "longitude": 6.5827, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Praxiszentrum für Gastroenterologie", "city": "Grevenbroich", "state_or_region": null, "postal_code": "41515", "country": "Germany", "latitude": 51.09102, "longitude": 6.5827, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Studiengesellschaft Mitteldeutschland GmbH", "city": "Halle", "state_or_region": null, "postal_code": "06108", "country": "Germany", "latitude": 51.48158, "longitude": 11.97947, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Studiengesellschaft Mitteldeutschland GmbH", "city": "Halle", "state_or_region": null, "postal_code": "06108", "country": "Germany", "latitude": 51.48158, "longitude": 11.97947, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Hamburg", "state_or_region": null, "postal_code": "21109", "country": "Germany", "latitude": 53.55073, "longitude": 9.99302, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Hamburg", "state_or_region": null, "postal_code": "22607", "country": "Germany", "latitude": 53.55073, "longitude": 9.99302, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07239570", "study_title": "A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease", "lead_sponsor": "Peter Rossing", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-20", "facility": "University Medical Center Hamburg-Eppendorf", "city": "Hamburg", "state_or_region": null, "postal_code": null, "country": "Germany", "latitude": 53.55073, "longitude": 9.99302, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07239570" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Hochschule Hannover", "city": "Hanover", "state_or_region": null, "postal_code": "30625", "country": "Germany", "latitude": 52.37052, "longitude": 9.73322, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Hochschule Hannover", "city": "Hanover", "state_or_region": null, "postal_code": "30625", "country": "Germany", "latitude": 52.37052, "longitude": 9.73322, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medizinische Hochschule Hannover", "city": "Hanover", "state_or_region": null, "postal_code": "30625", "country": "Germany", "latitude": 52.37052, "longitude": 9.73322, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitaetsklinikum Heidelberg", "city": "Heidelberg", "state_or_region": null, "postal_code": "69120", "country": "Germany", "latitude": 49.40768, "longitude": 8.69079, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Heidelberg", "city": "Heidelberg", "state_or_region": null, "postal_code": "69120", "country": "Germany", "latitude": 49.40768, "longitude": 8.69079, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Heidelberg", "city": "Heidelberg", "state_or_region": null, "postal_code": "69120", "country": "Germany", "latitude": 49.40768, "longitude": 8.69079, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Mesut Durmaz, Hof", "city": "Hof", "state_or_region": null, "postal_code": "95030", "country": "Germany", "latitude": 50.31297, "longitude": 11.91261, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitaetsklinikum des Saarlandes", "city": "Homburg", "state_or_region": null, "postal_code": "66424", "country": "Germany", "latitude": 49.32637, "longitude": 7.33867, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universität des Saarlandes", "city": "Homburg", "state_or_region": null, "postal_code": "66421", "country": "Germany", "latitude": 49.32637, "longitude": 7.33867, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universität des Saarlandes", "city": "Homburg", "state_or_region": null, "postal_code": "66421", "country": "Germany", "latitude": 49.32637, "longitude": 7.33867, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Eugastro GmbH", "city": "Leipzig", "state_or_region": null, "postal_code": "04103", "country": "Germany", "latitude": 51.33962, "longitude": 12.37129, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Eugastro GmbH", "city": "Leipzig", "state_or_region": null, "postal_code": "04103", "country": "Germany", "latitude": 51.33962, "longitude": 12.37129, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Eugastro GmbH", "city": "Leipzig", "state_or_region": null, "postal_code": "04103", "country": "Germany", "latitude": 51.33962, "longitude": 12.37129, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Eugastro GmbH", "city": "Leipzig", "state_or_region": null, "postal_code": "04103", "country": "Germany", "latitude": 51.33962, "longitude": 12.37129, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Leipzig", "state_or_region": null, "postal_code": "04249", "country": "Germany", "latitude": 51.33962, "longitude": 12.37129, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Universitätsklinikum Leipzig", "city": "Leipzig", "state_or_region": null, "postal_code": "04103", "country": "Germany", "latitude": 51.33962, "longitude": 12.37129, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Leipzig", "city": "Leipzig", "state_or_region": null, "postal_code": "04103", "country": "Germany", "latitude": 51.33962, "longitude": 12.37129, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Schleswig-Holstein, Campus Lübeck", "city": "Lübeck", "state_or_region": null, "postal_code": "23538", "country": "Germany", "latitude": 53.86893, "longitude": 10.68729, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Schleswig-Holstein, Campus Lübeck", "city": "Lübeck", "state_or_region": null, "postal_code": "23538", "country": "Germany", "latitude": 53.86893, "longitude": 10.68729, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Otto-von-Guericke-Universität Magdeburg", "city": "Magdeburg", "state_or_region": null, "postal_code": "39120", "country": "Germany", "latitude": 52.13129, "longitude": 11.63189, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Otto-von-Guericke-Universität Magdeburg", "city": "Magdeburg", "state_or_region": null, "postal_code": "39120", "country": "Germany", "latitude": 52.13129, "longitude": 11.63189, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsmedizin der Johannes Gutenberg-Universität Mainz", "city": "Mainz", "state_or_region": null, "postal_code": "55131", "country": "Germany", "latitude": 49.98185, "longitude": 8.28008, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsmedizin der Johannes Gutenberg-Universität Mainz", "city": "Mainz", "state_or_region": null, "postal_code": "55131", "country": "Germany", "latitude": 49.98185, "longitude": 8.28008, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsmedizin Johannes Gutenberg Universität Mainz", "city": "Mainz", "state_or_region": null, "postal_code": "55131", "country": "Germany", "latitude": 49.98185, "longitude": 8.28008, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "CRS Clinical Research Mannheim GmbH (hVIVO Mannheim)", "city": "Mannheim", "state_or_region": null, "postal_code": "68167", "country": "Germany", "latitude": 49.4891, "longitude": 8.46694, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Mannheim", "state_or_region": null, "postal_code": "68167", "country": "Germany", "latitude": 49.4891, "longitude": 8.46694, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Heidelberg", "city": "Mannheim", "state_or_region": null, "postal_code": "68167", "country": "Germany", "latitude": 49.4891, "longitude": 8.46694, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Heidelberg", "city": "Mannheim", "state_or_region": null, "postal_code": "68167", "country": "Germany", "latitude": 49.4891, "longitude": 8.46694, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Münster", "state_or_region": null, "postal_code": "48145", "country": "Germany", "latitude": 51.96236, "longitude": 7.62571, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Münster", "city": "Münster", "state_or_region": null, "postal_code": "49129", "country": "Germany", "latitude": 51.96236, "longitude": 7.62571, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Münster", "city": "Münster", "state_or_region": null, "postal_code": "49129", "country": "Germany", "latitude": 51.96236, "longitude": 7.62571, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ruppiner Kliniken", "city": "Neuruppin", "state_or_region": null, "postal_code": "16816", "country": "Germany", "latitude": 52.92815, "longitude": 12.80311, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Oldenburg", "state_or_region": null, "postal_code": "23758", "country": "Germany", "latitude": 53.14039, "longitude": 8.21479, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Pirna", "state_or_region": null, "postal_code": "01796", "country": "Germany", "latitude": 50.95843, "longitude": 13.93702, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinikum Ernst von Bergmann", "city": "Potsdam", "state_or_region": null, "postal_code": "14467", "country": "Germany", "latitude": 52.39886, "longitude": 13.06566, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinikum Ernst von Bergmann", "city": "Potsdam", "state_or_region": null, "postal_code": "14467", "country": "Germany", "latitude": 52.39886, "longitude": 13.06566, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sankt Ingbert", "state_or_region": null, "postal_code": "66386", "country": "Germany", "latitude": 49.27697, "longitude": 7.11672, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Tübingen", "city": "Tübingen", "state_or_region": null, "postal_code": "72076", "country": "Germany", "latitude": 48.52266, "longitude": 9.05222, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Universitaetsklinikum Ulm", "city": "Ulm", "state_or_region": null, "postal_code": "89075", "country": "Germany", "latitude": 48.39841, "longitude": 9.99155, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Wangen", "state_or_region": null, "postal_code": "88239", "country": "Germany", "latitude": 47.6895, "longitude": 9.83247, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "St. Josefs-Hospital Wiesbaden", "city": "Wiesbaden", "state_or_region": null, "postal_code": "65189", "country": "Germany", "latitude": 50.08601, "longitude": 8.24435, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "St. Josefs-Hospital Wiesbaden", "city": "Wiesbaden", "state_or_region": null, "postal_code": "65189", "country": "Germany", "latitude": 50.08601, "longitude": 8.24435, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Würzburg AÖR", "city": "Würzburg", "state_or_region": null, "postal_code": "97080", "country": "Germany", "latitude": 49.79391, "longitude": 9.95121, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitätsklinikum Würzburg AÖR", "city": "Würzburg", "state_or_region": null, "postal_code": "97080", "country": "Germany", "latitude": 49.79391, "longitude": 9.95121, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Versdias - Diabetologikum Amberg", "city": "Amberg", "state_or_region": "Bavaria", "postal_code": "92224", "country": "Germany", "latitude": 49.44287, "longitude": 11.86267, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "University General Hospital Of Alexandroupoli - First Department of Internal Medicine", "city": "Alexandroupoli", "state_or_region": null, "postal_code": "68100", "country": "Greece", "latitude": 40.84995, "longitude": 25.87644, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Athens Medical Center S.A. (Iatriko Psychikou) - Department of Internal Medicine & Metabolic Diseases", "city": "Athens", "state_or_region": null, "postal_code": "11525", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Evangelismos General Hospital of Athens", "city": "Athens", "state_or_region": null, "postal_code": "106 76", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Evangelismos General Hospital of Athens", "city": "Athens", "state_or_region": null, "postal_code": "106 76", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Evangelismos S.A. - Endocrinology department", "city": "Athens", "state_or_region": null, "postal_code": "10676", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "General Hospital Of Athens Alexandra - Clinical Therapeutics", "city": "Athens", "state_or_region": null, "postal_code": "11528", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Laiko General Hospital Of Athens - 1st department of Internal Medicine", "city": "Athens", "state_or_region": null, "postal_code": "115 27", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Thoracic General Hospital of Athens \"I Sotiria\"", "city": "Athens", "state_or_region": null, "postal_code": "115 27", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Thoracic General Hospital of Athens \"I Sotiria\"", "city": "Athens", "state_or_region": null, "postal_code": "115 27", "country": "Greece", "latitude": 37.98376, "longitude": 23.72784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University General Hospital of Heraklion", "city": "Heraklion", "state_or_region": null, "postal_code": "711 10", "country": "Greece", "latitude": 35.32787, "longitude": 25.14341, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University General Hospital of Heraklion", "city": "Heraklion", "state_or_region": null, "postal_code": "711 10", "country": "Greece", "latitude": 35.32787, "longitude": 25.14341, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "City Hospital Kliniki Monoprosopi I.K.E.", "city": "Kalamata", "state_or_region": null, "postal_code": "24100", "country": "Greece", "latitude": 37.03913, "longitude": 22.11265, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "General Hospital Of Lamia - Internal Medicine Clinic", "city": "Lamia", "state_or_region": null, "postal_code": "35100", "country": "Greece", "latitude": 38.89947, "longitude": 22.4335, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Athens Medical Center S.A. (Iatriko Athinon) - Diabetes and Obesity Unit", "city": "Marousi", "state_or_region": null, "postal_code": "15125", "country": "Greece", "latitude": 38.05, "longitude": 23.8, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Athens Medical Center S.A. (Iatriko Athinon) - Diabetes and Obesity Unit", "city": "Marousi", "state_or_region": null, "postal_code": "15125", "country": "Greece", "latitude": 38.05, "longitude": 23.8, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Athens Medical Center S.A. (Iatriko P. Falirou) - Diabetes and Clinical Research Center", "city": "Palaió Fáliro", "state_or_region": null, "postal_code": "17562", "country": "Greece", "latitude": 37.92812, "longitude": 23.70105, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Athens Medical Center S.A. (Iatriko Peristeriou) - Diabetes, obesity and cardiometabolic diseases department", "city": "Peristeri", "state_or_region": null, "postal_code": "121 31", "country": "Greece", "latitude": 38.01539, "longitude": 23.69187, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Athens Medical Center S.A. (Iatriko Peristeriou) - Diabetes, obesity and cardiometabolic diseases department", "city": "Peristeri", "state_or_region": null, "postal_code": "121 31", "country": "Greece", "latitude": 38.01539, "longitude": 23.69187, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Athens Medical Center S.A., European Interbalkan Medical Center - Department of Internal Medicine", "city": "Thessaloniki", "state_or_region": null, "postal_code": "546 39", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "General Hospital Of Thessaloniki G Gennimatas - Internal Medicine Clinic", "city": "Thessaloniki", "state_or_region": null, "postal_code": "54635", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ippokrateio General Hospital of Thessaloniki", "city": "Thessaloniki", "state_or_region": null, "postal_code": "54642", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ippokrateio General Hospital of Thessaloniki", "city": "Thessaloniki", "state_or_region": null, "postal_code": "54642", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "NextHealth S.A. - Department of Endocrinology, Metabolism & Diabetes", "city": "Thessaloniki", "state_or_region": null, "postal_code": "54635", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "NextHealth S.A. - Department of Endocrinology, Metabolism & Diabetes", "city": "Thessaloniki", "state_or_region": null, "postal_code": "54635", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Thermi Clinic S.A. - Diabetes and Internal Medicine Department", "city": "Thessaloniki", "state_or_region": null, "postal_code": "57001", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Thermi Clinic S.A. - Diabetes and Internal Medicine Department", "city": "Thessaloniki", "state_or_region": null, "postal_code": "57001", "country": "Greece", "latitude": 40.64072, "longitude": 22.93493, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Queen Mary Hospital", "city": "Hksar", "state_or_region": null, "postal_code": null, "country": "Hong Kong", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05356104", "study_title": "GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)", "lead_sponsor": "Chinese University of Hong Kong", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-05", "facility": "Chinese University of Hong Kong", "city": "Hong Kong", "state_or_region": null, "postal_code": null, "country": "Hong Kong", "latitude": 22.27832, "longitude": 114.17469, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05356104" }, { "compound_slugs": "liraglutide", "nct_id": "NCT05268237", "study_title": "Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus", "lead_sponsor": "Biolingus", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-02", "last_update_post_date": "2025-02-06", "facility": "Clinical Trials Unit, Chinese University of Hong Kong", "city": "Hong Kong", "state_or_region": null, "postal_code": null, "country": "Hong Kong", "latitude": 22.27832, "longitude": 114.17469, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05268237" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06937060", "study_title": "Effect of Semaglutide in Patients With Psoriasis and Obesity", "lead_sponsor": "The University of Hong Kong", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-04", "last_update_post_date": "2025-05-13", "facility": "The University of Hong Kong, Department of Medicine", "city": "Hong Kong", "state_or_region": null, "postal_code": null, "country": "Hong Kong", "latitude": 22.27832, "longitude": 114.17469, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937060" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Prince of Wales Hospital", "city": "Shatin", "state_or_region": null, "postal_code": "NT", "country": "Hong Kong", "latitude": 22.38333, "longitude": 114.18333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tuen Mun Hospital", "city": "Tuenmen", "state_or_region": null, "postal_code": "999077", "country": "Hong Kong", "latitude": 22.39175, "longitude": 113.97157, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "EURÉKA-CENTER Orvosi és Szolgáltató Betéti Társaság", "city": "Baja", "state_or_region": null, "postal_code": "6500", "country": "Hungary", "latitude": 46.18299, "longitude": 18.95307, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Békés Vármegyei Központi Kórház", "city": "Békéscsaba", "state_or_region": null, "postal_code": "5600", "country": "Hungary", "latitude": 46.68333, "longitude": 21.1, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Dr. Rethy Pal Hospital", "city": "Békéscsaba", "state_or_region": null, "postal_code": "5600", "country": "Hungary", "latitude": 46.68333, "longitude": 21.1, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Dr. Rethy Pal Hospital", "city": "Békéscsaba", "state_or_region": null, "postal_code": "5600", "country": "Hungary", "latitude": 46.68333, "longitude": 21.1, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Trial Pharma Kft.", "city": "Békéscsaba", "state_or_region": null, "postal_code": "5600", "country": "Hungary", "latitude": 46.68333, "longitude": 21.1, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Biatros Kft.", "city": "Biatorbágy", "state_or_region": null, "postal_code": "2051", "country": "Hungary", "latitude": 47.4706, "longitude": 18.81892, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Cardiogeneral Kft.", "city": "Budapest", "state_or_region": null, "postal_code": "H-1141", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet", "city": "Budapest", "state_or_region": null, "postal_code": "1097", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet", "city": "Budapest", "state_or_region": null, "postal_code": "1097", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Észak-Közép-budai Centrum, Szent János Kórház és Szakrendelő", "city": "Budapest", "state_or_region": null, "postal_code": "1023", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Obudai Egeszegugyi Centrum", "city": "Budapest", "state_or_region": null, "postal_code": "1036", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Obudai Egeszegugyi Centrum", "city": "Budapest", "state_or_region": null, "postal_code": "1036", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Óbudai Egészségügyi Centrum", "city": "Budapest", "state_or_region": null, "postal_code": "1036", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "PVN Kutató Kft.", "city": "Budapest", "state_or_region": null, "postal_code": "1102", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Budapest", "state_or_region": null, "postal_code": "1036", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Budapest", "state_or_region": null, "postal_code": "1089", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Budapest", "state_or_region": null, "postal_code": "1132", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Semmelweis Egyetem ÁOK", "city": "Budapest", "state_or_region": null, "postal_code": "1083", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Semmelweis Egyetem Sebeszeti, Transzplantacios es Gasztroenterologiai Klinika", "city": "Budapest", "state_or_region": null, "postal_code": "1082", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Semmelweis Egyetem Sebeszeti, Transzplantacios es Gasztroenterologiai Klinika", "city": "Budapest", "state_or_region": null, "postal_code": "1082", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Semmelweis Egyetem", "city": "Budapest", "state_or_region": null, "postal_code": "1082", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Semmelweis Egyetem", "city": "Budapest", "state_or_region": null, "postal_code": "1082", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Semmelweis Egyetem", "city": "Budapest", "state_or_region": null, "postal_code": "1083", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Semmelweis Egyetem", "city": "Budapest", "state_or_region": null, "postal_code": "1083", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Semmelweis Egyetem", "city": "Budapest", "state_or_region": null, "postal_code": "1088", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Semmelweis Egyetem", "city": "Budapest", "state_or_region": null, "postal_code": "1088", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Szent Margit Rendelőintézet Nonprofit Kft.", "city": "Budapest", "state_or_region": null, "postal_code": "1032", "country": "Hungary", "latitude": 47.49835, "longitude": 19.04045, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Debreceni Egyetem Klinikai Kozpont", "city": "Debrecen", "state_or_region": null, "postal_code": "4032", "country": "Hungary", "latitude": 47.53167, "longitude": 21.62444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Debreceni Egyetem", "city": "Debrecen", "state_or_region": null, "postal_code": "4031", "country": "Hungary", "latitude": 47.53167, "longitude": 21.62444, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Debrecen", "state_or_region": null, "postal_code": "4032", "country": "Hungary", "latitude": 47.53167, "longitude": 21.62444, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Szabolcs Szatmár Bereg Vármegyei Oktatókórház", "city": "Nyíregyháza", "state_or_region": null, "postal_code": "4400", "country": "Hungary", "latitude": 47.95539, "longitude": 21.71671, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Pécsi Tudományegyetem ÁOK", "city": "Pécs", "state_or_region": null, "postal_code": "7624", "country": "Hungary", "latitude": 46.07617, "longitude": 18.22814, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Salgótarján", "state_or_region": null, "postal_code": "3100", "country": "Hungary", "latitude": 48.09872, "longitude": 19.80303, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Szeged", "state_or_region": null, "postal_code": "6725", "country": "Hungary", "latitude": 46.253, "longitude": 20.14824, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Szegedi Tudományegyetem Gyermekgyógyászati Klinika", "city": "Szeged", "state_or_region": null, "postal_code": "6720", "country": "Hungary", "latitude": 46.253, "longitude": 20.14824, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ", "city": "Szeged", "state_or_region": null, "postal_code": "6725", "country": "Hungary", "latitude": 46.253, "longitude": 20.14824, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ", "city": "Szeged", "state_or_region": null, "postal_code": "6725", "country": "Hungary", "latitude": 46.253, "longitude": 20.14824, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Mentaház Kft.", "city": "Székesfehérvár", "state_or_region": null, "postal_code": "8000", "country": "Hungary", "latitude": 47.18995, "longitude": 18.41034, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CLINFAN Szolgáltató Kft", "city": "Szekszárd", "state_or_region": null, "postal_code": "7100", "country": "Hungary", "latitude": 46.34723, "longitude": 18.71189, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CLINFAN Szolgáltató Kft", "city": "Szekszárd", "state_or_region": null, "postal_code": "7100", "country": "Hungary", "latitude": 46.34723, "longitude": 18.71189, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Rendelőintézet", "city": "Szolnok", "state_or_region": null, "postal_code": "5000", "country": "Hungary", "latitude": 47.18066, "longitude": 20.19835, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Szolnok", "state_or_region": null, "postal_code": "5000", "country": "Hungary", "latitude": 47.18066, "longitude": 20.19835, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Zalaegerszeg", "state_or_region": null, "postal_code": "8900", "country": "Hungary", "latitude": 46.83695, "longitude": 16.84401, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Lausmed Kft.", "city": "Baja", "state_or_region": "Bács-Kiskun county", "postal_code": "6500", "country": "Hungary", "latitude": 46.18299, "longitude": 18.95307, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Dr. Lakatos Ferenc Kardiológus ,Belgyógyász Magán szakrendelés", "city": "Békéscsaba", "state_or_region": "Bekes County", "postal_code": "5600", "country": "Hungary", "latitude": 46.68333, "longitude": 21.1, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ", "city": "Szeged", "state_or_region": "Csongrád-Csanád", "postal_code": "6725", "country": "Hungary", "latitude": 46.253, "longitude": 20.14824, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ", "city": "Szeged", "state_or_region": "Csongrád-Csanád", "postal_code": "6725", "country": "Hungary", "latitude": 46.253, "longitude": 20.14824, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ", "city": "Szeged", "state_or_region": "Csongrád-Csanád", "postal_code": "6725", "country": "Hungary", "latitude": 46.253, "longitude": 20.14824, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Debreceni Egyetem", "city": "Debrecen", "state_or_region": "Hajdú-Bihar", "postal_code": "4032", "country": "Hungary", "latitude": 47.53167, "longitude": 21.62444, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Óbudai Egészségügyi Centrum", "city": "Budapest", "state_or_region": "Pest County", "postal_code": "1036", "country": "Hungary", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Szatmári-Med Kft.", "city": "Budapest", "state_or_region": "Pest County", "postal_code": "1213", "country": "Hungary", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medifarma-98 Kft.", "city": "Nyíregyháza", "state_or_region": "Szabolcs-Szatmár-Bereg", "postal_code": "4400", "country": "Hungary", "latitude": 47.95539, "longitude": 21.71671, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aryav Superspeciality Hospital", "city": "Ahemdabad", "state_or_region": null, "postal_code": "380060", "country": "India", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aryav Superspeciality Hospital", "city": "Ahemdabad", "state_or_region": null, "postal_code": "380060", "country": "India", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Avron Hospitals", "city": "Ahmedabad", "state_or_region": null, "postal_code": "380013", "country": "India", "latitude": 23.02579, "longitude": 72.58727, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gujarat Endocrine Centre", "city": "Ahmedabad", "state_or_region": null, "postal_code": "380006", "country": "India", "latitude": 23.02579, "longitude": 72.58727, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sardar Vallabhbhai Patel Institute of Medical Sciences and Research", "city": "Ahmedabad", "state_or_region": null, "postal_code": "380006", "country": "India", "latitude": 23.02579, "longitude": 72.58727, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AIIMS Bhubaneshwar", "city": "Bhubaneswar", "state_or_region": null, "postal_code": "751019", "country": "India", "latitude": 20.27241, "longitude": 85.83385, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "All India Institute of Medical Sciences", "city": "Bhubaneswar", "state_or_region": null, "postal_code": "751019", "country": "India", "latitude": 20.27241, "longitude": 85.83385, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Post Graduate Institute of Medical Education and Research", "city": "Chandigarh", "state_or_region": null, "postal_code": "14209-1120", "country": "India", "latitude": 30.73629, "longitude": 76.7884, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Post Graduate Institute of Medical Education and Research", "city": "Chandigarh", "state_or_region": null, "postal_code": "14209-1120", "country": "India", "latitude": 30.73629, "longitude": 76.7884, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Postgraduate Institute of Medical Education & Research", "city": "Chandigarh", "state_or_region": null, "postal_code": "160012", "country": "India", "latitude": 30.73629, "longitude": 76.7884, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "S.C.B. Medical College & Hospital", "city": "Cuttack", "state_or_region": null, "postal_code": "753007", "country": "India", "latitude": 20.46497, "longitude": 85.87927, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Amrita Institute of Medical Sciences and Research Center", "city": "Ernākulam", "state_or_region": null, "postal_code": "682041", "country": "India", "latitude": 9.96714, "longitude": 76.29036, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osmania Medical College & Hospital", "city": "Hyderabad, Afzalgunj", "state_or_region": null, "postal_code": "500012", "country": "India", "latitude": 17.38405, "longitude": 78.45636, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osmania Medical College & Hospital", "city": "Hyderabad, Afzalgunj", "state_or_region": null, "postal_code": "500012", "country": "India", "latitude": 17.38405, "longitude": 78.45636, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osmania Medical College & Hospital", "city": "Hyderabad, Afzalgunj", "state_or_region": null, "postal_code": "500012", "country": "India", "latitude": 17.38405, "longitude": 78.45636, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Asian Institute of Gastroenterology", "city": "Hyderabad", "state_or_region": null, "postal_code": "500032", "country": "India", "latitude": 17.38405, "longitude": 78.45636, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ManglamPlus Medicity Hospital", "city": "Jaipur", "state_or_region": null, "postal_code": "302020", "country": "India", "latitude": 26.91962, "longitude": 75.78781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SR Kalla Memorial Gastro & General Hospital", "city": "Jaipur", "state_or_region": null, "postal_code": "302006", "country": "India", "latitude": 26.91962, "longitude": 75.78781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SR Kalla Memorial Hospital", "city": "Jaipur", "state_or_region": null, "postal_code": "302001", "country": "India", "latitude": 26.91962, "longitude": 75.78781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SR Kalla Memorial Hospital", "city": "Jaipur", "state_or_region": null, "postal_code": "302001", "country": "India", "latitude": 26.91962, "longitude": 75.78781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Lisie Hospital", "city": "Kochi", "state_or_region": null, "postal_code": "682018", "country": "India", "latitude": 9.93988, "longitude": 76.26022, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Excel Endocrine Centre", "city": "Kolhāpur", "state_or_region": null, "postal_code": "416008", "country": "India", "latitude": 16.69563, "longitude": 74.23167, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shree Mahalaxmi Diatone Institute", "city": "Kolhāpur", "state_or_region": null, "postal_code": "416003", "country": "India", "latitude": 16.69563, "longitude": 74.23167, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "John C. Martin Centre for Liver Research & Innovations (JCMLRI)", "city": "Kolkata", "state_or_region": null, "postal_code": "700150", "country": "India", "latitude": 22.56263, "longitude": 88.36304, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Atharva Multispecialty Hospital and research Centre", "city": "Lucknow", "state_or_region": null, "postal_code": "226003", "country": "India", "latitude": 26.83928, "longitude": 80.92313, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Atharva Multispecialty Hospital and research Centre", "city": "Lucknow", "state_or_region": null, "postal_code": "226003", "country": "India", "latitude": 26.83928, "longitude": 80.92313, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sanjay Gandhi Post Graduate Institute of Medical Sciences", "city": "Lucknow", "state_or_region": null, "postal_code": "226 014", "country": "India", "latitude": 26.83928, "longitude": 80.92313, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sanjay Gandhi Post Graduate Institute of Medical Sciences", "city": "Lucknow", "state_or_region": null, "postal_code": "226014", "country": "India", "latitude": 26.83928, "longitude": 80.92313, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Dayanand Medical College and Hospital", "city": "Ludhiana", "state_or_region": null, "postal_code": "141001", "country": "India", "latitude": 30.91204, "longitude": 75.85379, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fortis Hospital - Mohali", "city": "Mohali", "state_or_region": null, "postal_code": "160062", "country": "India", "latitude": 30.67995, "longitude": 76.72211, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fortis Hospital, Mohali", "city": "Mohali", "state_or_region": null, "postal_code": "160062", "country": "India", "latitude": 30.67995, "longitude": 76.72211, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Topiwala National Medical College & B. Y. L. Nair Charitable Hospital", "city": "Mumbai", "state_or_region": null, "postal_code": "400008", "country": "India", "latitude": 19.07283, "longitude": 72.88261, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mysore Medical College", "city": "Mysore", "state_or_region": null, "postal_code": "570001", "country": "India", "latitude": 12.29791, "longitude": 76.63925, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "All India Institute of Medical Sciences (AIIMS) - Nagpur", "city": "Nagpur", "state_or_region": null, "postal_code": "441108", "country": "India", "latitude": 21.14631, "longitude": 79.08491, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diabetes Care and Research Centre", "city": "Nagpur", "state_or_region": null, "postal_code": "440010", "country": "India", "latitude": 21.14631, "longitude": 79.08491, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Midas Multispeciality Hospital Pvt. Ltd.", "city": "Nagpur", "state_or_region": null, "postal_code": "440010", "country": "India", "latitude": 21.14631, "longitude": 79.08491, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Midas Multispeciality Hospital Pvt. Ltd.", "city": "Nagpur", "state_or_region": null, "postal_code": "440010", "country": "India", "latitude": 21.14631, "longitude": 79.08491, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Midas Multispeciality Hospital Pvt.Ltd.", "city": "Nagpur", "state_or_region": null, "postal_code": "440010", "country": "India", "latitude": 21.14631, "longitude": 79.08491, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Supe Heart & Diabetes Hospital & Research Centre", "city": "Nashik", "state_or_region": null, "postal_code": "422002", "country": "India", "latitude": 19.99727, "longitude": 73.79096, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AIIMS, New Delhi", "city": "New Delhi", "state_or_region": null, "postal_code": "110029", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "All India Institute of Medical Sciences (AIIMS)", "city": "New Delhi", "state_or_region": null, "postal_code": "110029", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "All India Institute of Medical Sciences", "city": "New Delhi", "state_or_region": null, "postal_code": "110029", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "All India Institute of Medical Sciences", "city": "New Delhi", "state_or_region": null, "postal_code": "110029", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Insitute of Liver and Billiary Sciences", "city": "New Delhi", "state_or_region": null, "postal_code": "110 070", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Insitute of Liver and Billiary Sciences", "city": "New Delhi", "state_or_region": null, "postal_code": "110 070", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sir Ganga Ram Hospital", "city": "New Delhi", "state_or_region": null, "postal_code": "110060", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Deenanath Mangeshkar Hospital and Research Centre", "city": "Pune", "state_or_region": null, "postal_code": "411004", "country": "India", "latitude": 18.51957, "longitude": 73.85535, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "All India Institute of Medical Sciences - Rishikesh", "city": "Rishikesh", "state_or_region": null, "postal_code": "249203", "country": "India", "latitude": 30.10778, "longitude": 78.29255, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences", "city": "Rohtak", "state_or_region": null, "postal_code": "124001", "country": "India", "latitude": 28.89447, "longitude": 76.58917, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences", "city": "Rohtak", "state_or_region": null, "postal_code": "124001", "country": "India", "latitude": 28.89447, "longitude": 76.58917, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yashoda Hospitals - Secunderabad", "city": "Secunderabad", "state_or_region": null, "postal_code": "500003", "country": "India", "latitude": 17.50427, "longitude": 78.54263, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yashoda Hospitals - Secunderabad", "city": "Secunderabad", "state_or_region": null, "postal_code": "500003", "country": "India", "latitude": 17.50427, "longitude": 78.54263, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "BAPS Pramukh Swami Hospital", "city": "Surat", "state_or_region": null, "postal_code": "395009", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "BAPS Pramukh Swami Hospital", "city": "Surat", "state_or_region": null, "postal_code": "395009", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gujarat Gastro and Vascular Hospital", "city": "Surat", "state_or_region": null, "postal_code": "395009", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gujarat Gastro and Vascular Hospital", "city": "Surat", "state_or_region": null, "postal_code": "395009", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Surat Institute of Digestive Sciences Hospitals", "city": "Surat", "state_or_region": null, "postal_code": "395002", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Surat Institute of Digestive Sciences", "city": "Surat", "state_or_region": null, "postal_code": "395002", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Surat Institute of Digestive Sciences", "city": "Surat", "state_or_region": null, "postal_code": "395002", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jothydev's Diabetes Research Centre", "city": "Trivandrum", "state_or_region": null, "postal_code": "695032", "country": "India", "latitude": 8.4855, "longitude": 76.94924, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vishakha Institute of Medical Sciences", "city": "Visakhapatnam", "state_or_region": null, "postal_code": "530040", "country": "India", "latitude": 17.68009, "longitude": 83.20161, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Acharya Vinoba Bhave Rural Hospital", "city": "Wardha", "state_or_region": null, "postal_code": "442004", "country": "India", "latitude": 20.73933, "longitude": 78.59784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Endolife Specialty Hospitals", "city": "Guntur", "state_or_region": "Andhra Pradesh", "postal_code": "522001", "country": "India", "latitude": 16.29974, "longitude": 80.45729, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Endolife Specialty Hospitals", "city": "Guntur", "state_or_region": "Andhra Pradesh", "postal_code": "522001", "country": "India", "latitude": 16.29974, "longitude": 80.45729, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "BAPS Pramukh Swami Hospital", "city": "Surat", "state_or_region": "Gujarat", "postal_code": "395009", "country": "India", "latitude": 21.19594, "longitude": 72.83023, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06060392", "study_title": "Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus", "lead_sponsor": "Medanta, The Medicity, India", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-06", "last_update_post_date": "2025-06-13", "facility": "Division Of Endocrinology & Diabetes, Medanta The Medicity", "city": "Gurgaon", "state_or_region": "Haryana", "postal_code": "122001", "country": "India", "latitude": 28.4601, "longitude": 77.02635, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06060392" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Indira Gandhi Institute of child health", "city": "Bangalore", "state_or_region": "Karnataka", "postal_code": "560011", "country": "India", "latitude": 12.97194, "longitude": 77.59369, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "MS Ramaiah", "city": "Bengaluru", "state_or_region": "Karnataka", "postal_code": "560054", "country": "India", "latitude": 12.97194, "longitude": 77.59369, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Government Medical College, Kozhikode", "city": "Kozhikode", "state_or_region": "Kerala", "postal_code": "673008", "country": "India", "latitude": 11.24802, "longitude": 75.7804, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Sir Ganga Ram Hospital", "city": "New Delhi", "state_or_region": "National Capital Territory of Delhi", "postal_code": "110060", "country": "India", "latitude": 28.62137, "longitude": 77.2148, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Maulana Azad Medical College", "city": "Delhi", "state_or_region": "New Delhi", "postal_code": "110002", "country": "India", "latitude": 28.65195, "longitude": 77.23149, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Diabetes, Thyroid and Endocrine Centre", "city": "Jaipur", "state_or_region": "Rajasthan", "postal_code": "302006", "country": "India", "latitude": 26.91962, "longitude": 75.78781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "SMS Medical College & Hospital", "city": "Jaipur", "state_or_region": "Rajasthan", "postal_code": "302004", "country": "India", "latitude": 26.91962, "longitude": 75.78781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Diabetes Research Center, Hyderabad", "city": "Hyderabad", "state_or_region": "Telangana", "postal_code": "500082", "country": "India", "latitude": 17.38405, "longitude": 78.45636, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Nizams Institute of Medical Science", "city": "Hyderabad", "state_or_region": "Telangana", "postal_code": "500082", "country": "India", "latitude": 17.38405, "longitude": 78.45636, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Regency Hospital", "city": "Kanpur", "state_or_region": "Uttar Pradesh", "postal_code": "208006", "country": "India", "latitude": 26.46523, "longitude": 80.34975, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Institute of Child Health", "city": "Kolkata", "state_or_region": "West Bengal", "postal_code": "700017", "country": "India", "latitude": 22.56263, "longitude": 88.36304, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07064486", "study_title": "A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-10-28", "facility": "RSUP Fatmawati", "city": "Jakarta", "state_or_region": null, "postal_code": null, "country": "Indonesia", "latitude": -6.21462, "longitude": 106.84513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07064486" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07064486", "study_title": "A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-10-28", "facility": "RSUP Persahabatan", "city": "Jakarta", "state_or_region": null, "postal_code": null, "country": "Indonesia", "latitude": -6.21462, "longitude": 106.84513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07064486" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07064486", "study_title": "A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-10-28", "facility": "RSUPN Dr. Cipto Mangunkusumo", "city": "Jakarta", "state_or_region": null, "postal_code": null, "country": "Indonesia", "latitude": -6.21462, "longitude": 106.84513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07064486" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07064486", "study_title": "A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-10-28", "facility": "RS Universitas Indonesia", "city": "Depok", "state_or_region": "West Java", "postal_code": null, "country": "Indonesia", "latitude": -6.4, "longitude": 106.81861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07064486" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07423247", "study_title": "Tirzepatide (Spartina) in Obese Kidney Transplant Recipients", "lead_sponsor": "Shahid Beheshti University of Medical Sciences", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-20", "facility": "Nooshin Dalili", "city": "Tehran", "state_or_region": null, "postal_code": null, "country": "Iran", "latitude": 35.69439, "longitude": 51.42151, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07423247" }, { "compound_slugs": "semaglutide", "nct_id": "NCT04174755", "study_title": "Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV", "lead_sponsor": "University College Dublin", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-29", "facility": "Mater Misericordiae University Hospital", "city": "Dublin", "state_or_region": "Dublin", "postal_code": "D07 R2WY", "country": "Ireland", "latitude": 53.33306, "longitude": -6.24889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT04174755" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Emek Medical Center", "city": "Afula", "state_or_region": null, "postal_code": "1834111", "country": "Israel", "latitude": 32.60907, "longitude": 35.2892, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Assuta Ashdod Medical Center", "city": "Ashdod", "state_or_region": null, "postal_code": "7747629", "country": "Israel", "latitude": 31.79213, "longitude": 34.64966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Assuta Ashdod Medical Center", "city": "Ashdod", "state_or_region": null, "postal_code": "7747629", "country": "Israel", "latitude": 31.79213, "longitude": 34.64966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Barzilai Medical Center", "city": "Ashkelon", "state_or_region": null, "postal_code": "7830604", "country": "Israel", "latitude": 31.66926, "longitude": 34.57149, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Soroka Medical Center", "city": "Beersheba", "state_or_region": null, "postal_code": "8410101", "country": "Israel", "latitude": 31.25181, "longitude": 34.7913, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Soroka Medical Center", "city": "Beersheba", "state_or_region": null, "postal_code": "8410101", "country": "Israel", "latitude": 31.25181, "longitude": 34.7913, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Carmel Hospital", "city": "Haifa", "state_or_region": null, "postal_code": "3436212", "country": "Israel", "latitude": 32.81303, "longitude": 34.99928, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Carmel Hospital", "city": "Haifa", "state_or_region": null, "postal_code": "3436212", "country": "Israel", "latitude": 32.81303, "longitude": 34.99928, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Rambam Health Care Campus", "city": "Haifa", "state_or_region": null, "postal_code": "3109601", "country": "Israel", "latitude": 32.81303, "longitude": 34.99928, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rambam Health Care Campus", "city": "Haifa", "state_or_region": null, "postal_code": "3109601", "country": "Israel", "latitude": 32.81303, "longitude": 34.99928, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rambam Health Care Campus", "city": "Haifa", "state_or_region": null, "postal_code": "3109601", "country": "Israel", "latitude": 32.81303, "longitude": 34.99928, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rambam Health Care Campus", "city": "Haifa", "state_or_region": null, "postal_code": "3109601", "country": "Israel", "latitude": 32.81303, "longitude": 34.99928, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Rambam MC - Department of Pediatrics A", "city": "Haifa", "state_or_region": null, "postal_code": "31096", "country": "Israel", "latitude": 32.81303, "longitude": 34.99928, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Edith Wolfson Medical Center", "city": "Holon", "state_or_region": null, "postal_code": "5810001", "country": "Israel", "latitude": 32.01034, "longitude": 34.77918, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Edith Wolfson Medical Center", "city": "Holon", "state_or_region": null, "postal_code": "5810001", "country": "Israel", "latitude": 32.01034, "longitude": 34.77918, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hadassah Medical Center", "city": "Jerusalem", "state_or_region": null, "postal_code": "9112001", "country": "Israel", "latitude": 31.76904, "longitude": 35.21633, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Shaare Zedek MC - Endocrinology Department", "city": "Jerusalem", "state_or_region": null, "postal_code": "9103102", "country": "Israel", "latitude": 31.76904, "longitude": 35.21633, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Shaare Zedek Medical Center", "city": "Jerusalem", "state_or_region": null, "postal_code": "9013102", "country": "Israel", "latitude": 31.76904, "longitude": 35.21633, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shaare Zedek Medical Center", "city": "Jerusalem", "state_or_region": null, "postal_code": "9103102", "country": "Israel", "latitude": 31.76904, "longitude": 35.21633, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shaare Zedek Medical Center", "city": "Jerusalem", "state_or_region": null, "postal_code": "9103102", "country": "Israel", "latitude": 31.76904, "longitude": 35.21633, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shaare Zedek Medical Center", "city": "Jerusalem", "state_or_region": null, "postal_code": "9778419", "country": "Israel", "latitude": 31.76904, "longitude": 35.21633, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Meir Medical Center", "city": "Kfar Saba", "state_or_region": null, "postal_code": "4428164", "country": "Israel", "latitude": 32.175, "longitude": 34.90694, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Maccabi Health Services - Petah Tikva", "city": "Petah Tikva", "state_or_region": null, "postal_code": "4925110", "country": "Israel", "latitude": 32.08707, "longitude": 34.88747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rabin Medical Center", "city": "Petah Tikva", "state_or_region": null, "postal_code": "4941492", "country": "Israel", "latitude": 32.08707, "longitude": 34.88747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rabin Medical Center", "city": "Petah Tikva", "state_or_region": null, "postal_code": "4941492", "country": "Israel", "latitude": 32.08707, "longitude": 34.88747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rabin Medical Center", "city": "Petah Tikva", "state_or_region": null, "postal_code": "4941492", "country": "Israel", "latitude": 32.08707, "longitude": 34.88747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Schneider Children's Medical Center", "city": "Petah Tikva", "state_or_region": null, "postal_code": "4920235", "country": "Israel", "latitude": 32.08707, "longitude": 34.88747, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Schneider MC - Endrocrinology and Diabetes", "city": "Petah Tikva", "state_or_region": null, "postal_code": "49202", "country": "Israel", "latitude": 32.08707, "longitude": 34.88747, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06072963", "study_title": "COMMETS- Combination MCI Metabolic Syndrome", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-27", "facility": "Joseph Sagol Neuroscience center, Sheba Medical Center", "city": "Ramat Gan", "state_or_region": null, "postal_code": "5265601", "country": "Israel", "latitude": 32.08227, "longitude": 34.81065, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06072963" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Sheba Medical Center", "city": "Ramat Gan", "state_or_region": null, "postal_code": "5262100", "country": "Israel", "latitude": 32.08227, "longitude": 34.81065, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sheba Medical Center", "city": "Ramat Gan", "state_or_region": null, "postal_code": "5262100", "country": "Israel", "latitude": 32.08227, "longitude": 34.81065, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sheba Medical Center", "city": "Ramat Gan", "state_or_region": null, "postal_code": "5262100", "country": "Israel", "latitude": 32.08227, "longitude": 34.81065, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sheba Medical Center", "city": "Ramat Gan", "state_or_region": null, "postal_code": "5262100", "country": "Israel", "latitude": 32.08227, "longitude": 34.81065, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Assuta Medical Center", "city": "Tel Aviv", "state_or_region": null, "postal_code": "6971014", "country": "Israel", "latitude": 32.08088, "longitude": 34.78057, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sourasky Medical Center", "city": "Tel Aviv", "state_or_region": null, "postal_code": "6423906", "country": "Israel", "latitude": 32.08088, "longitude": 34.78057, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sourasky Medical Center", "city": "Tel Aviv", "state_or_region": null, "postal_code": "6423906", "country": "Israel", "latitude": 32.08088, "longitude": 34.78057, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sourasky Medical Center", "city": "Tel Aviv", "state_or_region": null, "postal_code": "6423906", "country": "Israel", "latitude": 32.08088, "longitude": 34.78057, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Shamir MC - Pediatric and Adolescents Endocrinology unit", "city": "Ẕerifin", "state_or_region": null, "postal_code": "7033001", "country": "Israel", "latitude": 31.95731, "longitude": 34.84852, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yitzhak Shamir Medical Center", "city": "Ẕerifin", "state_or_region": null, "postal_code": "7033001", "country": "Israel", "latitude": 31.95731, "longitude": 34.84852, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yitzhak Shamir Medical Center", "city": "Ẕerifin", "state_or_region": null, "postal_code": "7033001", "country": "Israel", "latitude": 31.95731, "longitude": 34.84852, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06497595", "study_title": "Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide", "lead_sponsor": "Sheba Medical Center", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-21", "facility": "Hadassah Medical Center", "city": "Jerusalem", "state_or_region": "Israel", "postal_code": "5251108", "country": "Israel", "latitude": 31.76904, "longitude": 35.21633, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06497595" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06497595", "study_title": "Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide", "lead_sponsor": "Sheba Medical Center", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-21", "facility": "Sheba medical center", "city": "Ramat Gan", "state_or_region": "Israel", "postal_code": "52621", "country": "Israel", "latitude": 32.08227, "longitude": 34.81065, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06497595" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bari", "state_or_region": null, "postal_code": "70124", "country": "Italy", "latitude": 41.12066, "longitude": 16.86982, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Azienda Ospedaliera Papa Giovanni XXIII", "city": "Bergamo", "state_or_region": null, "postal_code": "24127", "country": "Italy", "latitude": 45.69601, "longitude": 9.66721, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII", "city": "Bergamo", "state_or_region": null, "postal_code": "24127", "country": "Italy", "latitude": 45.69601, "longitude": 9.66721, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola", "city": "Bologna", "state_or_region": null, "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola", "city": "Bologna", "state_or_region": null, "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola", "city": "Bologna", "state_or_region": null, "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Policlinico S. Orsola-Malpighi", "city": "Bologna", "state_or_region": null, "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Policlinico S. Orsola-Malpighi", "city": "Bologna", "state_or_region": null, "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bologna", "state_or_region": null, "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Azienda Ospedaliera Spedali Civili di Brescia", "city": "Brescia", "state_or_region": null, "postal_code": "25121", "country": "Italy", "latitude": 45.53558, "longitude": 10.21472, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ospedale Specializzato in Gastroenterologia \"Saverio de Bellis\"", "city": "Castellana Grotte", "state_or_region": null, "postal_code": "70013", "country": "Italy", "latitude": 40.88643, "longitude": 17.16549, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ospedale Specializzato in Gastroenterologia \"Saverio de Bellis\"", "city": "Castellana Grotte", "state_or_region": null, "postal_code": "70013", "country": "Italy", "latitude": 40.88643, "longitude": 17.16549, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Azienda Ospedaliero-Universitaria Renato Dulbecco", "city": "Catanzaro", "state_or_region": null, "postal_code": "88100", "country": "Italy", "latitude": 38.88247, "longitude": 16.60086, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Chieti", "state_or_region": null, "postal_code": "66100", "country": "Italy", "latitude": 42.34827, "longitude": 14.16494, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliera Universitaria Careggi", "city": "Florence", "state_or_region": null, "postal_code": "50134", "country": "Italy", "latitude": 43.77925, "longitude": 11.24626, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Az.Osp. Universitaria \"Ospedali Riuniti\"", "city": "Foggia", "state_or_region": null, "postal_code": "71122", "country": "Italy", "latitude": 41.45845, "longitude": 15.55188, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Az.Osp. Universitaria \"Ospedali Riuniti\"", "city": "Foggia", "state_or_region": null, "postal_code": "71122", "country": "Italy", "latitude": 41.45845, "longitude": 15.55188, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Azienda Ospedaliera Luigi Sacco", "city": "Milan", "state_or_region": null, "postal_code": "20157", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico", "city": "Milan", "state_or_region": null, "postal_code": "20122", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico", "city": "Milan", "state_or_region": null, "postal_code": "20122", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico", "city": "Milan", "state_or_region": null, "postal_code": "20122", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico", "city": "Milan", "state_or_region": null, "postal_code": "20122", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione IRCCS Ca'Granda-Ospedale Maggiore Policlinico", "city": "Milan", "state_or_region": null, "postal_code": "20122", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ospedale San Raffaele", "city": "Milan", "state_or_region": null, "postal_code": "20132", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ospedale San Raffaele", "city": "Milan", "state_or_region": null, "postal_code": "20132", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Milan", "state_or_region": null, "postal_code": "20132", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Milan", "state_or_region": null, "postal_code": "20138", "country": "Italy", "latitude": 42.78235, "longitude": 12.59836, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Modena", "state_or_region": null, "postal_code": "41100", "country": "Italy", "latitude": 44.64783, "longitude": 10.92539, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Università di Modena e Reggio Emilia", "city": "Modena", "state_or_region": null, "postal_code": "41121", "country": "Italy", "latitude": 44.64783, "longitude": 10.92539, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Università di Modena e Reggio Emilia", "city": "Modena", "state_or_region": null, "postal_code": "41121", "country": "Italy", "latitude": 44.64783, "longitude": 10.92539, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliera Universitaria Federico II", "city": "Naples", "state_or_region": null, "postal_code": "80131", "country": "Italy", "latitude": 40.85216, "longitude": 14.26811, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Naples", "state_or_region": null, "postal_code": "80138", "country": "Italy", "latitude": 40.85216, "longitude": 14.26811, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ospedale Maggiore della Carità", "city": "Novara", "state_or_region": null, "postal_code": "28100", "country": "Italy", "latitude": 45.44694, "longitude": 8.62118, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedale - Università Padova", "city": "Padova", "state_or_region": null, "postal_code": "35128", "country": "Italy", "latitude": 44.38225, "longitude": 11.14261, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedale - Università Padova", "city": "Padova", "state_or_region": null, "postal_code": "35128", "country": "Italy", "latitude": 44.38225, "longitude": 11.14261, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedale - Università Padova", "city": "Padova", "state_or_region": null, "postal_code": "35128", "country": "Italy", "latitude": 44.38225, "longitude": 11.14261, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "A.O.U. Policlinico Paolo Giaccone", "city": "Palermo", "state_or_region": null, "postal_code": "90127", "country": "Italy", "latitude": 38.1166, "longitude": 13.3636, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone", "city": "Palermo", "state_or_region": null, "postal_code": "90127", "country": "Italy", "latitude": 38.1166, "longitude": 13.3636, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone", "city": "Palermo", "state_or_region": null, "postal_code": "90127", "country": "Italy", "latitude": 38.1166, "longitude": 13.3636, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Azienda Ospedaliero Universitaria Pisana Ospedale Cisanello", "city": "Pisa", "state_or_region": null, "postal_code": "56124", "country": "Italy", "latitude": 43.70853, "longitude": 10.4036, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliero Universitaria Pisana", "city": "Pisa", "state_or_region": null, "postal_code": "56124", "country": "Italy", "latitude": 43.70853, "longitude": 10.4036, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliero Universitaria Pisana", "city": "Pisa", "state_or_region": null, "postal_code": "56124", "country": "Italy", "latitude": 43.70853, "longitude": 10.4036, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ospedale Di Circolo", "city": "Rho", "state_or_region": null, "postal_code": "20017", "country": "Italy", "latitude": 45.53245, "longitude": 9.0402, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ospedale Di Circolo", "city": "Rho", "state_or_region": null, "postal_code": "20017", "country": "Italy", "latitude": 45.53245, "longitude": 9.0402, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Fondazione Policlinico Universitario Agostino Gemelli IRCS", "city": "Roma", "state_or_region": null, "postal_code": "00168", "country": "Italy", "latitude": 44.99364, "longitude": 11.10642, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Agostino Gemelli", "city": "Roma", "state_or_region": null, "postal_code": "00168", "country": "Italy", "latitude": 44.99364, "longitude": 11.10642, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Agostino Gemelli", "city": "Roma", "state_or_region": null, "postal_code": "00168", "country": "Italy", "latitude": 44.99364, "longitude": 11.10642, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Agostino Gemelli", "city": "Roma", "state_or_region": null, "postal_code": "00168", "country": "Italy", "latitude": 44.99364, "longitude": 11.10642, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Roma", "state_or_region": null, "postal_code": "00161", "country": "Italy", "latitude": 44.99364, "longitude": 11.10642, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Roma", "state_or_region": null, "postal_code": "00168", "country": "Italy", "latitude": 44.99364, "longitude": 11.10642, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "city": "Rome", "state_or_region": null, "postal_code": "00168", "country": "Italy", "latitude": 41.89193, "longitude": 12.51133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS", "city": "Rome", "state_or_region": null, "postal_code": "00168", "country": "Italy", "latitude": 41.89193, "longitude": 12.51133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Campus Bio-medico", "city": "Rome", "state_or_region": null, "postal_code": "00128", "country": "Italy", "latitude": 41.89193, "longitude": 12.51133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Campus Bio-medico", "city": "Rome", "state_or_region": null, "postal_code": "00128", "country": "Italy", "latitude": 41.89193, "longitude": 12.51133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Policlinico Universitario Campus Bio-Medico", "city": "Rome", "state_or_region": null, "postal_code": "00128", "country": "Italy", "latitude": 41.89193, "longitude": 12.51133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Humanitas", "city": "Rozzano", "state_or_region": null, "postal_code": "20089", "country": "Italy", "latitude": 45.38193, "longitude": 9.1559, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Humanitas", "city": "Rozzano", "state_or_region": null, "postal_code": "20089", "country": "Italy", "latitude": 45.38193, "longitude": 9.1559, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IRCCS Istituto Clinico Humanitas", "city": "Rozzano", "state_or_region": null, "postal_code": "20089", "country": "Italy", "latitude": 45.38193, "longitude": 9.1559, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Istituto Clinico Humanitas", "city": "Rozzano", "state_or_region": null, "postal_code": "20089", "country": "Italy", "latitude": 45.38193, "longitude": 9.1559, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Istituto Clinico Humanitas", "city": "Rozzano", "state_or_region": null, "postal_code": "20089", "country": "Italy", "latitude": 45.38193, "longitude": 9.1559, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IRCCS Ospedale \"Casa Sollievo della Sofferenza\"", "city": "San Giovanni Rotondo", "state_or_region": null, "postal_code": "71013", "country": "Italy", "latitude": 41.70643, "longitude": 15.7277, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino", "city": "Torino", "state_or_region": null, "postal_code": "10126", "country": "Italy", "latitude": 44.88856, "longitude": 11.99138, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universita Degli Studi di Torino", "city": "Torino", "state_or_region": null, "postal_code": "10126", "country": "Italy", "latitude": 44.88856, "longitude": 11.99138, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universita Degli Studi di Torino", "city": "Torino", "state_or_region": null, "postal_code": "10126", "country": "Italy", "latitude": 44.88856, "longitude": 11.99138, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "IRCCS materno infantile Burlo Garofolo - Clinica Pediatrica", "city": "Trieste", "state_or_region": null, "postal_code": "34137", "country": "Italy", "latitude": 45.64953, "longitude": 13.77678, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Azienda Ospedaliera Universitaria Integrata Verona", "city": "Verona", "state_or_region": null, "postal_code": "37134", "country": "Italy", "latitude": 45.43854, "longitude": 10.9938, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Policlinico GB Rossi Borgo Roma", "city": "Verona", "state_or_region": null, "postal_code": "37136", "country": "Italy", "latitude": 45.43854, "longitude": 10.9938, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "ASL Avezzano Sulmona L'Aquila - Ospedale San Salvatore - UOC Diabetologia", "city": "L’Aquila", "state_or_region": "Abbruzzo", "postal_code": "67100", "country": "Italy", "latitude": 42.35055, "longitude": 13.39954, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Università degli studi G. D'Annunzio Chieti Pescara - CAST", "city": "Chieti", "state_or_region": "Abruzzo", "postal_code": "66100", "country": "Italy", "latitude": 42.34827, "longitude": 14.16494, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "A.O.U. Bologna_ Policlinico S.Orsola Malpighi", "city": "Bologna", "state_or_region": "BO", "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07314684", "study_title": "GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM", "lead_sponsor": "Federico II University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-01-02", "facility": "Azienda Ospedaliera Sant'Anna e San Sebastiano", "city": "Caserta", "state_or_region": "Caserta", "postal_code": "81100", "country": "Italy", "latitude": 41.07262, "longitude": 14.33231, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07314684" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "AOU IRCCS Policlinico di Sant'Orsola Malpighi - UOC Endocrinologia e Prevenzione e Cura del Diabete", "city": "Bologna", "state_or_region": "Emilia-Romagna", "postal_code": "40138", "country": "Italy", "latitude": 44.49381, "longitude": 11.33875, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "IRCCS Ospedale Policlinico San Martino - U.O.D. Dietetica e Nutrizione Clinica", "city": "Genoa", "state_or_region": "Liguria", "postal_code": "16132", "country": "Italy", "latitude": 44.40478, "longitude": 8.94439, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Spedali Civili Brescia - SSD Endocrinologia", "city": "Brescia", "state_or_region": "Lombardy", "postal_code": "25123", "country": "Italy", "latitude": 45.53558, "longitude": 10.21472, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico - UO Endocrinologia", "city": "Milan", "state_or_region": "Lombardy", "postal_code": "20122", "country": "Italy", "latitude": 45.46427, "longitude": 9.18951, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Ospedale San Raffaele S.r.l. - Unità di Cardio-metabolismo e Trials Clinici", "city": "Milan", "state_or_region": "Lombardy", "postal_code": "20132", "country": "Italy", "latitude": 45.46427, "longitude": 9.18951, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07314684", "study_title": "GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM", "lead_sponsor": "Federico II University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-01-02", "facility": "Federico II University", "city": "Naples", "state_or_region": "Napoli", "postal_code": "80131", "country": "Italy", "latitude": 40.85216, "longitude": 14.26811, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07314684" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Azienda Ospedaliera di Perugia;Ospedale S. Maria della Misericordia", "city": "Perugia", "state_or_region": "Pg", "postal_code": "06129", "country": "Italy", "latitude": 43.1122, "longitude": 12.38878, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "AOU Maggiore della Carità di Novara - Dipartimento Interaziendale Strutturale Materno Infantile - SCDU Pediatria", "city": "Novara", "state_or_region": "Piedmont", "postal_code": "28100", "country": "Italy", "latitude": 45.44694, "longitude": 8.62118, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "D.A.I. Oncologico - U.O.C. di Chirurgia Generale ad indirizzo Oncologico", "city": "Messina", "state_or_region": "Sicily", "postal_code": "98124", "country": "Italy", "latitude": 38.19394, "longitude": 15.55256, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "INRCA Ancona - UOC Clinica Medica e Geriatrica", "city": "Ancorna", "state_or_region": "The Marches", "postal_code": "60127", "country": "Italy", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Azienda Ospedaliero Universitaria Pisana", "city": "Pisa", "state_or_region": "Tuscany", "postal_code": "56126", "country": "Italy", "latitude": 43.70853, "longitude": 10.4036, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "A.O.U.I Verona - Ospedale Donna Bambino Borgo Trento - Pediatria B", "city": "Verona", "state_or_region": "Veneto", "postal_code": "37126", "country": "Italy", "latitude": 45.43854, "longitude": 10.9938, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "TOSAKI Clinic for Diabetes and Endocrinology_Diabetes and Endocrinology", "city": "Aichi", "state_or_region": null, "postal_code": "468-0009", "country": "Japan", "latitude": 32.51879, "longitude": 130.62158, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hyogo Prefectural Amagasaki General Medical Center", "city": "Amagasaki", "state_or_region": null, "postal_code": "660-8550", "country": "Japan", "latitude": 34.71667, "longitude": 135.41667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kansai Rosai Hospital", "city": "Amagasaki", "state_or_region": null, "postal_code": "660-8511", "country": "Japan", "latitude": 34.71667, "longitude": 135.41667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Asahikawa-shi", "state_or_region": null, "postal_code": "070-8530", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Asahikawa Medical University Hospital", "city": "Asahikawa", "state_or_region": null, "postal_code": "078-8510", "country": "Japan", "latitude": 43.77063, "longitude": 142.36489, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Juntendo University Hospital", "city": "Bunkyō City", "state_or_region": null, "postal_code": "113-8431", "country": "Japan", "latitude": 35.5331, "longitude": 139.4217, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The University of Tokyo Hospital", "city": "Bunkyō City", "state_or_region": null, "postal_code": "113-8654", "country": "Japan", "latitude": 35.5331, "longitude": 139.4217, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The University of Tokyo Hospital", "city": "Bunkyō City", "state_or_region": null, "postal_code": "113-8655", "country": "Japan", "latitude": 35.5331, "longitude": 139.4217, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The University of Tokyo Hospital", "city": "Bunkyō City", "state_or_region": null, "postal_code": "113-8655", "country": "Japan", "latitude": 35.5331, "longitude": 139.4217, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Metropolitan Komagome Hospital", "city": "Bunkyō City", "state_or_region": null, "postal_code": "113-8677", "country": "Japan", "latitude": 35.5331, "longitude": 139.4217, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Institute of Science Tokyo Hospital", "city": "Bunkyō", "state_or_region": null, "postal_code": "113-8519", "country": "Japan", "latitude": 35.37517, "longitude": 139.92991, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Akaicho Clinic_Internal medicine", "city": "Chiba-shi, Chiba", "state_or_region": null, "postal_code": "260-0804", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Japan Institute for Health Security National Kohnodai Medical Center", "city": "Chiba, Ichikawa", "state_or_region": null, "postal_code": "272-8516", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chiba University Hospital", "city": "Chiba", "state_or_region": null, "postal_code": "260-8677", "country": "Japan", "latitude": 35.6, "longitude": 140.11667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chiba University Hospital", "city": "Chiba", "state_or_region": null, "postal_code": "260-8677", "country": "Japan", "latitude": 35.6, "longitude": 140.11667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fukuoka University Chikushi Hospital", "city": "Chikushino-shi", "state_or_region": null, "postal_code": "818-0067", "country": "Japan", "latitude": 33.49631, "longitude": 130.5156, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Chūōku", "state_or_region": null, "postal_code": "103-0002", "country": "Japan", "latitude": 33.63867, "longitude": 130.67068, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ehime University Hospital", "city": "Ehime, Toon", "state_or_region": null, "postal_code": "791-0295", "country": "Japan", "latitude": 33.79427, "longitude": 132.89011, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ehime University Hospital", "city": "Ehime, Toon", "state_or_region": null, "postal_code": "791-0295", "country": "Japan", "latitude": 33.79427, "longitude": 132.89011, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fukuiken Saiseikai Hospital", "city": "Fukui, Fukui", "state_or_region": null, "postal_code": "918-8503", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fukuiken Saiseikai Hospital", "city": "Fukui", "state_or_region": null, "postal_code": "918-8503", "country": "Japan", "latitude": 34.84214, "longitude": 135.54836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Kyushu Medical Center", "city": "Fukuoka, Fukuoka", "state_or_region": null, "postal_code": "810-8563", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Kyushu Medical Center", "city": "Fukuoka, Fukuoka", "state_or_region": null, "postal_code": "810-8563", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kurume University Hospital", "city": "Fukuoka, Kurume", "state_or_region": null, "postal_code": "830-0011", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kurume University Hospital", "city": "Fukuoka, Kurume", "state_or_region": null, "postal_code": "830-0011", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fukuoka University Hospital", "city": "Fukuoka", "state_or_region": null, "postal_code": "814-0180", "country": "Japan", "latitude": 33.6, "longitude": 130.41667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hamanomachi Hospital", "city": "Fukuoka", "state_or_region": null, "postal_code": "810-8539", "country": "Japan", "latitude": 33.6, "longitude": 130.41667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gifu Municipal Hospital", "city": "Gifu, Gifu", "state_or_region": null, "postal_code": "500-8513", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gifu Municipal Hospital", "city": "Gifu, Gifu", "state_or_region": null, "postal_code": "500-8513", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ogaki Municipal Hospital", "city": "Gifu, Ogaki", "state_or_region": null, "postal_code": "503-8502", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gifu Municipal Hospital", "city": "Gifu", "state_or_region": null, "postal_code": "500-8513", "country": "Japan", "latitude": 35.42291, "longitude": 136.76039, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of the Ryukyus Hospital", "city": "Ginowan", "state_or_region": null, "postal_code": "901-2725", "country": "Japan", "latitude": 26.26265, "longitude": 127.76147, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hamamatsu University Hospital", "city": "Hamamatsu", "state_or_region": null, "postal_code": "431-3192", "country": "Japan", "latitude": 34.7, "longitude": 137.73333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nagano Municipal Hospital", "city": "Hanishina-gun", "state_or_region": null, "postal_code": "381-8551", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nagano Municipal Hospital", "city": "Hanishina-gun", "state_or_region": null, "postal_code": "381-8551", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital", "city": "Hiroshima", "state_or_region": null, "postal_code": "730-0052", "country": "Japan", "latitude": 34.4, "longitude": 132.45, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hiroshima University Hospital", "city": "Hiroshima", "state_or_region": null, "postal_code": "734-8551", "country": "Japan", "latitude": 34.4, "longitude": 132.45, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hiroshima University Hospital", "city": "Hiroshima", "state_or_region": null, "postal_code": "734-8551", "country": "Japan", "latitude": 34.4, "longitude": 132.45, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hiroshima University Hospital", "city": "Hiroshima", "state_or_region": null, "postal_code": "734-8551", "country": "Japan", "latitude": 34.4, "longitude": 132.45, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Japan Community Health Care Organization Hokkaido Hospital", "city": "Hokkaido, Sapporo", "state_or_region": null, "postal_code": "062-8618", "country": "Japan", "latitude": 43.06667, "longitude": 141.35, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Japan Community Health Care Organization Hokkaido Hospital", "city": "Hokkaido, Sapporo", "state_or_region": null, "postal_code": "062-8618", "country": "Japan", "latitude": 43.06667, "longitude": 141.35, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hyogo College of Medicine Hospital", "city": "Hyogo, Nishinomiya", "state_or_region": null, "postal_code": "663-8501", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Medical University Ibaraki Medical Center", "city": "Ibaraki, Inashiki-gun", "state_or_region": null, "postal_code": "300-0395", "country": "Japan", "latitude": 34.81641, "longitude": 135.56828, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Medical University Ibaraki Medical Center", "city": "Ibaraki, Inashiki-gun", "state_or_region": null, "postal_code": "300-0395", "country": "Japan", "latitude": 34.81641, "longitude": 135.56828, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Naka Kinen Clinic_Internal medicine", "city": "Ibaraki", "state_or_region": null, "postal_code": "311-0113", "country": "Japan", "latitude": 34.81641, "longitude": 135.56828, "site_statuses": "ACTIVE_NOT_RECRUITING; RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Naka Kinen Clinic_Internal medicine", "city": "Ibaraki", "state_or_region": null, "postal_code": "311-0113", "country": "Japan", "latitude": 34.81641, "longitude": 135.56828, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Kohnodai Medical Center", "city": "Ichikawa", "state_or_region": null, "postal_code": "272-8516", "country": "Japan", "latitude": 35.73413, "longitude": 139.9065, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokai University Hospital", "city": "Isehara", "state_or_region": null, "postal_code": "259-1193", "country": "Japan", "latitude": 35.39932, "longitude": 139.31019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokai University Hospital", "city": "Isehara", "state_or_region": null, "postal_code": "259-1193", "country": "Japan", "latitude": 35.39932, "longitude": 139.31019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kanazawa University Hospital", "city": "Ishikawa, Kanazawa", "state_or_region": null, "postal_code": "920-8641", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kanazawa University Hospital", "city": "Ishikawa, Kanazawa", "state_or_region": null, "postal_code": "920-8641", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nihon University Itabashi Hospital", "city": "Itabashiku", "state_or_region": null, "postal_code": "173-8610", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shimane University Hospital", "city": "Izumo", "state_or_region": null, "postal_code": "693-8501", "country": "Japan", "latitude": 35.36667, "longitude": 132.76667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shimane University Hospital", "city": "Izumo", "state_or_region": null, "postal_code": "693-8501", "country": "Japan", "latitude": 35.36667, "longitude": 132.76667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shimane University Hospital", "city": "Izumo", "state_or_region": null, "postal_code": "693-8501", "country": "Japan", "latitude": 35.36667, "longitude": 132.76667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Juntendo University Shizuoka Hospital", "city": "Izunokuni", "state_or_region": null, "postal_code": "410-2211", "country": "Japan", "latitude": 35.03907, "longitude": 138.95143, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kagoshima University Hospital", "city": "Kagoshima, Kagoshima", "state_or_region": null, "postal_code": "890-8520", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kagoshima University Hospital", "city": "Kagoshima, Kagoshima", "state_or_region": null, "postal_code": "890-8520", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kagoshima University Hospital", "city": "Kagoshima", "state_or_region": null, "postal_code": "890-8520", "country": "Japan", "latitude": 31.56667, "longitude": 130.55, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Kamakura-shi", "state_or_region": null, "postal_code": "247-0056", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shin-yurigaoka General Hospital", "city": "Kanagawa, Kawasaki", "state_or_region": null, "postal_code": "215-0026", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shin-yurigaoka General Hospital", "city": "Kanagawa, Kawasaki", "state_or_region": null, "postal_code": "215-0026", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Fujisawa City Hospital_Kidney internal medicine", "city": "Kanagawa", "state_or_region": null, "postal_code": "251-8550", "country": "Japan", "latitude": 37.58333, "longitude": 139.91667, "site_statuses": "COMPLETED; RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nara Medical University Hospital", "city": "Kashihara", "state_or_region": null, "postal_code": "634-0813", "country": "Japan", "latitude": 34.58333, "longitude": 135.61667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "St. Marianna University Hospital", "city": "Kawasaki-shi", "state_or_region": null, "postal_code": "216-8511", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "St. Marianna University Hospital", "city": "Kawasaki", "state_or_region": null, "postal_code": "216-8511", "country": "Japan", "latitude": 35.52056, "longitude": 139.71722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kagawa University Hospital", "city": "Kita-gun", "state_or_region": null, "postal_code": "761-0793", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kagawa University Hospital", "city": "Kita-gun", "state_or_region": null, "postal_code": "761-0793", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Higashijujo Sakai Diabetes Clinic_Internal Medicine", "city": "Kita-ku, Tokyo", "state_or_region": null, "postal_code": "114-0001", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kagawa University Hospital", "city": "Kita-ku", "state_or_region": null, "postal_code": "761-0701", "country": "Japan", "latitude": 35.75264, "longitude": 139.73348, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kobe University Hospital", "city": "Kobe", "state_or_region": null, "postal_code": "650-0017", "country": "Japan", "latitude": 34.6913, "longitude": 135.183, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kobe University Hospital", "city": "Kobe", "state_or_region": null, "postal_code": "650-0017", "country": "Japan", "latitude": 34.6913, "longitude": 135.183, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yamanashi Prefectural Central Hospital", "city": "Kofu", "state_or_region": null, "postal_code": "400-8506", "country": "Japan", "latitude": 35.66667, "longitude": 138.56667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Koga-shi", "state_or_region": null, "postal_code": "306-0232", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kumamoto Shinto General Hospital", "city": "Kumamoto", "state_or_region": null, "postal_code": "862-8655", "country": "Japan", "latitude": 32.80589, "longitude": 130.69181, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kumamoto Shinto General Hospital", "city": "Kumamoto", "state_or_region": null, "postal_code": "862-8655", "country": "Japan", "latitude": 32.80589, "longitude": 130.69181, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kumamoto Shinto General Hospital", "city": "Kumamoto", "state_or_region": null, "postal_code": "862-8655", "country": "Japan", "latitude": 32.80589, "longitude": 130.69181, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kumamoto University Hospital", "city": "Kumamoto", "state_or_region": null, "postal_code": "860-8556", "country": "Japan", "latitude": 32.80589, "longitude": 130.69181, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kumamoto University Hospital", "city": "Kumamoto", "state_or_region": null, "postal_code": "860-8556", "country": "Japan", "latitude": 32.80589, "longitude": 130.69181, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kumamoto University Hospital", "city": "Kumamoto", "state_or_region": null, "postal_code": "860-8556", "country": "Japan", "latitude": 32.80589, "longitude": 130.69181, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Kure Medical Center and Chugoku Cancer Center", "city": "Kure", "state_or_region": null, "postal_code": "737-0023", "country": "Japan", "latitude": 34.23222, "longitude": 132.56658, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Kure Medical Center and Chugoku Cancer Center", "city": "Kure", "state_or_region": null, "postal_code": "737-0023", "country": "Japan", "latitude": 34.23222, "longitude": 132.56658, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kurume University Hospital", "city": "Kurume", "state_or_region": null, "postal_code": "830-0011", "country": "Japan", "latitude": 33.31667, "longitude": 130.51667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital Kyoto Prefectural University of Medicine", "city": "Kyoto", "state_or_region": null, "postal_code": "602-8566", "country": "Japan", "latitude": 35.02107, "longitude": 135.75385, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital Kyoto Prefectural University of Medicine", "city": "Kyoto", "state_or_region": null, "postal_code": "602-8566", "country": "Japan", "latitude": 35.02107, "longitude": 135.75385, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital,Kyoto Prefectural University of Medicine", "city": "Kyoto", "state_or_region": null, "postal_code": "602-8566", "country": "Japan", "latitude": 35.02107, "longitude": 135.75385, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Saiseikai Maebashi Hospital", "city": "Maebashi", "state_or_region": null, "postal_code": "371-0821", "country": "Japan", "latitude": 36.4, "longitude": 139.08333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Saiseikai Central Hospital", "city": "Minatoku", "state_or_region": null, "postal_code": "108-0073", "country": "Japan", "latitude": 32.57237, "longitude": 130.59341, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Toranomon Hospital", "city": "Minatoku", "state_or_region": null, "postal_code": "105-8470", "country": "Japan", "latitude": 32.57237, "longitude": 130.59341, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Mitaka-shi", "state_or_region": null, "postal_code": "181-0013", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Mito", "state_or_region": null, "postal_code": "310-0826", "country": "Japan", "latitude": 36.35, "longitude": 140.45, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Miyazaki", "state_or_region": null, "postal_code": "880-0034", "country": "Japan", "latitude": 31.91667, "longitude": 131.41667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Miyazaki Hospital", "city": "Miyazaki", "state_or_region": null, "postal_code": "889-1692", "country": "Japan", "latitude": 31.91667, "longitude": 131.41667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Miyazaki Hospital", "city": "Miyazaki", "state_or_region": null, "postal_code": "889-1692", "country": "Japan", "latitude": 31.91667, "longitude": 131.41667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Japanese Red Cross Musashino Hospital", "city": "Musashino-shi", "state_or_region": null, "postal_code": "180-8610", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Japanese Red Cross Musashino Hospital", "city": "Musashino", "state_or_region": null, "postal_code": "186-8610", "country": "Japan", "latitude": 35.70611, "longitude": 139.55944, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Japanese Red Cross Musashino Hospital", "city": "Musashino", "state_or_region": null, "postal_code": "186-8610", "country": "Japan", "latitude": 35.70611, "longitude": 139.55944, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shinshu University Hospital", "city": "Nagano, Matsumoto", "state_or_region": null, "postal_code": "390-8621", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Shinshu University Hospital", "city": "Nagano, Matsumoto", "state_or_region": null, "postal_code": "390-8621", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nagasaki Medical Center", "city": "Nagasaki, Omura", "state_or_region": null, "postal_code": "856-8562", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nagasaki Medical Center", "city": "Nagasaki, Omura", "state_or_region": null, "postal_code": "856-8562", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nagasaki University Hospital", "city": "Nagasaki", "state_or_region": null, "postal_code": "852-8501", "country": "Japan", "latitude": 32.75, "longitude": 129.88333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Meitetsu Hospital", "city": "Nagoya", "state_or_region": null, "postal_code": "451-8511", "country": "Japan", "latitude": 35.18147, "longitude": 136.90641, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nagoya City University Hospital", "city": "Nagoya", "state_or_region": null, "postal_code": "467-8602", "country": "Japan", "latitude": 35.18147, "longitude": 136.90641, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Nagoya", "state_or_region": null, "postal_code": "467-8602", "country": "Japan", "latitude": 35.18147, "longitude": 136.90641, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Nagoya", "state_or_region": null, "postal_code": "468-0009", "country": "Japan", "latitude": 35.18147, "longitude": 136.90641, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Naka", "state_or_region": null, "postal_code": "311-0113", "country": "Japan", "latitude": 36.05, "longitude": 140.16667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Naka", "state_or_region": null, "postal_code": "311-0133", "country": "Japan", "latitude": 36.05, "longitude": 140.16667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nara Medical University Hospital", "city": "Nara, Kashihara", "state_or_region": null, "postal_code": "634-8522", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nara Medical University Hospital", "city": "Nara, Kashihara", "state_or_region": null, "postal_code": "634-8522", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "International University of Health and Welfare Narita Hospital", "city": "Narita", "state_or_region": null, "postal_code": "286-0105", "country": "Japan", "latitude": 35.78333, "longitude": 140.31667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "International University of Health and Welfare Narita Hospital", "city": "Narita", "state_or_region": null, "postal_code": "286-0105", "country": "Japan", "latitude": 35.78333, "longitude": 140.31667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "International University of Health and Welfare Narita Hospital", "city": "Narita", "state_or_region": null, "postal_code": "286-8520", "country": "Japan", "latitude": 35.78333, "longitude": 140.31667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Niigata University Medical and Dental Hospital", "city": "Niigata", "state_or_region": null, "postal_code": "951-8520", "country": "Japan", "latitude": 37.92259, "longitude": 139.04125, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Niigata University Medical and Dental Hospital", "city": "Niigata", "state_or_region": null, "postal_code": "951-8520", "country": "Japan", "latitude": 37.92259, "longitude": 139.04125, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Nishinomiya-shi", "state_or_region": null, "postal_code": "663-8113", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hyogo College of Medicine Hospital", "city": "Nishinomiya", "state_or_region": null, "postal_code": "663-8501", "country": "Japan", "latitude": 34.71562, "longitude": 135.33199, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hyogo Medical University Hospital", "city": "Nishinomiya", "state_or_region": null, "postal_code": "663-8501", "country": "Japan", "latitude": 34.71562, "longitude": 135.33199, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ogaki Municipal Hospital", "city": "Ōgaki", "state_or_region": null, "postal_code": "503-0864", "country": "Japan", "latitude": 35.35, "longitude": 136.61667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Abe Clinic", "city": "Ōita", "state_or_region": null, "postal_code": "870-0039", "country": "Japan", "latitude": 33.23333, "longitude": 131.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Oita Cardiovascular Hospital", "city": "Ōita", "state_or_region": null, "postal_code": "870-0837", "country": "Japan", "latitude": 33.23333, "longitude": 131.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Oita Cardiovascular Hospital", "city": "Ōita", "state_or_region": null, "postal_code": "870-0837", "country": "Japan", "latitude": 33.23333, "longitude": 131.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Oita Cardiovascular Hospital", "city": "Ōita", "state_or_region": null, "postal_code": "870-0837", "country": "Japan", "latitude": 33.23333, "longitude": 131.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Okayama University Hospital", "city": "Okayama", "state_or_region": null, "postal_code": "700-8558", "country": "Japan", "latitude": 34.65, "longitude": 133.93333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Okayama University Hospital", "city": "Okayama", "state_or_region": null, "postal_code": "700-8558", "country": "Japan", "latitude": 34.65, "longitude": 133.93333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Okayama University Hospital", "city": "Okayama", "state_or_region": null, "postal_code": "700-8558", "country": "Japan", "latitude": 34.65, "longitude": 133.93333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Nagasaki Medical Center", "city": "Ōmura", "state_or_region": null, "postal_code": "856-8562", "country": "Japan", "latitude": 32.92139, "longitude": 129.95389, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Osaka National Hospital", "city": "Osaka", "state_or_region": null, "postal_code": "540-0006", "country": "Japan", "latitude": 34.69379, "longitude": 135.50107, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka City University Hospital", "city": "Osaka", "state_or_region": null, "postal_code": "545-0051", "country": "Japan", "latitude": 34.69379, "longitude": 135.50107, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka City University Hospital", "city": "Osaka", "state_or_region": null, "postal_code": "545-0051", "country": "Japan", "latitude": 34.69379, "longitude": 135.50107, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka General Medical Center", "city": "Osaka", "state_or_region": null, "postal_code": "558-8558", "country": "Japan", "latitude": 34.69379, "longitude": 135.50107, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka Keisatsu Hospital", "city": "Osaka", "state_or_region": null, "postal_code": "543-0042", "country": "Japan", "latitude": 34.69379, "longitude": 135.50107, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka Metropolitan University Hospital", "city": "Osaka", "state_or_region": null, "postal_code": "545-8586", "country": "Japan", "latitude": 34.69379, "longitude": 135.50107, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Saga University Hospital", "city": "Saga", "state_or_region": null, "postal_code": "849-8501", "country": "Japan", "latitude": 33.23333, "longitude": 130.3, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Saga University Hospital", "city": "Saga", "state_or_region": null, "postal_code": "849-8501", "country": "Japan", "latitude": 33.23333, "longitude": 130.3, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Saga University Hospital", "city": "Saga", "state_or_region": null, "postal_code": "849-8501", "country": "Japan", "latitude": 33.23333, "longitude": 130.3, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hanyu General Hospital_Internal Medicine", "city": "Saitama", "state_or_region": null, "postal_code": "348-8505", "country": "Japan", "latitude": 35.90807, "longitude": 139.65657, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Koshigaya Municipal Hospital_Internal medicine", "city": "Saitama", "state_or_region": null, "postal_code": "343-8577", "country": "Japan", "latitude": 35.90807, "longitude": 139.65657, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bell Land General Hospital", "city": "Sakai", "state_or_region": null, "postal_code": "599-8247", "country": "Japan", "latitude": 34.58216, "longitude": 135.46653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka Rosai Hospital", "city": "Sakai", "state_or_region": null, "postal_code": "591-8025", "country": "Japan", "latitude": 34.58216, "longitude": 135.46653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka Rosai Hospital", "city": "Sakai", "state_or_region": null, "postal_code": "591-8025", "country": "Japan", "latitude": 34.58216, "longitude": 135.46653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka Rosai Hospital", "city": "Sakai", "state_or_region": null, "postal_code": "591-8025", "country": "Japan", "latitude": 34.58216, "longitude": 135.46653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Seichokai Bell Land General Hospital", "city": "Sakai", "state_or_region": null, "postal_code": "599-8247", "country": "Japan", "latitude": 34.58216, "longitude": 135.46653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Seichokai Bell Land General Hospital", "city": "Sakai", "state_or_region": null, "postal_code": "599-8247", "country": "Japan", "latitude": 34.58216, "longitude": 135.46653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hokkaido University Hospital", "city": "Sapporo", "state_or_region": null, "postal_code": "060-8648", "country": "Japan", "latitude": 43.06667, "longitude": 141.35, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sapporo", "state_or_region": null, "postal_code": "062-0007", "country": "Japan", "latitude": 43.06667, "longitude": 141.35, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sapporo Kosei General Hospital", "city": "Sapporo", "state_or_region": null, "postal_code": "060-0033", "country": "Japan", "latitude": 43.06667, "longitude": 141.35, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sapporo Kosei General Hospital", "city": "Sapporo", "state_or_region": null, "postal_code": "060-0033", "country": "Japan", "latitude": 43.06667, "longitude": 141.35, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Shinden Higashi Clinic_Internal medicine", "city": "Sendai-shi, Miyagi", "state_or_region": null, "postal_code": "983-0039", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Shinden Higashi Clinic", "city": "Sendai-shi, Miyagi", "state_or_region": null, "postal_code": "983-0039", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sendai Tokushukai Hospital", "city": "Sendai", "state_or_region": null, "postal_code": "981-3116", "country": "Japan", "latitude": 38.26667, "longitude": 140.86667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sendai Tokushukai Hospital", "city": "Sendai", "state_or_region": null, "postal_code": "981-3116", "country": "Japan", "latitude": 38.26667, "longitude": 140.86667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "JCHO Shimonoseki Medical Center", "city": "Shimonoseki", "state_or_region": null, "postal_code": "750-0061", "country": "Japan", "latitude": 33.95548, "longitude": 130.93713, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jichi Medical University Hospital", "city": "Shimotsuke", "state_or_region": null, "postal_code": "329-0498", "country": "Japan", "latitude": 36.41323, "longitude": 139.86622, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Medical University Hospital", "city": "Shinjuku-ku", "state_or_region": null, "postal_code": "160-0023", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Center for Global Health and Medicine", "city": "Shinjyuku-ku", "state_or_region": null, "postal_code": "162-8655", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Iwate Medical University Hospital", "city": "Shiwa-gun Yahaba-cho", "state_or_region": null, "postal_code": "028-3695", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Iwate Medical University Hospital", "city": "Shiwa-gun", "state_or_region": null, "postal_code": "028-3695", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Iwate Medical University Hospital", "city": "Shiwa-gun", "state_or_region": null, "postal_code": "028-3695", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hamamatsu University Hospital", "city": "Shizuoka, Hamamatsu", "state_or_region": null, "postal_code": "431-3192", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hamamatsu University Hospital", "city": "Shizuoka, Hamamatsu", "state_or_region": null, "postal_code": "431-3192", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Juntendo University Shizuoka Hospital", "city": "Shizuoka, Izunokuni", "state_or_region": null, "postal_code": "410-2295", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Juntendo University Shizuoka Hospital", "city": "Shizuoka, Izunokuni", "state_or_region": null, "postal_code": "410-2295", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Omihachiman Community Medical Center_Nephrology", "city": "Siga", "state_or_region": null, "postal_code": "523-0082", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "ACTIVE_NOT_RECRUITING; RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Soka Sugiura Internal Medicine Clinic", "city": "Soka-shi, Saitama", "state_or_region": null, "postal_code": "340-0015", "country": "Japan", "latitude": 35.90807, "longitude": 139.65657, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Suita Hospital", "city": "Suita-Shi", "state_or_region": null, "postal_code": "564-0013", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Suita Hospital", "city": "Suita-Shi", "state_or_region": null, "postal_code": "564-0013", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Osaka Saiseikai Suita hospital", "city": "Suita", "state_or_region": null, "postal_code": "564-0013", "country": "Japan", "latitude": 34.76143, "longitude": 135.51567, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The University of Osaka Hospital", "city": "Suita", "state_or_region": null, "postal_code": "565-0871", "country": "Japan", "latitude": 34.76143, "longitude": 135.51567, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The University of Osaka Hospital", "city": "Suita", "state_or_region": null, "postal_code": "565-0871", "country": "Japan", "latitude": 34.76143, "longitude": 135.51567, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The University of Osaka Hospital", "city": "Suita", "state_or_region": null, "postal_code": "565-0871", "country": "Japan", "latitude": 34.76143, "longitude": 135.51567, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kagawa Prefectural Central Hospital", "city": "Takamatsu", "state_or_region": null, "postal_code": "760-8557", "country": "Japan", "latitude": 34.33333, "longitude": 134.05, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Takamatsu", "state_or_region": null, "postal_code": "760-0018", "country": "Japan", "latitude": 34.33333, "longitude": 134.05, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Takasaki General Medical Center", "city": "Takasaki-shi", "state_or_region": null, "postal_code": "370-0829", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Takasaki General Medical Center", "city": "Takasaki-shi", "state_or_region": null, "postal_code": "370-0829", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Takasaki General Medical Center", "city": "Takasaki", "state_or_region": null, "postal_code": "370-0829", "country": "Japan", "latitude": 36.33333, "longitude": 139.01667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nippon Medical School Hospital", "city": "Tokyo, Bunkyo-ku", "state_or_region": null, "postal_code": "113-8603", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nippon Medical School Hospital", "city": "Tokyo, Bunkyo-ku", "state_or_region": null, "postal_code": "113-8603", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Toranomon Hospital", "city": "Tokyo, Minato-ku", "state_or_region": null, "postal_code": "105-8470", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Toranomon Hospital", "city": "Tokyo, Minato-ku", "state_or_region": null, "postal_code": "105-8470", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Fukuwa Clinic_Internal Medicine", "city": "Tokyo", "state_or_region": null, "postal_code": "104-0031", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "ACTIVE_NOT_RECRUITING; RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Fukuwa Clinic", "city": "Tokyo", "state_or_region": null, "postal_code": "104-0031", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Institute of Science Tokyo Hospital", "city": "Tokyo", "state_or_region": null, "postal_code": "113-8519", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Institute of Science Tokyo Hospital", "city": "Tokyo", "state_or_region": null, "postal_code": "113-8519", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Juntendo University Hospital", "city": "Tokyo", "state_or_region": null, "postal_code": "113-8431", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Kato Clinic of Internal Medicine_Internal Medicine", "city": "Tokyo", "state_or_region": null, "postal_code": "125-0054", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Kato Clinic of Internal Medicine", "city": "Tokyo", "state_or_region": null, "postal_code": "125-0054", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nihon University Itabashi Hospital", "city": "Tokyo", "state_or_region": null, "postal_code": "173-8610", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nihon University Itabashi Hospital", "city": "Tokyo", "state_or_region": null, "postal_code": "173-8610", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "ToCROM Clinic_Internal Medicine", "city": "Tokyo", "state_or_region": null, "postal_code": "160-0008", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Medical University Hospital", "city": "Tokyo", "state_or_region": null, "postal_code": "160-0023", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Medical University Hospital", "city": "Tokyo", "state_or_region": null, "postal_code": "160-0023", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tokyo Women's Medical University", "city": "Tokyo", "state_or_region": null, "postal_code": "162-8666", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Tokyo-Eki Center-building Clinic_Internal Medicine", "city": "Tokyo", "state_or_region": null, "postal_code": "103-0027", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Tokyo-Eki Center-building Clinic_Internal Medicine", "city": "Tokyo", "state_or_region": null, "postal_code": "103-0027", "country": "Japan", "latitude": 35.6895, "longitude": 139.69171, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nagano Municipal Hospital", "city": "Tomitake", "state_or_region": null, "postal_code": "381-8551", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ehime University Hospital", "city": "Tōon", "state_or_region": null, "postal_code": "791-0295", "country": "Japan", "latitude": 33.79427, "longitude": 132.89011, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Sekino Hospital", "city": "Toshimaku", "state_or_region": null, "postal_code": "171-0014", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fujita Health University Hospital", "city": "Toyoake-shi", "state_or_region": null, "postal_code": "470-1192", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fujita Health University Hospital", "city": "Toyoake-shi", "state_or_region": null, "postal_code": "470-1192", "country": "Japan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mie University Hospital", "city": "Tsu", "state_or_region": null, "postal_code": "514-8507", "country": "Japan", "latitude": 34.73333, "longitude": 136.51667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mie University Hospital", "city": "Tsu", "state_or_region": null, "postal_code": "514-8507", "country": "Japan", "latitude": 34.73333, "longitude": 136.51667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mie University Hospital", "city": "Tsu", "state_or_region": null, "postal_code": "514-8507", "country": "Japan", "latitude": 34.73333, "longitude": 136.51667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Hospital Organization Ureshino Medical Center", "city": "Ureshino", "state_or_region": null, "postal_code": "843-0393", "country": "Japan", "latitude": 35.85558, "longitude": 139.52068, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Wakayama Medical University Hospital", "city": "Wakayama", "state_or_region": null, "postal_code": "641-8509", "country": "Japan", "latitude": 34.23333, "longitude": 135.16667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Wakayama Medical University Hospital", "city": "Wakayama", "state_or_region": null, "postal_code": "641-8509", "country": "Japan", "latitude": 34.23333, "longitude": 135.16667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yamagata University Hospital", "city": "Yamagata", "state_or_region": null, "postal_code": "990-9585", "country": "Japan", "latitude": 38.23333, "longitude": 140.36667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yokohama City University Hospital", "city": "Yokohama", "state_or_region": null, "postal_code": "236-0004", "country": "Japan", "latitude": 35.43333, "longitude": 139.65, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yokohama City University Hospital", "city": "Yokohama", "state_or_region": null, "postal_code": "236-0004", "country": "Japan", "latitude": 35.43333, "longitude": 139.65, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yokohama City University Hospital", "city": "Yokohama", "state_or_region": null, "postal_code": "236-0004", "country": "Japan", "latitude": 35.43333, "longitude": 139.65, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Seino Internal Medicine Clinic_Internal medicine", "city": "Koriyama-shi, Fukushima", "state_or_region": "Fukushima, Japan", "postal_code": "963-8851", "country": "Japan", "latitude": 37.75, "longitude": 140.46667, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Speciality Hospital (TSH)", "city": "Amman", "state_or_region": null, "postal_code": "11194", "country": "Jordan", "latitude": 31.95522, "longitude": 35.94503, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Speciality Hospital (TSH)", "city": "Amman", "state_or_region": null, "postal_code": "11194", "country": "Jordan", "latitude": 31.95522, "longitude": 35.94503, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jordan University Hospital", "city": "Jordan", "state_or_region": null, "postal_code": "13046", "country": "Jordan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jordan University Hospital", "city": "Jordan", "state_or_region": null, "postal_code": "13046", "country": "Jordan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Asfendiyarov Kazakh National Medical University", "city": "Almaty", "state_or_region": null, "postal_code": "050000", "country": "Kazakhstan", "latitude": 43.25249, "longitude": 76.9115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Asfendiyarov Kazakh National Medical University", "city": "Almaty", "state_or_region": null, "postal_code": "050000", "country": "Kazakhstan", "latitude": 43.25249, "longitude": 76.9115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Institute of Gastroenterology, Hepatology and Metabolism LLP", "city": "Almaty", "state_or_region": null, "postal_code": "050026", "country": "Kazakhstan", "latitude": 43.25249, "longitude": 76.9115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Institute of Gastroenterology, Hepatology and Metabolism LLP", "city": "Almaty", "state_or_region": null, "postal_code": "050026", "country": "Kazakhstan", "latitude": 43.25249, "longitude": 76.9115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06410352", "study_title": "Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome", "lead_sponsor": "University Medical Center, Kazakhstan", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-26", "facility": "Kuat Pernekulovich Oshakbayev", "city": "Astana", "state_or_region": "Astana", "postal_code": "010000", "country": "Kazakhstan", "latitude": 51.1801, "longitude": 71.44598, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06410352" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07574723", "study_title": "Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity", "lead_sponsor": "Dasman Diabetes Institute", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-08", "facility": "Dasman Diabetes Institute", "city": "Kuwait City", "state_or_region": null, "postal_code": "15462", "country": "Kuwait", "latitude": 29.367, "longitude": 47.97429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07574723" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07096908", "study_title": "Tirzepatide Use in People With Obesity and Type 1 Diabetes", "lead_sponsor": "Dasman Diabetes Institute", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-20", "facility": "Dasman Diabetes Institute", "city": "Kuwait City", "state_or_region": "Sharq", "postal_code": "15462", "country": "Kuwait", "latitude": 29.367, "longitude": 47.97429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07096908" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Ampang", "city": "Ampang", "state_or_region": null, "postal_code": "68000", "country": "Malaysia", "latitude": 3.15, "longitude": 101.76667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Ampang", "city": "Ampang", "state_or_region": null, "postal_code": "68000", "country": "Malaysia", "latitude": 3.15, "longitude": 101.76667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Universiti Sains Malaysia", "city": "Kota Bharu, Kelantan", "state_or_region": null, "postal_code": "16150", "country": "Malaysia", "latitude": 6.12361, "longitude": 102.24333, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universiti Sains Malaysia", "city": "Kota Bharu", "state_or_region": null, "postal_code": "16150", "country": "Malaysia", "latitude": 6.12361, "longitude": 102.24333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universiti Sains Malaysia", "city": "Kota Bharu", "state_or_region": null, "postal_code": "16150", "country": "Malaysia", "latitude": 6.12361, "longitude": 102.24333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Prince Court Medical Centre", "city": "Kuala Lumpur", "state_or_region": null, "postal_code": "50450", "country": "Malaysia", "latitude": 3.1412, "longitude": 101.68653, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Malaya Medical Centre", "city": "Kuala Lumpur", "state_or_region": null, "postal_code": "59100", "country": "Malaysia", "latitude": 3.1412, "longitude": 101.68653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Malaya Medical Centre", "city": "Kuala Lumpur", "state_or_region": null, "postal_code": "59100", "country": "Malaysia", "latitude": 3.1412, "longitude": 101.68653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Melaka", "city": "Malacca", "state_or_region": null, "postal_code": "75400", "country": "Malaysia", "latitude": 2.196, "longitude": 102.2405, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Queen Elizabeth Hospital", "city": "Putrajaya", "state_or_region": null, "postal_code": "0000", "country": "Malaysia", "latitude": 2.93527, "longitude": 101.69112, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Queen Elizabeth Hospital", "city": "Putrajaya", "state_or_region": null, "postal_code": "0000", "country": "Malaysia", "latitude": 2.93527, "longitude": 101.69112, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Hospital Tunku Azizah", "city": "Kampung Baru", "state_or_region": "Kuala Lumpur", "postal_code": "50300", "country": "Malaysia", "latitude": 3.16544, "longitude": 101.70394, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "University Malaya Medical Centre", "city": "Kuala Lumpur", "state_or_region": "Kuala Lumpur", "postal_code": "59100", "country": "Malaysia", "latitude": 3.1412, "longitude": 101.68653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "University Malaya Medical Centre", "city": "Lembah Pantai", "state_or_region": "Kuala Lumpur", "postal_code": "59100", "country": "Malaysia", "latitude": null, "longitude": null, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "University Malaya Medical Centre", "city": "Lembah Pantai", "state_or_region": "Kuala Lumpur", "postal_code": "59100", "country": "Malaysia", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Raja Permaisuri Bainun Ipoh", "city": "Ipoh", "state_or_region": "Perak", "postal_code": "30450", "country": "Malaysia", "latitude": 4.5841, "longitude": 101.0829, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Pulau Pinang", "city": "George Town", "state_or_region": "Pulau Pinang", "postal_code": "10990", "country": "Malaysia", "latitude": 5.41123, "longitude": 100.33543, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Miri", "city": "Miri", "state_or_region": "Sarawak", "postal_code": "98000", "country": "Malaysia", "latitude": 4.39928, "longitude": 113.99163, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Sibu", "city": "Sibu", "state_or_region": "Sarawak", "postal_code": "96000", "country": "Malaysia", "latitude": 2.3, "longitude": 111.81667, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Hospital Sibu", "city": "Sibu", "state_or_region": "Sarawak", "postal_code": "96000", "country": "Malaysia", "latitude": 2.3, "longitude": 111.81667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Sungai Buloh", "city": "Sungai Buloh", "state_or_region": "Selangor", "postal_code": "47000", "country": "Malaysia", "latitude": 3.21, "longitude": 101.561, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigacion Clinica del Pacifico (CICPA)", "city": "Acapulco de Juárez", "state_or_region": null, "postal_code": "39670", "country": "Mexico", "latitude": 16.84942, "longitude": -99.90891, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigacion Clinica del Pacifico (CICPA)", "city": "Acapulco de Juárez", "state_or_region": null, "postal_code": "39670", "country": "Mexico", "latitude": 16.84942, "longitude": -99.90891, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Centro de Atención e Investigación Clínica", "city": "Aguascalientes", "state_or_region": null, "postal_code": "20129", "country": "Mexico", "latitude": 21.88262, "longitude": -102.2843, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "San Peregrino Unidad de Investigación", "city": "Aguascalientes", "state_or_region": null, "postal_code": "20230", "country": "Mexico", "latitude": 21.88262, "longitude": -102.2843, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "San Peregrino Unidad de Investigación", "city": "Aguascalientes", "state_or_region": null, "postal_code": "20230", "country": "Mexico", "latitude": 21.88262, "longitude": -102.2843, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Center Metas", "city": "Chihuahua City", "state_or_region": null, "postal_code": "31110", "country": "Mexico", "latitude": 28.63528, "longitude": -106.08889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Scientia Investigacion Clinica S.C.", "city": "Chihuahua City", "state_or_region": null, "postal_code": "31207", "country": "Mexico", "latitude": 28.63528, "longitude": -106.08889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Scientia Investigacion Clinica S.C.", "city": "Chihuahua City", "state_or_region": null, "postal_code": "31207", "country": "Mexico", "latitude": 28.63528, "longitude": -106.08889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Estudios de Investigacion Metabolicos y Cardiovasculares, S.C.", "city": "Ciudad Madero", "state_or_region": null, "postal_code": "89440", "country": "Mexico", "latitude": 22.2475, "longitude": -97.83665, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Estudios de Investigacion Metabolicos y Cardiovasculares, S.C.", "city": "Ciudad Madero", "state_or_region": null, "postal_code": "89440", "country": "Mexico", "latitude": 22.2475, "longitude": -97.83665, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación y Gastroenterología", "city": "Col. Xoco", "state_or_region": null, "postal_code": "03339", "country": "Mexico", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación y Gastroenterología", "city": "Col. Xoco", "state_or_region": null, "postal_code": "03339", "country": "Mexico", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación y Gastroenterología", "city": "Cuauhtémoc", "state_or_region": null, "postal_code": "06700", "country": "Mexico", "latitude": 19.44506, "longitude": -99.14612, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Diabetes, Obesidad y Nutrición S.C.", "city": "Cuernavaca", "state_or_region": null, "postal_code": "62250", "country": "Mexico", "latitude": 18.9261, "longitude": -99.23075, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Diabetes, Obesidad y Nutrición S.C.", "city": "Cuernavaca", "state_or_region": null, "postal_code": "62250", "country": "Mexico", "latitude": 18.9261, "longitude": -99.23075, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Diabetes, Obesidad y Nutricion", "city": "Cuernavaca", "state_or_region": null, "postal_code": "62250", "country": "Mexico", "latitude": 18.9261, "longitude": -99.23075, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Investigaciones Aplicadas a la Neurociencia A.C.", "city": "Durango", "state_or_region": null, "postal_code": "34000", "country": "Mexico", "latitude": 24.02032, "longitude": -104.65756, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto de Investigaciones Aplicadas a la Neurociencia A.C.", "city": "Durango", "state_or_region": null, "postal_code": "34000", "country": "Mexico", "latitude": 24.02032, "longitude": -104.65756, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Boca Clinical Trials Mexico S.C.", "city": "Guadajalara", "state_or_region": null, "postal_code": "44600", "country": "Mexico", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Boca Clinical Trials Mexico S.C.", "city": "Guadajalara", "state_or_region": null, "postal_code": "44600", "country": "Mexico", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación Clínica y Medicina Traslacional (CIMeT)", "city": "Guadalajara", "state_or_region": null, "postal_code": "44340", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación Clínica y Medicina Traslacional (CIMeT)", "city": "Guadalajara", "state_or_region": null, "postal_code": "44340", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación Clínica y Medicina Traslacional (CIMeT)", "city": "Guadalajara", "state_or_region": null, "postal_code": "44340", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Centro de Investigacion Medica de Occidente, S.C.", "city": "Guadalajara", "state_or_region": null, "postal_code": "44260", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General de Occidente", "city": "Guadalajara", "state_or_region": null, "postal_code": "45170", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General de Occidente", "city": "Guadalajara", "state_or_region": null, "postal_code": "45170", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Private Practice - Dr. Arechavaleta Granell Maria del Rosario", "city": "Guadalajara", "state_or_region": null, "postal_code": "44670", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Unidad de Investigación Clínica y Atención Médica HEPA S.C.", "city": "Guadalajara", "state_or_region": null, "postal_code": "44670", "country": "Mexico", "latitude": 20.67738, "longitude": -103.34749, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Health Pharma Querétaro", "city": "Juriquilla", "state_or_region": null, "postal_code": "76230", "country": "Mexico", "latitude": 20.7114, "longitude": -100.45705, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Health Pharma Querétaro", "city": "Juriquilla", "state_or_region": null, "postal_code": "76230", "country": "Mexico", "latitude": 20.7114, "longitude": -100.45705, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kohler & Milstein Research S.A. De C.V.", "city": "Mérida", "state_or_region": null, "postal_code": "97070", "country": "Mexico", "latitude": 20.967, "longitude": -89.62318, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Care and Research SA de CV", "city": "Mérida", "state_or_region": null, "postal_code": "97070", "country": "Mexico", "latitude": 20.967, "longitude": -89.62318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Care and Research SA de CV", "city": "Mérida", "state_or_region": null, "postal_code": "97070", "country": "Mexico", "latitude": 20.967, "longitude": -89.62318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Care and Research", "city": "Mérida", "state_or_region": null, "postal_code": "97070", "country": "Mexico", "latitude": 20.967, "longitude": -89.62318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Care and Research", "city": "Mérida", "state_or_region": null, "postal_code": "97070", "country": "Mexico", "latitude": 20.967, "longitude": -89.62318, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Médico Lic. Arturo Montiel Rojas ISSEMYM", "city": "Metepec", "state_or_region": null, "postal_code": "52170", "country": "Mexico", "latitude": 19.25934, "longitude": -99.60175, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación Clinica Chapultepec", "city": "Mexico City", "state_or_region": null, "postal_code": "04100", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación Clinica Chapultepec", "city": "Mexico City", "state_or_region": null, "postal_code": "04100", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación y Gastroenterología - S.C.", "city": "Mexico City", "state_or_region": null, "postal_code": "03330", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación y Gastroenterología", "city": "Mexico City", "state_or_region": null, "postal_code": "06700", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigación y Gastroenterología", "city": "Mexico City", "state_or_region": null, "postal_code": "06700", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares", "city": "Mexico City", "state_or_region": null, "postal_code": "11650", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinicos Asociados BOCM SC", "city": "Mexico City", "state_or_region": null, "postal_code": "03300", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinicos Asociados BOCM SC", "city": "Mexico City", "state_or_region": null, "postal_code": "03300", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Grupo Medico Camino Sc", "city": "Mexico City", "state_or_region": null, "postal_code": "03310", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", "city": "Mexico City", "state_or_region": null, "postal_code": "14080", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", "city": "Mexico City", "state_or_region": null, "postal_code": "14080", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", "city": "Mexico City", "state_or_region": null, "postal_code": "14080", "country": "Mexico", "latitude": 19.42847, "longitude": -99.12766, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CEINV Salud", "city": "Monterrey", "state_or_region": null, "postal_code": "64020", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Christus - Latam Hub Center of Excellence and Innovation S.C.", "city": "Monterrey", "state_or_region": null, "postal_code": "64060", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Clínica García Flores SC", "city": "Monterrey", "state_or_region": null, "postal_code": "64610", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Servicios de Oncología Médica Integral - Monterrey", "city": "Monterrey", "state_or_region": null, "postal_code": "66220", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Servicios de Oncología Médica Integral - Monterrey", "city": "Monterrey", "state_or_region": null, "postal_code": "66220", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigacion Clinica Chapultepec", "city": "Morelia", "state_or_region": null, "postal_code": "58260", "country": "Mexico", "latitude": 19.70078, "longitude": -101.18443, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Investigacion Clinica Chapultepec", "city": "Morelia", "state_or_region": null, "postal_code": "58260", "country": "Mexico", "latitude": 19.70078, "longitude": -101.18443, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinica de Enfermedades Cronicas y Procedimientos Especiales, SC", "city": "Morelia", "state_or_region": null, "postal_code": "58249", "country": "Mexico", "latitude": 19.70078, "longitude": -101.18443, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Boca Clinical Trials Mexico SC", "city": "Puebla City", "state_or_region": null, "postal_code": "72160", "country": "Mexico", "latitude": 19.04778, "longitude": -98.20723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Boca Clinical Trials Mexico SC", "city": "Puebla City", "state_or_region": null, "postal_code": "72160", "country": "Mexico", "latitude": 19.04778, "longitude": -98.20723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Consultorio de Endocrinología y Pediatría", "city": "Puebla City", "state_or_region": null, "postal_code": "72190", "country": "Mexico", "latitude": 19.04778, "longitude": -98.20723, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Consultorio Médico de Endocrinología y Pediatría", "city": "Puebla City", "state_or_region": null, "postal_code": "72190", "country": "Mexico", "latitude": 19.04778, "longitude": -98.20723, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Avant Sante Research Center", "city": "San Pedro Garza García", "state_or_region": null, "postal_code": "66260", "country": "Mexico", "latitude": 25.66158, "longitude": -100.4034, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fundación Santos y de la Garza Evía I.B.P", "city": "San Pedro Garza García", "state_or_region": null, "postal_code": "66278", "country": "Mexico", "latitude": 25.66158, "longitude": -100.4034, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Oncare Vasconcelos", "city": "San Pedro Garza García", "state_or_region": null, "postal_code": "66220", "country": "Mexico", "latitude": 25.66158, "longitude": -100.4034, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research Institute S.C.", "city": "Tlalnepantla", "state_or_region": null, "postal_code": "54055", "country": "Mexico", "latitude": 19.54005, "longitude": -99.19538, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research Institute S.C.", "city": "Tlalnepantla", "state_or_region": null, "postal_code": "54055", "country": "Mexico", "latitude": 19.54005, "longitude": -99.19538, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FAICIC S. de R.L. de C.V.", "city": "Veracruz", "state_or_region": null, "postal_code": "91900", "country": "Mexico", "latitude": 19.18095, "longitude": -96.1429, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FAICIC S. de R.L. de C.V.", "city": "Veracruz", "state_or_region": null, "postal_code": "91900", "country": "Mexico", "latitude": 19.18095, "longitude": -96.1429, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Practice Dr Rosa Isela Luna Ceballos", "city": "Veracruz", "state_or_region": null, "postal_code": "91910", "country": "Mexico", "latitude": 19.18095, "longitude": -96.1429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Practice Dr Rosa Isela Luna Ceballos", "city": "Veracruz", "state_or_region": null, "postal_code": "91910", "country": "Mexico", "latitude": 19.18095, "longitude": -96.1429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Alta Especialidad del Estado de Veracruz", "city": "Xalapa", "state_or_region": null, "postal_code": "91020", "country": "Mexico", "latitude": 19.53124, "longitude": -96.91589, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro de Alta Especialidad del Estado de Veracruz", "city": "Xalapa", "state_or_region": null, "postal_code": "91020", "country": "Mexico", "latitude": 19.53124, "longitude": -96.91589, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General de Occidente", "city": "Zapopan", "state_or_region": null, "postal_code": "45170", "country": "Mexico", "latitude": 20.72111, "longitude": -103.38742, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07295223", "study_title": "Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)", "lead_sponsor": "Instituto Mexicano del Seguro Social", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-01-05", "facility": "Hospital de Especialidades No.1, Centro Médico Nacional del Bajío", "city": "León", "state_or_region": "Guanajuato", "postal_code": "37320", "country": "Mexico", "latitude": 21.12183, "longitude": -101.68253, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07295223" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07297589", "study_title": "Epicardial Cardiac Fat-CT (EPIC-CT)", "lead_sponsor": "Instituto Mexicano del Seguro Social", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2026-01-02", "facility": "Unidad Medica de Alta Especialidad No. 1, Bajío", "city": "León", "state_or_region": "Guanajuato", "postal_code": "37260,", "country": "Mexico", "latitude": 21.12183, "longitude": -101.68253, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07297589" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07401992", "study_title": "Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis", "lead_sponsor": "Hospital Universitario Dr. Jose E. Gonzalez", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-11", "facility": "Hospital Universitario Dr. José E. González", "city": "Monterrey", "state_or_region": "N.L.", "postal_code": "64460", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07401992" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "CHRISTUS - Latam Hub Excellence and Innovation Center", "city": "Monterrey", "state_or_region": "Nuevo León", "postal_code": "64060", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "IECSI Centro de Investigación Clínica", "city": "Monterrey", "state_or_region": "Nuevo León", "postal_code": "64310", "country": "Mexico", "latitude": 25.68435, "longitude": -100.31721, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Jeroen Bosch Zkh", "city": "'s-Hertogenbosch", "state_or_region": null, "postal_code": "5223 GZ", "country": "Netherlands", "latitude": 51.69917, "longitude": 5.30417, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Progress Clinical Research - Den Bosch", "city": "'s-Hertogenbosch", "state_or_region": null, "postal_code": "5223 LA", "country": "Netherlands", "latitude": 51.69917, "longitude": 5.30417, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Meander MC", "city": "Amersfoort", "state_or_region": null, "postal_code": "3813 TZ", "country": "Netherlands", "latitude": 52.155, "longitude": 5.3875, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Amsterdam UMC Locatie VUMC", "city": "Amsterdam", "state_or_region": null, "postal_code": "1081HV", "country": "Netherlands", "latitude": 52.37403, "longitude": 4.88969, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Amsterdam UMC, locatie AMC", "city": "Amsterdam", "state_or_region": null, "postal_code": "1105 AZ", "country": "Netherlands", "latitude": 52.37403, "longitude": 4.88969, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Amsterdam UMC, locatie VUmc", "city": "Amsterdam", "state_or_region": null, "postal_code": "1081 HZ", "country": "Netherlands", "latitude": 52.37403, "longitude": 4.88969, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Amsterdam UMC, locatie VUmc", "city": "Amsterdam", "state_or_region": null, "postal_code": "1081 HZ", "country": "Netherlands", "latitude": 52.37403, "longitude": 4.88969, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Progress Clinical Research Amsterdam", "city": "Amsterdam", "state_or_region": null, "postal_code": "1081 GN", "country": "Netherlands", "latitude": 52.37403, "longitude": 4.88969, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Rijnstate Ziekenhuis", "city": "Arnhem", "state_or_region": null, "postal_code": "6815 AD", "country": "Netherlands", "latitude": 51.98, "longitude": 5.91111, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Albert SchweitzerZiekenhuis", "city": "Dordrecht", "state_or_region": null, "postal_code": "3318 AT", "country": "Netherlands", "latitude": 51.81, "longitude": 4.67361, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Albert SchweitzerZiekenhuis", "city": "Dordrecht", "state_or_region": null, "postal_code": "3318 AT", "country": "Netherlands", "latitude": 51.81, "longitude": 4.67361, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Catharina Zkh Eindhoven - Interne geneeskunde", "city": "Eindhoven", "state_or_region": null, "postal_code": "5623 EJ", "country": "Netherlands", "latitude": 51.44083, "longitude": 5.47778, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Spaarne Gasthuis Hoofddorp - Interne", "city": "Hoofddorp", "state_or_region": null, "postal_code": "2134 TM", "country": "Netherlands", "latitude": 52.3025, "longitude": 4.68889, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Bethesda Diabetes Research Center", "city": "Hoogeveen", "state_or_region": null, "postal_code": "7909 AA", "country": "Netherlands", "latitude": 52.7225, "longitude": 6.47639, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Radboud Universitair Medisch Centrum", "city": "Nijmegen", "state_or_region": null, "postal_code": "6525 GA", "country": "Netherlands", "latitude": 51.8425, "longitude": 5.85278, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Radboudumc", "city": "Nijmegen", "state_or_region": null, "postal_code": "6525 GA", "country": "Netherlands", "latitude": 51.8425, "longitude": 5.85278, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Radboudumc", "city": "Nijmegen", "state_or_region": null, "postal_code": "6525 GA", "country": "Netherlands", "latitude": 51.8425, "longitude": 5.85278, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Radboudumc", "city": "Nijmegen", "state_or_region": null, "postal_code": "6525 GA", "country": "Netherlands", "latitude": 51.8425, "longitude": 5.85278, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Erasmus Medisch Centrum", "city": "Rotterdam", "state_or_region": null, "postal_code": "3015 GD", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Erasmus Medisch Centrum", "city": "Rotterdam", "state_or_region": null, "postal_code": "3015 GD", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Erasmus Medisch Centrum", "city": "Rotterdam", "state_or_region": null, "postal_code": "3015 GD", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Erasmus Medisch Centrum", "city": "Rotterdam", "state_or_region": null, "postal_code": "3015 GD", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Erasmus Medisch Centrum", "city": "Rotterdam", "state_or_region": null, "postal_code": "3015 GD", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ikazia Ziekenhuis", "city": "Rotterdam", "state_or_region": null, "postal_code": "3083 AN", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ikazia Ziekenhuis", "city": "Rotterdam", "state_or_region": null, "postal_code": "3083 AN", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Ikazia Ziekenhuis", "city": "Rotterdam", "state_or_region": null, "postal_code": "3083 AN", "country": "Netherlands", "latitude": 51.9225, "longitude": 4.47917, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Franciscus Gasthuis", "city": "Schiedam", "state_or_region": null, "postal_code": "3118 JH", "country": "Netherlands", "latitude": 51.91917, "longitude": 4.38889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Franciscus Gasthuis", "city": "Schiedam", "state_or_region": null, "postal_code": "3118 JH", "country": "Netherlands", "latitude": 51.91917, "longitude": 4.38889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medisch Centrum Thomsonplein", "city": "The Hague", "state_or_region": null, "postal_code": "2565 KV", "country": "Netherlands", "latitude": 52.07667, "longitude": 4.29861, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tweesteden Ziekenhuis, locatie Tilburg", "city": "Tilburg", "state_or_region": null, "postal_code": "5042 AD", "country": "Netherlands", "latitude": 51.55551, "longitude": 5.0913, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitair Medisch Centrum Utrecht", "city": "Utrecht", "state_or_region": null, "postal_code": "3584 CX", "country": "Netherlands", "latitude": 52.09083, "longitude": 5.12222, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitair Medisch Centrum Utrecht", "city": "Utrecht", "state_or_region": null, "postal_code": "3584 CX", "country": "Netherlands", "latitude": 52.09083, "longitude": 5.12222, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitair Medisch Centrum Utrecht", "city": "Utrecht", "state_or_region": null, "postal_code": "3584 CX", "country": "Netherlands", "latitude": 52.09083, "longitude": 5.12222, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Praktijk Dokters van Nederhoven", "city": "Zwijndrecht", "state_or_region": null, "postal_code": "3334 SB", "country": "Netherlands", "latitude": 51.8175, "longitude": 4.63333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Progress Clinical Research - Zwolle", "city": "Zwolle", "state_or_region": null, "postal_code": "8025 AZ", "country": "Netherlands", "latitude": 52.5125, "longitude": 6.09444, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Progress Clinical Research Zwolle", "city": "Zwolle", "state_or_region": null, "postal_code": "8025 AZ", "country": "Netherlands", "latitude": 52.5125, "longitude": 6.09444, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06184633", "study_title": "DUTCH Weight Control in Atrial Fibrillation Study", "lead_sponsor": "Rijnstate Hospital", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-09", "last_update_post_date": "2024-09-19", "facility": "Rijnstate Hospital", "city": "Arnhem", "state_or_region": "Gelderland", "postal_code": null, "country": "Netherlands", "latitude": 51.98, "longitude": 5.91111, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06184633" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "PreCare Trial & Recruitment", "city": "Born", "state_or_region": "Limburg", "postal_code": "6121 XK", "country": "Netherlands", "latitude": 51.03167, "longitude": 5.80972, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Progress Clinical Research Den Bosch", "city": "'s-Hertogenbosch", "state_or_region": "North Brabant", "postal_code": "5223 LA", "country": "Netherlands", "latitude": 51.69917, "longitude": 5.30417, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aotearoa Clinical Trials", "city": "Auckland", "state_or_region": null, "postal_code": "2025", "country": "New Zealand", "latitude": -36.84853, "longitude": 174.76349, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New Zealand Clinical Research (Auckland)", "city": "Auckland", "state_or_region": null, "postal_code": "1010", "country": "New Zealand", "latitude": -36.84853, "longitude": 174.76349, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06700538", "study_title": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "lead_sponsor": "Arrowhead Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Research Site 3", "city": "Auckland", "state_or_region": null, "postal_code": "2025", "country": "New Zealand", "latitude": -36.84853, "longitude": 174.76349, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06700538" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06700538", "study_title": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "lead_sponsor": "Arrowhead Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Research Site 5", "city": "Auckland", "state_or_region": null, "postal_code": "0632", "country": "New Zealand", "latitude": -36.84853, "longitude": 174.76349, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06700538" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Waitemata Clinical Research", "city": "Auckland", "state_or_region": null, "postal_code": "0626", "country": "New Zealand", "latitude": -36.84853, "longitude": 174.76349, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06700538", "study_title": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "lead_sponsor": "Arrowhead Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Research Site 2", "city": "Christchurch", "state_or_region": null, "postal_code": "8011", "country": "New Zealand", "latitude": -43.53333, "longitude": 172.63333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06700538" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Trials New Zealand Ltd", "city": "Hamilton", "state_or_region": null, "postal_code": "3204", "country": "New Zealand", "latitude": -37.78333, "longitude": 175.28333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06700538", "study_title": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "lead_sponsor": "Arrowhead Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Research Site 4", "city": "Hamilton", "state_or_region": null, "postal_code": "3216", "country": "New Zealand", "latitude": -37.78333, "longitude": 175.28333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06700538" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aotearoa Clinical Trials - Whangarei", "city": "Whangarei", "state_or_region": null, "postal_code": "0110", "country": "New Zealand", "latitude": -35.73167, "longitude": 174.32391, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New Zealand Clinical Research (NZCR)", "city": "Grafton", "state_or_region": "Auckland", "postal_code": "1010", "country": "New Zealand", "latitude": -36.86029, "longitude": 174.76566, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New Zealand Clinical Research (NZCR)", "city": "Grafton", "state_or_region": "Auckland", "postal_code": "1010", "country": "New Zealand", "latitude": -36.86029, "longitude": 174.76566, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06700538", "study_title": "A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus", "lead_sponsor": "Arrowhead Pharmaceuticals", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Research Site 1", "city": "Grafton", "state_or_region": "Auckland", "postal_code": "1010", "country": "New Zealand", "latitude": -36.86029, "longitude": 174.76566, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06700538" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Middlemore Hospital", "city": "Papatoetoe", "state_or_region": "Auckland", "postal_code": "2025", "country": "New Zealand", "latitude": -36.9682, "longitude": 174.84019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Middlemore Hospital", "city": "Papatoetoe", "state_or_region": "Auckland", "postal_code": "2025", "country": "New Zealand", "latitude": -36.9682, "longitude": 174.84019, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Christchurch Hospital", "city": "Christchurch", "state_or_region": "Canterbury", "postal_code": "8140", "country": "New Zealand", "latitude": -43.53333, "longitude": 172.63333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Christchurch Hospital", "city": "Christchurch", "state_or_region": "Canterbury", "postal_code": "8140", "country": "New Zealand", "latitude": -43.53333, "longitude": 172.63333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New Zealand Clinical Research (NZCR) Christchurch", "city": "Christchurch Central City", "state_or_region": "Christchurch", "postal_code": "8011", "country": "New Zealand", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Momentum Clinical Research Dunedin", "city": "Central Dunedin", "state_or_region": "Dunedin", "postal_code": "9016", "country": "New Zealand", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Waikato Hospital", "city": "Hamilton", "state_or_region": "Waikato Region", "postal_code": "3240", "country": "New Zealand", "latitude": -37.78333, "longitude": 175.28333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Waikato Hospital", "city": "Hamilton", "state_or_region": "Waikato Region", "postal_code": "3240", "country": "New Zealand", "latitude": -37.78333, "longitude": 175.28333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "nad-plus", "nct_id": "NCT06971224", "study_title": "NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals", "lead_sponsor": "Haukeland University Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-05", "last_update_post_date": "2025-09-15", "facility": "Haukeland University Hospital", "city": "Bergen", "state_or_region": null, "postal_code": null, "country": "Norway", "latitude": 60.39299, "longitude": 5.32415, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06971224" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Oslo Universitetssykehus Ullevål", "city": "Oslo", "state_or_region": null, "postal_code": "0450", "country": "Norway", "latitude": 59.91273, "longitude": 10.74609, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitetssykehuset Nord-Norge HF", "city": "Tromsø", "state_or_region": null, "postal_code": "9038", "country": "Norway", "latitude": 69.6489, "longitude": 18.95508, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07513168", "study_title": "Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults", "lead_sponsor": "Asian Institute Of Medical Sciences", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-07", "last_update_post_date": "2026-04-06", "facility": "Asian Institute of Medical Sciences", "city": "Hyderābād", "state_or_region": "Sindh", "postal_code": "71000", "country": "Pakistan", "latitude": 25.39689, "longitude": 68.37718, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07513168" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07588438", "study_title": "Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.", "lead_sponsor": "Las Rías Medical Center", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-19", "facility": "Centro Médico Las Rias", "city": "Asunción", "state_or_region": null, "postal_code": null, "country": "Paraguay", "latitude": -25.28646, "longitude": -57.647, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07588438" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Gabinet Leczenia Otylosci i Chorob Dietozaleznych", "city": "Bialystok", "state_or_region": null, "postal_code": "15-281", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Kresmed Sp. z o. o.", "city": "Bialystok", "state_or_region": null, "postal_code": "15-481", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Kresmed Sp. z o. o.", "city": "Bialystok", "state_or_region": null, "postal_code": "15-481", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "KRESMED Sp. z o.o.", "city": "Bialystok", "state_or_region": null, "postal_code": "15-481", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Renew Clinic Sp. z o.o.", "city": "Bialystok", "state_or_region": null, "postal_code": "15-797", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bialystok", "state_or_region": null, "postal_code": "15-897", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Uniwersytecki Szpital Kliniczny w Bialymstoku", "city": "Bialystok", "state_or_region": null, "postal_code": "15-276", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "ACTIVE_NOT_RECRUITING; RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Uniwersytecki Szpital Kliniczny w Bialymstoku", "city": "Bialystok", "state_or_region": null, "postal_code": "15-276", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Uniwersytecki Szpital Kliniczny w Bialymstoku", "city": "Bialystok", "state_or_region": null, "postal_code": "15-276", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Athleticomed Sp. z o.o.", "city": "Bydgoszcz", "state_or_region": null, "postal_code": "85-752", "country": "Poland", "latitude": 53.1235, "longitude": 18.00762, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Gierach-Med", "city": "Bygdoszcz", "state_or_region": null, "postal_code": "85-796", "country": "Poland", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Gierach-Med", "city": "Bygdoszcz", "state_or_region": null, "postal_code": "85-796", "country": "Poland", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "ETG Lublin Sp. z o.o.", "city": "Dębica", "state_or_region": null, "postal_code": "39-200", "country": "Poland", "latitude": 50.05146, "longitude": 21.41141, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Samodzielny Zespol Publicznych Zakladow Opieki Zdrowotnej im. Dzieci Warszawy w Dziekanowie Lesnym", "city": "Dziekanów Leśny", "state_or_region": null, "postal_code": "05-092", "country": "Poland", "latitude": 52.35243, "longitude": 20.85124, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centrum Badan Klinicznych PI-House sp. z o.o.", "city": "Gdansk", "state_or_region": null, "postal_code": "80-546", "country": "Poland", "latitude": 54.35227, "longitude": 18.64912, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Gdynia", "state_or_region": null, "postal_code": "81-338", "country": "Poland", "latitude": 54.51889, "longitude": 18.53188, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Nowy Szpital Sp. z o.o.", "city": "Gmina Świecie", "state_or_region": null, "postal_code": "86-100", "country": "Poland", "latitude": 53.40953, "longitude": 18.44742, "site_statuses": "ACTIVE_NOT_RECRUITING; NOT_YET_RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centrum Medyczne Pratia Katowice", "city": "Katowice", "state_or_region": null, "postal_code": "40-081", "country": "Poland", "latitude": 50.2597, "longitude": 19.02173, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero", "city": "Katowice", "state_or_region": null, "postal_code": "40-600", "country": "Poland", "latitude": 50.2597, "longitude": 19.02173, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gyncentrum sp. z o.o. NZOZ Holsamed - oddział Libero", "city": "Katowice", "state_or_region": null, "postal_code": "40-600", "country": "Poland", "latitude": 50.2597, "longitude": 19.02173, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Pro Familia Altera Sp. z o.o.", "city": "Katowice", "state_or_region": null, "postal_code": "40-648", "country": "Poland", "latitude": 50.2597, "longitude": 19.02173, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Uniwersyteckie Centrum Kliniczne SUM w Katowicach", "city": "Katowice", "state_or_region": null, "postal_code": "40-752", "country": "Poland", "latitude": 50.2597, "longitude": 19.02173, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Vita Longa Sp. z o. o.", "city": "Katowice", "state_or_region": null, "postal_code": "40-748", "country": "Poland", "latitude": 50.2597, "longitude": 19.02173, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Specjalistyczna Praktyka Lekarska Diabetologia, Leczenie Cukrzycy i Otyłości lek. Monika Piwowar", "city": "Kielce", "state_or_region": null, "postal_code": "25-355", "country": "Poland", "latitude": 50.87033, "longitude": 20.62752, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Małopolskie Centrum Kliniczne", "city": "Krakow", "state_or_region": null, "postal_code": "30-149", "country": "Poland", "latitude": 50.06143, "longitude": 19.93658, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Centre FutureMeds Krakow", "city": "Krakow", "state_or_region": null, "postal_code": "31-501", "country": "Poland", "latitude": 50.06143, "longitude": 19.93658, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Centre FutureMeds Krakow", "city": "Krakow", "state_or_region": null, "postal_code": "31-501", "country": "Poland", "latitude": 50.06143, "longitude": 19.93658, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Krakow", "state_or_region": null, "postal_code": "31-261", "country": "Poland", "latitude": 50.06143, "longitude": 19.93658, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FutureMeds Lodz", "city": "Lodz", "state_or_region": null, "postal_code": "91-363", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FutureMeds Lodz", "city": "Lodz", "state_or_region": null, "postal_code": "91-363", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Lodz", "state_or_region": null, "postal_code": "90-338", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Santa Familia PTG Lodz", "city": "Lodz", "state_or_region": null, "postal_code": "90-302", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Santa Sp. z o.o.", "city": "Lodz", "state_or_region": null, "postal_code": "90-302", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Santa SP. z o.o", "city": "Lodz", "state_or_region": null, "postal_code": "90-302", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Santa SP. z o.o", "city": "Lodz", "state_or_region": null, "postal_code": "90-302", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "SP ZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi", "city": "Lodz", "state_or_region": null, "postal_code": "92-213", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "SPZOZ Uniwersytecki Szpital Kliniczny Nr 1 im. Norberta Barlickiego UM w Lodzi", "city": "Lodz", "state_or_region": null, "postal_code": "90-153", "country": "Poland", "latitude": 51.77058, "longitude": 19.47395, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Clinical Best Solutions Sp. z o.o., Sp. k", "city": "Lublin", "state_or_region": null, "postal_code": "20-011", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medrise Sp. z o.o.", "city": "Lublin", "state_or_region": null, "postal_code": "20-582", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Lublin", "state_or_region": null, "postal_code": "20-718", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Terpa Sp. z o.o. Sp. k.", "city": "Lublin", "state_or_region": null, "postal_code": "20-333", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Terpa Sp. z o.o. Sp. k.", "city": "Lublin", "state_or_region": null, "postal_code": "20-333", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie", "city": "Lublin", "state_or_region": null, "postal_code": "20-081", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie", "city": "Lublin", "state_or_region": null, "postal_code": "20-081", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Zanamed Medical Clinic Sp. z o.o.", "city": "Lublin", "state_or_region": null, "postal_code": "20-601", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ID Clinic", "city": "Mysłowice", "state_or_region": null, "postal_code": "41-400", "country": "Poland", "latitude": 50.20745, "longitude": 19.16668, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ID Clinic", "city": "Mysłowice", "state_or_region": null, "postal_code": "41-400", "country": "Poland", "latitude": 50.20745, "longitude": 19.16668, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ID Clinic", "city": "Mysłowice", "state_or_region": null, "postal_code": "41-400", "country": "Poland", "latitude": 50.20745, "longitude": 19.16668, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Wojewodzki Szpital Specjalistyczny w Olsztynie", "city": "Olsztyn", "state_or_region": null, "postal_code": "10-561", "country": "Poland", "latitude": 53.78376, "longitude": 20.49272, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Twoja Przychodnia Opolskie Centrum Medyczne", "city": "Opole", "state_or_region": null, "postal_code": "45-819", "country": "Poland", "latitude": 50.67119, "longitude": 17.92604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Twoja Przychodnia Opolskie Centrum Medyczne", "city": "Opole", "state_or_region": null, "postal_code": "45-819", "country": "Poland", "latitude": 50.67119, "longitude": 17.92604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Uniwersytecki Szpital Kliniczny w Opolu", "city": "Opole", "state_or_region": null, "postal_code": "45-401", "country": "Poland", "latitude": 50.67119, "longitude": 17.92604, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Formed 2 Sp. z o.o.", "city": "Oświęcim", "state_or_region": null, "postal_code": "32-600", "country": "Poland", "latitude": 50.03437, "longitude": 19.21037, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Formed 2 Sp. z o.o.", "city": "Oświęcim", "state_or_region": null, "postal_code": "32-600", "country": "Poland", "latitude": 50.03437, "longitude": 19.21037, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Formed 2 Sp. z o.o.", "city": "Oświęcim", "state_or_region": null, "postal_code": "32-600", "country": "Poland", "latitude": 50.03437, "longitude": 19.21037, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IRMED", "city": "Piotrkow Trybunalski", "state_or_region": null, "postal_code": "97-300", "country": "Poland", "latitude": 51.40547, "longitude": 19.70321, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IRMED", "city": "Piotrkow Trybunalski", "state_or_region": null, "postal_code": "97-300", "country": "Poland", "latitude": 51.40547, "longitude": 19.70321, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Centrum Zdrowia Metabolicznego Paweł Bogdański", "city": "Poznan", "state_or_region": null, "postal_code": "60-589", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Maciej Wiza Gaja Poradnie Lekarskie", "city": "Poznan", "state_or_region": null, "postal_code": "61-251", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Poznan", "state_or_region": null, "postal_code": "60-354", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Twoja Przychodnia PCM", "city": "Poznan", "state_or_region": null, "postal_code": "60-324", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Twoja Przychodnia PCM", "city": "Poznan", "state_or_region": null, "postal_code": "60-324", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uniwersyteckie Centrum Stomatologii i Medycyny Specjalistycznej", "city": "Poznan", "state_or_region": null, "postal_code": "60-354", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uniwersyteckie Centrum Stomatologii i Medycyny Specjalistycznej", "city": "Poznan", "state_or_region": null, "postal_code": "60-354", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uniwersyteckie Centrum Stomatologii i Medycyny Specjalistycznej", "city": "Poznan", "state_or_region": null, "postal_code": "60-354", "country": "Poland", "latitude": 52.40692, "longitude": 16.92993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Radom", "state_or_region": null, "postal_code": "26-600", "country": "Poland", "latitude": 51.40253, "longitude": 21.14714, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centrum Medyczne Medyk Sp.zo.o. Sp.k.", "city": "Rzeszów", "state_or_region": null, "postal_code": "35-055", "country": "Poland", "latitude": 50.04132, "longitude": 21.99901, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Kliniczny Szpital Wojewodzki nr 2 im. Sw. Jadwigi Krolowej w Rzeszowie", "city": "Rzeszów", "state_or_region": null, "postal_code": "35-301", "country": "Poland", "latitude": 50.04132, "longitude": 21.99901, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Korczowski Bartosz, Gabinet Lekarski", "city": "Rzeszów", "state_or_region": null, "postal_code": "35-302", "country": "Poland", "latitude": 50.04132, "longitude": 21.99901, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Korczowski Bartosz, Gabinet Lekarski", "city": "Rzeszów", "state_or_region": null, "postal_code": "35-302", "country": "Poland", "latitude": 50.04132, "longitude": 21.99901, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Private Practice - Dr. Lukasz Krupa", "city": "Rzeszów", "state_or_region": null, "postal_code": "35-055", "country": "Poland", "latitude": 50.04132, "longitude": 21.99901, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Velocity Nova Sp. z o.o.", "city": "Staszów", "state_or_region": null, "postal_code": "28-200", "country": "Poland", "latitude": 50.56307, "longitude": 21.16593, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Twoja Przychodnia SCM", "city": "Szczecin", "state_or_region": null, "postal_code": "71-434", "country": "Poland", "latitude": 53.42894, "longitude": 14.55302, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Twoja Przychodnia SCM", "city": "Szczecin", "state_or_region": null, "postal_code": "71-434", "country": "Poland", "latitude": 53.42894, "longitude": 14.55302, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Uniwersytecki Szpital Kliniczny Nr 2 PUM W Szczecinie", "city": "Szczecin", "state_or_region": null, "postal_code": "70-111", "country": "Poland", "latitude": 53.42894, "longitude": 14.55302, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Szpitale Tczewskie S.A.", "city": "Tczew", "state_or_region": null, "postal_code": "83-110", "country": "Poland", "latitude": 54.09242, "longitude": 18.77787, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bodyclinic sp. z o.o. sp.k.", "city": "Warsaw", "state_or_region": null, "postal_code": "03-712", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bodyclinic sp. z o.o. sp.k.", "city": "Warsaw", "state_or_region": null, "postal_code": "03-712", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Care Access Polska Sp. Z o.o.", "city": "Warsaw", "state_or_region": null, "postal_code": "00-719", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "FutureMeds Sp. z o.o.", "city": "Warsaw", "state_or_region": null, "postal_code": "03-291", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FutureMeds Warszawa Centrum", "city": "Warsaw", "state_or_region": null, "postal_code": "00-215", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FutureMeds Warszawa Centrum", "city": "Warsaw", "state_or_region": null, "postal_code": "00-215", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Gyncentrum Sp. z o. o.", "city": "Warsaw", "state_or_region": null, "postal_code": "00-124", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś", "city": "Warsaw", "state_or_region": null, "postal_code": "04-501", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś", "city": "Warsaw", "state_or_region": null, "postal_code": "04-501", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś", "city": "Warsaw", "state_or_region": null, "postal_code": "04-501", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medon Clinical Research Sp. z o.o.", "city": "Warsaw", "state_or_region": null, "postal_code": "02-679", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MTZ Clinical Research Powered by Pratia", "city": "Warsaw", "state_or_region": null, "postal_code": "02-172", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07254572", "study_title": "Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes", "lead_sponsor": "National Institute of Cardiology, Warsaw, Poland", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-07", "last_update_post_date": "2025-11-28", "facility": "National Institute of Cardiology, Department of Coronary Artery and Structural Heart Diseases", "city": "Warsaw", "state_or_region": null, "postal_code": null, "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07254572" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "NBR Polska Tomasz Klodawski", "city": "Warsaw", "state_or_region": null, "postal_code": "00-710", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NZOZ GynCentrum - Oddział Warszawa", "city": "Warsaw", "state_or_region": null, "postal_code": "00-124", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NZOZ GynCentrum - Oddział Warszawa", "city": "Warsaw", "state_or_region": null, "postal_code": "00-124", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NZOZ GynCentrum - Oddział Warszawa", "city": "Warsaw", "state_or_region": null, "postal_code": "00-124", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "PANSTWOWY INSTYTUT MEDYCZNY MSWiA", "city": "Warsaw", "state_or_region": null, "postal_code": "02-507", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Państwowy Instytut Medyczny MSWiA", "city": "Warsaw", "state_or_region": null, "postal_code": "02-507", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "PANSTWOWY INSTYTUT MEDYCZNY MSWiA", "city": "Warsaw", "state_or_region": null, "postal_code": "02-507", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Przychodnie Care Access", "city": "Warsaw", "state_or_region": null, "postal_code": "00-719", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Warsaw", "state_or_region": null, "postal_code": "00-124", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Warsaw", "state_or_region": null, "postal_code": "02-507", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Szpital Czerniakowski", "city": "Warsaw", "state_or_region": null, "postal_code": "00-737", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vivamed Sp. z o.o.", "city": "Warsaw", "state_or_region": null, "postal_code": "03-580", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vivamed Sp. z o.o.", "city": "Warsaw", "state_or_region": null, "postal_code": "03-580", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Centrum Medyczne Oporow", "city": "Wroclaw", "state_or_region": null, "postal_code": "52-416", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centrum Medyczne Oporow", "city": "Wroclaw", "state_or_region": null, "postal_code": "52-416", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EMC Instytut Medyczny S.A. - Wroclaw", "city": "Wroclaw", "state_or_region": null, "postal_code": "54-144", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EMC Instytut Medyczny S.A. - Wroclaw", "city": "Wroclaw", "state_or_region": null, "postal_code": "54-144", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FutureMeds Wroclaw", "city": "Wroclaw", "state_or_region": null, "postal_code": "53-673", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FutureMeds Wroclaw", "city": "Wroclaw", "state_or_region": null, "postal_code": "53-673", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Wroclaw", "state_or_region": null, "postal_code": "51-162", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Melita Medical", "city": "Wroclaw", "state_or_region": null, "postal_code": "53-611", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Melita Medical", "city": "Wroclaw", "state_or_region": null, "postal_code": "53-611", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Wojewódzki Szpital Specjalistyczny im. J. Gromkowskiego", "city": "Wroclaw", "state_or_region": null, "postal_code": "51-149", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Szyszko", "city": "Zabrze", "state_or_region": null, "postal_code": "41-800", "country": "Poland", "latitude": 50.32492, "longitude": 18.78576, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Szyszko", "city": "Zabrze", "state_or_region": null, "postal_code": "41-800", "country": "Poland", "latitude": 50.32492, "longitude": 18.78576, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Szyszko", "city": "Zabrze", "state_or_region": null, "postal_code": "41-800", "country": "Poland", "latitude": 50.32492, "longitude": 18.78576, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ETG Zamość", "city": "Zamość", "state_or_region": null, "postal_code": "22-400", "country": "Poland", "latitude": 50.72314, "longitude": 23.25196, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ETG Zamość", "city": "Zamość", "state_or_region": null, "postal_code": "22-400", "country": "Poland", "latitude": 50.72314, "longitude": 23.25196, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ETG Zamość", "city": "Zamość", "state_or_region": null, "postal_code": "22-400", "country": "Poland", "latitude": 50.72314, "longitude": 23.25196, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Kardio Life - Tomasz Borkowski", "city": "Włocławek", "state_or_region": "Kuyavian-Pomeranian Voivodeship", "postal_code": "87-800", "country": "Poland", "latitude": 52.64817, "longitude": 19.0678, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Krakow", "state_or_region": "Lesser Poland Voivodeship", "postal_code": "30-033", "country": "Poland", "latitude": 50.06143, "longitude": 19.93658, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Wroclaw", "state_or_region": "Lower Silesian Voivodeship", "postal_code": "51-162", "country": "Poland", "latitude": 51.10286, "longitude": 17.03006, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Terpa Sp. z o.o. Sp. k.", "city": "Lublin", "state_or_region": "Lubelskie Voivodeship", "postal_code": "20-333", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ", "city": "Lublin", "state_or_region": "Lublin Voivodeship", "postal_code": "20-049", "country": "Poland", "latitude": 51.25058, "longitude": 22.57009, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Warsaw", "state_or_region": "Masovian Voivodeship", "postal_code": "01-696", "country": "Poland", "latitude": 52.22977, "longitude": 21.01178, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Kliniczny Szpital Wojewodzki nr 2 im. Sw. Jadwigi Krolowej w Rzeszowie", "city": "Rzeszów", "state_or_region": "Podkarpackie Voivodeship", "postal_code": "35-301", "country": "Poland", "latitude": 50.04132, "longitude": 21.99901, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "\"Zdrowie Osteo-Medic\" s.c. Lidia i Artur Racewicz, Agnieszka i Jerzy Supronik", "city": "Bialystok", "state_or_region": "Podlaskie Voivodeship", "postal_code": "15-351", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05340868", "study_title": "Genetics of the Acute Response to Oral Semaglutide", "lead_sponsor": "Medical University of Bialystok", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-11", "last_update_post_date": "2025-03-26", "facility": "Clinical Research Centre, Medical University of Bialystok", "city": "Bialystok", "state_or_region": "Podlaskie Voivodeship", "postal_code": "15-276", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05340868" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "NZOZ Vita-Diabetica Malgorzata Buraczyk", "city": "Bialystok", "state_or_region": "Podlaskie Voivodeship", "postal_code": "15-879", "country": "Poland", "latitude": 53.13333, "longitude": 23.16433, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Gdynia", "state_or_region": "Pomeranian Voivodeship", "postal_code": "81-384", "country": "Poland", "latitude": 54.51889, "longitude": 18.53188, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Chorzów", "state_or_region": "Silesian Voivodeship", "postal_code": "41-500", "country": "Poland", "latitude": 50.30582, "longitude": 18.9742, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Kielce", "state_or_region": "Świętokrzyskie Voivodeship", "postal_code": "25-338", "country": "Poland", "latitude": 50.87033, "longitude": 20.62752, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "ULS Almada-Seixal E.P.E. - HGO_Serviço de Endocrinologia", "city": "Almada", "state_or_region": null, "postal_code": "2805-267", "country": "Portugal", "latitude": 38.67902, "longitude": -9.1569, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "ULS Do Oeste E.P.E. - Unidade Caldas da Rainha_CAMI - Unidade de Diabetes", "city": "Caldas da Rainha", "state_or_region": null, "postal_code": "2500-176", "country": "Portugal", "latitude": 39.40326, "longitude": -9.13839, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Casa De Saúde De Santa Filomena S.A._Unidade de Ensaios Clínicos", "city": "Coimbra", "state_or_region": null, "postal_code": "3000-150", "country": "Portugal", "latitude": 40.20686, "longitude": -8.41996, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "ULS Do Baixo Mondego, E.P.E. - HDFF_Serviço Cardiologia", "city": "Figueira da Foz Municipality", "state_or_region": null, "postal_code": "3094-001", "country": "Portugal", "latitude": 40.15085, "longitude": -8.86179, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Associação Protectora dos Diabéticos de Portugal", "city": "Lisbon", "state_or_region": null, "postal_code": "1050-078", "country": "Portugal", "latitude": 38.72509, "longitude": -9.1498, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria", "city": "Lisbon", "state_or_region": null, "postal_code": "1649-035", "country": "Portugal", "latitude": 38.72509, "longitude": -9.1498, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital da Luz Lisboa, S.A._Serviço de Medicina Interna", "city": "Lisbon", "state_or_region": null, "postal_code": "1500-650", "country": "Portugal", "latitude": 38.72509, "longitude": -9.1498, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Cardiolima Centro Diagnostico Cardio-Pulmonar De Ponte De Lima Lda", "city": "Ponte de Lima", "state_or_region": null, "postal_code": "4990-029", "country": "Portugal", "latitude": 41.76719, "longitude": -8.58393, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "CUF Porto_Serviço de Pediatria", "city": "Porto", "state_or_region": null, "postal_code": "4100-180", "country": "Portugal", "latitude": 41.1485, "longitude": -8.61097, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "ULS De Santo António, E.P.E. _CMIN_Serviço de Pediatria", "city": "Porto", "state_or_region": null, "postal_code": "4050-651", "country": "Portugal", "latitude": 41.1485, "longitude": -8.61097, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "ULS De Matosinhos, E.P.E - HPH_Serviço de Endocrinologia", "city": "Senhora Da Hora, Matosinhos", "state_or_region": null, "postal_code": "4464-513", "country": "Portugal", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Ucardio Centro Clinico Unidade Cardiovascular", "city": "Torres Novas", "state_or_region": null, "postal_code": "2350-111", "country": "Portugal", "latitude": 39.47581, "longitude": -8.54348, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Hospital Trofa Saude Senhor do Bonfim S.A_Unidade de Ensaios Clínicos", "city": "Vila do Conde", "state_or_region": null, "postal_code": "4480-565", "country": "Portugal", "latitude": 41.35326, "longitude": -8.74516, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital Trofa Saude Senhor do Bonfim S.A_Unidade de Ensaios Clínicos", "city": "Vila do Conde", "state_or_region": null, "postal_code": "4480-565", "country": "Portugal", "latitude": 41.35326, "longitude": -8.74516, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Hospital da Luz Arrábida, S.A_Serviço de Endocrinologia", "city": "Vila Nova de Gaia", "state_or_region": null, "postal_code": "4400-346", "country": "Portugal", "latitude": 41.12401, "longitude": -8.61241, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital da Luz Arrábida, S.A_Serviço de Endocrinologia", "city": "Vila Nova de Gaia", "state_or_region": null, "postal_code": "4400-346", "country": "Portugal", "latitude": 41.12401, "longitude": -8.61241, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "ULS De Gaia/Espinho_H.Santos Silva_Unidade Ensaios Clínicos", "city": "Vila Nova de Gaia", "state_or_region": null, "postal_code": "4434-502", "country": "Portugal", "latitude": 41.12401, "longitude": -8.61241, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Isis Clinical Res. Ctr P.S.C.", "city": "Guaynabo", "state_or_region": null, "postal_code": "00968", "country": "Puerto Rico", "latitude": 18.35745, "longitude": -66.111, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Isis Clinical Research Center", "city": "Guaynabo", "state_or_region": null, "postal_code": "00968", "country": "Puerto Rico", "latitude": 18.35745, "longitude": -66.111, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Isis Clinical Research Center", "city": "Guaynabo", "state_or_region": null, "postal_code": "00968", "country": "Puerto Rico", "latitude": 18.35745, "longitude": -66.111, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Reuviva Research Center", "city": "Guaynabo", "state_or_region": null, "postal_code": "00968", "country": "Puerto Rico", "latitude": 18.35745, "longitude": -66.111, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "CMRC Headlands, LLC", "city": "San Juan", "state_or_region": null, "postal_code": "00918", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CMRC Headlands, LLC", "city": "San Juan", "state_or_region": null, "postal_code": "00918", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CMRC Headlands, LLC", "city": "San Juan", "state_or_region": null, "postal_code": "00918", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FDI Clinical Research", "city": "San Juan", "state_or_region": null, "postal_code": "00927", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "FDI Clinical Research", "city": "San Juan", "state_or_region": null, "postal_code": "00927", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinical Investigations Group, LLC", "city": "San Juan", "state_or_region": null, "postal_code": "00909", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinical Investigations Group, LLC", "city": "San Juan", "state_or_region": null, "postal_code": "00909", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Klinical Investigations Group", "city": "San Juan", "state_or_region": null, "postal_code": "00909", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Latin Clinical Trial Center", "city": "San Juan", "state_or_region": null, "postal_code": "00909", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Latin Clinical Trial Center", "city": "San Juan", "state_or_region": null, "postal_code": "00909", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "University Pediatric Hospital", "city": "San Juan", "state_or_region": null, "postal_code": "00935", "country": "Puerto Rico", "latitude": 18.46633, "longitude": -66.10572, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Județean de Urgență Bacău", "city": "Bacau", "state_or_region": null, "postal_code": "600114", "country": "Romania", "latitude": 46.56718, "longitude": 26.91384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Județean de Urgență Bacău", "city": "Bacau", "state_or_region": null, "postal_code": "600114", "country": "Romania", "latitude": 46.56718, "longitude": 26.91384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Spitalul Judetean de Urgenta Dr. Constantin Opris Baia Mare", "city": "Baia Mare", "state_or_region": null, "postal_code": "430031", "country": "Romania", "latitude": 47.65729, "longitude": 23.56808, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Mariodiab Clinic SRL", "city": "Brasov", "state_or_region": null, "postal_code": "500101", "country": "Romania", "latitude": 45.64861, "longitude": 25.60613, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Mariodiab Clinic SRL", "city": "Brasov", "state_or_region": null, "postal_code": "500101", "country": "Romania", "latitude": 45.64861, "longitude": 25.60613, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Arensia Clinics S.R.L.", "city": "Bucharest", "state_or_region": null, "postal_code": "011658", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Delta Health Care", "city": "Bucharest", "state_or_region": null, "postal_code": "014142", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Kilostop Junior SRL", "city": "Bucharest", "state_or_region": null, "postal_code": "010073", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sc Nicodiab Srl", "city": "Bucharest", "state_or_region": null, "postal_code": "010507", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "SC Nutrilife SRL", "city": "Bucharest", "state_or_region": null, "postal_code": "013764", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Clinic Colentina", "city": "Bucharest", "state_or_region": null, "postal_code": "020125", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Clinic Colentina", "city": "Bucharest", "state_or_region": null, "postal_code": "020125", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Clinic Colentina", "city": "Bucharest", "state_or_region": null, "postal_code": "020125", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Spitalul Clinic de Urgenta pentru Copii \"M.S.Curie\"", "city": "Bucharest", "state_or_region": null, "postal_code": "041451", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Universitar de Urgență București", "city": "Bucharest", "state_or_region": null, "postal_code": "050098", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Universitar de Urgență București", "city": "Bucharest", "state_or_region": null, "postal_code": "050098", "country": "Romania", "latitude": 44.43225, "longitude": 26.10626, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Mat Cord Biomedica S.R.L.", "city": "Buzău", "state_or_region": null, "postal_code": "120133", "country": "Romania", "latitude": 45.15, "longitude": 26.83333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cluj Napoca Clinical County Hospital", "city": "Cluj-Napoca", "state_or_region": null, "postal_code": "400006", "country": "Romania", "latitude": 46.76667, "longitude": 23.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Institutul Regional de Gastroenterologie și Hepatologie Prof. Dr. Octavian Fodor", "city": "Cluj-Napoca", "state_or_region": null, "postal_code": "400162", "country": "Romania", "latitude": 46.76667, "longitude": 23.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Regional Institute of Gastroenterology Hepatology \"Prof. Dr. O. Fodor\"", "city": "Cluj-Napoca", "state_or_region": null, "postal_code": "400162", "country": "Romania", "latitude": 46.76667, "longitude": 23.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Regional Institute of Gastroenterology Hepatology \"Prof. Dr. O. Fodor\"", "city": "Cluj-Napoca", "state_or_region": null, "postal_code": "400162", "country": "Romania", "latitude": 46.76667, "longitude": 23.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Constanta County Emergency Clinical Hospital Sf.Ap.Andrei", "city": "Constanța", "state_or_region": null, "postal_code": "900591", "country": "Romania", "latitude": 44.18073, "longitude": 28.63432, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Constanta County Emergency Clinical Hospital Sf.Ap.Andrei", "city": "Constanța", "state_or_region": null, "postal_code": "900591", "country": "Romania", "latitude": 44.18073, "longitude": 28.63432, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Constanta County Emergency Clinical Hospital Sf.Ap.Andrei", "city": "Constanța", "state_or_region": null, "postal_code": "900591", "country": "Romania", "latitude": 44.18073, "longitude": 28.63432, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Clinic Judetean De Urgenta Craiova", "city": "Craiova", "state_or_region": null, "postal_code": "200642", "country": "Romania", "latitude": 44.31667, "longitude": 23.8, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Clinic Județean de Urgență", "city": "Craiova", "state_or_region": null, "postal_code": "200642", "country": "Romania", "latitude": 44.31667, "longitude": 23.8, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spitalul Clinic Județean de Urgență", "city": "Craiova", "state_or_region": null, "postal_code": "200642", "country": "Romania", "latitude": 44.31667, "longitude": 23.8, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "S.C Milena Sante SRL", "city": "Galati", "state_or_region": null, "postal_code": "800001", "country": "Romania", "latitude": 45.43687, "longitude": 28.05028, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastromedica Srl", "city": "Iași", "state_or_region": null, "postal_code": "700506", "country": "Romania", "latitude": 47.16667, "longitude": 27.6, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Spitalul Clinic Judetean De Urgenta Bihor", "city": "Oradea", "state_or_region": null, "postal_code": "410469", "country": "Romania", "latitude": 47.0458, "longitude": 21.91833, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sc Sal Med Srl", "city": "Piteşti", "state_or_region": null, "postal_code": "110424", "country": "Romania", "latitude": 44.85, "longitude": 24.86667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Clinica Korall S.R.L. Satu Mare", "city": "Satu Mare", "state_or_region": null, "postal_code": "440055", "country": "Romania", "latitude": 47.79926, "longitude": 22.86255, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spital Judetean De Urgenta Satu Mare", "city": "Satu Mare", "state_or_region": null, "postal_code": "440055", "country": "Romania", "latitude": 47.79926, "longitude": 22.86255, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spital Judetean De Urgenta Satu Mare", "city": "Satu Mare", "state_or_region": null, "postal_code": "440055", "country": "Romania", "latitude": 47.79926, "longitude": 22.86255, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spital Judetean de Urgenta", "city": "Satu Mare", "state_or_region": null, "postal_code": "440055", "country": "Romania", "latitude": 47.79926, "longitude": 22.86255, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Cabinet Medical Dr Geru SRL", "city": "Timișoara", "state_or_region": null, "postal_code": "300288", "country": "Romania", "latitude": 45.75372, "longitude": 21.22571, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "S.C Centrul de Gastroenterologie Dr. Goldis S.R.L", "city": "Timișoara", "state_or_region": null, "postal_code": "300002", "country": "Romania", "latitude": 45.75372, "longitude": 21.22571, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "S.C Centrul de Gastroenterologie Dr. Goldis S.R.L", "city": "Timișoara", "state_or_region": null, "postal_code": "300002", "country": "Romania", "latitude": 45.75372, "longitude": 21.22571, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara", "city": "Timișoara", "state_or_region": null, "postal_code": "300226", "country": "Romania", "latitude": 45.75372, "longitude": 21.22571, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara", "city": "Timișoara", "state_or_region": null, "postal_code": "300723", "country": "Romania", "latitude": 45.75372, "longitude": 21.22571, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara", "city": "Timișoara", "state_or_region": null, "postal_code": "300723", "country": "Romania", "latitude": 45.75372, "longitude": 21.22571, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Grandmed SRL", "city": "Oradea", "state_or_region": "Bihor County", "postal_code": "410159", "country": "Romania", "latitude": 47.0458, "longitude": 21.91833, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "S.C. Top Diabet Srl", "city": "Craiova", "state_or_region": "Dolj", "postal_code": "200515", "country": "Romania", "latitude": 44.31667, "longitude": 23.8, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "S.C. Top Diabet Srl", "city": "Craiova", "state_or_region": "Dolj", "postal_code": "200515", "country": "Romania", "latitude": 44.31667, "longitude": 23.8, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CMI Dr Pop Lavinia", "city": "Baia Mare", "state_or_region": "Maramureş", "postal_code": "430222", "country": "Romania", "latitude": 47.65729, "longitude": 23.56808, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sc Mediab Srl", "city": "Târgu Mureş", "state_or_region": "Mureș County", "postal_code": "540142", "country": "Romania", "latitude": 46.54245, "longitude": 24.55747, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "King Abdulaziz Medical City, National Guard Health Affairs", "city": "Riyadh", "state_or_region": null, "postal_code": "14611", "country": "Saudi Arabia", "latitude": 24.68773, "longitude": 46.72185, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "King Abdulaziz Medical City, National Guard Health Affairs", "city": "Riyadh", "state_or_region": null, "postal_code": "14611", "country": "Saudi Arabia", "latitude": 24.68773, "longitude": 46.72185, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "King Faisal Specialist Hospital and Research Center", "city": "Riyadh", "state_or_region": null, "postal_code": "11564", "country": "Saudi Arabia", "latitude": 24.68773, "longitude": 46.72185, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "King Faisal Specialist Hospital and Research Center", "city": "Riyadh", "state_or_region": null, "postal_code": "11564", "country": "Saudi Arabia", "latitude": 24.68773, "longitude": 46.72185, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07101939", "study_title": "A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)", "lead_sponsor": "Actimed Therapeutics Ltd", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-17", "facility": "Clinical Hospital Center 'Dr Dragisa Misovic - Dedinje'", "city": "Belgrade", "state_or_region": null, "postal_code": null, "country": "Serbia", "latitude": 44.80401, "longitude": 20.46513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07101939" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07101939", "study_title": "A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)", "lead_sponsor": "Actimed Therapeutics Ltd", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-17", "facility": "Clinical Hospital Center Bezanijska kosa", "city": "Belgrade", "state_or_region": null, "postal_code": null, "country": "Serbia", "latitude": 44.80401, "longitude": 20.46513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07101939" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Institute for Mother and Child Health Care of Serbia", "city": "Belgrade", "state_or_region": null, "postal_code": "11070", "country": "Serbia", "latitude": 44.80401, "longitude": 20.46513, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "University Children's Hospital Tirsova", "city": "Belgrade", "state_or_region": null, "postal_code": "11000", "country": "Serbia", "latitude": 44.80401, "longitude": 20.46513, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07101939", "study_title": "A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)", "lead_sponsor": "Actimed Therapeutics Ltd", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-17", "facility": "University Clinical Center of Serbia", "city": "Belgrade", "state_or_region": null, "postal_code": null, "country": "Serbia", "latitude": 44.80401, "longitude": 20.46513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07101939" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07101939", "study_title": "A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)", "lead_sponsor": "Actimed Therapeutics Ltd", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-17", "facility": "University Clinical Center Kragujevac", "city": "Kragujevac", "state_or_region": null, "postal_code": null, "country": "Serbia", "latitude": 44.01667, "longitude": 20.91667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07101939" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07101939", "study_title": "A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)", "lead_sponsor": "Actimed Therapeutics Ltd", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-17", "facility": "Klinika Za Endocrinologiju, Dijabetes I Bolesti Metabolizma", "city": "Niš", "state_or_region": null, "postal_code": null, "country": "Serbia", "latitude": 43.32472, "longitude": 21.90333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07101939" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Institute for Health Care of Children and Adolescents", "city": "Novi Sad", "state_or_region": null, "postal_code": "21000", "country": "Serbia", "latitude": 45.25167, "longitude": 19.83694, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07101939", "study_title": "A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)", "lead_sponsor": "Actimed Therapeutics Ltd", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-17", "facility": "University Clinical Center of Vojvodina", "city": "Novi Sad", "state_or_region": null, "postal_code": null, "country": "Serbia", "latitude": 45.25167, "longitude": 19.83694, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07101939" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07101939", "study_title": "A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)", "lead_sponsor": "Actimed Therapeutics Ltd", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-17", "facility": "Opsta bolnica Pancevo", "city": "Pančevo", "state_or_region": null, "postal_code": null, "country": "Serbia", "latitude": 44.87177, "longitude": 20.64167, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07101939" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Changi General Hospital", "city": "Singapore", "state_or_region": null, "postal_code": "529889", "country": "Singapore", "latitude": 1.28967, "longitude": 103.85007, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Changi General Hospital", "city": "Singapore", "state_or_region": null, "postal_code": "529889", "country": "Singapore", "latitude": 1.28967, "longitude": 103.85007, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National University Hospital", "city": "Singapore", "state_or_region": null, "postal_code": "119074", "country": "Singapore", "latitude": 1.28967, "longitude": 103.85007, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National University Hospital", "city": "Singapore", "state_or_region": null, "postal_code": "119074", "country": "Singapore", "latitude": 1.28967, "longitude": 103.85007, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Singapore General Hospital", "city": "Singapore", "state_or_region": null, "postal_code": "169608", "country": "Singapore", "latitude": 1.28967, "longitude": 103.85007, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Singapore General Hospital", "city": "Singapore", "state_or_region": null, "postal_code": "169608", "country": "Singapore", "latitude": 1.28967, "longitude": 103.85007, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica", "city": "Banská Bystrica", "state_or_region": null, "postal_code": "97517", "country": "Slovakia", "latitude": 48.73947, "longitude": 19.14932, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica", "city": "Banská Bystrica", "state_or_region": null, "postal_code": "97517", "country": "Slovakia", "latitude": 48.73947, "longitude": 19.14932, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "DIADA, s.r.o.", "city": "Bardejov", "state_or_region": null, "postal_code": "08501", "country": "Slovakia", "latitude": 49.29175, "longitude": 21.27271, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "DIA - CLARUS s.r.o.", "city": "Bojnice", "state_or_region": null, "postal_code": "97201", "country": "Slovakia", "latitude": 48.78511, "longitude": 18.5864, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cliniq s.r.o.", "city": "Bratislava", "state_or_region": null, "postal_code": "81109", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cliniq s.r.o.", "city": "Bratislava", "state_or_region": null, "postal_code": "81109", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Diacrin s. r. o.", "city": "Bratislava", "state_or_region": null, "postal_code": "83101", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "KARDIO-SANUS, spol. s r.o.", "city": "Bratislava", "state_or_region": null, "postal_code": "84108", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "MEDISPEKTRUM s.r.o.", "city": "Bratislava", "state_or_region": null, "postal_code": "851 01", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "MEDISPEKTRUM s.r.o.", "city": "Bratislava", "state_or_region": null, "postal_code": "851 01", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Metabol KLINIK s.r.o.", "city": "Bratislava", "state_or_region": null, "postal_code": "811 08", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Narodny Ustav Detskych Chorob", "city": "Bratislava", "state_or_region": null, "postal_code": "833 40", "country": "Slovakia", "latitude": 48.14816, "longitude": 17.10674, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Diab - Int, s.r.o.", "city": "Bytča", "state_or_region": null, "postal_code": "014 01", "country": "Slovakia", "latitude": 49.22404, "longitude": 18.55878, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Detska Fakultna nemocnica Kosice", "city": "Košice", "state_or_region": null, "postal_code": "040 01", "country": "Slovakia", "latitude": 48.71441, "longitude": 21.25802, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "ENDOMED, s.r.o.", "city": "Košice", "state_or_region": null, "postal_code": "04013", "country": "Slovakia", "latitude": 48.71441, "longitude": 21.25802, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ENDOMED", "city": "Košice", "state_or_region": null, "postal_code": "040 13", "country": "Slovakia", "latitude": 48.71441, "longitude": 21.25802, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ENDOMED", "city": "Košice", "state_or_region": null, "postal_code": "040 13", "country": "Slovakia", "latitude": 48.71441, "longitude": 21.25802, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "HUMAN-CARE, s.r.o.", "city": "Košice", "state_or_region": null, "postal_code": "040 01", "country": "Slovakia", "latitude": 48.71441, "longitude": 21.25802, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Narodny Endokrinologicky a diabetologicky ustav", "city": "Ľubochňa", "state_or_region": null, "postal_code": "03491", "country": "Slovakia", "latitude": 49.12011, "longitude": 19.16891, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "IN-DIA s.r.o.", "city": "Lučenec", "state_or_region": null, "postal_code": "984 01", "country": "Slovakia", "latitude": 48.33249, "longitude": 19.66708, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "SIN AZUCAR s.r.o.", "city": "Malacky", "state_or_region": null, "postal_code": "901 01", "country": "Slovakia", "latitude": 48.43604, "longitude": 17.02188, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "DIAMARTIN, s. r. o.", "city": "Martin", "state_or_region": null, "postal_code": "036 01", "country": "Slovakia", "latitude": 49.06651, "longitude": 18.92399, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro LM", "city": "Prešov", "state_or_region": null, "postal_code": "080 01", "country": "Slovakia", "latitude": 48.99923, "longitude": 21.2355, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro LM", "city": "Prešov", "state_or_region": null, "postal_code": "080 01", "country": "Slovakia", "latitude": 48.99923, "longitude": 21.2355, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "MEDI-DIA s.r.o.", "city": "Sabinov", "state_or_region": null, "postal_code": "08301", "country": "Slovakia", "latitude": 49.10309, "longitude": 21.0988, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "LUDIA, s. r. o.", "city": "Spišská Nová Ves", "state_or_region": null, "postal_code": "05201", "country": "Slovakia", "latitude": 48.94464, "longitude": 20.56153, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "ARETEUS s.r.o.", "city": "Trebišov", "state_or_region": null, "postal_code": "075 01", "country": "Slovakia", "latitude": 48.62858, "longitude": 21.71954, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07373834", "study_title": "Tirzepatide and Muscle Outcomes in Obesity", "lead_sponsor": "University Medical Centre Ljubljana", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2026-01-28", "facility": "Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana", "city": "Ljubljana", "state_or_region": null, "postal_code": "1000", "country": "Slovenia", "latitude": 46.05108, "longitude": 14.50513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07373834" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06613854", "study_title": "Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes", "lead_sponsor": "University Medical Centre Ljubljana", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-30", "facility": "University Medical Centre Ljubljana, Diabetes Outpatient Clinic", "city": "Ljubljana", "state_or_region": null, "postal_code": "1000", "country": "Slovenia", "latitude": 46.05108, "longitude": 14.50513, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06613854" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charlotte Maxeke Johannesburg Academic Hospital", "city": "Johannesburg", "state_or_region": null, "postal_code": "2000", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Lenasia Clinical Trial Centre", "city": "Johannesburg", "state_or_region": null, "postal_code": "1827", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Practice Dr Naeem Moosa", "city": "Johannesburg", "state_or_region": null, "postal_code": "1827", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inspired GI Care", "city": "Plumstead", "state_or_region": null, "postal_code": "7800", "country": "South Africa", "latitude": -34.01909, "longitude": 18.47835, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inspired GI Care", "city": "Plumstead", "state_or_region": null, "postal_code": "7800", "country": "South Africa", "latitude": -34.01909, "longitude": 18.47835, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Phoenix Pharma", "city": "Port Elizabeth", "state_or_region": "Eastern Cape", "postal_code": "6001", "country": "South Africa", "latitude": -33.96109, "longitude": 25.61494, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "IATROS International", "city": "Bloemfontein", "state_or_region": "Free State", "postal_code": "9301", "country": "South Africa", "latitude": -29.12107, "longitude": 26.214, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medi-Clinic Bloemfontein", "city": "Bloemfontein", "state_or_region": "Free State", "postal_code": "9301", "country": "South Africa", "latitude": -29.12107, "longitude": 26.214, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hemant Makan", "city": "Johannesburg", "state_or_region": "Gauteng", "postal_code": "1827", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Newtown Clinical Research", "city": "Johannesburg", "state_or_region": "Gauteng", "postal_code": "2001", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sandton Medical Research", "city": "Johannesburg", "state_or_region": "Gauteng", "postal_code": "2196", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Soweto Clinical Trial Centre", "city": "Johannesburg", "state_or_region": "Gauteng", "postal_code": "1818", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Wits Bara Clinical Trial Site", "city": "Johannesburg", "state_or_region": "Gauteng", "postal_code": "2013", "country": "South Africa", "latitude": -26.20227, "longitude": 28.04363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Lenasia Clinical Trial Centre", "city": "Lenasia", "state_or_region": "Gauteng", "postal_code": "1827", "country": "South Africa", "latitude": -26.32052, "longitude": 27.83564, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Trial Systems (CTC)", "city": "Pretoria", "state_or_region": "Gauteng", "postal_code": "0186", "country": "South Africa", "latitude": -25.74486, "longitude": 28.18783, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Dr Pillay's Rooms", "city": "Durban", "state_or_region": "KwaZulu-Natal", "postal_code": "4450", "country": "South Africa", "latitude": -29.8579, "longitude": 31.0292, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Tread Research (Pty)Ltd", "city": "Cape Town", "state_or_region": "Western Cape", "postal_code": "7500", "country": "South Africa", "latitude": -33.92584, "longitude": 18.42322, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Dr Hendrik Snyman's Practice", "city": "Mossel Bay", "state_or_region": "Western Cape", "postal_code": "6500", "country": "South Africa", "latitude": -34.18307, "longitude": 22.14605, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Paarl Research Centre", "city": "Paarl, Cape Town", "state_or_region": "Western Cape", "postal_code": "7646", "country": "South Africa", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Trials Network Helderberg (Pty) Ltd", "city": "Somerset West", "state_or_region": "Western Cape", "postal_code": "7130", "country": "South Africa", "latitude": -34.08401, "longitude": 18.82113, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Korea University Ansan Hospital", "city": "Ansan-si", "state_or_region": null, "postal_code": "15355", "country": "South Korea", "latitude": 37.32361, "longitude": 126.82194, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Soon Chun Hyang University Bucheon Hospital", "city": "Bucheon-si", "state_or_region": null, "postal_code": "14584", "country": "South Korea", "latitude": 37.49889, "longitude": 126.78306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Soon Chun Hyang University Hospital Bucheon", "city": "Bucheon-si", "state_or_region": null, "postal_code": "14584", "country": "South Korea", "latitude": 37.49889, "longitude": 126.78306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Soon Chun Hyang University Hospital Bucheon", "city": "Bucheon-si", "state_or_region": null, "postal_code": "14584", "country": "South Korea", "latitude": 37.49889, "longitude": 126.78306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pusan National University Hospital", "city": "Busan", "state_or_region": null, "postal_code": "49241", "country": "South Korea", "latitude": 35.10168, "longitude": 129.03004, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pusan National University Hospital", "city": "Busan", "state_or_region": null, "postal_code": "49241", "country": "South Korea", "latitude": 35.10168, "longitude": 129.03004, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Pusan National University Hospital", "city": "Busan", "state_or_region": null, "postal_code": "49241", "country": "South Korea", "latitude": 35.10168, "longitude": 129.03004, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pusan National University Yangsan Hospital", "city": "Busan", "state_or_region": null, "postal_code": "50612", "country": "South Korea", "latitude": 35.10168, "longitude": 129.03004, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Keimyung University Dongsan Hospital", "city": "Daegu", "state_or_region": null, "postal_code": "42601", "country": "South Korea", "latitude": 35.87028, "longitude": 128.59111, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Daegu", "state_or_region": null, "postal_code": "41404", "country": "South Korea", "latitude": 35.87028, "longitude": 128.59111, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Daejeon", "state_or_region": null, "postal_code": "35015", "country": "South Korea", "latitude": 36.34913, "longitude": 127.38493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yeungnam University Medical Center", "city": "Deagu", "state_or_region": null, "postal_code": "42415", "country": "South Korea", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Boramae Medical Center", "city": "Dongjak-gu", "state_or_region": null, "postal_code": "07061", "country": "South Korea", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chung-Ang University Hospital", "city": "Dongjak-gu", "state_or_region": null, "postal_code": "06973", "country": "South Korea", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hanyang University Guri Hospital", "city": "Guri-si", "state_or_region": null, "postal_code": "11923", "country": "South Korea", "latitude": 37.5986, "longitude": 127.1394, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Guri-si", "state_or_region": null, "postal_code": "11923", "country": "South Korea", "latitude": 37.5986, "longitude": 127.1394, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Chosun University Hospital_Endocrinology", "city": "Gwangju", "state_or_region": null, "postal_code": "61453", "country": "South Korea", "latitude": 35.15472, "longitude": 126.91556, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hallym UMC_Pyeongchon", "city": "Gyeonggi-do", "state_or_region": null, "postal_code": "14068", "country": "South Korea", "latitude": 37.58944, "longitude": 126.76917, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hanyang University GURI Hospital", "city": "Gyeonggi-do", "state_or_region": null, "postal_code": "471-101", "country": "South Korea", "latitude": 37.58944, "longitude": 126.76917, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yeungnam Univeristy Medical Center", "city": "Gyeongsan-si", "state_or_region": null, "postal_code": "42415", "country": "South Korea", "latitude": 35.82333, "longitude": 128.73778, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inha University Hospital", "city": "Incheon", "state_or_region": null, "postal_code": "22332", "country": "South Korea", "latitude": 37.45646, "longitude": 126.70515, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inha University Hospital", "city": "Incheon", "state_or_region": null, "postal_code": "22332", "country": "South Korea", "latitude": 37.45646, "longitude": 126.70515, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inha University Hospital", "city": "Incheon", "state_or_region": null, "postal_code": "22332", "country": "South Korea", "latitude": 37.45646, "longitude": 126.70515, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Incheon", "state_or_region": null, "postal_code": "21565", "country": "South Korea", "latitude": 37.45646, "longitude": 126.70515, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gyeongsang National University Hospital", "city": "Jinju", "state_or_region": null, "postal_code": "52727", "country": "South Korea", "latitude": 35.19278, "longitude": 128.08472, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kyungpook National University Hospital", "city": "Junggu", "state_or_region": null, "postal_code": "41944", "country": "South Korea", "latitude": 34.79433, "longitude": 126.94369, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Asan Medical Center_Endocrinology", "city": "Seoul", "state_or_region": null, "postal_code": "05505", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Asan Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "05505", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Asan Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "05505", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Asan Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "05505", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chung-Ang University Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "6973", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chung-Ang University Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "6973", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hanyang University Seoul Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "04763", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Kangbuk Samsung Hospital_Endocrinology", "city": "Seoul", "state_or_region": null, "postal_code": "03181", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Korea University Guro Hospital_Endocrinology", "city": "Seoul", "state_or_region": null, "postal_code": "08308", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Korea University Guro Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "08308", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Korea University Guro Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "08308", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Korea University Guro Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "08308", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Nowon Eulji Medical Center, Eulji University_Endocrinology", "city": "Seoul", "state_or_region": null, "postal_code": "01830", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Seoul", "state_or_region": null, "postal_code": "05278", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Seoul", "state_or_region": null, "postal_code": "06351", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Samsung Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "06351", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Samsung Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "6351", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Samsung Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "6351", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07732426", "study_title": "Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies", "lead_sponsor": "Seoul National University Hospital", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-28", "facility": "Seoul National University Hospital", "city": "Seoul", "state_or_region": null, "postal_code": null, "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07732426" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Seoul National University Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "03080", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Seoul National University Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "03080", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Seoul National University Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "03080", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Severance Hospital, Yonsei University Health System", "city": "Seoul", "state_or_region": null, "postal_code": "03722", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 2, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SMG-SNU Boramae Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "07061", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SMG-SNU Boramae Medical Center", "city": "Seoul", "state_or_region": null, "postal_code": "07061", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Catholic Univ. of Korea Seoul St. Mary's Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "06591", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Catholic University of Korea, Eunpyeong St. Mary's Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "03312", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "The Catholic University of Korea, Seoul ST. Mary's Hospital_Endocrinology", "city": "Seoul", "state_or_region": null, "postal_code": "06591", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "The Catholic University of Korea, Seoul ST. Mary's Hospital", "city": "Seoul", "state_or_region": null, "postal_code": "06591", "country": "South Korea", "latitude": 37.566, "longitude": 126.9784, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Wonju Severance Christian Hospital", "city": "Wŏnju", "state_or_region": null, "postal_code": "26426", "country": "South Korea", "latitude": 37.35139, "longitude": 127.94528, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yonsei University Wonju Severance Christian Hospital", "city": "Wŏnju", "state_or_region": null, "postal_code": "26426", "country": "South Korea", "latitude": 37.35139, "longitude": 127.94528, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yonsei University Wonju Severance Christian Hospital", "city": "Wŏnju", "state_or_region": null, "postal_code": "26426", "country": "South Korea", "latitude": 37.35139, "longitude": 127.94528, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Korea University Ansan Hospital_Endocrinology", "city": "Ansan-si", "state_or_region": "Gyeonggi-do", "postal_code": "15355", "country": "South Korea", "latitude": 37.32361, "longitude": 126.82194, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "National Health Insurance Corporation Ilsan Hospital", "city": "Goyang-si", "state_or_region": "Gyeonggi-do", "postal_code": "10444", "country": "South Korea", "latitude": 37.65639, "longitude": 126.835, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Pusan National University Yangsan Hospital_Family Medicine", "city": "Yangsan", "state_or_region": "Gyeongsangnam-do", "postal_code": "50612", "country": "South Korea", "latitude": 35.34199, "longitude": 129.03358, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHUAC-Complejo Hospitalario Universitario A Coruña", "city": "A Coruña", "state_or_region": null, "postal_code": "15006", "country": "Spain", "latitude": 43.37135, "longitude": -8.396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complejo Hospitalario Universitario A Coruña", "city": "A Coruña", "state_or_region": null, "postal_code": "15006", "country": "Spain", "latitude": 43.37135, "longitude": -8.396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complejo Hospitalario Universitario A Coruña", "city": "A Coruña", "state_or_region": null, "postal_code": "15006", "country": "Spain", "latitude": 43.37135, "longitude": -8.396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Complejo Hospitalario Universitario A Coruña", "city": "A Coruña", "state_or_region": null, "postal_code": "15006", "country": "Spain", "latitude": 43.37135, "longitude": -8.396, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Centro de Salud A Estrada", "city": "A Estrada", "state_or_region": null, "postal_code": "36680", "country": "Spain", "latitude": 42.68911, "longitude": -8.48842, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Centro Periferico De Especialidades Bola Azul", "city": "Almería", "state_or_region": null, "postal_code": "04009", "country": "Spain", "latitude": 36.83814, "longitude": -2.45974, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital Comarcal de Antequera", "city": "Antequera", "state_or_region": null, "postal_code": "29200", "country": "Spain", "latitude": 37.01938, "longitude": -4.56123, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Germans Trias i Pujol", "city": "Badalona", "state_or_region": null, "postal_code": "08916", "country": "Spain", "latitude": 41.45004, "longitude": 2.24741, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CAPSBE_CAP Ernest LLuch", "city": "Barcelona", "state_or_region": null, "postal_code": "08028", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Médico Teknon", "city": "Barcelona", "state_or_region": null, "postal_code": "08022", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centro Médico Teknon", "city": "Barcelona", "state_or_region": null, "postal_code": "08022", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07242534", "study_title": "Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.", "lead_sponsor": "Fundacion Dexeus", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus", "city": "Barcelona", "state_or_region": null, "postal_code": "08028", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07242534" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Equip D´Atencio Primaria Barcelona Sardenya", "city": "Barcelona", "state_or_region": null, "postal_code": "08025", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Clínic de Barcelona", "city": "Barcelona", "state_or_region": null, "postal_code": "08036", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Clinic i Provincial", "city": "Barcelona", "state_or_region": null, "postal_code": "08036", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hospital Universitari Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Hospital Vall d'Hebrón_Endocrinología pediatríca", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Hospital Vall d'Hebron", "city": "Barcelona", "state_or_region": null, "postal_code": "08035", "country": "Spain", "latitude": 41.38879, "longitude": 2.15899, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Hospital Vithas Sevilla", "city": "Castilleja de la Cuesta", "state_or_region": null, "postal_code": "41950", "country": "Spain", "latitude": 37.38594, "longitude": -6.05258, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Hospital Vithas Sevilla", "city": "Castilleja de la Cuesta", "state_or_region": null, "postal_code": "41950", "country": "Spain", "latitude": 37.38594, "longitude": -6.05258, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Eap Osona Sud Alt Congost S.L.P", "city": "Centelles (Barcelona)", "state_or_region": null, "postal_code": "08540", "country": "Spain", "latitude": 41.79746, "longitude": 2.21902, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Eap Osona Sud Alt Congost S.L.P", "city": "Centelles (Barcelona)", "state_or_region": null, "postal_code": "08540", "country": "Spain", "latitude": 41.79746, "longitude": 2.21902, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Reina Sofia", "city": "Córdoba", "state_or_region": null, "postal_code": "14004", "country": "Spain", "latitude": 37.89155, "longitude": -4.77275, "site_statuses": "ACTIVE_NOT_RECRUITING; NOT_YET_RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hospital Universitario Reina Sofia", "city": "Córdoba", "state_or_region": null, "postal_code": "14004", "country": "Spain", "latitude": 37.89155, "longitude": -4.77275, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Reina Sofía", "city": "Córdoba", "state_or_region": null, "postal_code": "14004", "country": "Spain", "latitude": 37.89155, "longitude": -4.77275, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Reina Sofía", "city": "Córdoba", "state_or_region": null, "postal_code": "14004", "country": "Spain", "latitude": 37.89155, "longitude": -4.77275, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Hospital Sant Joan de Déu", "city": "Esplugues de Llobregat", "state_or_region": null, "postal_code": "08950", "country": "Spain", "latitude": 41.37732, "longitude": 2.08809, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Arquitecto Marcide", "city": "Ferrol", "state_or_region": null, "postal_code": "15405", "country": "Spain", "latitude": 43.48451, "longitude": -8.23293, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Arquitecto Marcide", "city": "Ferrol", "state_or_region": null, "postal_code": "15405", "country": "Spain", "latitude": 43.48451, "longitude": -8.23293, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Naval", "city": "Ferrol", "state_or_region": null, "postal_code": "15405", "country": "Spain", "latitude": 43.48451, "longitude": -8.23293, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Hospital Naval Ferrol", "city": "Ferrol", "state_or_region": null, "postal_code": "15405", "country": "Spain", "latitude": 43.48451, "longitude": -8.23293, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Universitario de Getafe", "city": "Getafe", "state_or_region": null, "postal_code": "28905", "country": "Spain", "latitude": 40.30571, "longitude": -3.73295, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Cabueñes", "city": "Gijón", "state_or_region": null, "postal_code": "33394", "country": "Spain", "latitude": 43.53573, "longitude": -5.66152, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital de Cabueñes", "city": "Gijón", "state_or_region": null, "postal_code": "33394", "country": "Spain", "latitude": 43.53573, "longitude": -5.66152, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Clínica Bofill", "city": "Girona", "state_or_region": null, "postal_code": "17002", "country": "Spain", "latitude": 41.98311, "longitude": 2.82493, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clínica Bofill", "city": "Girona", "state_or_region": null, "postal_code": "17002", "country": "Spain", "latitude": 41.98311, "longitude": 2.82493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Infanta Elena", "city": "Huelva", "state_or_region": null, "postal_code": "21007", "country": "Spain", "latitude": 37.26638, "longitude": -6.94004, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital de Bellvitge", "city": "L'Hospitalet de Llobregat", "state_or_region": null, "postal_code": "08907", "country": "Spain", "latitude": 41.35967, "longitude": 2.10028, "site_statuses": "ACTIVE_NOT_RECRUITING; NOT_YET_RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Clínica Palacios Madrid", "city": "Madrid", "state_or_region": null, "postal_code": "28009", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Fundacion Jiménez Díaz", "city": "Madrid", "state_or_region": null, "postal_code": "28040", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "ACTIVE_NOT_RECRUITING; NOT_YET_RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hosp. Univ. Ruber Juan Bravo_Endocrinología", "city": "Madrid", "state_or_region": null, "postal_code": "28006", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Clínico San Carlos", "city": "Madrid", "state_or_region": null, "postal_code": "28040", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General Universitario Gregorio Marañon", "city": "Madrid", "state_or_region": null, "postal_code": "28007", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General Universitario Gregorio Marañon", "city": "Madrid", "state_or_region": null, "postal_code": "28028", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital General Universitario Gregorio Marañon", "city": "Madrid", "state_or_region": null, "postal_code": "28028", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hospital Infantil Universitario Niño Jesús", "city": "Madrid", "state_or_region": null, "postal_code": "28009", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario 12 de Octubre", "city": "Madrid", "state_or_region": null, "postal_code": "28041", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario 12 de Octubre", "city": "Madrid", "state_or_region": null, "postal_code": "28041", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital Universitario de Fuenlabrada", "city": "Madrid", "state_or_region": null, "postal_code": "28942", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital Universitario de la Princesa", "city": "Madrid", "state_or_region": null, "postal_code": "28006", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Hospital Universitario de la Princesa", "city": "Madrid", "state_or_region": null, "postal_code": "28006", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario La Paz", "city": "Madrid", "state_or_region": null, "postal_code": "28046", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario La Paz", "city": "Madrid", "state_or_region": null, "postal_code": "28046", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario La Paz", "city": "Madrid", "state_or_region": null, "postal_code": "28046", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario La Paz", "city": "Madrid", "state_or_region": null, "postal_code": "28046", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hospital Universitario Sanitas Virgen del Mar", "city": "Madrid", "state_or_region": null, "postal_code": "28016", "country": "Spain", "latitude": 40.4165, "longitude": -3.70256, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Puerta de Hierro", "city": "Majadahonda", "state_or_region": null, "postal_code": "28222", "country": "Spain", "latitude": 40.47353, "longitude": -3.87182, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Puerta de Hierro", "city": "Majadahonda", "state_or_region": null, "postal_code": "28222", "country": "Spain", "latitude": 40.47353, "longitude": -3.87182, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "H. Clinico Univ. Virgen de la Victoria", "city": "Málaga", "state_or_region": null, "postal_code": "29010", "country": "Spain", "latitude": 36.72016, "longitude": -4.42034, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "H.R.U Málaga - Hospital General", "city": "Málaga", "state_or_region": null, "postal_code": "29011", "country": "Spain", "latitude": 36.72016, "longitude": -4.42034, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Althaia Xarxa Assistencial Universitaria De Manresa Fundacio Privada", "city": "Manresa", "state_or_region": null, "postal_code": "08243", "country": "Spain", "latitude": 41.72815, "longitude": 1.82399, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Central de Asturias", "city": "Oviedo", "state_or_region": null, "postal_code": "33011", "country": "Spain", "latitude": 43.36029, "longitude": -5.84476, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Central de Asturias", "city": "Oviedo", "state_or_region": null, "postal_code": "33011", "country": "Spain", "latitude": 43.36029, "longitude": -5.84476, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari Son Espases", "city": "Palma", "state_or_region": null, "postal_code": "07120", "country": "Spain", "latitude": 39.56939, "longitude": 2.65024, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complejo Hospitalario de Navarra", "city": "Pamplona", "state_or_region": null, "postal_code": "31009", "country": "Spain", "latitude": 42.81687, "longitude": -1.64323, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complejo Hospitalario de Navarra", "city": "Pamplona", "state_or_region": null, "postal_code": "31009", "country": "Spain", "latitude": 42.81687, "longitude": -1.64323, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CHOP - Hospital Universitario Montecelo", "city": "Pontevedra", "state_or_region": null, "postal_code": "36004", "country": "Spain", "latitude": 42.431, "longitude": -8.64435, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complexo Hospitalario Universitario de Pontevedra", "city": "Pontevedra", "state_or_region": null, "postal_code": "36071", "country": "Spain", "latitude": 42.431, "longitude": -8.64435, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Complexo Hospitalario Universitario de Pontevedra", "city": "Pontevedra", "state_or_region": null, "postal_code": "36071", "country": "Spain", "latitude": 42.431, "longitude": -8.64435, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "H. Univ. Marqués de Valdecilla_Endocrinología", "city": "Santander", "state_or_region": null, "postal_code": "39008", "country": "Spain", "latitude": 43.46589, "longitude": -3.80493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Marqués de Valdecilla", "city": "Santander", "state_or_region": null, "postal_code": "39005", "country": "Spain", "latitude": 43.46589, "longitude": -3.80493, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Marqués de Valdecilla", "city": "Santander", "state_or_region": null, "postal_code": "39008", "country": "Spain", "latitude": 43.46589, "longitude": -3.80493, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Centro de Saúde Concepción Arenal", "city": "Santiago de Compostela", "state_or_region": null, "postal_code": "15701", "country": "Spain", "latitude": 42.88052, "longitude": -8.54569, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Clínica Gaias Santiago", "city": "Santiago de Compostela", "state_or_region": null, "postal_code": "15702", "country": "Spain", "latitude": 42.88052, "longitude": -8.54569, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Clínico de Santiago", "city": "Santiago de Compostela", "state_or_region": null, "postal_code": "15706", "country": "Spain", "latitude": 42.88052, "longitude": -8.54569, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Clínico de Santiago", "city": "Santiago de Compostela", "state_or_region": null, "postal_code": "15706", "country": "Spain", "latitude": 42.88052, "longitude": -8.54569, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Clínica Nuevas Tecnologías en Diabetes y Endocrinología", "city": "Seville", "state_or_region": null, "postal_code": "41003", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "ACTIVE_NOT_RECRUITING; NOT_YET_RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Clínica Nuevas Tecnologías en Diabetes y Endocrinología", "city": "Seville", "state_or_region": null, "postal_code": "41003", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "H. Infanta Luisa_Endocrino y Obesidad", "city": "Seville", "state_or_region": null, "postal_code": "41010", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "H. Infanta Luisa_Endocrino y Obesidad", "city": "Seville", "state_or_region": null, "postal_code": "41010", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Virgen Del Rocio", "city": "Seville", "state_or_region": null, "postal_code": "41013", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Hospital Universitario Virgen del Rocío", "city": "Seville", "state_or_region": null, "postal_code": "41013", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Virgen Macarena", "city": "Seville", "state_or_region": null, "postal_code": "41009", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitario Virgen Macarena", "city": "Seville", "state_or_region": null, "postal_code": "41009", "country": "Spain", "latitude": 37.38283, "longitude": -5.97317, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07242534", "study_title": "Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.", "lead_sponsor": "Fundacion Dexeus", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "Dexeus Mujer Tarragona", "city": "Tarragona", "state_or_region": null, "postal_code": "43206", "country": "Spain", "latitude": 41.11905, "longitude": 1.24544, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07242534" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07239570", "study_title": "A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease", "lead_sponsor": "Peter Rossing", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-20", "facility": "Hospital Clinico de Valencia", "city": "Valencia", "state_or_region": null, "postal_code": null, "country": "Spain", "latitude": 39.47391, "longitude": -0.37966, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07239570" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Clinico de Valencia", "city": "Valencia", "state_or_region": null, "postal_code": "46010", "country": "Spain", "latitude": 39.47391, "longitude": -0.37966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Hospital Universitari i Politecnic La Fe", "city": "Valencia", "state_or_region": null, "postal_code": "46026", "country": "Spain", "latitude": 39.47391, "longitude": -0.37966, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari i Politecnic La Fe", "city": "Valencia", "state_or_region": null, "postal_code": "46026", "country": "Spain", "latitude": 39.47391, "longitude": -0.37966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari i Politecnic La Fe", "city": "Valencia", "state_or_region": null, "postal_code": "46026", "country": "Spain", "latitude": 39.47391, "longitude": -0.37966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hospital Universitari i Politecnic La Fe", "city": "Valencia", "state_or_region": null, "postal_code": "46026", "country": "Spain", "latitude": 39.47391, "longitude": -0.37966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hospital Universitario Doctor Peset", "city": "Valencia", "state_or_region": null, "postal_code": "46017", "country": "Spain", "latitude": 39.47391, "longitude": -0.37966, "site_statuses": "ACTIVE_NOT_RECRUITING; NOT_YET_RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hosp. Recoletas Salud Campo Grande_Endoc y Nutric", "city": "Valladolid", "state_or_region": null, "postal_code": "47004", "country": "Spain", "latitude": 41.65541, "longitude": -4.72353, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "ABS La Roca CAP Vicenç_Endocrino", "city": "La Roca Del Vallés", "state_or_region": "Barcelona", "postal_code": "08430", "country": "Spain", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07242534", "study_title": "Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.", "lead_sponsor": "Fundacion Dexeus", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "Dexeus Mujer Sabadell", "city": "Sabadell", "state_or_region": "Barcelona", "postal_code": null, "country": "Spain", "latitude": 41.54329, "longitude": 2.10942, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07242534" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07242534", "study_title": "Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.", "lead_sponsor": "Fundacion Dexeus", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "Dexeus Mujer Sant Cugat", "city": "Sant Cugat del Vallès", "state_or_region": "Barcelona", "postal_code": "08195", "country": "Spain", "latitude": 41.47063, "longitude": 2.08611, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07242534" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Equip D'assistencia Primaria Vic S.L.P.", "city": "Vic", "state_or_region": "Barcelona", "postal_code": "08500", "country": "Spain", "latitude": 41.93012, "longitude": 2.25486, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "HU de Fuenlabrada_Endocrinología", "city": "Fuenlabrada", "state_or_region": "Madrid", "postal_code": "28042", "country": "Spain", "latitude": 40.28419, "longitude": -3.79415, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07242534", "study_title": "Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.", "lead_sponsor": "Fundacion Dexeus", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "Dexeus Mujer Reus", "city": "Reus", "state_or_region": "Tarragona", "postal_code": "43202", "country": "Spain", "latitude": 41.15612, "longitude": 1.10687, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07242534" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Karolinska Universitetssjukhuset Huddinge", "city": "Huddinge", "state_or_region": null, "postal_code": "141 86", "country": "Sweden", "latitude": 59.23705, "longitude": 17.98192, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "liraglutide; semaglutide", "nct_id": "NCT06836284", "study_title": "The Evira Study: Additional Support During Obesity Treatment", "lead_sponsor": "Karolinska Institutet", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-05-05", "facility": "HKH Crown Princess Victoria's Childrens and youth Hospital Linköping", "city": "Linköping", "state_or_region": null, "postal_code": null, "country": "Sweden", "latitude": 58.41086, "longitude": 15.62157, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06836284" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Universitetssjukhuset i Linköping", "city": "Linköping", "state_or_region": null, "postal_code": "581 85", "country": "Sweden", "latitude": 58.41086, "longitude": 15.62157, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07239570", "study_title": "A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease", "lead_sponsor": "Peter Rossing", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-20", "facility": "Lund University", "city": "Malmö", "state_or_region": null, "postal_code": null, "country": "Sweden", "latitude": 55.60587, "longitude": 13.00073, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07239570" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "CTC GoCo Mölndal", "city": "Mölndal", "state_or_region": null, "postal_code": "431 53", "country": "Sweden", "latitude": 57.6554, "longitude": 12.01378, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Enheten för Kliniska Studier (EKS), Örebro", "city": "Örebro", "state_or_region": null, "postal_code": "701 85", "country": "Sweden", "latitude": 59.27412, "longitude": 15.2066, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "CTC Stockholm", "city": "Stockholm", "state_or_region": null, "postal_code": "171 64", "country": "Sweden", "latitude": 59.32938, "longitude": 18.06871, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07275697", "study_title": "Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study", "lead_sponsor": "Emma Svennberg", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Karolinska University Hospital", "city": "Stockholm", "state_or_region": null, "postal_code": "141 86", "country": "Sweden", "latitude": 59.32938, "longitude": 18.06871, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07275697" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05501483", "study_title": "Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes", "lead_sponsor": "Karolinska Institutet", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-02", "last_update_post_date": "2025-02-26", "facility": "Karolinska University Hospital", "city": "Stockholm", "state_or_region": null, "postal_code": "14186", "country": "Sweden", "latitude": 59.32938, "longitude": 18.06871, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05501483" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Barn och ungdomscentrum Västerbotten - NU", "city": "Umeå", "state_or_region": null, "postal_code": "907 37", "country": "Sweden", "latitude": 63.82842, "longitude": 20.25972, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Akademiska barnsjukhuset - klinisk forskningsmottagning", "city": "Uppsala", "state_or_region": null, "postal_code": "75185", "country": "Sweden", "latitude": 59.85882, "longitude": 17.63889, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "liraglutide; semaglutide", "nct_id": "NCT06836284", "study_title": "The Evira Study: Additional Support During Obesity Treatment", "lead_sponsor": "Karolinska Institutet", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-05-05", "facility": "Ystad lasarett, Barn och ungdomsmedicinmottagningen", "city": "Ystad", "state_or_region": null, "postal_code": null, "country": "Sweden", "latitude": 55.42966, "longitude": 13.82041, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06836284" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Epatocentro Ticino", "city": "Arzo", "state_or_region": null, "postal_code": "6900", "country": "Switzerland", "latitude": 45.87606, "longitude": 8.94103, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fondazione Epatocentro Ticino", "city": "Arzo", "state_or_region": null, "postal_code": "6900", "country": "Switzerland", "latitude": 45.87606, "longitude": 8.94103, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital Basel", "city": "Basel", "state_or_region": null, "postal_code": "4056", "country": "Switzerland", "latitude": 47.55839, "longitude": 7.57327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07284511", "study_title": "A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar", "lead_sponsor": "McGill University Health Centre/Research Institute of the McGill University Health Centre", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-27", "facility": "Insel Hospital, University Hospital Bern", "city": "Bern", "state_or_region": null, "postal_code": "3010", "country": "Switzerland", "latitude": 46.94809, "longitude": 7.44744, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07284511" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital Bern", "city": "Bern", "state_or_region": null, "postal_code": "3010", "country": "Switzerland", "latitude": 46.94809, "longitude": 7.44744, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopitaux Universitaires de Geneve (HUG)", "city": "Geneva", "state_or_region": null, "postal_code": "1205", "country": "Switzerland", "latitude": 46.20222, "longitude": 6.14569, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hopitaux Universitaires de Geneve (HUG)", "city": "Geneva", "state_or_region": null, "postal_code": "1205", "country": "Switzerland", "latitude": 46.20222, "longitude": 6.14569, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05586802", "study_title": "Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome", "lead_sponsor": "Georgios Papadakis", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-11", "facility": "Service of Endocrinology, Diabetes & Metabolism", "city": "Lausanne", "state_or_region": null, "postal_code": "1011", "country": "Switzerland", "latitude": 46.516, "longitude": 6.63282, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05586802" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Luzern Kantonsspital", "city": "Lucerne", "state_or_region": null, "postal_code": "6000", "country": "Switzerland", "latitude": 47.05048, "longitude": 8.30635, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06630585", "study_title": "GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes", "lead_sponsor": "University of Bern", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-26", "facility": "Luzerner Kantonspital", "city": "Lucerne", "state_or_region": null, "postal_code": "6000", "country": "Switzerland", "latitude": 47.05048, "longitude": 8.30635, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06630585" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kantonsspital Olten", "city": "Olten", "state_or_region": null, "postal_code": "4600", "country": "Switzerland", "latitude": 47.34999, "longitude": 7.90329, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital Zurich", "city": "Zurich", "state_or_region": null, "postal_code": "8091", "country": "Switzerland", "latitude": 47.36667, "longitude": 8.55, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Hospital Zurich", "city": "Zurich", "state_or_region": null, "postal_code": "8091", "country": "Switzerland", "latitude": 47.36667, "longitude": 8.55, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06630585", "study_title": "GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes", "lead_sponsor": "University of Bern", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-26", "facility": "DiaCenTRE - Hirslanden Clinique des Grangettes", "city": "Chêne-Bougeries", "state_or_region": "Canton of Geneva", "postal_code": "1224", "country": "Switzerland", "latitude": 46.19843, "longitude": 6.18642, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06630585" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06630585", "study_title": "GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes", "lead_sponsor": "University of Bern", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-26", "facility": "Kantonsspital Olten", "city": "Olten", "state_or_region": "Canton of Solothurn", "postal_code": "4600", "country": "Switzerland", "latitude": 47.34999, "longitude": 7.90329, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06630585" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Changhua Christian Hospital", "city": "Changhua", "state_or_region": null, "postal_code": "50006", "country": "Taiwan", "latitude": 24.0692, "longitude": 120.5512, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Changhua Christian Hospital", "city": "Changhua", "state_or_region": null, "postal_code": "50006", "country": "Taiwan", "latitude": 24.0692, "longitude": 120.5512, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Changhua", "state_or_region": null, "postal_code": "50006", "country": "Taiwan", "latitude": 24.0692, "longitude": 120.5512, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chiayi Christian Hospital", "city": "Chiayi City", "state_or_region": null, "postal_code": "600", "country": "Taiwan", "latitude": 23.47917, "longitude": 120.44889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Chang Gung Memorial Hospital - Kaohsiung Branch", "city": "Kaohsiung City", "state_or_region": null, "postal_code": "833", "country": "Taiwan", "latitude": 22.61626, "longitude": 120.31333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "E-Da Hospital", "city": "Kaohsiung City", "state_or_region": null, "postal_code": "824005", "country": "Taiwan", "latitude": 22.61626, "longitude": 120.31333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "E-Da hospital", "city": "Kaohsiung City", "state_or_region": null, "postal_code": "82445", "country": "Taiwan", "latitude": 22.61626, "longitude": 120.31333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kaohsiung Medical University Chung-Ho Memorial Hospital", "city": "Kaohsiung City", "state_or_region": null, "postal_code": "807", "country": "Taiwan", "latitude": 22.61626, "longitude": 120.31333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Kaohsiung City", "state_or_region": null, "postal_code": "81362", "country": "Taiwan", "latitude": 22.61626, "longitude": 120.31333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chang Gung Memorial Hospital at Kaohsiung", "city": "Kaohsiung Niao Sung Dist", "state_or_region": null, "postal_code": "83301", "country": "Taiwan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kaohsiung Medical University Chung-Ho Memorial Hospital", "city": "Kaohsuing City", "state_or_region": null, "postal_code": "80756", "country": "Taiwan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kaohsiung Medical University Chung-Ho Memorial Hospital", "city": "Kaohsuing City", "state_or_region": null, "postal_code": "80756", "country": "Taiwan", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fu Jen Catholic University Hospital", "city": "New Taipei City", "state_or_region": null, "postal_code": "24352", "country": "Taiwan", "latitude": 25.06199, "longitude": 121.45703, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "New Taipei City", "state_or_region": null, "postal_code": "220", "country": "Taiwan", "latitude": 25.06199, "longitude": 121.45703, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taipei Tzu Chi General Hospital", "city": "New Taipei City", "state_or_region": null, "postal_code": "231", "country": "Taiwan", "latitude": 25.06199, "longitude": 121.45703, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "China Medical University Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "404332", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "China Medical University Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "404332", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Chung Shan Medical University Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "402", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chung Shan Medical University Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "40201", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chung Shan Medical University Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "40201", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Taichung", "state_or_region": null, "postal_code": "40201", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Taichung", "state_or_region": null, "postal_code": "40705", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Taichung", "state_or_region": null, "postal_code": "433004", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taichung Veterans General Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "407", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taichung Veterans General Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "40705", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taichung Veterans General Hospital", "city": "Taichung", "state_or_region": null, "postal_code": "40705", "country": "Taiwan", "latitude": 24.1469, "longitude": 120.6839, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chi Mei Medical Center", "city": "Tainan", "state_or_region": null, "postal_code": "71004", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chi Mei Medical Center", "city": "Tainan", "state_or_region": null, "postal_code": "71004", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chi Mei Medical Center", "city": "Tainan", "state_or_region": null, "postal_code": "71004", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "National Cheng Kung University Hospital", "city": "Tainan", "state_or_region": null, "postal_code": "704", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Cheng Kung University Hospital", "city": "Tainan", "state_or_region": null, "postal_code": "704", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Cheng Kung University Hospital", "city": "Tainan", "state_or_region": null, "postal_code": "70403", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Cheng Kung University Hospital", "city": "Tainan", "state_or_region": null, "postal_code": "70403", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Tainan", "state_or_region": null, "postal_code": "704", "country": "Taiwan", "latitude": 22.99083, "longitude": 120.21333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cathay General Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "106", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "National Taiwan University Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "10002", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Taiwan University Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "10002", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Taiwan University Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "10048", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "National Taiwan University Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "10048", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Taipei", "state_or_region": null, "postal_code": "10002", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Taipei Mackay Children's Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "104", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taipei Medical University Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "110", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taipei Medical University Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "110301", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taipei Medical University Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "110301", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taipei Veterans General Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "11217", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taipei Veterans General Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "112201", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Taipei Veterans General Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "112201", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide; tirzepatide", "nct_id": "NCT07589322", "study_title": "Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs", "lead_sponsor": "Tri-Service General Hospital (TSGH)", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-15", "facility": "Tri-Service General Hospital", "city": "Taipei", "state_or_region": null, "postal_code": "114202", "country": "Taiwan", "latitude": 25.05306, "longitude": 121.52639, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07589322" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chang Gung Medical Foundation (CGMF) - Linkou Bran", "city": "Taoyuan", "state_or_region": null, "postal_code": "33305", "country": "Taiwan", "latitude": 24.99368, "longitude": 121.29696, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chang Gung Medical Foundation (CGMF) - Linkou Bran", "city": "Taoyuan", "state_or_region": null, "postal_code": "33305", "country": "Taiwan", "latitude": 24.99368, "longitude": 121.29696, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Chang Gung Medical Foundation-Linkou Branch", "city": "Taoyuan", "state_or_region": null, "postal_code": "333", "country": "Taiwan", "latitude": 24.99368, "longitude": 121.29696, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chang Gung Medical Foundation-Linkou Branch", "city": "Taoyuan", "state_or_region": null, "postal_code": "333", "country": "Taiwan", "latitude": 24.99368, "longitude": 121.29696, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Chang Gung Memorial Hospital Linkou-Dept of Pediatrics", "city": "Taoyuan", "state_or_region": null, "postal_code": "333", "country": "Taiwan", "latitude": 24.99368, "longitude": 121.29696, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Taoyuan", "state_or_region": null, "postal_code": "333", "country": "Taiwan", "latitude": 24.99368, "longitude": 121.29696, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Yung Kang City", "state_or_region": null, "postal_code": "71044", "country": "Taiwan", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "King Chulalongkorn Memorial Hospital_Ped-Nutrition", "city": "Bangkok", "state_or_region": null, "postal_code": "10300", "country": "Thailand", "latitude": 13.75398, "longitude": 100.50144, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Ramathibodi Hospital", "city": "Bangkok", "state_or_region": null, "postal_code": "10400", "country": "Thailand", "latitude": 13.75398, "longitude": 100.50144, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Siriraj Hospital", "city": "Bangkok", "state_or_region": null, "postal_code": "10700", "country": "Thailand", "latitude": 13.75398, "longitude": 100.50144, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Maharaj Nakorn Chiang Mai", "city": "Chiang Mai", "state_or_region": null, "postal_code": "50200", "country": "Thailand", "latitude": 18.79038, "longitude": 98.98468, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Srinagarind Hospital", "city": "Khon Kaen", "state_or_region": null, "postal_code": "40002", "country": "Thailand", "latitude": 16.44671, "longitude": 102.833, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Maharat Nakhon Ratchasima Hospital", "city": "Nakhon Ratchasima", "state_or_region": null, "postal_code": "30000", "country": "Thailand", "latitude": 14.97066, "longitude": 102.10196, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Thammasat Hospital_CRC", "city": "Pathum Thani", "state_or_region": null, "postal_code": "12120", "country": "Thailand", "latitude": 14.01346, "longitude": 100.53049, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Adana Sehir Egitim ve Arastirma Hastanesi", "city": "Adana", "state_or_region": null, "postal_code": "01370", "country": "Turkey (Türkiye)", "latitude": 36.98615, "longitude": 35.32531, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Adana Şehir Eğitim ve Araştırma Hastanesi", "city": "Adana", "state_or_region": null, "postal_code": "01060", "country": "Turkey (Türkiye)", "latitude": 36.98615, "longitude": 35.32531, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Çukurova Üniversitesi Tıp Fakültesi Adana Hastanesi", "city": "Adana", "state_or_region": null, "postal_code": "01790", "country": "Turkey (Türkiye)", "latitude": 36.98615, "longitude": 35.32531, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Ankara Bilkent Şehir Hastanesi-Dahiliye", "city": "Ankara", "state_or_region": null, "postal_code": "06800", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ankara Bilkent Şehir Hastanesi", "city": "Ankara", "state_or_region": null, "postal_code": "06800", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Ankara Sehir Hastanesi Dahiliye Klinigi", "city": "Ankara", "state_or_region": null, "postal_code": "06800", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ankara Üniversitesi Tıp Fakültesi Hastanesi", "city": "Ankara", "state_or_region": null, "postal_code": "06230", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gazi Universitesi Tip Fakultesi", "city": "Ankara", "state_or_region": null, "postal_code": "06560", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gazi Universitesi Tip Fakultesi", "city": "Ankara", "state_or_region": null, "postal_code": "06560", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gazi University Health Research and Application Center Gazi Hospital", "city": "Ankara", "state_or_region": null, "postal_code": "06560", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gazi University Health Research and Application Center Gazi Hospital", "city": "Ankara", "state_or_region": null, "postal_code": "06560", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hacettepe Üniversitesi Hastanesi- Nefroloji", "city": "Ankara", "state_or_region": null, "postal_code": "06230", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Hacettepe Universitesi Tip Fakultesi Nefroloji Bilim Dali", "city": "Ankara", "state_or_region": null, "postal_code": "06230", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hacettepe Universitesi Tip Fakultesi", "city": "Ankara", "state_or_region": null, "postal_code": "06230", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hacettepe Universitesi", "city": "Ankara", "state_or_region": null, "postal_code": "06230", "country": "Turkey (Türkiye)", "latitude": 39.91987, "longitude": 32.85427, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Antalya Egitim ve Arastırma Hastanesi", "city": "Antalya", "state_or_region": null, "postal_code": "07100", "country": "Turkey (Türkiye)", "latitude": 36.90812, "longitude": 30.69556, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bursa Şehir Hastanesi", "city": "Bursa", "state_or_region": null, "postal_code": "16110", "country": "Turkey (Türkiye)", "latitude": 40.19559, "longitude": 29.06013, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uludag Universitesi Tip Fakultesi", "city": "Bursa", "state_or_region": null, "postal_code": "16059", "country": "Turkey (Türkiye)", "latitude": 40.19559, "longitude": 29.06013, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uludag Universitesi Tip Fakultesi", "city": "Bursa", "state_or_region": null, "postal_code": "16059", "country": "Turkey (Türkiye)", "latitude": 40.19559, "longitude": 29.06013, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uludag Universitesi", "city": "Bursa", "state_or_region": null, "postal_code": "16059", "country": "Turkey (Türkiye)", "latitude": 40.19559, "longitude": 29.06013, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Uludag Universitesi", "city": "Bursa", "state_or_region": null, "postal_code": "16059", "country": "Turkey (Türkiye)", "latitude": 40.19559, "longitude": 29.06013, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Eskisehir Osmangazi University", "city": "Eskişehir", "state_or_region": null, "postal_code": "26480", "country": "Turkey (Türkiye)", "latitude": 39.77667, "longitude": 30.52056, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Eskisehir Osmangazi University", "city": "Eskişehir", "state_or_region": null, "postal_code": "26480", "country": "Turkey (Türkiye)", "latitude": 39.77667, "longitude": 30.52056, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi", "city": "Fatih", "state_or_region": null, "postal_code": "34093", "country": "Turkey (Türkiye)", "latitude": 41.0225, "longitude": 28.94083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi", "city": "Fatih", "state_or_region": null, "postal_code": "34093", "country": "Turkey (Türkiye)", "latitude": 41.0225, "longitude": 28.94083, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Gaziantep Üniversitesi Hastanesi- Endokrinoloji", "city": "Gaziantep", "state_or_region": null, "postal_code": "27070", "country": "Turkey (Türkiye)", "latitude": 37.05944, "longitude": 37.3825, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Gaziantep Universitesi Tip Fakultesi Hastanesi", "city": "Gaziantep", "state_or_region": null, "postal_code": "27070", "country": "Turkey (Türkiye)", "latitude": 37.05944, "longitude": 37.3825, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mustafa Kemal Universitesi", "city": "Hatay", "state_or_region": null, "postal_code": "31030", "country": "Turkey (Türkiye)", "latitude": 38.40227, "longitude": 27.10486, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mustafa Kemal Universitesi", "city": "Hatay", "state_or_region": null, "postal_code": "31030", "country": "Turkey (Türkiye)", "latitude": 38.40227, "longitude": 27.10486, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bezmialem Vakf Üniversitesi", "city": "Istanbul", "state_or_region": null, "postal_code": "34093", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bezmialem Vakf Üniversitesi", "city": "Istanbul", "state_or_region": null, "postal_code": "34093", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Göztepe Prof. Dr.Süleyman Yalçın Şehir Hastanesi- Dahiliye", "city": "Istanbul", "state_or_region": null, "postal_code": "34722", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Koc Universitesi Hastanesi", "city": "Istanbul", "state_or_region": null, "postal_code": "34010", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Koc Universitesi Hastanesi", "city": "Istanbul", "state_or_region": null, "postal_code": "34010", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Memorial Bahçelievler Hospital", "city": "Istanbul", "state_or_region": null, "postal_code": "34180", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Memorial Bahçelievler Hospital", "city": "Istanbul", "state_or_region": null, "postal_code": "34180", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "T.C SB Goztepe Prof. Dr. Suleyman Yalcin City Hospital", "city": "Istanbul", "state_or_region": null, "postal_code": "34722", "country": "Turkey (Türkiye)", "latitude": 41.01384, "longitude": 28.94966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Ege Universitesi Hastanesi- Endokrinoloji", "city": "Izmir", "state_or_region": null, "postal_code": "35100", "country": "Turkey (Türkiye)", "latitude": 38.41273, "longitude": 27.13838, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ege Universitesi Hastanesi", "city": "Izmir", "state_or_region": null, "postal_code": "35100", "country": "Turkey (Türkiye)", "latitude": 38.41273, "longitude": 27.13838, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ege Universitesi Hastanesi", "city": "Izmir", "state_or_region": null, "postal_code": "35100", "country": "Turkey (Türkiye)", "latitude": 38.41273, "longitude": 27.13838, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Ege Universitesi Tip Fakultesi Hastanesi", "city": "Izmir", "state_or_region": null, "postal_code": "35100", "country": "Turkey (Türkiye)", "latitude": 38.41273, "longitude": 27.13838, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ege Universitesi Tip Fakultesi", "city": "Izmir", "state_or_region": null, "postal_code": "35030", "country": "Turkey (Türkiye)", "latitude": 38.41273, "longitude": 27.13838, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ege Universitesi Tip Fakultesi", "city": "Izmir", "state_or_region": null, "postal_code": "35030", "country": "Turkey (Türkiye)", "latitude": 38.41273, "longitude": 27.13838, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kocaeli University Medical Faculty Hospital", "city": "İzmit", "state_or_region": null, "postal_code": "41380", "country": "Turkey (Türkiye)", "latitude": 40.76499, "longitude": 29.92928, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kocaeli University Medical Faculty Hospital", "city": "İzmit", "state_or_region": null, "postal_code": "41380", "country": "Turkey (Türkiye)", "latitude": 40.76499, "longitude": 29.92928, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Kocaeli Üniversitesi Araştıma ve Uygulama Hastanesi - Nefroloji", "city": "Kocaeli", "state_or_region": null, "postal_code": "41380", "country": "Turkey (Türkiye)", "latitude": 39.62497, "longitude": 27.51145, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Kocaeli University Nephrology Department", "city": "Kocaeli", "state_or_region": null, "postal_code": "41380", "country": "Turkey (Türkiye)", "latitude": 39.62497, "longitude": 27.51145, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mersin University", "city": "Mersin", "state_or_region": null, "postal_code": "33110", "country": "Turkey (Türkiye)", "latitude": 36.81196, "longitude": 34.63886, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mersin University", "city": "Mersin", "state_or_region": null, "postal_code": "33110", "country": "Turkey (Türkiye)", "latitude": 36.81196, "longitude": 34.63886, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Antalya Egitim ve Arastırma Hastanesi", "city": "Muratpaşa", "state_or_region": null, "postal_code": "07050", "country": "Turkey (Türkiye)", "latitude": 36.89157, "longitude": 30.76498, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "T.C. Sağlik Bakanliği- Marmara Üniversitesi İstanbul Pendik Eğitim Ve Araştirma Hastanesi", "city": "Pendik", "state_or_region": null, "postal_code": "34899", "country": "Turkey (Türkiye)", "latitude": 40.8775, "longitude": 29.2725, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Recep Tayyip Erdogan Universitesi Egitim ve Arastirma Hastanesi", "city": "Rize", "state_or_region": null, "postal_code": "53020", "country": "Turkey (Türkiye)", "latitude": 41.02083, "longitude": 40.52194, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Recep Tayyip Erdogan Universitesi Egitim ve Arastirma Hastanesi", "city": "Rize", "state_or_region": null, "postal_code": "53020", "country": "Turkey (Türkiye)", "latitude": 41.02083, "longitude": 40.52194, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Recep Tayyip Erdogan University Training and Research Hospital", "city": "Rize", "state_or_region": null, "postal_code": "53100", "country": "Turkey (Türkiye)", "latitude": 41.02083, "longitude": 40.52194, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Karadeniz Teknik Universitesi Tip Fakultesi", "city": "Trabzon", "state_or_region": null, "postal_code": "61080", "country": "Turkey (Türkiye)", "latitude": 41.005, "longitude": 39.72694, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Erciyes Üniversitesi Hastanesi - Nefroloji", "city": "Kayseri", "state_or_region": "Melikgazi", "postal_code": "38039", "country": "Turkey (Türkiye)", "latitude": 38.73222, "longitude": 35.48528, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Diagnostic Center", "city": "Ivano-Frankivsk", "state_or_region": null, "postal_code": "76018", "country": "Ukraine", "latitude": 48.92312, "longitude": 24.71248, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Center of Limited Liability Company \"Medical Center \"Consilium Medical\"", "city": "Kiev", "state_or_region": null, "postal_code": "04050", "country": "Ukraine", "latitude": 50.45466, "longitude": 30.5238, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Center of Family Medicine Plus", "city": "Kyiv", "state_or_region": null, "postal_code": "04210", "country": "Ukraine", "latitude": 50.45466, "longitude": 30.5238, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Edelweiss Medics", "city": "Kyiv", "state_or_region": null, "postal_code": "02002", "country": "Ukraine", "latitude": 50.45466, "longitude": 30.5238, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medbud Clinic", "city": "Kyiv", "state_or_region": null, "postal_code": "03037", "country": "Ukraine", "latitude": 50.45466, "longitude": 30.5238, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Center Ok!Clinic+", "city": "Kyiv", "state_or_region": null, "postal_code": "02091", "country": "Ukraine", "latitude": 50.45466, "longitude": 30.5238, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Progastro Clinic", "city": "Lviv", "state_or_region": null, "postal_code": "79019", "country": "Ukraine", "latitude": 49.83826, "longitude": 24.02324, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Limited liability company \"Medical center Health Clinic\"", "city": "Vinnytsia", "state_or_region": null, "postal_code": "21009", "country": "Ukraine", "latitude": 49.2322, "longitude": 28.46871, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Center Salutem", "city": "Vinnytsia", "state_or_region": null, "postal_code": "21001", "country": "Ukraine", "latitude": 49.2322, "longitude": 28.46871, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Municipal Nonprofit Enterprise \"Vinnytsia Regional Clinical Hospital n.a. M. I. Pyrohov of Vinnytsia Regio -T", "city": "Vinnytsia", "state_or_region": null, "postal_code": "21018", "country": "Ukraine", "latitude": 49.2322, "longitude": 28.46871, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CRZ Vidnovlennya", "city": "Zhytomyr", "state_or_region": null, "postal_code": "10014", "country": "Ukraine", "latitude": 50.26235, "longitude": 28.67913, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT07675980", "study_title": "Thymosin-α1 for Recurrent Implantation Failure", "lead_sponsor": "Fakih IVF Fertility Center", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-30", "facility": "Fakih IVF", "city": "Abu Dhabi", "state_or_region": null, "postal_code": null, "country": "United Arab Emirates", "latitude": 24.45118, "longitude": 54.39696, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07675980" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aberdeen Royal Infirmary", "city": "Aberdeen", "state_or_region": null, "postal_code": "AB25 2ZN", "country": "United Kingdom", "latitude": 57.14369, "longitude": -2.09814, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aberdeen Royal Infirmary", "city": "Aberdeen", "state_or_region": null, "postal_code": "AB25 2ZN", "country": "United Kingdom", "latitude": 57.14369, "longitude": -2.09814, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aberdeen Royal Infirmary", "city": "Aberdeen", "state_or_region": null, "postal_code": "AB25 2ZN", "country": "United Kingdom", "latitude": 57.14369, "longitude": -2.09814, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Aberdeen", "state_or_region": null, "postal_code": "AB25 2ZN", "country": "United Kingdom", "latitude": 57.14369, "longitude": -2.09814, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Addlestone", "state_or_region": null, "postal_code": "KT15 2BH", "country": "United Kingdom", "latitude": 51.37135, "longitude": -0.49353, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P91604 St John's Medical Centre", "city": "Altrincham", "state_or_region": null, "postal_code": "WA14 1PF", "country": "United Kingdom", "latitude": 53.38752, "longitude": -2.34848, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Elpida Clinical Trials - Ashton Clinic", "city": "Ashton in Makerfield", "state_or_region": null, "postal_code": "WN4 8LB", "country": "United Kingdom", "latitude": 53.48333, "longitude": -2.65, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P89008 Ashton Medical Group", "city": "Ashton-under-Lyne", "state_or_region": null, "postal_code": "OL6 6EW", "country": "United Kingdom", "latitude": 53.48876, "longitude": -2.0989, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Banbury", "state_or_region": null, "postal_code": "OX16 9AD", "country": "United Kingdom", "latitude": 52.0632, "longitude": -1.34222, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Birmingham Children's Hospital", "city": "Birmingham", "state_or_region": null, "postal_code": "B4 6NH", "country": "United Kingdom", "latitude": 52.48142, "longitude": -1.89983, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "Y02319 SSP Bolton General Practice", "city": "Bolton", "state_or_region": null, "postal_code": "BL1 4TH", "country": "United Kingdom", "latitude": 53.58333, "longitude": -2.43333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "ss-31", "nct_id": "NCT07531251", "study_title": "Clinical Trial in Patients With Barth Syndrome- 4TAZPower", "lead_sponsor": "Stealth BioTherapeutics Inc.", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-13", "facility": "Bristol Royal Hospital for Children Upper Maudlin Street Paul O'Gorman Building", "city": "Bristol", "state_or_region": null, "postal_code": null, "country": "United Kingdom", "latitude": 51.45523, "longitude": -2.59665, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07531251" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bristol", "state_or_region": null, "postal_code": "BS34 5TF", "country": "United Kingdom", "latitude": 51.45523, "longitude": -2.59665, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bristol", "state_or_region": null, "postal_code": "BS34 6BQ", "country": "United Kingdom", "latitude": 51.45523, "longitude": -2.59665, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southmead Hospital", "city": "Bristol", "state_or_region": null, "postal_code": "BS10 5NB", "country": "United Kingdom", "latitude": 51.45523, "longitude": -2.59665, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Bristol", "city": "Bristol", "state_or_region": null, "postal_code": "BS82RA", "country": "United Kingdom", "latitude": 51.45523, "longitude": -2.59665, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Bristol", "city": "Bristol", "state_or_region": null, "postal_code": "BS82RA", "country": "United Kingdom", "latitude": 51.45523, "longitude": -2.59665, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P83012 Tower Family Healthcare", "city": "Bury", "state_or_region": null, "postal_code": "BL9 0NJ", "country": "United Kingdom", "latitude": 53.6, "longitude": -2.3, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Frimley Park Hospital", "city": "Camberley", "state_or_region": null, "postal_code": "GU16 7UJ", "country": "United Kingdom", "latitude": 51.33705, "longitude": -0.74261, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Frimley Park Hospital", "city": "Camberley", "state_or_region": null, "postal_code": "GU16 7UJ", "country": "United Kingdom", "latitude": 51.33705, "longitude": -0.74261, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Addenbrooke's Hospital", "city": "Cambridge", "state_or_region": null, "postal_code": "CB2 0SL", "country": "United Kingdom", "latitude": 52.2, "longitude": 0.11667, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P88007 Cheadle Hulme Medical Group (was Cheadle Hulme Health Centre) (Bridge House)", "city": "Cheshire", "state_or_region": null, "postal_code": "SK8 5LL", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P91014 Washway Road Medical Centre", "city": "Cheshire", "state_or_region": null, "postal_code": "M33 7SS", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "4 Medical Solutions, Ltd - Manchester", "city": "Clifton", "state_or_region": null, "postal_code": "M27 8FF", "country": "United Kingdom", "latitude": 54.63331, "longitude": -2.72324, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Derby City General Hospital", "city": "Derby", "state_or_region": null, "postal_code": "DE22 3NE", "country": "United Kingdom", "latitude": 52.92277, "longitude": -1.47663, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ninewells Hospital and Medical School", "city": "Dundee", "state_or_region": null, "postal_code": "DD1 9SY", "country": "United Kingdom", "latitude": 56.46913, "longitude": -2.97489, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Queen Elizabeth Hospital Birmingham", "city": "Edgbaston, Birmingham", "state_or_region": null, "postal_code": "B15 2WB", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Queen Elizabeth Hospital Birmingham", "city": "Edgbaston, Birmingham", "state_or_region": null, "postal_code": "B15 2WB", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Elpida Clinical Trials - Edgware Community Hospital", "city": "Edgware", "state_or_region": null, "postal_code": "HA8 0AD", "country": "United Kingdom", "latitude": 51.6128, "longitude": -0.27539, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Edinburgh", "state_or_region": null, "postal_code": "EH4 2XU", "country": "United Kingdom", "latitude": 55.95206, "longitude": -3.19648, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Enfield", "city": "Enfield, London", "state_or_region": null, "postal_code": "EN3 4GS", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - North London", "city": "Enfield", "state_or_region": null, "postal_code": "EN3 4GS", "country": "United Kingdom", "latitude": 51.65147, "longitude": -0.08497, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Devon & Exeter Hospital", "city": "Exeter", "state_or_region": null, "postal_code": "EX2 5DW", "country": "United Kingdom", "latitude": 50.7236, "longitude": -3.52751, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Devon and Exeter Hospital, Wonford", "city": "Exeter", "state_or_region": null, "postal_code": "EX2 5AX", "country": "United Kingdom", "latitude": 50.7236, "longitude": -3.52751, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Devon and Exeter Hospital, Wonford", "city": "Exeter", "state_or_region": null, "postal_code": "EX2 5AX", "country": "United Kingdom", "latitude": 50.7236, "longitude": -3.52751, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Royal Hospital for Children", "city": "Glagow", "state_or_region": null, "postal_code": "G51 4TF", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Glasgow", "city": "Glasgow", "state_or_region": null, "postal_code": "G51 4RY", "country": "United Kingdom", "latitude": 55.86515, "longitude": -4.25763, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Glasgow", "city": "Glasgow", "state_or_region": null, "postal_code": "G51 4TY", "country": "United Kingdom", "latitude": 55.86515, "longitude": -4.25763, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Glasgow", "city": "Glasgow", "state_or_region": null, "postal_code": "G51 4TY", "country": "United Kingdom", "latitude": 55.86515, "longitude": -4.25763, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "Y02790 SSP Bolton Medical Centre", "city": "Great Lever", "state_or_region": null, "postal_code": "BL3 6PY", "country": "United Kingdom", "latitude": 53.56132, "longitude": -2.42073, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Hounslow", "state_or_region": null, "postal_code": "TW3 3LN", "country": "United Kingdom", "latitude": 51.46839, "longitude": -0.36092, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hull Royal Infirmary", "city": "Hull", "state_or_region": null, "postal_code": "HU3 2JZ", "country": "United Kingdom", "latitude": 53.7446, "longitude": -0.33525, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hull Royal Infirmary", "city": "Hull", "state_or_region": null, "postal_code": "HU3 2JZ", "country": "United Kingdom", "latitude": 53.7446, "longitude": -0.33525, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P89002 The Brooke Surgery", "city": "Hyde SK14", "state_or_region": null, "postal_code": "SK14 1AT", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ipswich Hospital", "city": "Ipswich", "state_or_region": null, "postal_code": "IP4 5PD", "country": "United Kingdom", "latitude": 52.05917, "longitude": 1.15545, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Leeds General Infirmary", "city": "Leeds", "state_or_region": null, "postal_code": "LS1 3EX", "country": "United Kingdom", "latitude": 53.79648, "longitude": -1.54785, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Leicester Royal Infirmary", "city": "Leicester", "state_or_region": null, "postal_code": "LE1 5WW", "country": "United Kingdom", "latitude": 52.6386, "longitude": -1.13169, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Aintree University Hospital", "city": "Liverpool", "state_or_region": null, "postal_code": "L9 7Al", "country": "United Kingdom", "latitude": 53.41058, "longitude": -2.97794, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Alder Hey Children's Hospital", "city": "Liverpool", "state_or_region": null, "postal_code": "L12 2AP", "country": "United Kingdom", "latitude": 53.41058, "longitude": -2.97794, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Alder Hey Children's Hospital", "city": "Liverpool", "state_or_region": null, "postal_code": "L14 5AB", "country": "United Kingdom", "latitude": 53.41058, "longitude": -2.97794, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Liverpool University Hospitals NHS Foundation Trust", "city": "Liverpool", "state_or_region": null, "postal_code": "L9 7AL", "country": "United Kingdom", "latitude": 53.41058, "longitude": -2.97794, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "4 Medical Solutions, Ltd - London", "city": "London", "state_or_region": null, "postal_code": "IG1 4HP", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chelsea and Westminster Hospital", "city": "London", "state_or_region": null, "postal_code": "SW10 9NH", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Chelsea and Westminster Hospital", "city": "London", "state_or_region": null, "postal_code": "SW10 9NH", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06318442", "study_title": "The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes", "lead_sponsor": "Imperial College London", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2024-09", "last_update_post_date": "2024-10-02", "facility": "Imperial College Healthcare NHS Trust", "city": "London", "state_or_region": null, "postal_code": null, "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06318442" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "King's College Hospital", "city": "London", "state_or_region": null, "postal_code": "SE5 9RL", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "King's College Hospital", "city": "London", "state_or_region": null, "postal_code": "SE5 9RS", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "King's College Hospital", "city": "London", "state_or_region": null, "postal_code": "SE5 9RS", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Paediatric and Adolescent OutpatientsElizabeth Garrett Anderson WingUniversity College Hospital", "city": "London", "state_or_region": null, "postal_code": "WC1E 6DB", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Free Hospital", "city": "London", "state_or_region": null, "postal_code": "NW3 2Qg", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Free Hospital", "city": "London", "state_or_region": null, "postal_code": "NW32PF", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal Free Hospital", "city": "London", "state_or_region": null, "postal_code": "NW32QG", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal London Hospital", "city": "London", "state_or_region": null, "postal_code": "E1 1FR", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Royal London Hospital", "city": "London", "state_or_region": null, "postal_code": "E1 2AJ", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "University College Hospital - Paediatric Services", "city": "London", "state_or_region": null, "postal_code": "NW1 1BU", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P83025 St Gabriels Medical Centre", "city": "Manchester", "state_or_region": null, "postal_code": "M25 0HT", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P84012 Northenden Group Practice", "city": "Manchester", "state_or_region": null, "postal_code": "M22 4DH", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P84017 Ladybarn Group Practice", "city": "Manchester", "state_or_region": null, "postal_code": "M20 4SS", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P84034 Barlow Medical Centre", "city": "Manchester", "state_or_region": null, "postal_code": null, "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P84035 Bodey Medical Centre", "city": "Manchester", "state_or_region": null, "postal_code": "M14 6WP", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P84068 Chorlton Family Practice", "city": "Manchester", "state_or_region": null, "postal_code": "M21 9NJ", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P84630 The Arch Medical Practice", "city": "Manchester", "state_or_region": null, "postal_code": "M15 5TJ", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P84678 Didsbury Medical Centre", "city": "Manchester", "state_or_region": null, "postal_code": "M20 2ER", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P86004 Peterloo Medical Centre", "city": "Manchester", "state_or_region": null, "postal_code": "M24 4DZ", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P87019 Silverdale Medical Practice", "city": "Manchester", "state_or_region": null, "postal_code": "M27 8 HP", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P91006 Urmston Group Practice", "city": "Manchester", "state_or_region": null, "postal_code": "M41 8AA", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P92620 SSP Ince Surgery (Lower Ince)", "city": "Manchester", "state_or_region": null, "postal_code": "WN3 4NW", "country": "United Kingdom", "latitude": 53.48095, "longitude": -2.23743, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Freeman Hospital", "city": "Newcastle upon Tyne", "state_or_region": null, "postal_code": "NE7 7DN", "country": "United Kingdom", "latitude": 54.97328, "longitude": -1.61396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Newcastle General Hospital", "city": "Newcastle upon Tyne", "state_or_region": null, "postal_code": "NE4 6BE", "country": "United Kingdom", "latitude": 54.97328, "longitude": -1.61396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Newcastle General Hospital", "city": "Newcastle upon Tyne", "state_or_region": null, "postal_code": "NE4 6BE", "country": "United Kingdom", "latitude": 54.97328, "longitude": -1.61396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Royal Victoria Infirmary", "city": "Newcastle upon Tyne", "state_or_region": null, "postal_code": "NE1 4PL", "country": "United Kingdom", "latitude": 54.97328, "longitude": -1.61396, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Accellacare North London", "city": "Northwood", "state_or_region": null, "postal_code": "HA6 2RN", "country": "United Kingdom", "latitude": 51.61162, "longitude": -0.42454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Accellacare North London", "city": "Northwood", "state_or_region": null, "postal_code": "HA6 2RN", "country": "United Kingdom", "latitude": 51.61162, "longitude": -0.42454, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Queen's Medical Centre", "city": "Nottingham", "state_or_region": null, "postal_code": "NG7 2UH", "country": "United Kingdom", "latitude": 52.9536, "longitude": -1.15047, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P85010 Woodlands Medical Practice", "city": "Oldham", "state_or_region": null, "postal_code": "OL9 0LH", "country": "United Kingdom", "latitude": 53.54051, "longitude": -2.1183, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P85011 CH Medical Practice", "city": "Oldham", "state_or_region": null, "postal_code": "OL9 8NH", "country": "United Kingdom", "latitude": 53.54051, "longitude": -2.1183, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Accellacare - South London", "city": "Orpington, London", "state_or_region": null, "postal_code": "BR5 3QG", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Accellacare - South London", "city": "Orpington, London", "state_or_region": null, "postal_code": "BR5 3QG", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The John Radcliffe Hospital", "city": "Oxford", "state_or_region": null, "postal_code": "OX3 9DU", "country": "United Kingdom", "latitude": 51.75222, "longitude": -1.25596, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Atlantic Medical", "city": "Penzance", "state_or_region": null, "postal_code": "TR18 3DX", "country": "United Kingdom", "latitude": 50.11861, "longitude": -5.53715, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Penzance", "state_or_region": null, "postal_code": "TR18 3DX", "country": "United Kingdom", "latitude": 50.11861, "longitude": -5.53715, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Poole", "state_or_region": null, "postal_code": "BH16 5PW", "country": "United Kingdom", "latitude": 50.71429, "longitude": -1.98458, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Preston", "city": "Preston", "state_or_region": null, "postal_code": "PR2 9QB", "country": "United Kingdom", "latitude": 53.76282, "longitude": -2.70452, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Preston", "city": "Preston", "state_or_region": null, "postal_code": "PR2 9RB", "country": "United Kingdom", "latitude": 53.76282, "longitude": -2.70452, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Preston", "city": "Preston", "state_or_region": null, "postal_code": "PR2 9RB", "country": "United Kingdom", "latitude": 53.76282, "longitude": -2.70452, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P86022 Stonefield Street Surgery", "city": "Rochdale", "state_or_region": null, "postal_code": "OL16 4JF", "country": "United Kingdom", "latitude": 53.61766, "longitude": -2.1552, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Manchester", "city": "Rochdale", "state_or_region": null, "postal_code": "OL11 4AU", "country": "United Kingdom", "latitude": 53.61766, "longitude": -2.1552, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Rochdale", "city": "Rochdale", "state_or_region": null, "postal_code": "OL11 4AU", "country": "United Kingdom", "latitude": 53.61766, "longitude": -2.1552, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Rochdale", "city": "Rochdale", "state_or_region": null, "postal_code": "OL11 4AU", "country": "United Kingdom", "latitude": 53.61766, "longitude": -2.1552, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P91013 Boundary House Medical Centre", "city": "Sale", "state_or_region": null, "postal_code": null, "country": "United Kingdom", "latitude": 53.42519, "longitude": -2.32443, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P91021 Firsway Health Centre", "city": "Sale", "state_or_region": null, "postal_code": "M33 4BR", "country": "United Kingdom", "latitude": 53.42519, "longitude": -2.32443, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P87027 Langworthy Medical Practice", "city": "Salford", "state_or_region": null, "postal_code": "M6 5WW", "country": "United Kingdom", "latitude": 53.48771, "longitude": -2.29042, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Sheffield", "city": "Sheffield", "state_or_region": null, "postal_code": "S2 5FX", "country": "United Kingdom", "latitude": 53.38297, "longitude": -1.4659, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Sheffield", "city": "Sheffield", "state_or_region": null, "postal_code": "S2 5FX", "country": "United Kingdom", "latitude": 53.38297, "longitude": -1.4659, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - Sheffield", "city": "Sheffield", "state_or_region": null, "postal_code": "S2 5FX", "country": "United Kingdom", "latitude": 53.38297, "longitude": -1.4659, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Sheffield Children's Hospital", "city": "Sheffield", "state_or_region": null, "postal_code": "S10 2TH", "country": "United Kingdom", "latitude": 53.38297, "longitude": -1.4659, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Soham", "state_or_region": null, "postal_code": "CB7 5JD", "country": "United Kingdom", "latitude": 52.33543, "longitude": 0.33654, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Southampton General Hospital", "city": "Southampton", "state_or_region": null, "postal_code": "SO16 6YD", "country": "United Kingdom", "latitude": 50.90395, "longitude": -1.40428, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southampton General Hospital", "city": "Southampton", "state_or_region": null, "postal_code": "SO16 6YD", "country": "United Kingdom", "latitude": 50.90395, "longitude": -1.40428, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southampton General Hospital", "city": "Southampton", "state_or_region": null, "postal_code": "SO16 6YD", "country": "United Kingdom", "latitude": 50.90395, "longitude": -1.40428, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P88632 Stockport Medical Group", "city": "Stockport", "state_or_region": null, "postal_code": "SK3 9NX", "country": "United Kingdom", "latitude": 53.40979, "longitude": -2.15761, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P87016 The Sides Medical Centre", "city": "Swinton", "state_or_region": null, "postal_code": "M27 0EW", "country": "United Kingdom", "latitude": 53.5, "longitude": -2.35, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "P87025 The Lakes Medical Practice", "city": "Swinton", "state_or_region": null, "postal_code": "M27 4AF", "country": "United Kingdom", "latitude": 53.5, "longitude": -2.35, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "St George's Hospital", "city": "Tooting, London", "state_or_region": null, "postal_code": "SW17 0QT", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "St George's Hospital", "city": "Tooting, London", "state_or_region": null, "postal_code": "SW17 0QT", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Wansford", "state_or_region": null, "postal_code": "PE8 6PL", "country": "United Kingdom", "latitude": 52.57851, "longitude": -0.42001, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07247084", "study_title": "A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-07", "facility": "Y02322 SSP Leigh Family Practice", "city": "Wigen", "state_or_region": null, "postal_code": "WN7 2PE", "country": "United Kingdom", "latitude": null, "longitude": null, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07247084" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Yate", "state_or_region": null, "postal_code": "BS37 4AX", "country": "United Kingdom", "latitude": 51.54074, "longitude": -2.41839, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - York", "city": "York", "state_or_region": null, "postal_code": "YO24 4LJ", "country": "United Kingdom", "latitude": 53.95763, "longitude": -1.08271, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Biopartners - York", "city": "York", "state_or_region": null, "postal_code": "YO24 4LJ", "country": "United Kingdom", "latitude": 53.95763, "longitude": -1.08271, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Panthera Clinic - York", "city": "York", "state_or_region": null, "postal_code": "YO24 4LJ", "country": "United Kingdom", "latitude": 53.95763, "longitude": -1.08271, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07065383", "study_title": "Rebalancing the Fat Content of the Heart and Muscles", "lead_sponsor": "University of Aberdeen", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2025-07", "last_update_post_date": "2026-04-30", "facility": "Cardiac Research Office, Aberdeen Royal Infirmary", "city": "Aberdeen", "state_or_region": "Aberdeenshire", "postal_code": "AB25 2ZD", "country": "United Kingdom", "latitude": 57.14369, "longitude": -2.09814, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07065383" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07364175", "study_title": "A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults", "lead_sponsor": "Cambridge University Hospitals NHS Foundation Trust", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-29", "facility": "Cambridge University Hospitals NHS Foundation Trust", "city": "Cambridge", "state_or_region": "Cambridgeshire", "postal_code": "CB2 0QQ", "country": "United Kingdom", "latitude": 52.2, "longitude": 0.11667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07364175" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Exeter", "state_or_region": "Devon", "postal_code": "EX25DW", "country": "United Kingdom", "latitude": 50.7236, "longitude": -3.52751, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07443956", "study_title": "Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis", "lead_sponsor": "NHS Greater Glasgow and Clyde", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-05-04", "facility": "University Hospitals Birmingham NHS Foundation Trust", "city": "Birmingham", "state_or_region": "England", "postal_code": "B12 2GW", "country": "United Kingdom", "latitude": 52.48142, "longitude": -1.89983, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07443956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07443956", "study_title": "Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis", "lead_sponsor": "NHS Greater Glasgow and Clyde", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-05-04", "facility": "University Hospitals Coventry and Warwickshire NHS Trust", "city": "Coventry", "state_or_region": "England", "postal_code": "CV2 2DX", "country": "United Kingdom", "latitude": 52.40656, "longitude": -1.51217, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07443956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07443956", "study_title": "Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis", "lead_sponsor": "NHS Greater Glasgow and Clyde", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-05-04", "facility": "The Newcastle Upon Tyne Hospitals NHS Foundation Trust", "city": "Newcastle upon Tyne", "state_or_region": "England", "postal_code": "NE7 7DN", "country": "United Kingdom", "latitude": 54.97328, "longitude": -1.61396, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07443956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "London", "state_or_region": "Greater London", "postal_code": "SW1P2PF", "country": "United Kingdom", "latitude": 51.50853, "longitude": -0.12574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Leicester", "state_or_region": "Leicestershire", "postal_code": "LE54PW", "country": "United Kingdom", "latitude": 52.6386, "longitude": -1.13169, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07411560", "study_title": "A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Parexel Research Unit", "city": "Harrow", "state_or_region": "Middlesex", "postal_code": "HA1 3UJ", "country": "United Kingdom", "latitude": 51.57835, "longitude": -0.33208, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07411560" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07443956", "study_title": "Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis", "lead_sponsor": "NHS Greater Glasgow and Clyde", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-05-04", "facility": "NHS Greater Glasgow and Clyde", "city": "Glasgow", "state_or_region": "Scotland", "postal_code": "G12 0XH", "country": "United Kingdom", "latitude": 55.86515, "longitude": -4.25763, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07443956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Rotherham", "state_or_region": "South Yorkshire", "postal_code": "S651DA", "country": "United Kingdom", "latitude": 53.43012, "longitude": -1.35678, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cahaba Research, Inc. - Trussville Location", "city": "Birmingham", "state_or_region": "Alabama", "postal_code": "35235", "country": "United States", "latitude": 33.52066, "longitude": -86.80249, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Flourish Research", "city": "Birmingham", "state_or_region": "Alabama", "postal_code": "35205", "country": "United States", "latitude": 33.52066, "longitude": -86.80249, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Birmingham", "state_or_region": "Alabama", "postal_code": "35205", "country": "United States", "latitude": 33.52066, "longitude": -86.80249, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Uni of Alabama at Birmingham", "city": "Birmingham", "state_or_region": "Alabama", "postal_code": "35294", "country": "United States", "latitude": 33.52066, "longitude": -86.80249, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Uni of Alabama at Birmingham", "city": "Birmingham", "state_or_region": "Alabama", "postal_code": "35296", "country": "United States", "latitude": 33.52066, "longitude": -86.80249, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Alabama at Birmingham", "city": "Birmingham", "state_or_region": "Alabama", "postal_code": "35233", "country": "United States", "latitude": 33.52066, "longitude": -86.80249, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Digestive Health Specialists", "city": "Dothan", "state_or_region": "Alabama", "postal_code": "36301", "country": "United States", "latitude": 31.22323, "longitude": -85.39049, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Digestive Health Specialists", "city": "Dothan", "state_or_region": "Alabama", "postal_code": "36301", "country": "United States", "latitude": 31.22323, "longitude": -85.39049, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Chambliss Clinical Trials, LLC", "city": "Montgomery", "state_or_region": "Alabama", "postal_code": "36106", "country": "United States", "latitude": 32.36681, "longitude": -86.29997, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Cahaba Research", "city": "Pelham", "state_or_region": "Alabama", "postal_code": "35124", "country": "United States", "latitude": 33.28567, "longitude": -86.80999, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MFA Clinical Research", "city": "Tuscaloosa", "state_or_region": "Alabama", "postal_code": "35405", "country": "United States", "latitude": 33.20984, "longitude": -87.56917, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale", "city": "Avondale", "state_or_region": "Arizona", "postal_code": "85392", "country": "United States", "latitude": 33.4356, "longitude": -112.3496, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler", "city": "Chandler", "state_or_region": "Arizona", "postal_code": "85225", "country": "United States", "latitude": 33.30616, "longitude": -111.84125, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Institute for Liver Health II dba Arizona Clinical Trials - Chandler", "city": "Chandler", "state_or_region": "Arizona", "postal_code": "85224", "country": "United States", "latitude": 33.30616, "longitude": -111.84125, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "The Institute for Liver Health II dba Arizona Clinical Trials - Mesa", "city": "Chandler", "state_or_region": "Arizona", "postal_code": "85225", "country": "United States", "latitude": 33.30616, "longitude": -111.84125, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff", "city": "Flagstaff", "state_or_region": "Arizona", "postal_code": "86001", "country": "United States", "latitude": 35.19807, "longitude": -111.65127, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Gilbert", "city": "Gilbert", "state_or_region": "Arizona", "postal_code": "85297", "country": "United States", "latitude": 33.35283, "longitude": -111.78903, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Elligo Health Research Inc", "city": "Gilbert", "state_or_region": "Arizona", "postal_code": "85296", "country": "United States", "latitude": 33.35283, "longitude": -111.78903, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gilbert Center for Family Medicine", "city": "Gilbert", "state_or_region": "Arizona", "postal_code": "85296", "country": "United States", "latitude": 33.35283, "longitude": -111.78903, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spectrum Research Institute", "city": "Gilbert", "state_or_region": "Arizona", "postal_code": "85297", "country": "United States", "latitude": 33.35283, "longitude": -111.78903, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale", "city": "Glendale", "state_or_region": "Arizona", "postal_code": "85306", "country": "United States", "latitude": 33.53865, "longitude": -112.18599, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Glendale", "state_or_region": "Arizona", "postal_code": "85308", "country": "United States", "latitude": 33.53865, "longitude": -112.18599, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Mesa", "city": "Mesa", "state_or_region": "Arizona", "postal_code": "85210", "country": "United States", "latitude": 33.42227, "longitude": -111.82264, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Mesa", "state_or_region": "Arizona", "postal_code": "85213", "country": "United States", "latitude": 33.42227, "longitude": -111.82264, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Helios Clinical Research - Paradise Valley", "city": "Paradise Valley", "state_or_region": "Arizona", "postal_code": "85253", "country": "United States", "latitude": 33.53115, "longitude": -111.94265, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Arizona Liver Health - Peoria 85381", "city": "Peoria", "state_or_region": "Arizona", "postal_code": "85381", "country": "United States", "latitude": 33.5806, "longitude": -112.23738, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Institute for Liver Health II DBA Arizona Clinical Trials", "city": "Peoria", "state_or_region": "Arizona", "postal_code": "85381", "country": "United States", "latitude": 33.5806, "longitude": -112.23738, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Institute for Liver Health II DBA Arizona Clinical Trials", "city": "Peoria", "state_or_region": "Arizona", "postal_code": "85381", "country": "United States", "latitude": 33.5806, "longitude": -112.23738, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Institute for Liver Health II dba Arizona Liver Health - Peoria", "city": "Peoria", "state_or_region": "Arizona", "postal_code": "85381", "country": "United States", "latitude": 33.5806, "longitude": -112.23738, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Phoenix PV", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85032", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "DM Clinical Research - Phoenix", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85012", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Helios Clinical Research - Phoenix", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85028", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "HOPE Research Institute", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85032", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85012", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Medical Dermatology Specialists", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85006", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85016", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06499857", "study_title": "Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation", "lead_sponsor": "University of Chicago", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-14", "facility": "The University of Arizona College of Medicine- Phoenix", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85004", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06499857" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Velocity Clinical Research-Phoenix", "city": "Phoenix", "state_or_region": "Arizona", "postal_code": "85006", "country": "United States", "latitude": 33.44838, "longitude": -112.07404, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Headlands Research - Scottsdale", "city": "Scottsdale", "state_or_region": "Arizona", "postal_code": "85260", "country": "United States", "latitude": 33.50921, "longitude": -111.89903, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Scottsdale Medical Specialists, Ltd", "city": "Scottsdale", "state_or_region": "Arizona", "postal_code": "85258", "country": "United States", "latitude": 33.50921, "longitude": -111.89903, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Scottsdale Medical Specialists, Ltd", "city": "Scottsdale", "state_or_region": "Arizona", "postal_code": "85258", "country": "United States", "latitude": 33.50921, "longitude": -111.89903, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Sun City", "city": "Sun City", "state_or_region": "Arizona", "postal_code": "85351", "country": "United States", "latitude": 33.59754, "longitude": -112.27182, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Medical Research-Sun City", "city": "Sun City", "state_or_region": "Arizona", "postal_code": "85351", "country": "United States", "latitude": 33.59754, "longitude": -112.27182, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07673900", "study_title": "Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants", "lead_sponsor": "Terrestrial Bio, Inc.", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-31", "facility": "Celerion Clinical Research", "city": "Tempe", "state_or_region": "Arizona", "postal_code": "85283", "country": "United States", "latitude": 33.41477, "longitude": -111.90931, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07673900" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Tempe", "state_or_region": "Arizona", "postal_code": "85281", "country": "United States", "latitude": 33.41477, "longitude": -111.90931, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson Southeast", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85748", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85704", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Adobe Clinical Research, LLC", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85712", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Adobe Clinical Research, LLC", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85712", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Arizona Liver Health - Tucson", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85712", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Arizona Liver Health - Tucson", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85712", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Del Sol Research Management, LLC", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85715", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Del Sol Research Management, LLC", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85715", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Del Sol Research Management, LLC", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85715", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Institute for Liver Health II dba Arizona Clinical Trials - Tucson", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85712", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "The Institute for Liver Health II dba Arizona Liver Health-Tucson", "city": "Tucson", "state_or_region": "Arizona", "postal_code": "85712", "country": "United States", "latitude": 32.22174, "longitude": -110.92648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Arkansas Clinical Research", "city": "Little Rock", "state_or_region": "Arkansas", "postal_code": "72205", "country": "United States", "latitude": 34.74648, "longitude": -92.28959, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Little Rock", "state_or_region": "Arkansas", "postal_code": "72205", "country": "United States", "latitude": 34.74648, "longitude": -92.28959, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Woodland Int. Research Group", "city": "Little Rock", "state_or_region": "Arkansas", "postal_code": "72211", "country": "United States", "latitude": 34.74648, "longitude": -92.28959, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Woodland International Research Group, Inc.", "city": "Little Rock", "state_or_region": "Arkansas", "postal_code": "72211", "country": "United States", "latitude": 34.74648, "longitude": -92.28959, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Arkansas Gastroenterology - North Little Rock", "city": "North Little Rock", "state_or_region": "Arkansas", "postal_code": "72117", "country": "United States", "latitude": 34.76954, "longitude": -92.26709, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Smart Cures Clinical Research", "city": "Anaheim", "state_or_region": "California", "postal_code": "92806", "country": "United States", "latitude": 33.83529, "longitude": -117.9145, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Smart Cures Clinical Research", "city": "Anaheim", "state_or_region": "California", "postal_code": "92806", "country": "United States", "latitude": 33.83529, "longitude": -117.9145, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Medvin Clinical Research - Apple Valley", "city": "Apple Valley", "state_or_region": "California", "postal_code": "92307", "country": "United States", "latitude": 34.50083, "longitude": -117.18588, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cedars-Sinai Medical Center", "city": "Beverly Hills", "state_or_region": "California", "postal_code": "90211", "country": "United States", "latitude": 34.07362, "longitude": -118.40036, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cedars-Sinai Medical Center", "city": "Beverly Hills", "state_or_region": "California", "postal_code": "90211", "country": "United States", "latitude": 34.07362, "longitude": -118.40036, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06976853", "study_title": "Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease", "lead_sponsor": "Washington University School of Medicine", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-05", "facility": "Cedars-Sinai Medical Center", "city": "Beverly Hills", "state_or_region": "California", "postal_code": "90211", "country": "United States", "latitude": 34.07362, "longitude": -118.40036, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06976853" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hope Clinical Research", "city": "Canoga Park", "state_or_region": "California", "postal_code": "91303", "country": "United States", "latitude": 34.20112, "longitude": -118.59814, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hope Clinical Research", "city": "Canoga Park", "state_or_region": "California", "postal_code": "91303", "country": "United States", "latitude": 34.20112, "longitude": -118.59814, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "San Fernando Valley Health Institute", "city": "Canoga Park", "state_or_region": "California", "postal_code": "91304", "country": "United States", "latitude": 34.20112, "longitude": -118.59814, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "San Fernando Valley Health", "city": "Canoga Park", "state_or_region": "California", "postal_code": "91304", "country": "United States", "latitude": 34.20112, "longitude": -118.59814, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Chula Vista", "city": "Chula Vista", "state_or_region": "California", "postal_code": "91911", "country": "United States", "latitude": 32.64005, "longitude": -117.0842, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Chula Vista", "city": "Chula Vista", "state_or_region": "California", "postal_code": "91911", "country": "United States", "latitude": 32.64005, "longitude": -117.0842, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "John Muir Physician Network Clinical Research Center", "city": "Concord", "state_or_region": "California", "postal_code": "94520", "country": "United States", "latitude": 37.97798, "longitude": -122.03107, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern California Research Center", "city": "Coronado", "state_or_region": "California", "postal_code": "92118", "country": "United States", "latitude": 32.68589, "longitude": -117.18309, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern California Research Center", "city": "Coronado", "state_or_region": "California", "postal_code": "92118", "country": "United States", "latitude": 32.68589, "longitude": -117.18309, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07527910", "study_title": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "lead_sponsor": "Regeneron Pharmaceuticals", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Southern California Research Center", "city": "Coronado", "state_or_region": "California", "postal_code": "92118", "country": "United States", "latitude": 32.68589, "longitude": -117.18309, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07527910" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "FDRC", "city": "Costa Mesa", "state_or_region": "California", "postal_code": "92627", "country": "United States", "latitude": 33.64113, "longitude": -117.91867, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Medvin Clinical Research - Covina", "city": "Covina", "state_or_region": "California", "postal_code": "91722", "country": "United States", "latitude": 34.09001, "longitude": -117.89034, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Covina", "state_or_region": "California", "postal_code": "91723", "country": "United States", "latitude": 34.09001, "longitude": -117.89034, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "liraglutide; semaglutide", "nct_id": "NCT07225816", "study_title": "Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-21", "facility": "Altasciences Clinical LA, Inc.", "city": "Cypress", "state_or_region": "California", "postal_code": "90630", "country": "United States", "latitude": 33.81696, "longitude": -118.03729, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07225816" }, { "compound_slugs": "semaglutide; tirzepatide", "nct_id": "NCT07202247", "study_title": "Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial", "lead_sponsor": "City of Hope Medical Center", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-17", "facility": "City of Hope Medical Center", "city": "Duarte", "state_or_region": "California", "postal_code": "91010", "country": "United States", "latitude": 34.13945, "longitude": -117.97729, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07202247" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Encinitas", "state_or_region": "California", "postal_code": "92024", "country": "United States", "latitude": 33.03699, "longitude": -117.29198, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Headlands Research California, LLC", "city": "Escondido", "state_or_region": "California", "postal_code": "92025", "country": "United States", "latitude": 33.11921, "longitude": -117.08642, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Headlands Research California, LLC", "city": "Escondido", "state_or_region": "California", "postal_code": "92025", "country": "United States", "latitude": 33.11921, "longitude": -117.08642, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Neighborhood Healthcare - Escondido", "city": "Escondido", "state_or_region": "California", "postal_code": "92025", "country": "United States", "latitude": 33.11921, "longitude": -117.08642, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Neighborhood Healthcare", "city": "Escondido", "state_or_region": "California", "postal_code": "92025", "country": "United States", "latitude": 33.11921, "longitude": -117.08642, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Neighborhood Healthcare", "city": "Escondido", "state_or_region": "California", "postal_code": "92025", "country": "United States", "latitude": 33.11921, "longitude": -117.08642, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ark Clinical Research - Fountain Valley", "city": "Fountain Valley", "state_or_region": "California", "postal_code": "92708", "country": "United States", "latitude": 33.70918, "longitude": -117.95367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ARK Clinical Research", "city": "Fountain Valley", "state_or_region": "California", "postal_code": "92708", "country": "United States", "latitude": 33.70918, "longitude": -117.95367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ARK Clinical Research", "city": "Fountain Valley", "state_or_region": "California", "postal_code": "92708", "country": "United States", "latitude": 33.70918, "longitude": -117.95367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Ark Clinical Research", "city": "Fountain Valley", "state_or_region": "California", "postal_code": "92708", "country": "United States", "latitude": 33.70918, "longitude": -117.95367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "First OC Dermatology Research Inc", "city": "Fountain Valley", "state_or_region": "California", "postal_code": "92708", "country": "United States", "latitude": 33.70918, "longitude": -117.95367, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Center For Dermatology Clinical Research, Inc.", "city": "Fremont", "state_or_region": "California", "postal_code": "94538", "country": "United States", "latitude": 37.54827, "longitude": -121.98857, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fresno Clinical Research Center", "city": "Fresno", "state_or_region": "California", "postal_code": "93720", "country": "United States", "latitude": 36.74773, "longitude": -119.77237, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fresno Clinical Research Center", "city": "Fresno", "state_or_region": "California", "postal_code": "93720", "country": "United States", "latitude": 36.74773, "longitude": -119.77237, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Garden Grove", "state_or_region": "California", "postal_code": "92844", "country": "United States", "latitude": 33.77391, "longitude": -117.94145, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Gardena-69773", "city": "Gardena", "state_or_region": "California", "postal_code": "90247", "country": "United States", "latitude": 33.88835, "longitude": -118.30896, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "NorCal Medical Research, Inc", "city": "Greenbrae", "state_or_region": "California", "postal_code": "94904", "country": "United States", "latitude": 37.94854, "longitude": -122.5247, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Newport Huntington Medical Group", "city": "Huntington Beach", "state_or_region": "California", "postal_code": "92648", "country": "United States", "latitude": 33.6603, "longitude": -117.99923, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "National Research Institute - Huntington Park", "city": "Huntington Park", "state_or_region": "California", "postal_code": "90255", "country": "United States", "latitude": 33.98168, "longitude": -118.22507, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Huntington Park", "city": "Huntington Park", "state_or_region": "California", "postal_code": "90255", "country": "United States", "latitude": 33.98168, "longitude": -118.22507, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Huntington Park", "city": "Huntington Park", "state_or_region": "California", "postal_code": "90255", "country": "United States", "latitude": 33.98168, "longitude": -118.22507, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Velocity Clinical Research, Huntington Park", "city": "Huntington Park", "state_or_region": "California", "postal_code": "90255", "country": "United States", "latitude": 33.98168, "longitude": -118.22507, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "310 Clinical Research", "city": "Inglewood", "state_or_region": "California", "postal_code": "90301", "country": "United States", "latitude": 33.96168, "longitude": -118.35313, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "310 Clinical Research", "city": "Inglewood", "state_or_region": "California", "postal_code": "90301", "country": "United States", "latitude": 33.96168, "longitude": -118.35313, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UCSD - Altman Clinical and Translational Research Institute (ACTRI)", "city": "La Jolla", "state_or_region": "California", "postal_code": "92037", "country": "United States", "latitude": 32.84727, "longitude": -117.2742, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Diabetes & Endocrine Specialists - La Mesa", "city": "La Mesa", "state_or_region": "California", "postal_code": "91942", "country": "United States", "latitude": 32.76783, "longitude": -117.02308, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Purushotham & Akther Kotha MD, Inc", "city": "La Mesa", "state_or_region": "California", "postal_code": "91942", "country": "United States", "latitude": 32.76783, "longitude": -117.02308, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, San Diego", "city": "La Mesa", "state_or_region": "California", "postal_code": "91942", "country": "United States", "latitude": 32.76783, "longitude": -117.02308, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, San Diego", "city": "La Mesa", "state_or_region": "California", "postal_code": "91942", "country": "United States", "latitude": 32.76783, "longitude": -117.02308, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Orange County Research Center", "city": "Lake Forest", "state_or_region": "California", "postal_code": "92630", "country": "United States", "latitude": 33.64697, "longitude": -117.68922, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "First Valley Medical Group", "city": "Lancaster", "state_or_region": "California", "postal_code": "93534", "country": "United States", "latitude": 34.69804, "longitude": -118.13674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Om Research LLC", "city": "Lancaster", "state_or_region": "California", "postal_code": "93534", "country": "United States", "latitude": 34.69804, "longitude": -118.13674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Om Research, LLC", "city": "Lancaster", "state_or_region": "California", "postal_code": "93534", "country": "United States", "latitude": 34.69804, "longitude": -118.13674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Om Research, LLC", "city": "Lancaster", "state_or_region": "California", "postal_code": "93534", "country": "United States", "latitude": 34.69804, "longitude": -118.13674, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Trials Research - Lincoln", "city": "Lincoln", "state_or_region": "California", "postal_code": "95648", "country": "United States", "latitude": 38.89156, "longitude": -121.29301, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Trials Research_Sacramento", "city": "Lincoln", "state_or_region": "California", "postal_code": "95648", "country": "United States", "latitude": 38.89156, "longitude": -121.29301, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Loma Linda University Faculty Medical Clinics", "city": "Loma Linda", "state_or_region": "California", "postal_code": "92354", "country": "United States", "latitude": 34.04835, "longitude": -117.26115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Loma Linda", "state_or_region": "California", "postal_code": "92350", "country": "United States", "latitude": 34.04835, "longitude": -117.26115, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Torrance Clinical Research Institute, Inc.", "city": "Lomita", "state_or_region": "California", "postal_code": "90717", "country": "United States", "latitude": 33.79224, "longitude": -118.31507, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ARK Clinical Research", "city": "Long Beach", "state_or_region": "California", "postal_code": "90815", "country": "United States", "latitude": 33.76696, "longitude": -118.18923, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ark Clinical Research", "city": "Long Beach", "state_or_region": "California", "postal_code": "90815", "country": "United States", "latitude": 33.76696, "longitude": -118.18923, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Ark Clinical Research", "city": "Long Beach", "state_or_region": "California", "postal_code": "90815", "country": "United States", "latitude": 33.76696, "longitude": -118.18923, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Ark Clinical Research", "city": "Long Beach", "state_or_region": "California", "postal_code": "90815", "country": "United States", "latitude": 33.76696, "longitude": -118.18923, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ARK Clinical Research", "city": "Long Beach", "state_or_region": "California", "postal_code": "90815", "country": "United States", "latitude": 33.76696, "longitude": -118.18923, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Long Beach", "state_or_region": "California", "postal_code": "90807", "country": "United States", "latitude": 33.76696, "longitude": -118.18923, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA Long Beach Healthcare System, Long Beach, CA", "city": "Long Beach", "state_or_region": "California", "postal_code": "90822", "country": "United States", "latitude": 33.76696, "longitude": -118.18923, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Pacific Clinical Studies", "city": "Los Alamitos", "state_or_region": "California", "postal_code": "90720", "country": "United States", "latitude": 33.80307, "longitude": -118.07256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Pacific Clinical Studies", "city": "Los Alamitos", "state_or_region": "California", "postal_code": "90720", "country": "United States", "latitude": 33.80307, "longitude": -118.07256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "United Medical Doctors - Los Alamitos", "city": "Los Alamitos", "state_or_region": "California", "postal_code": "90720", "country": "United States", "latitude": 33.80307, "longitude": -118.07256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "United Medical Doctors - Los Alamitos", "city": "Los Alamitos", "state_or_region": "California", "postal_code": "90720", "country": "United States", "latitude": 33.80307, "longitude": -118.07256, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Children's Hospital Los Angeles", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90027", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06994338", "study_title": "Tirzepatide for Alcohol Use Disorder", "lead_sponsor": "University of Southern California", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-10", "last_update_post_date": "2025-10-14", "facility": "Keck School of Medicine, University of Southern California", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90032", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06994338" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07602699", "study_title": "Multi-Site Trial of Tirzepatide for Smoking Cessation", "lead_sponsor": "University of Southern California", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Keck School of Medicine, University of Southern California", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90033", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07602699" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Los Angeles Institute for Metabolic Research", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90015", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Los Angeles Institute for Metabolic Research", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90015", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Los Angeles Institute for Metabolic Research", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90015", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Los Angeles Institute for Metabolic Research", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90015", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Metropolis Dermatology", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90017", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Westlake", "city": "Los Angeles", "state_or_region": "California", "postal_code": "90057", "country": "United States", "latitude": 34.05223, "longitude": -118.24368, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Catalina Research Institute, LLC", "city": "Montclair", "state_or_region": "California", "postal_code": "91763", "country": "United States", "latitude": 34.07751, "longitude": -117.68978, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Catalina Research Institute, LLC", "city": "Montclair", "state_or_region": "California", "postal_code": "91763", "country": "United States", "latitude": 34.07751, "longitude": -117.68978, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Catalina Research Institute, LLC", "city": "Montclair", "state_or_region": "California", "postal_code": "91763", "country": "United States", "latitude": 34.07751, "longitude": -117.68978, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "United Medical Doctors - Murrieta", "city": "Murrieta", "state_or_region": "California", "postal_code": "92563", "country": "United States", "latitude": 33.55391, "longitude": -117.21392, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Infinity Clinical Research", "city": "Norco", "state_or_region": "California", "postal_code": "92860", "country": "United States", "latitude": 33.93113, "longitude": -117.54866, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "California Medical Research Associates", "city": "Northridge", "state_or_region": "California", "postal_code": "91324", "country": "United States", "latitude": 34.22834, "longitude": -118.53675, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "California Medical Research Associates", "city": "Northridge", "state_or_region": "California", "postal_code": "91324", "country": "United States", "latitude": 34.22834, "longitude": -118.53675, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Northridge", "state_or_region": "California", "postal_code": "91325", "country": "United States", "latitude": 34.22834, "longitude": -118.53675, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Northridge Clinical Trials", "city": "Northridge", "state_or_region": "California", "postal_code": "91325", "country": "United States", "latitude": 34.22834, "longitude": -118.53675, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Valley Clinical Trials, Inc.", "city": "Northridge", "state_or_region": "California", "postal_code": "91325", "country": "United States", "latitude": 34.22834, "longitude": -118.53675, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Valley Clinical Trials", "city": "Northridge", "state_or_region": "California", "postal_code": "91325", "country": "United States", "latitude": 34.22834, "longitude": -118.53675, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Oceanside", "state_or_region": "California", "postal_code": "92058", "country": "United States", "latitude": 33.19587, "longitude": -117.37948, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinnova Research Solutions", "city": "Orange", "state_or_region": "California", "postal_code": "92868", "country": "United States", "latitude": 33.78779, "longitude": -117.85311, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinnova Research Solutions", "city": "Orange", "state_or_region": "California", "postal_code": "92868", "country": "United States", "latitude": 33.78779, "longitude": -117.85311, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Knowledge Research Center", "city": "Orange", "state_or_region": "California", "postal_code": "92868", "country": "United States", "latitude": 33.78779, "longitude": -117.85311, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fomat Medical Research", "city": "Oxnard", "state_or_region": "California", "postal_code": "93030", "country": "United States", "latitude": 34.1975, "longitude": -119.17705, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fomat Medical Research", "city": "Oxnard", "state_or_region": "California", "postal_code": "93030", "country": "United States", "latitude": 34.1975, "longitude": -119.17705, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Fomat Medical Research", "city": "Oxnard", "state_or_region": "California", "postal_code": "93030", "country": "United States", "latitude": 34.1975, "longitude": -119.17705, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Desert Oasis Healthcare", "city": "Palm Springs", "state_or_region": "California", "postal_code": "92262", "country": "United States", "latitude": 33.8303, "longitude": -116.54529, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT05912621", "study_title": "Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity", "lead_sponsor": "Stanford University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2024-12-04", "facility": "Clinical and Translational Research Unit", "city": "Palo Alto", "state_or_region": "California", "postal_code": "94305", "country": "United States", "latitude": 37.44188, "longitude": -122.14302, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05912621" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06657209", "study_title": "Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide", "lead_sponsor": "Stanford University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-20", "facility": "Stanford University", "city": "Palo Alto", "state_or_region": "California", "postal_code": "94304", "country": "United States", "latitude": 37.44188, "longitude": -122.14302, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06657209" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA Palo Alto Health Care System, Palo Alto, CA", "city": "Palo Alto", "state_or_region": "California", "postal_code": "94304-1207", "country": "United States", "latitude": 37.44188, "longitude": -122.14302, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "California Liver Research Center", "city": "Pasadena", "state_or_region": "California", "postal_code": "91105", "country": "United States", "latitude": 34.14778, "longitude": -118.14452, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "California Liver Research Institute", "city": "Pasadena", "state_or_region": "California", "postal_code": "91105", "country": "United States", "latitude": 34.14778, "longitude": -118.14452, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07527910", "study_title": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "lead_sponsor": "Regeneron Pharmaceuticals", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "California Liver Research Institute", "city": "Pasadena", "state_or_region": "California", "postal_code": "91105", "country": "United States", "latitude": 34.14778, "longitude": -118.14452, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07527910" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Pomona", "state_or_region": "California", "postal_code": "91768", "country": "United States", "latitude": 34.05529, "longitude": -117.75228, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cadena Care Institute, LLC", "city": "Poway", "state_or_region": "California", "postal_code": "92064", "country": "United States", "latitude": 32.96282, "longitude": -117.03586, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cadena Care Institute, LLC", "city": "Poway", "state_or_region": "California", "postal_code": "92064", "country": "United States", "latitude": 32.96282, "longitude": -117.03586, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ficramed Research Institute", "city": "Poway", "state_or_region": "California", "postal_code": "92064", "country": "United States", "latitude": 32.96282, "longitude": -117.03586, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ficramed Research Institute", "city": "Poway", "state_or_region": "California", "postal_code": "92064", "country": "United States", "latitude": 32.96282, "longitude": -117.03586, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inland Empire Clinical Trials, LLC", "city": "Rialto", "state_or_region": "California", "postal_code": "92377", "country": "United States", "latitude": 34.1064, "longitude": -117.37032, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Inland Empire Clinical Trials, LLC", "city": "Rialto", "state_or_region": "California", "postal_code": "92377", "country": "United States", "latitude": 34.1064, "longitude": -117.37032, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Artemis Institute for Clinical Research", "city": "Riverside", "state_or_region": "California", "postal_code": "92503", "country": "United States", "latitude": 33.95335, "longitude": -117.39616, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Medvin Clinical Research - Riverside", "city": "Riverside", "state_or_region": "California", "postal_code": "92508", "country": "United States", "latitude": 33.95335, "longitude": -117.39616, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Peninsula Research Associates", "city": "Rolling Hills Estates", "state_or_region": "California", "postal_code": "90274", "country": "United States", "latitude": 33.78779, "longitude": -118.35813, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sacramento", "state_or_region": "California", "postal_code": "95821", "country": "United States", "latitude": 38.58157, "longitude": -121.4944, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology", "city": "Sacramento", "state_or_region": "California", "postal_code": "95821", "country": "United States", "latitude": 38.58157, "longitude": -121.4944, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Metro Clinical Trials", "city": "San Bernardino", "state_or_region": "California", "postal_code": "92404", "country": "United States", "latitude": 34.10834, "longitude": -117.28977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Metro Clinical Trials", "city": "San Bernardino", "state_or_region": "California", "postal_code": "92404", "country": "United States", "latitude": 34.10834, "longitude": -117.28977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Acclaim Clinical Research", "city": "San Diego", "state_or_region": "California", "postal_code": "92120", "country": "United States", "latitude": 32.71571, "longitude": -117.16472, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Acclaim Clinical Research", "city": "San Diego", "state_or_region": "California", "postal_code": "92120", "country": "United States", "latitude": 32.71571, "longitude": -117.16472, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Linda Vista Health Care Ctr", "city": "San Diego", "state_or_region": "California", "postal_code": "92111", "country": "United States", "latitude": 32.71571, "longitude": -117.16472, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Associates Research Group, Inc.", "city": "San Diego", "state_or_region": "California", "postal_code": "92123", "country": "United States", "latitude": 32.71571, "longitude": -117.16472, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Associates Research Group", "city": "San Diego", "state_or_region": "California", "postal_code": "92123", "country": "United States", "latitude": 32.71571, "longitude": -117.16472, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Rheumatology Center of San Diego", "city": "San Diego", "state_or_region": "California", "postal_code": "92128", "country": "United States", "latitude": 32.71571, "longitude": -117.16472, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Wetlin Research Associates, Inc.", "city": "San Diego", "state_or_region": "California", "postal_code": "92120", "country": "United States", "latitude": 32.71571, "longitude": -117.16472, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "N America Res Inst - San Dimas", "city": "San Dimas", "state_or_region": "California", "postal_code": "91773", "country": "United States", "latitude": 34.10668, "longitude": -117.80673, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07204249", "study_title": "Glutide for Ending Methamphetamine", "lead_sponsor": "San Francisco Department of Public Health", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Center on Substance Use and Health", "city": "San Francisco", "state_or_region": "California", "postal_code": "94102", "country": "United States", "latitude": 37.77493, "longitude": -122.41942, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07204249" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Quest Clinical Research", "city": "San Francisco", "state_or_region": "California", "postal_code": "94115", "country": "United States", "latitude": 37.77493, "longitude": -122.41942, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "NorCal Endocrinology and Internal Medicine", "city": "San Ramon", "state_or_region": "California", "postal_code": "94583", "country": "United States", "latitude": 37.77993, "longitude": -121.97802, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Santa Ana", "city": "Santa Ana", "state_or_region": "California", "postal_code": "92704", "country": "United States", "latitude": 33.74557, "longitude": -117.86783, "site_statuses": "TERMINATED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Providence Saint John's Medical Foundation", "city": "Santa Monica", "state_or_region": "California", "postal_code": "90404", "country": "United States", "latitude": 34.01949, "longitude": -118.49138, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Encompass Clinical Research, Spring Valley", "city": "Spring Valley", "state_or_region": "California", "postal_code": "91978", "country": "United States", "latitude": 32.74477, "longitude": -116.99892, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06657209", "study_title": "Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide", "lead_sponsor": "Stanford University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-20", "facility": "Stanford University, Clinical and Translational Research Unit (CTRU)", "city": "Stanford", "state_or_region": "California", "postal_code": "94304", "country": "United States", "latitude": 37.42411, "longitude": -122.16608, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06657209" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05173714", "study_title": "Sit Less, Interact and Move More (SLIMM) 2 Study", "lead_sponsor": "Srinvasan Beddhu", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-27", "facility": "Stanford University", "city": "Stanford", "state_or_region": "California", "postal_code": "94305", "country": "United States", "latitude": 37.42411, "longitude": -122.16608, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05173714" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Medvin Clinical Research - Temecula", "city": "Temecula", "state_or_region": "California", "postal_code": "92592", "country": "United States", "latitude": 33.49364, "longitude": -117.14836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT05708859", "study_title": "Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT", "lead_sponsor": "Matthew J. Budoff", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-10", "last_update_post_date": "2024-10-15", "facility": "Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute)", "city": "Torrance", "state_or_region": "California", "postal_code": "90502", "country": "United States", "latitude": 33.83585, "longitude": -118.34063, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05708859" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Medvin Clinical Research - Tujunga", "city": "Tujunga", "state_or_region": "California", "postal_code": "91042", "country": "United States", "latitude": 34.25223, "longitude": -118.28841, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Clinical Investigators, Inc.", "city": "Tustin", "state_or_region": "California", "postal_code": "92780", "country": "United States", "latitude": 33.74585, "longitude": -117.82617, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Velocity Clin Res - Van Nuys", "city": "Van Nuys", "state_or_region": "California", "postal_code": "91405", "country": "United States", "latitude": 34.18667, "longitude": -118.44897, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Van Nuys", "city": "Van Nuys", "state_or_region": "California", "postal_code": "91405", "country": "United States", "latitude": 34.18667, "longitude": -118.44897, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Om Research, LLC", "city": "Victorville", "state_or_region": "California", "postal_code": "92395", "country": "United States", "latitude": 34.53611, "longitude": -117.29116, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Diablo Clinical Research, Inc.", "city": "Walnut Creek", "state_or_region": "California", "postal_code": "94598", "country": "United States", "latitude": 37.90631, "longitude": -122.06496, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Diablo Clinical Research, Inc.", "city": "Walnut Creek", "state_or_region": "California", "postal_code": "94598", "country": "United States", "latitude": 37.90631, "longitude": -122.06496, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Diablo Clinical Research, Inc.", "city": "Walnut Creek", "state_or_region": "California", "postal_code": "94598", "country": "United States", "latitude": 37.90631, "longitude": -122.06496, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diablo Clinical Research", "city": "Walnut Creek", "state_or_region": "California", "postal_code": "94598", "country": "United States", "latitude": 37.90631, "longitude": -122.06496, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Flourish Research - CA", "city": "Walnut Creek", "state_or_region": "California", "postal_code": "94598", "country": "United States", "latitude": 37.90631, "longitude": -122.06496, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Focus Clinical Research", "city": "West Hills", "state_or_region": "California", "postal_code": "91307", "country": "United States", "latitude": 34.19731, "longitude": -118.64398, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA Greater Los Angeles Healthcare System, West Los Angeles, CA", "city": "West Los Angeles", "state_or_region": "California", "postal_code": "90073-1003", "country": "United States", "latitude": 34.0462, "longitude": -118.43068, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Medvin Clinical Research - Whittier", "city": "Whittier", "state_or_region": "California", "postal_code": "90602", "country": "United States", "latitude": 33.97918, "longitude": -118.03284, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide; tirzepatide", "nct_id": "NCT06575738", "study_title": "Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-15", "facility": "Childrens Hospital Colorado", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06575738" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Rocky Mount Reg VA Med-DN", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tesamorelin", "nct_id": "NCT06554717", "study_title": "Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV", "lead_sponsor": "Massachusetts General Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-19", "facility": "University of Colorado - Anschutz Medical Campus", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06554717" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06582875", "study_title": "Glucagon-Like Peptide-1 Receptor Agonist in ADPKD", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-05", "last_update_post_date": "2025-05-06", "facility": "University of Colorado - Anschutz Medical Campus", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06582875" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05819138", "study_title": "Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-04", "facility": "University of Colorado Anschutz Medical Campus", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05819138" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05822609", "study_title": "Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes", "lead_sponsor": "University of Washington", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-06-02", "facility": "University of Colorado Anschutz Medical Campus", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05822609" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Colorado Anschutz Medical Campus", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07602699", "study_title": "Multi-Site Trial of Tirzepatide for Smoking Cessation", "lead_sponsor": "University of Southern California", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "University of Colorado Anschutz Medical Campus", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07602699" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05819853", "study_title": "Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-08", "last_update_post_date": "2025-08-28", "facility": "University of Colorado Anschutz/Children's Hospital Colorado Aurora", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05819853" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "University of Colorado Hospital", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06975111", "study_title": "Focusing on the Menopausal Transition to Improve Mid-Life Women's Health", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-21", "facility": "University of Colorado-School of Medicine", "city": "Aurora", "state_or_region": "Colorado", "postal_code": "80045", "country": "United States", "latitude": 39.72943, "longitude": -104.83192, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06975111" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Future Innovative Treatments", "city": "Colorado Springs", "state_or_region": "Colorado", "postal_code": "80907", "country": "United States", "latitude": 38.83388, "longitude": -104.82136, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Future Innovative Treatments", "city": "Colorado Springs", "state_or_region": "Colorado", "postal_code": "80907", "country": "United States", "latitude": 38.83388, "longitude": -104.82136, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Denver Gastroenterology PC", "city": "Englewood", "state_or_region": "Colorado", "postal_code": "80113", "country": "United States", "latitude": 39.64777, "longitude": -104.98776, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Denver Gastroenterology PC", "city": "Englewood", "state_or_region": "Colorado", "postal_code": "80113", "country": "United States", "latitude": 39.64777, "longitude": -104.98776, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Denver Gastroenterology", "city": "Englewood", "state_or_region": "Colorado", "postal_code": "80113", "country": "United States", "latitude": 39.64777, "longitude": -104.98776, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bridgeport", "state_or_region": "Connecticut", "postal_code": "06606", "country": "United States", "latitude": 41.17923, "longitude": -73.18945, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Connecticut Gastroenterology Clinical Research Foundation", "city": "Bristol", "state_or_region": "Connecticut", "postal_code": "06010", "country": "United States", "latitude": 41.67176, "longitude": -72.94927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Connecticut Gastroenterology Clinical Research Foundation", "city": "Bristol", "state_or_region": "Connecticut", "postal_code": "06010", "country": "United States", "latitude": 41.67176, "longitude": -72.94927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Hamden", "state_or_region": "Connecticut", "postal_code": "06517", "country": "United States", "latitude": 41.39593, "longitude": -72.89677, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical Research Center of Connecticut", "city": "Hamden", "state_or_region": "Connecticut", "postal_code": "06518", "country": "United States", "latitude": 41.39593, "longitude": -72.89677, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06411210", "study_title": "Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment", "lead_sponsor": "Yale University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-08-04", "facility": "Yale Pediatric Diabetes Center, Adult and Children's Progam", "city": "New Haven", "state_or_region": "Connecticut", "postal_code": "06520", "country": "United States", "latitude": 41.30815, "longitude": -72.92816, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06411210" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07223983", "study_title": "Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)", "lead_sponsor": "Yale University", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-12", "facility": "Yale School of Medicine", "city": "New Haven", "state_or_region": "Connecticut", "postal_code": "06520", "country": "United States", "latitude": 41.30815, "longitude": -72.92816, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07223983" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07602699", "study_title": "Multi-Site Trial of Tirzepatide for Smoking Cessation", "lead_sponsor": "University of Southern California", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Yale University School of Medicine", "city": "New Haven", "state_or_region": "Connecticut", "postal_code": "06510", "country": "United States", "latitude": 41.30815, "longitude": -72.92816, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07602699" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Yale University School of Medicine", "city": "New Haven", "state_or_region": "Connecticut", "postal_code": "06520", "country": "United States", "latitude": 41.30815, "longitude": -72.92816, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Stamford", "state_or_region": "Connecticut", "postal_code": "06905", "country": "United States", "latitude": 41.05343, "longitude": -73.53873, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Stamford Therapeutics Consortium", "city": "Stamford", "state_or_region": "Connecticut", "postal_code": "06905", "country": "United States", "latitude": 41.05343, "longitude": -73.53873, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Nemours Children's Health - Delaware", "city": "Wilmington", "state_or_region": "Delaware", "postal_code": "19803", "country": "United States", "latitude": 39.74595, "longitude": -75.54659, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06691243", "study_title": "Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV", "lead_sponsor": "University of Maryland, Baltimore", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-08", "last_update_post_date": "2025-08-24", "facility": "Institute of Human Virology at the University of Maryland School of Medicine", "city": "Washington D.C.", "state_or_region": "District of Columbia", "postal_code": "20002", "country": "United States", "latitude": 38.89511, "longitude": -77.03637, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06691243" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "OMEGA Research Group", "city": "Altamonte Springs", "state_or_region": "Florida", "postal_code": "32714", "country": "United States", "latitude": 28.66111, "longitude": -81.36562, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Synergy Healthcare", "city": "Bradenton", "state_or_region": "Florida", "postal_code": "34209", "country": "United States", "latitude": 27.49893, "longitude": -82.57482, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Synergy Healthcare", "city": "Bradenton", "state_or_region": "Florida", "postal_code": "34209", "country": "United States", "latitude": 27.49893, "longitude": -82.57482, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Synergy Healthcare of Tampa", "city": "Brandon", "state_or_region": "Florida", "postal_code": "33511", "country": "United States", "latitude": 27.9378, "longitude": -82.28592, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Synergy Healthcare of Tampa", "city": "Brandon", "state_or_region": "Florida", "postal_code": "33511", "country": "United States", "latitude": 27.9378, "longitude": -82.28592, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Access research Institute", "city": "Brooksville", "state_or_region": "Florida", "postal_code": "34613", "country": "United States", "latitude": 28.55554, "longitude": -82.38991, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Access research Institute", "city": "Brooksville", "state_or_region": "Florida", "postal_code": "34613", "country": "United States", "latitude": 28.55554, "longitude": -82.38991, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research of West Florida, Inc.", "city": "Clearwater", "state_or_region": "Florida", "postal_code": "33765", "country": "United States", "latitude": 27.96585, "longitude": -82.8001, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tampa Bay Medical Research", "city": "Clearwater", "state_or_region": "Florida", "postal_code": "33761", "country": "United States", "latitude": 27.96585, "longitude": -82.8001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "TBMR & Alcanza", "city": "Clearwater", "state_or_region": "Florida", "postal_code": "33761", "country": "United States", "latitude": 27.96585, "longitude": -82.8001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "K2 Medical Research - Winter Garden", "city": "Clermont", "state_or_region": "Florida", "postal_code": "34711", "country": "United States", "latitude": 28.54944, "longitude": -81.77285, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "K2 Medical Research WINTER GARDEN", "city": "Clermont", "state_or_region": "Florida", "postal_code": "34711", "country": "United States", "latitude": 28.54944, "longitude": -81.77285, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hi Tech and Global Research, LLC", "city": "Coral Gables", "state_or_region": "Florida", "postal_code": "33134", "country": "United States", "latitude": 25.72149, "longitude": -80.26838, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Hi Tech and Global Research, LLC", "city": "Coral Gables", "state_or_region": "Florida", "postal_code": "33134", "country": "United States", "latitude": 25.72149, "longitude": -80.26838, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Crystal River", "state_or_region": "Florida", "postal_code": "34429", "country": "United States", "latitude": 28.90248, "longitude": -82.5926, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cenara Clinical Research", "city": "Cutler Bay", "state_or_region": "Florida", "postal_code": "33189", "country": "United States", "latitude": 25.5783, "longitude": -80.3377, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cenara Clinical Research", "city": "Cutler Bay", "state_or_region": "Florida", "postal_code": "33189", "country": "United States", "latitude": 25.5783, "longitude": -80.3377, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "K2 Medical Research - Daytona Beach", "city": "Daytona Beach", "state_or_region": "Florida", "postal_code": "32114", "country": "United States", "latitude": 29.21081, "longitude": -81.02283, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - Delray Beach", "city": "Delray Beach", "state_or_region": "Florida", "postal_code": "33484", "country": "United States", "latitude": 26.46146, "longitude": -80.07282, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "ERG Holding Company, LLC / Evolution Research Group, LLC", "city": "Delray Beach", "state_or_region": "Florida", "postal_code": "33445", "country": "United States", "latitude": 26.46146, "longitude": -80.07282, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AMR Clinical", "city": "Doral", "state_or_region": "Florida", "postal_code": "33172", "country": "United States", "latitude": 25.81954, "longitude": -80.35533, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "DM Clinical Research - MIA", "city": "Doral", "state_or_region": "Florida", "postal_code": "33166", "country": "United States", "latitude": 25.81954, "longitude": -80.35533, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "Universal Axon Clinical Research (Rovia - UACR)", "city": "Doral", "state_or_region": "Florida", "postal_code": "33166", "country": "United States", "latitude": 25.81954, "longitude": -80.35533, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Northeast Research Institute (NERI)", "city": "Fleming Island", "state_or_region": "Florida", "postal_code": "32003", "country": "United States", "latitude": 30.0933, "longitude": -81.71898, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Northeast Research Institute", "city": "Fleming Island", "state_or_region": "Florida", "postal_code": "32003", "country": "United States", "latitude": 30.0933, "longitude": -81.71898, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Northeast Research Institute", "city": "Fleming Island", "state_or_region": "Florida", "postal_code": "32003", "country": "United States", "latitude": 30.0933, "longitude": -81.71898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Northeast Research Institute", "city": "Fleming Island", "state_or_region": "Florida", "postal_code": "32003", "country": "United States", "latitude": 30.0933, "longitude": -81.71898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Northeast Research Institute", "city": "Fleming Island", "state_or_region": "Florida", "postal_code": "32003", "country": "United States", "latitude": 30.0933, "longitude": -81.71898, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC - Fort Myers", "city": "Fort Myers", "state_or_region": "Florida", "postal_code": "33912", "country": "United States", "latitude": 26.62168, "longitude": -81.84059, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC - Fort Myers", "city": "Fort Myers", "state_or_region": "Florida", "postal_code": "33912", "country": "United States", "latitude": 26.62168, "longitude": -81.84059, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC - Fort Myers", "city": "Fort Myers", "state_or_region": "Florida", "postal_code": "33912", "country": "United States", "latitude": 26.62168, "longitude": -81.84059, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "ERG Holding Company, LLC / Evolution Research Group, LLC", "city": "Fort Myers", "state_or_region": "Florida", "postal_code": "33192", "country": "United States", "latitude": 26.62168, "longitude": -81.84059, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southwest General Healthcare Center", "city": "Fort Myers", "state_or_region": "Florida", "postal_code": "33907", "country": "United States", "latitude": 26.62168, "longitude": -81.84059, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Florida College of Medicine", "city": "Gainesville", "state_or_region": "Florida", "postal_code": "32610", "country": "United States", "latitude": 29.65163, "longitude": -82.32483, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Florida", "city": "Gainesville", "state_or_region": "Florida", "postal_code": "32610", "country": "United States", "latitude": 29.65163, "longitude": -82.32483, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Evolution Clinical Trials", "city": "Hialeah Gardens", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.8651, "longitude": -80.3245, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Evolution Clinical Trials", "city": "Hialeah Gardens", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.8651, "longitude": -80.3245, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Neoclinical Research", "city": "Hialeah", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.8576, "longitude": -80.27811, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Neoclinical Research", "city": "Hialeah", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.8576, "longitude": -80.27811, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "NeoClinical Research", "city": "Hialeah", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.8576, "longitude": -80.27811, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Encore Medical Research LLC", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Encore Medical Research LLC", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Encore Medical Research LLC", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Encore Medical Research LLC", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Encore Medical Research LLC", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Encore Medical Research", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Encore Medical Research", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Encore Medical Research", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33021", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Skin Care Research", "city": "Hollywood", "state_or_region": "Florida", "postal_code": "33021", "country": "United States", "latitude": 26.0112, "longitude": -80.14949, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Global Research Associates", "city": "Homestead", "state_or_region": "Florida", "postal_code": "33030", "country": "United States", "latitude": 25.46872, "longitude": -80.47756, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Global Research Associates", "city": "Homestead", "state_or_region": "Florida", "postal_code": "33030", "country": "United States", "latitude": 25.46872, "longitude": -80.47756, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Nature Coast Clinical Research - Inverness", "city": "Inverness", "state_or_region": "Florida", "postal_code": "34452", "country": "United States", "latitude": 28.83582, "longitude": -82.33037, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Encore Borland-Groover Clinical Research", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32256", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "Gateway Community Services", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32204", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Jacksonville Ctr for Clin Res", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32216", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Jacksonville Ctr For Clin Res", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32216", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07218445", "study_title": "The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity", "lead_sponsor": "Mayo Clinic", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Mayo Clinic in Florida", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32224", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218445" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Northeast Research Institute", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32204", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Northeast Research Institute", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32204", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32209", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Westside Center For Clinical Research", "city": "Jacksonville", "state_or_region": "Florida", "postal_code": "32205", "country": "United States", "latitude": 30.33218, "longitude": -81.65565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Health Awareness", "city": "Jupiter", "state_or_region": "Florida", "postal_code": "33458", "country": "United States", "latitude": 26.93422, "longitude": -80.09421, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Vida Clinical Research", "city": "Kissimmee", "state_or_region": "Florida", "postal_code": "34741", "country": "United States", "latitude": 28.30468, "longitude": -81.41667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "K2 MEDICAL Research THE VILLAGES", "city": "Lady Lake", "state_or_region": "Florida", "postal_code": "32159", "country": "United States", "latitude": 28.91749, "longitude": -81.92286, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Lake Center for Clinical Research", "city": "Lady Lake", "state_or_region": "Florida", "postal_code": "32159", "country": "United States", "latitude": 28.91749, "longitude": -81.92286, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Lake Center for Clinical Research", "city": "Lady Lake", "state_or_region": "Florida", "postal_code": "32159", "country": "United States", "latitude": 28.91749, "longitude": -81.92286, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Accel Research Sites - Lakeland", "city": "Lakeland", "state_or_region": "Florida", "postal_code": "33803", "country": "United States", "latitude": 28.03947, "longitude": -81.9498, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research of Central Florida - Lakeland", "city": "Lakeland", "state_or_region": "Florida", "postal_code": "33805", "country": "United States", "latitude": 28.03947, "longitude": -81.9498, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Florida Research Institute", "city": "Lakewood Rch", "state_or_region": "Florida", "postal_code": "34211", "country": "United States", "latitude": 27.3863, "longitude": -82.4332, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Florida Research Institute", "city": "Lakewood Rch", "state_or_region": "Florida", "postal_code": "34211", "country": "United States", "latitude": 27.3863, "longitude": -82.4332, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tampa Bay Medical Research - Largo", "city": "Largo", "state_or_region": "Florida", "postal_code": "33777", "country": "United States", "latitude": 27.90979, "longitude": -82.78842, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tampa Bay Medical Research - Largo", "city": "Largo", "state_or_region": "Florida", "postal_code": "33777", "country": "United States", "latitude": 27.90979, "longitude": -82.78842, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Leesburg", "state_or_region": "Florida", "postal_code": "34748", "country": "United States", "latitude": 28.81082, "longitude": -81.87786, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "K2 Medical Research", "city": "Maitland", "state_or_region": "Florida", "postal_code": "32751", "country": "United States", "latitude": 28.62778, "longitude": -81.36312, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Life Clinical Trials", "city": "Margate", "state_or_region": "Florida", "postal_code": "33063", "country": "United States", "latitude": 26.24453, "longitude": -80.20644, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "CZ Rheumatology", "city": "Miami Beach", "state_or_region": "Florida", "postal_code": "33140", "country": "United States", "latitude": 25.79065, "longitude": -80.13005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Floridian Clinical Research, LLC", "city": "Miami Lakes", "state_or_region": "Florida", "postal_code": "33016-1518", "country": "United States", "latitude": 25.90871, "longitude": -80.30866, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Floridian Clinical Research", "city": "Miami Lakes", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.90871, "longitude": -80.30866, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Floridian Clinical Research", "city": "Miami Lakes", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.90871, "longitude": -80.30866, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Indago Research & Health Center, Inc", "city": "Miami Lakes", "state_or_region": "Florida", "postal_code": "33016", "country": "United States", "latitude": 25.90871, "longitude": -80.30866, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Bioclinical Research Alliance", "city": "Miami", "state_or_region": "Florida", "postal_code": "33155", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Bioclinical Research Alliance", "city": "Miami", "state_or_region": "Florida", "postal_code": "33155", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "BioMed Research & Medical Center", "city": "Miami", "state_or_region": "Florida", "postal_code": "33156", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "BioMed Research & Medical Center", "city": "Miami", "state_or_region": "Florida", "postal_code": "33156", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ECIR Miami Holdings LLC dba IMIC", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ECIR Miami Holdings LLC dba IMIC", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Entrust Clinical Research", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Entrust Clinical Research", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Evolution Clinical Trials", "city": "Miami", "state_or_region": "Florida", "postal_code": "33122-1722", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro Health Research - Miami", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro Health Research - Miami", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "IMIC Research a Rovia Clinical Research Company", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MplusM - Century Research", "city": "Miami", "state_or_region": "Florida", "postal_code": "33173", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New Horizon Research Center-Miami-69732", "city": "Miami", "state_or_region": "Florida", "postal_code": "33165", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "New Horizon Research Center", "city": "Miami", "state_or_region": "Florida", "postal_code": "33165", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "New Horizon Research Center", "city": "Miami", "state_or_region": "Florida", "postal_code": "33165", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Optimus U Corporation-Miami-69452", "city": "Miami", "state_or_region": "Florida", "postal_code": "33135", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Optimus U Corporation-Miami-69452", "city": "Miami", "state_or_region": "Florida", "postal_code": "33135", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "Paramo Health", "city": "Miami", "state_or_region": "Florida", "postal_code": "33175", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "Paramo Health", "city": "Miami", "state_or_region": "Florida", "postal_code": "33176", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Associates of South Florida - Miami - Southwest 8th Street", "city": "Miami", "state_or_region": "Florida", "postal_code": "33134", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Associates of South Florida - Miami - Southwest 8th Street", "city": "Miami", "state_or_region": "Florida", "postal_code": "33134", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Associates of South Florida, LLC", "city": "Miami", "state_or_region": "Florida", "postal_code": "33134", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Associates of South Florida, LLC", "city": "Miami", "state_or_region": "Florida", "postal_code": "33134", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Schiff Center Liver Diseases", "city": "Miami", "state_or_region": "Florida", "postal_code": "33136", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Schiff Center Liver Diseases", "city": "Miami", "state_or_region": "Florida", "postal_code": "33136", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06774079", "study_title": "Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients", "lead_sponsor": "University of Miami", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-30", "facility": "University of Miami", "city": "Miami", "state_or_region": "Florida", "postal_code": "33136", "country": "United States", "latitude": 25.77427, "longitude": -80.19366, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06774079" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "South Broward Research LLC", "city": "Miramar", "state_or_region": "Florida", "postal_code": "33027", "country": "United States", "latitude": 25.98731, "longitude": -80.23227, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "South Broward Research LLC", "city": "Miramar", "state_or_region": "Florida", "postal_code": "33027", "country": "United States", "latitude": 25.98731, "longitude": -80.23227, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "South Broward Research LLC", "city": "Miramar", "state_or_region": "Florida", "postal_code": "33027", "country": "United States", "latitude": 25.98731, "longitude": -80.23227, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "South Broward Research LLC", "city": "Miramar", "state_or_region": "Florida", "postal_code": "33027", "country": "United States", "latitude": 25.98731, "longitude": -80.23227, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Broward Research", "city": "Miramar", "state_or_region": "Florida", "postal_code": "33027", "country": "United States", "latitude": 25.98731, "longitude": -80.23227, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Pros Research", "city": "Naples", "state_or_region": "Florida", "postal_code": "34102", "country": "United States", "latitude": 26.14234, "longitude": -81.79596, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI PROS Research", "city": "Naples", "state_or_region": "Florida", "postal_code": "34102", "country": "United States", "latitude": 26.14234, "longitude": -81.79596, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Advanced Research Institute", "city": "New Port Richey", "state_or_region": "Florida", "postal_code": "34653", "country": "United States", "latitude": 28.24418, "longitude": -82.71927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Suncoast Clinical Research, Inc.", "city": "New Port Richey", "state_or_region": "Florida", "postal_code": "34652", "country": "United States", "latitude": 28.24418, "longitude": -82.71927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "West Orange Endocrinology", "city": "Ocoee", "state_or_region": "Florida", "postal_code": "34761", "country": "United States", "latitude": 28.56917, "longitude": -81.54396, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "West Orange Endocrinology", "city": "Ocoee", "state_or_region": "Florida", "postal_code": "34761", "country": "United States", "latitude": 28.56917, "longitude": -81.54396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "West Orange Endocrinology", "city": "Ocoee", "state_or_region": "Florida", "postal_code": "34761", "country": "United States", "latitude": 28.56917, "longitude": -81.54396, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Orange City", "state_or_region": "Florida", "postal_code": "32763", "country": "United States", "latitude": 28.94888, "longitude": -81.29867, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07184086", "study_title": "A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2025-10", "last_update_post_date": "2025-10-08", "facility": "Advent Health-Res Inst", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32804", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07184086" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charter Research - Orlando", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32803", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Charter Research - Winter Park", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32803", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charter Research", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32803", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charter Research", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32803", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Digestive and Liver Center of Florida", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32825", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Digestive and Liver Center of Florida", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32825", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Endoscopic Research, Inc", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32828", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Endoscopic Research, Inc", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32828", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Headlands Research Orlando", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32806", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "K2 Medical Research", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32806", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "TERMINATED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "OMEGA Research Group", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32808", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Orlando Health", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32806", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Orlando Health", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32806", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Orlando VA Healthcare System, Orlando, FL", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32827", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Orlando", "state_or_region": "Florida", "postal_code": "32806", "country": "United States", "latitude": 28.53834, "longitude": -81.37924, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Oviedo Medical Research, LLC", "city": "Oviedo", "state_or_region": "Florida", "postal_code": "32765", "country": "United States", "latitude": 28.67, "longitude": -81.20812, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Vitalia Medical Research", "city": "Palm Beach Gardens", "state_or_region": "Florida", "postal_code": "33410", "country": "United States", "latitude": 26.82339, "longitude": -80.13865, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Innovation Medical Research Center", "city": "Palmetto Bay", "state_or_region": "Florida", "postal_code": "33157", "country": "United States", "latitude": 25.62177, "longitude": -80.32477, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Innovation Medical Research Center", "city": "Palmetto Bay", "state_or_region": "Florida", "postal_code": "33157", "country": "United States", "latitude": 25.62177, "longitude": -80.32477, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Center for Diab,Obes & Metab", "city": "Pembroke Pines", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.00315, "longitude": -80.22394, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Trial Services Corp", "city": "Pembroke Pines", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.00315, "longitude": -80.22394, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MplusM - Best Choice Medical and Research Service", "city": "Pembroke Pines", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.00315, "longitude": -80.22394, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MplusM - Best Choice Medical and Research Service", "city": "Pembroke Pines", "state_or_region": "Florida", "postal_code": "33024", "country": "United States", "latitude": 26.00315, "longitude": -80.22394, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro Health Research - Pensacola", "city": "Pensacola", "state_or_region": "Florida", "postal_code": "32504", "country": "United States", "latitude": 30.42131, "longitude": -87.21691, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro Health Research - Pensacola", "city": "Pensacola", "state_or_region": "Florida", "postal_code": "32504", "country": "United States", "latitude": 30.42131, "longitude": -87.21691, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Progressive Medical Research", "city": "Port Orange", "state_or_region": "Florida", "postal_code": "32127", "country": "United States", "latitude": 29.13832, "longitude": -80.99561, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Progressive Medical Research", "city": "Port Orange", "state_or_region": "Florida", "postal_code": "32127", "country": "United States", "latitude": 29.13832, "longitude": -80.99561, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialist, LLC - Riverview", "city": "Riverview", "state_or_region": "Florida", "postal_code": "33578", "country": "United States", "latitude": 27.86614, "longitude": -82.32648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialist, LLC - Riverview", "city": "Riverview", "state_or_region": "Florida", "postal_code": "33578", "country": "United States", "latitude": 27.86614, "longitude": -82.32648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists - Riverview", "city": "Riverview", "state_or_region": "Florida", "postal_code": "33578", "country": "United States", "latitude": 27.86614, "longitude": -82.32648, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC - Brandon", "city": "Riverview", "state_or_region": "Florida", "postal_code": "33578", "country": "United States", "latitude": 27.86614, "longitude": -82.32648, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Northeast Research Institute", "city": "Saint Augustine", "state_or_region": "Florida", "postal_code": "32080", "country": "United States", "latitude": 29.89469, "longitude": -81.31452, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - St. Petersburg", "city": "St. Petersburg", "state_or_region": "Florida", "postal_code": "33710", "country": "United States", "latitude": 27.77086, "longitude": -82.67927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Global Clinical Professionals", "city": "St. Petersburg", "state_or_region": "Florida", "postal_code": "33714", "country": "United States", "latitude": 27.77086, "longitude": -82.67927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Global Clinical Professionals", "city": "St. Petersburg", "state_or_region": "Florida", "postal_code": "33714", "country": "United States", "latitude": 27.77086, "longitude": -82.67927, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Precision Clinical Research", "city": "Sunrise", "state_or_region": "Florida", "postal_code": "33351", "country": "United States", "latitude": 26.13397, "longitude": -80.1131, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Precision Clinical Research", "city": "Sunrise", "state_or_region": "Florida", "postal_code": "33351", "country": "United States", "latitude": 26.13397, "longitude": -80.1131, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - Tamarac", "city": "Tamarac", "state_or_region": "Florida", "postal_code": "33321", "country": "United States", "latitude": 26.21286, "longitude": -80.24977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "IBIS Behavioral Health", "city": "Tampa", "state_or_region": "Florida", "postal_code": "33605", "country": "United States", "latitude": 27.94752, "longitude": -82.45843, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "International Center for Research", "city": "Tampa", "state_or_region": "Florida", "postal_code": "33614", "country": "United States", "latitude": 27.94752, "longitude": -82.45843, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "International Center for Research", "city": "Tampa", "state_or_region": "Florida", "postal_code": "33618", "country": "United States", "latitude": 27.94752, "longitude": -82.45843, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "International Center for Research", "city": "Tampa", "state_or_region": "Florida", "postal_code": "33618", "country": "United States", "latitude": 27.94752, "longitude": -82.45843, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Jedidiah Clinical Research", "city": "Tampa", "state_or_region": "Florida", "postal_code": "33619", "country": "United States", "latitude": 27.94752, "longitude": -82.45843, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research", "city": "Tampa", "state_or_region": "Florida", "postal_code": "33607", "country": "United States", "latitude": 27.94752, "longitude": -82.45843, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Charter Research - Lady Lake", "city": "The Villages", "state_or_region": "Florida", "postal_code": "32162", "country": "United States", "latitude": 28.93408, "longitude": -81.95994, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charter Research", "city": "The Villages", "state_or_region": "Florida", "postal_code": "32162", "country": "United States", "latitude": 28.93408, "longitude": -81.95994, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Charter Research", "city": "The Villages", "state_or_region": "Florida", "postal_code": "32162", "country": "United States", "latitude": 28.93408, "longitude": -81.95994, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC - Sarasota", "city": "University Park", "state_or_region": "Florida", "postal_code": "34201", "country": "United States", "latitude": 25.74649, "longitude": -80.36755, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC - University Park", "city": "University Park", "state_or_region": "Florida", "postal_code": "34201", "country": "United States", "latitude": 25.74649, "longitude": -80.36755, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC - University Park", "city": "University Park", "state_or_region": "Florida", "postal_code": "34201", "country": "United States", "latitude": 25.74649, "longitude": -80.36755, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Covenant Metabolic Specialists, LLC", "city": "University Park", "state_or_region": "Florida", "postal_code": "34201", "country": "United States", "latitude": 25.74649, "longitude": -80.36755, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "TruDerm & TruSpa", "city": "Wellington", "state_or_region": "Florida", "postal_code": "33449", "country": "United States", "latitude": 26.65868, "longitude": -80.24144, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Metabolic Research Institute, Inc.", "city": "West Palm Beach", "state_or_region": "Florida", "postal_code": "33401", "country": "United States", "latitude": 26.71534, "longitude": -80.05337, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Encore Medical Research - Weston", "city": "Weston", "state_or_region": "Florida", "postal_code": "33331", "country": "United States", "latitude": 26.10037, "longitude": -80.39977, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Encore Medical Research of Weston", "city": "Weston", "state_or_region": "Florida", "postal_code": "33331", "country": "United States", "latitude": 26.10037, "longitude": -80.39977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Encore Medical Research of Weston", "city": "Weston", "state_or_region": "Florida", "postal_code": "33331", "country": "United States", "latitude": 26.10037, "longitude": -80.39977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Encore Medical Research of Weston", "city": "Weston", "state_or_region": "Florida", "postal_code": "33331", "country": "United States", "latitude": 26.10037, "longitude": -80.39977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Encore Medical Research of Weston", "city": "Weston", "state_or_region": "Florida", "postal_code": "33331", "country": "United States", "latitude": 26.10037, "longitude": -80.39977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Clinical Research of Cent FL", "city": "Winter Haven", "state_or_region": "Florida", "postal_code": "33880", "country": "United States", "latitude": 28.02224, "longitude": -81.73286, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Conquest Research", "city": "Winter Park", "state_or_region": "Florida", "postal_code": "32789", "country": "United States", "latitude": 28.6, "longitude": -81.33924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Conquest Research", "city": "Winter Park", "state_or_region": "Florida", "postal_code": "32789", "country": "United States", "latitude": 28.6, "longitude": -81.33924, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Conquest Research", "city": "Winter Park", "state_or_region": "Florida", "postal_code": "32789", "country": "United States", "latitude": 28.6, "longitude": -81.33924, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Florida Medical Clinic, P.A.", "city": "Zephyrhills", "state_or_region": "Florida", "postal_code": "33542", "country": "United States", "latitude": 28.23362, "longitude": -82.18119, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Florida Medical Clinic, P.A.", "city": "Zephyrhills", "state_or_region": "Florida", "postal_code": "33542", "country": "United States", "latitude": 28.23362, "longitude": -82.18119, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Albany", "state_or_region": "Georgia", "postal_code": "31707", "country": "United States", "latitude": 31.57851, "longitude": -84.15574, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Children's Healthcare Atlanta", "city": "Atlanta", "state_or_region": "Georgia", "postal_code": "30329", "country": "United States", "latitude": 33.749, "longitude": -84.38798, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07428746", "study_title": "Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes", "lead_sponsor": "Emory University", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-08-03", "facility": "Grady Memorial Hospital", "city": "Atlanta", "state_or_region": "Georgia", "postal_code": "30303", "country": "United States", "latitude": 33.749, "longitude": -84.38798, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07428746" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Piedmont Hospital", "city": "Atlanta", "state_or_region": "Georgia", "postal_code": "30309", "country": "United States", "latitude": 33.749, "longitude": -84.38798, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "UD Research", "city": "Atlanta", "state_or_region": "Georgia", "postal_code": "30342", "country": "United States", "latitude": 33.749, "longitude": -84.38798, "site_statuses": "WITHDRAWN", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centricity Research, Endocrine Consultants", "city": "Columbus", "state_or_region": "Georgia", "postal_code": "31904", "country": "United States", "latitude": 32.46098, "longitude": -84.98771, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Columbus Research Foundation", "city": "Columbus", "state_or_region": "Georgia", "postal_code": "31904", "country": "United States", "latitude": 32.46098, "longitude": -84.98771, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hope Clin Res & Wellness", "city": "Conyers", "state_or_region": "Georgia", "postal_code": "30094", "country": "United States", "latitude": 33.66761, "longitude": -84.01769, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southeast Clinical Research Center", "city": "Dalton", "state_or_region": "Georgia", "postal_code": "30720", "country": "United States", "latitude": 34.7698, "longitude": -84.97022, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Accel Research Sites-NeuroStudies", "city": "Decatur", "state_or_region": "Georgia", "postal_code": "30030", "country": "United States", "latitude": 33.77483, "longitude": -84.29631, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Atlanta VA Medical and Rehab Center, Decatur, GA", "city": "Decatur", "state_or_region": "Georgia", "postal_code": "30033-4004", "country": "United States", "latitude": 33.77483, "longitude": -84.29631, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07040592", "study_title": "Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide", "lead_sponsor": "Yale University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-24", "facility": "Atlanta VA Medical Center", "city": "Decatur", "state_or_region": "Georgia", "postal_code": "30033", "country": "United States", "latitude": 33.77483, "longitude": -84.29631, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07040592" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Southeast Research Specialists", "city": "Douglasville", "state_or_region": "Georgia", "postal_code": "30135", "country": "United States", "latitude": 33.7515, "longitude": -84.74771, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Javara-Fayetteville-67354", "city": "Fayetteville", "state_or_region": "Georgia", "postal_code": "30214", "country": "United States", "latitude": 33.44873, "longitude": -84.45493, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Center for Adv Res & Education", "city": "Gainesville", "state_or_region": "Georgia", "postal_code": "30501", "country": "United States", "latitude": 34.29788, "longitude": -83.82407, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Balanced Life Health Care Solutions", "city": "Lawrenceville", "state_or_region": "Georgia", "postal_code": "30046", "country": "United States", "latitude": 33.95621, "longitude": -83.98796, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Teak Research Consults", "city": "Lawrenceville", "state_or_region": "Georgia", "postal_code": "30043", "country": "United States", "latitude": 33.95621, "longitude": -83.98796, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Lilburn", "state_or_region": "Georgia", "postal_code": "30047", "country": "United States", "latitude": 33.8901, "longitude": -84.14297, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Associates of Central Georgia", "city": "Macon", "state_or_region": "Georgia", "postal_code": "31201", "country": "United States", "latitude": 32.84069, "longitude": -83.6324, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Associates of Central Georgia", "city": "Macon", "state_or_region": "Georgia", "postal_code": "31201", "country": "United States", "latitude": 32.84069, "longitude": -83.6324, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Atlanta Research Center for Rheumatology", "city": "Marietta", "state_or_region": "Georgia", "postal_code": "30060", "country": "United States", "latitude": 33.9526, "longitude": -84.54993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastrointestinal Specialists of Georgia", "city": "Marietta", "state_or_region": "Georgia", "postal_code": "30060", "country": "United States", "latitude": 33.9526, "longitude": -84.54993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EmVenio Research Center at Prime Healthcare - Riverdale", "city": "Riverdale", "state_or_region": "Georgia", "postal_code": "30274", "country": "United States", "latitude": 33.57261, "longitude": -84.41326, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EmVenio Research Center at Prime Healthcare - Riverdale", "city": "Riverdale", "state_or_region": "Georgia", "postal_code": "30274", "country": "United States", "latitude": 33.57261, "longitude": -84.41326, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Endocrine Research Solutions, Inc", "city": "Roswell", "state_or_region": "Georgia", "postal_code": "30076", "country": "United States", "latitude": 34.02316, "longitude": -84.36159, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Eastside Bariatric and Gen Surg", "city": "Snellville", "state_or_region": "Georgia", "postal_code": "30078", "country": "United States", "latitude": 33.85733, "longitude": -84.01991, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rophe Adult and Pediatric Medicine/SKYCRNG", "city": "Union City", "state_or_region": "Georgia", "postal_code": "30291", "country": "United States", "latitude": 33.58706, "longitude": -84.54243, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rophe Adult and Pediatric Medicine", "city": "Union City", "state_or_region": "Georgia", "postal_code": "30291", "country": "United States", "latitude": 33.58706, "longitude": -84.54243, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Satilla Rheumatology & Internal Medicine", "city": "Waycross", "state_or_region": "Georgia", "postal_code": "31501", "country": "United States", "latitude": 31.21368, "longitude": -82.3557, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "North Georgia Clinical Research", "city": "Woodstock", "state_or_region": "Georgia", "postal_code": "30189-4255", "country": "United States", "latitude": 34.10149, "longitude": -84.51938, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "East West Med Res Inst", "city": "Honolulu", "state_or_region": "Hawaii", "postal_code": "96814", "country": "United States", "latitude": 21.30694, "longitude": -157.85833, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Pacific Diabetes & Endocrine Center", "city": "Honolulu", "state_or_region": "Hawaii", "postal_code": "96817", "country": "United States", "latitude": 21.30694, "longitude": -157.85833, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pacific Diabetes & Endocrine Center", "city": "Honolulu", "state_or_region": "Hawaii", "postal_code": "96817", "country": "United States", "latitude": 21.30694, "longitude": -157.85833, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Medical Research Partners", "city": "Ammon", "state_or_region": "Idaho", "postal_code": "83406", "country": "United States", "latitude": 43.46964, "longitude": -111.96664, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Medical Research Partners", "city": "Ammon", "state_or_region": "Idaho", "postal_code": "83406", "country": "United States", "latitude": 43.46964, "longitude": -111.96664, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Elite Clinical Trials - Blackfoot", "city": "Blackfoot", "state_or_region": "Idaho", "postal_code": "83221", "country": "United States", "latitude": 43.19047, "longitude": -112.34498, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Elite Clinical Trials", "city": "Blackfoot", "state_or_region": "Idaho", "postal_code": "83221", "country": "United States", "latitude": 43.19047, "longitude": -112.34498, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Family First Clinical Research", "city": "Idaho Falls", "state_or_region": "Idaho", "postal_code": "83404", "country": "United States", "latitude": 43.46658, "longitude": -112.03414, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Grand Teton Research Group", "city": "Idaho Falls", "state_or_region": "Idaho", "postal_code": "83404", "country": "United States", "latitude": 43.46658, "longitude": -112.03414, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Grand Teton Research Group", "city": "Idaho Falls", "state_or_region": "Idaho", "postal_code": "83404", "country": "United States", "latitude": 43.46658, "longitude": -112.03414, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Idaho Falls", "state_or_region": "Idaho", "postal_code": "83404", "country": "United States", "latitude": 43.46658, "longitude": -112.03414, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Solaris Clinical Research", "city": "Meridian", "state_or_region": "Idaho", "postal_code": "83646", "country": "United States", "latitude": 43.61211, "longitude": -116.39151, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Solaris Clinical Research", "city": "Meridian", "state_or_region": "Idaho", "postal_code": "83646", "country": "United States", "latitude": 43.61211, "longitude": -116.39151, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Solaris Clinical Research", "city": "Meridian", "state_or_region": "Idaho", "postal_code": "83646", "country": "United States", "latitude": 43.61211, "longitude": -116.39151, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Ann & Robert H. Lurie Children's Hospital of Chicago", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60611", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Cedar-Crosse Research Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60607", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Cedar-Crosse Research Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60607", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Cedar-Crosse Research Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60607", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Great Lakes Clinical Trials - Ravenswood", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60640", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "ACTIVE_NOT_RECRUITING; RECRUITING", "status_conflict": true, "source_location_rows": 2, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Great Lakes Clinical Trials - Ravenswood", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60640", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Great Lakes Clinical Trials", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60640", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60640", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06734273", "study_title": "Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss", "lead_sponsor": "Nicholas Skertich", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-08", "facility": "Rush University Medical Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60612", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06734273" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rush University Medical Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60612", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Rush University Medical Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60612", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "Ruth M. Rothstein CORE Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60612", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Chicago Medical Center", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60637", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07602699", "study_title": "Multi-Site Trial of Tirzepatide for Smoking Cessation", "lead_sponsor": "University of Southern California", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "University of Chicago Pritzker School of Medicine", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60637", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07602699" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06499857", "study_title": "Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation", "lead_sponsor": "University of Chicago", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-14", "facility": "University of Chicago", "city": "Chicago", "state_or_region": "Illinois", "postal_code": "60637", "country": "United States", "latitude": 41.85003, "longitude": -87.65005, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06499857" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Macoupin Fam Practice Ctr, LLP", "city": "Gillespie", "state_or_region": "Illinois", "postal_code": "62033", "country": "United States", "latitude": 39.12977, "longitude": -89.81954, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Investigation Spec Gurnee", "city": "Gurnee", "state_or_region": "Illinois", "postal_code": "60031", "country": "United States", "latitude": 42.3703, "longitude": -87.90202, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Edward Hines Jr. VA Hospital, Hines, IL", "city": "Hines", "state_or_region": "Illinois", "postal_code": "60141-3030", "country": "United States", "latitude": 41.85364, "longitude": -87.8395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Melrose Park", "state_or_region": "Illinois", "postal_code": "60160", "country": "United States", "latitude": 41.90059, "longitude": -87.85673, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Greater Chicago Specialty Physicians", "city": "Schaumburg", "state_or_region": "Illinois", "postal_code": "60195", "country": "United States", "latitude": 42.03336, "longitude": -88.08341, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Arnold Arthritis & Rheumatology", "city": "Skokie", "state_or_region": "Illinois", "postal_code": "60076", "country": "United States", "latitude": 42.03336, "longitude": -87.73339, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Endeavor Health", "city": "Skokie", "state_or_region": "Illinois", "postal_code": "60077", "country": "United States", "latitude": 42.03336, "longitude": -87.73339, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Endeavor Health", "city": "Skokie", "state_or_region": "Illinois", "postal_code": "60077", "country": "United States", "latitude": 42.03336, "longitude": -87.73339, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Evanston Premier Healthcare Research LLC", "city": "Skokie", "state_or_region": "Illinois", "postal_code": "60077", "country": "United States", "latitude": 42.03336, "longitude": -87.73339, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Evanston Premier Hlthcr Res", "city": "Skokie", "state_or_region": "Illinois", "postal_code": "60077", "country": "United States", "latitude": 42.03336, "longitude": -87.73339, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Skokie", "state_or_region": "Illinois", "postal_code": "60077", "country": "United States", "latitude": 42.03336, "longitude": -87.73339, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "NorthShore University Health System", "city": "Skokie", "state_or_region": "Illinois", "postal_code": "60077", "country": "United States", "latitude": 42.03336, "longitude": -87.73339, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Willow Rheumatology and Wellness PLLC", "city": "Willowbrook", "state_or_region": "Illinois", "postal_code": "60527", "country": "United States", "latitude": 41.76975, "longitude": -87.93589, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Evansville", "state_or_region": "Indiana", "postal_code": "47710", "country": "United States", "latitude": 37.97476, "longitude": -87.55585, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ASHA Clinical Research - Munster, LLC", "city": "Hammond", "state_or_region": "Indiana", "postal_code": "46324", "country": "United States", "latitude": 41.58337, "longitude": -87.50004, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ASHA Clinical Research - Munster, LLC", "city": "Hammond", "state_or_region": "Indiana", "postal_code": "46324", "country": "United States", "latitude": 41.58337, "longitude": -87.50004, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Dawes Fretzin Clinical Research Group, LLC", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46250", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Indiana University Health University Hospital", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46202", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Indiana University Health University Hospital", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46202", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Indiana University Health University Hospital", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46202", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Indiana University Health University Hospital", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46202", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "IU Health - Riley Physicians Endo-Diab", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46202", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Midwest Inst For Clin Res", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46260", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Midwest Inst For Clin Res", "city": "Indianapolis", "state_or_region": "Indiana", "postal_code": "46260", "country": "United States", "latitude": 39.76838, "longitude": -86.15804, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Health Partners", "city": "New Albany", "state_or_region": "Indiana", "postal_code": "47150", "country": "United States", "latitude": 38.28562, "longitude": -85.82413, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Health Partners", "city": "New Albany", "state_or_region": "Indiana", "postal_code": "47150", "country": "United States", "latitude": 38.28562, "longitude": -85.82413, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Health Partners", "city": "New Albany", "state_or_region": "Indiana", "postal_code": "47150", "country": "United States", "latitude": 38.28562, "longitude": -85.82413, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Lake Cumberland Rheumatology", "city": "New Albany", "state_or_region": "Indiana", "postal_code": "47150", "country": "United States", "latitude": 38.28562, "longitude": -85.82413, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Deaconess Clinic- Gateway", "city": "Newburgh", "state_or_region": "Indiana", "postal_code": "47630", "country": "United States", "latitude": 37.94449, "longitude": -87.40529, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "The Indiana Clinical Trials Center, PC", "city": "Plainfield", "state_or_region": "Indiana", "postal_code": "46168", "country": "United States", "latitude": 39.70421, "longitude": -86.39944, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Digestive Research Alliance of Michiana", "city": "South Bend", "state_or_region": "Indiana", "postal_code": "46635", "country": "United States", "latitude": 41.68338, "longitude": -86.25001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Digestive Research Alliance of Michiana", "city": "South Bend", "state_or_region": "Indiana", "postal_code": "46635", "country": "United States", "latitude": 41.68338, "longitude": -86.25001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Digestive Research Alliance of Michiana", "city": "South Bend", "state_or_region": "Indiana", "postal_code": "46635", "country": "United States", "latitude": 41.68338, "longitude": -86.25001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Velocity Clin. Res Valparaiso", "city": "Valparaiso", "state_or_region": "Indiana", "postal_code": "46383", "country": "United States", "latitude": 41.47309, "longitude": -87.06114, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Ames", "state_or_region": "Iowa", "postal_code": "50010", "country": "United States", "latitude": 42.03471, "longitude": -93.61994, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Iowa Digestive Disease Center", "city": "Clive", "state_or_region": "Iowa", "postal_code": "50325", "country": "United States", "latitude": 41.60304, "longitude": -93.72411, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Iowa Diabetes and Endocrinology Research Center", "city": "West Des Moines", "state_or_region": "Iowa", "postal_code": "50265", "country": "United States", "latitude": 41.57721, "longitude": -93.71133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Iowa Diabetes and Endocrinology Research Center", "city": "West Des Moines", "state_or_region": "Iowa", "postal_code": "50265", "country": "United States", "latitude": 41.57721, "longitude": -93.71133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Iowa Diabetes and Endocrinology Research Center", "city": "West Des Moines", "state_or_region": "Iowa", "postal_code": "50266", "country": "United States", "latitude": 41.57721, "longitude": -93.71133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Iowa Diabetes and Endocrinology Research Center", "city": "West Des Moines", "state_or_region": "Iowa", "postal_code": "50266", "country": "United States", "latitude": 41.57721, "longitude": -93.71133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Iowa Diabetes Research", "city": "West Des Moines", "state_or_region": "Iowa", "postal_code": "50266", "country": "United States", "latitude": 41.57721, "longitude": -93.71133, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AMR Clinical", "city": "El Dorado", "state_or_region": "Kansas", "postal_code": "67042", "country": "United States", "latitude": 37.81724, "longitude": -96.86225, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Kansas Medical Center", "city": "Kansas City", "state_or_region": "Kansas", "postal_code": "66160", "country": "United States", "latitude": 39.11417, "longitude": -94.62746, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Johnson County Clinical Trials", "city": "Lenexa", "state_or_region": "Kansas", "postal_code": "66219", "country": "United States", "latitude": 38.95362, "longitude": -94.73357, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Alliance for Multispecialty Research", "city": "Newton", "state_or_region": "Kansas", "postal_code": "67114", "country": "United States", "latitude": 38.04668, "longitude": -97.34504, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Newton", "state_or_region": "Kansas", "postal_code": "67114", "country": "United States", "latitude": 38.04668, "longitude": -97.34504, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Cotton O'Neil Clinical Research Center", "city": "Topeka", "state_or_region": "Kansas", "postal_code": "66606", "country": "United States", "latitude": 39.04833, "longitude": -95.67804, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Cotton O'Neil Diab & Endo Ctr", "city": "Topeka", "state_or_region": "Kansas", "postal_code": "66606", "country": "United States", "latitude": 39.04833, "longitude": -95.67804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Cotton O'Neil Diabetes & Endocrinology", "city": "Topeka", "state_or_region": "Kansas", "postal_code": "66606", "country": "United States", "latitude": 39.04833, "longitude": -95.67804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Cotton O'Neil Diabetes & Endocrinology", "city": "Topeka", "state_or_region": "Kansas", "postal_code": "66606", "country": "United States", "latitude": 39.04833, "longitude": -95.67804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cotton O'Neil Digestive Health Center", "city": "Topeka", "state_or_region": "Kansas", "postal_code": "66606", "country": "United States", "latitude": 39.04833, "longitude": -95.67804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cotton O'Neil Mulvane", "city": "Topeka", "state_or_region": "Kansas", "postal_code": "66606", "country": "United States", "latitude": 39.04833, "longitude": -95.67804, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kansas Medical Clinic PA", "city": "Topeka", "state_or_region": "Kansas", "postal_code": "66606-1707", "country": "United States", "latitude": 39.04833, "longitude": -95.67804, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Wichita", "state_or_region": "Kansas", "postal_code": "67226", "country": "United States", "latitude": 37.69224, "longitude": -97.33754, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Equity Medical - Bowling Green", "city": "Bowling Green", "state_or_region": "Kentucky", "postal_code": "42104", "country": "United States", "latitude": 36.99032, "longitude": -86.4436, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bowling Green", "state_or_region": "Kentucky", "postal_code": "42101", "country": "United States", "latitude": 36.99032, "longitude": -86.4436, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AMR Clinical", "city": "Lexington", "state_or_region": "Kentucky", "postal_code": "40509", "country": "United States", "latitude": 37.98869, "longitude": -84.47772, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AMR Lexington", "city": "Lexington", "state_or_region": "Kentucky", "postal_code": "40509", "country": "United States", "latitude": 37.98869, "longitude": -84.47772, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "The Research Group of Lexington LLC", "city": "Lexington", "state_or_region": "Kentucky", "postal_code": "40503", "country": "United States", "latitude": 37.98869, "longitude": -84.47772, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06721507", "study_title": "2024 Tirzepatide-Bariatric Surgery", "lead_sponsor": "Marlene Starr", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-14", "facility": "University of Kentucky", "city": "Lexington", "state_or_region": "Kentucky", "postal_code": "40506", "country": "United States", "latitude": 37.98869, "longitude": -84.47772, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06721507" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Health Partners", "city": "Louisville", "state_or_region": "Kentucky", "postal_code": "40218", "country": "United States", "latitude": 38.25424, "longitude": -85.75941, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Health Partners", "city": "Louisville", "state_or_region": "Kentucky", "postal_code": "40218", "country": "United States", "latitude": 38.25424, "longitude": -85.75941, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "L-MARC Research Center", "city": "Louisville", "state_or_region": "Kentucky", "postal_code": "40213", "country": "United States", "latitude": 38.25424, "longitude": -85.75941, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "L-MARC Research Center", "city": "Louisville", "state_or_region": "Kentucky", "postal_code": "40213", "country": "United States", "latitude": 38.25424, "longitude": -85.75941, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Monroe Biomedical Research - Louisville", "city": "Louisville", "state_or_region": "Kentucky", "postal_code": "40213", "country": "United States", "latitude": 38.25424, "longitude": -85.75941, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Delta Research Partners of Bastrop, LLC", "city": "Bastrop", "state_or_region": "Louisiana", "postal_code": "71220", "country": "United States", "latitude": 32.77828, "longitude": -91.91144, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Delta Research Partners, LLC", "city": "Bastrop", "state_or_region": "Louisiana", "postal_code": "71220", "country": "United States", "latitude": 32.77828, "longitude": -91.91144, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Delta Research Partners, LLC", "city": "Bastrop", "state_or_region": "Louisiana", "postal_code": "71220", "country": "United States", "latitude": 32.77828, "longitude": -91.91144, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07184086", "study_title": "A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2025-10", "last_update_post_date": "2025-10-08", "facility": "Pennington Biomed Res Ctr", "city": "Baton Rouge", "state_or_region": "Louisiana", "postal_code": "70808-4124", "country": "United States", "latitude": 30.44332, "longitude": -91.18747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07184086" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Pennington Biomed Res Ctr", "city": "Baton Rouge", "state_or_region": "Louisiana", "postal_code": "70808-4124", "country": "United States", "latitude": 30.44332, "longitude": -91.18747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "Pennington Biomedical Research Center", "city": "Baton Rouge", "state_or_region": "Louisiana", "postal_code": "70808", "country": "United States", "latitude": 30.44332, "longitude": -91.18747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "semaglutide", "nct_id": "NCT04873050", "study_title": "Treatment to Regress to Normoglycemia in Women with a Recent History of GDM", "lead_sponsor": "Woman's", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-03", "last_update_post_date": "2025-03-13", "facility": "Woman's Hospital", "city": "Baton Rouge", "state_or_region": "Louisiana", "postal_code": "70817", "country": "United States", "latitude": 30.44332, "longitude": -91.18747, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT04873050" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Accurate Clinical Research, Inc", "city": "Lake Charles", "state_or_region": "Louisiana", "postal_code": "70605", "country": "United States", "latitude": 30.21309, "longitude": -93.2044, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tandem Clinical Research", "city": "Marrero", "state_or_region": "Louisiana", "postal_code": "70072", "country": "United States", "latitude": 29.89937, "longitude": -90.10035, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tandem Clinical Research", "city": "Marrero", "state_or_region": "Louisiana", "postal_code": "70072", "country": "United States", "latitude": 29.89937, "longitude": -90.10035, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tandem Clinical Research", "city": "Marrero", "state_or_region": "Louisiana", "postal_code": "70072", "country": "United States", "latitude": 29.89937, "longitude": -90.10035, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07527910", "study_title": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "lead_sponsor": "Regeneron Pharmaceuticals", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Tandem Clinical Research, Plaza II", "city": "Metairie", "state_or_region": "Louisiana", "postal_code": "70006", "country": "United States", "latitude": 29.98409, "longitude": -90.15285, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07527910" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - New Iberia", "city": "New Iberia", "state_or_region": "Louisiana", "postal_code": "70560", "country": "United States", "latitude": 30.00354, "longitude": -91.81873, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - New Iberia", "city": "New Iberia", "state_or_region": "Louisiana", "postal_code": "70560", "country": "United States", "latitude": 30.00354, "longitude": -91.81873, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - New Iberia", "city": "New Iberia", "state_or_region": "Louisiana", "postal_code": "70560", "country": "United States", "latitude": 30.00354, "longitude": -91.81873, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Shreveport", "state_or_region": "Louisiana", "postal_code": "71105", "country": "United States", "latitude": 32.52515, "longitude": -93.75018, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Louisiana Research Center, LLC", "city": "Shreveport", "state_or_region": "Louisiana", "postal_code": "71105", "country": "United States", "latitude": 32.52515, "longitude": -93.75018, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Louisiana Research Center, LLC", "city": "Shreveport", "state_or_region": "Louisiana", "postal_code": "71105", "country": "United States", "latitude": 32.52515, "longitude": -93.75018, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Louisiana Research Center", "city": "Shreveport", "state_or_region": "Louisiana", "postal_code": "71105", "country": "United States", "latitude": 32.52515, "longitude": -93.75018, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Louisiana Research Center", "city": "Shreveport", "state_or_region": "Louisiana", "postal_code": "71105", "country": "United States", "latitude": 32.52515, "longitude": -93.75018, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Louisiana Research Center", "city": "Shreveport", "state_or_region": "Louisiana", "postal_code": "71105", "country": "United States", "latitude": 32.52515, "longitude": -93.75018, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Delta Research Partners of West Monroe", "city": "West Monroe", "state_or_region": "Louisiana", "postal_code": "71291", "country": "United States", "latitude": 32.51848, "longitude": -92.14764, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Barry J. Reiner, MD LLC", "city": "Baltimore", "state_or_region": "Maryland", "postal_code": "21229", "country": "United States", "latitude": 39.29038, "longitude": -76.61219, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06691243", "study_title": "Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV", "lead_sponsor": "University of Maryland, Baltimore", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-08", "last_update_post_date": "2025-08-24", "facility": "Institute of Human Virology at the University of Maryland School of Medicine", "city": "Baltimore", "state_or_region": "Maryland", "postal_code": "21201", "country": "United States", "latitude": 39.29038, "longitude": -76.61219, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06691243" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06847399", "study_title": "Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder", "lead_sponsor": "Johns Hopkins University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-09", "last_update_post_date": "2025-09-22", "facility": "Johns Hopkins University", "city": "Baltimore", "state_or_region": "Maryland", "postal_code": "21146", "country": "United States", "latitude": 39.29038, "longitude": -76.61219, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06847399" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mercy Medical Center - Baltimore", "city": "Baltimore", "state_or_region": "Maryland", "postal_code": "21202", "country": "United States", "latitude": 39.29038, "longitude": -76.61219, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Mercy Medical Center", "city": "Baltimore", "state_or_region": "Maryland", "postal_code": "21202", "country": "United States", "latitude": 39.29038, "longitude": -76.61219, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tesamorelin", "nct_id": "NCT03150511", "study_title": "Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury", "lead_sponsor": "Johns Hopkins University", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-12", "facility": "Sami Tuffaha", "city": "Baltimore", "state_or_region": "Maryland", "postal_code": "21205", "country": "United States", "latitude": 39.29038, "longitude": -76.61219, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT03150511" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06548490", "study_title": "GLP-1R Agonist Treatment for Opioid Use Disorder", "lead_sponsor": "Milton S. Hershey Medical Center", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-28", "facility": "University of Maryland Baltimore", "city": "Baltimore", "state_or_region": "Maryland", "postal_code": "21223", "country": "United States", "latitude": 39.29038, "longitude": -76.61219, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06548490" }, { "compound_slugs": "semaglutide", "nct_id": "NCT03884075", "study_title": "Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)", "lead_sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08-06", "last_update_post_date": "2026-08-10", "facility": "National Institutes of Health Clinical Center", "city": "Bethesda", "state_or_region": "Maryland", "postal_code": "20892", "country": "United States", "latitude": 38.98067, "longitude": -77.10026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT03884075" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07046819", "study_title": "Tirzepatide in MetALD", "lead_sponsor": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07-16", "last_update_post_date": "2026-08-12", "facility": "National Institutes of Health Clinical Center", "city": "Bethesda", "state_or_region": "Maryland", "postal_code": "20892", "country": "United States", "latitude": 38.98067, "longitude": -77.10026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07046819" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07559500", "study_title": "Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)", "lead_sponsor": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-07-22", "last_update_post_date": "2026-07-28", "facility": "National Institutes of Health Clinical Center", "city": "Bethesda", "state_or_region": "Maryland", "postal_code": "20892", "country": "United States", "latitude": 38.98067, "longitude": -77.10026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07559500" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Capital Digestive Care - Chevy Chase", "city": "Chevy Chase", "state_or_region": "Maryland", "postal_code": "20815", "country": "United States", "latitude": 39.00287, "longitude": -77.07115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Capital Digestive Care - Chevy Chase", "city": "Chevy Chase", "state_or_region": "Maryland", "postal_code": "20815", "country": "United States", "latitude": 39.00287, "longitude": -77.07115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Capital Digestive Care - Chevy Chase", "city": "Chevy Chase", "state_or_region": "Maryland", "postal_code": "20815", "country": "United States", "latitude": 39.00287, "longitude": -77.07115, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "Centennial Medical Group (CMG)", "city": "Columbia", "state_or_region": "Maryland", "postal_code": "21045", "country": "United States", "latitude": 39.24038, "longitude": -76.83942, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Klein & Associates, M.D., P.A.", "city": "Cumberland", "state_or_region": "Maryland", "postal_code": "21502", "country": "United States", "latitude": 39.65287, "longitude": -78.76252, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Klein & Associates, M.D., P.A.", "city": "Hagerstown", "state_or_region": "Maryland", "postal_code": "21740", "country": "United States", "latitude": 39.64176, "longitude": -77.71999, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "MD Medical Research", "city": "Oxon Hill", "state_or_region": "Maryland", "postal_code": "20745", "country": "United States", "latitude": 38.80345, "longitude": -76.9897, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Dermatology and Skin Cancer Specialists, LLC", "city": "Rockville", "state_or_region": "Maryland", "postal_code": "20850", "country": "United States", "latitude": 39.084, "longitude": -77.15276, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Endo And Metab Cons", "city": "Rockville", "state_or_region": "Maryland", "postal_code": "20852", "country": "United States", "latitude": 39.084, "longitude": -77.15276, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Endo and Metabolic Consultants", "city": "Rockville", "state_or_region": "Maryland", "postal_code": "20852", "country": "United States", "latitude": 39.084, "longitude": -77.15276, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Endocrine and Metabolic Consultants", "city": "Rockville", "state_or_region": "Maryland", "postal_code": "20852", "country": "United States", "latitude": 39.084, "longitude": -77.15276, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Rockville", "state_or_region": "Maryland", "postal_code": "20852", "country": "United States", "latitude": 39.084, "longitude": -77.15276, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Boston Medical Center", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02118", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Brigham & Women's Hospital", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02115-5804", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06639464", "study_title": "Semaglutide for Helping Opioid Recovery", "lead_sponsor": "Brigham and Women's Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-09", "last_update_post_date": "2025-09-26", "facility": "Brigham and Women's Hospital", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02115", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06639464" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06727331", "study_title": "Study of Tirzepatide for Recovery and Alcohol Use Management", "lead_sponsor": "Brigham and Women's Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-09", "facility": "Brigham and Women's Hospital", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02115", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06727331" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07095517", "study_title": "Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors", "lead_sponsor": "Massachusetts General Hospital", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-27", "facility": "Massachusetts General Hospital Cancer Center", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02114", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07095517" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT05933499", "study_title": "Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity", "lead_sponsor": "Massachusetts General Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-27", "facility": "Massachusetts General Hospital", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02114", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05933499" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06003153", "study_title": "GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH", "lead_sponsor": "Massachusetts General Hospital", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-08", "facility": "Massachusetts General Hospital", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02114", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06003153" }, { "compound_slugs": "tesamorelin", "nct_id": "NCT06554717", "study_title": "Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV", "lead_sponsor": "Massachusetts General Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-19", "facility": "Massachusetts General Hospital", "city": "Boston", "state_or_region": "Massachusetts", "postal_code": "02114", "country": "United States", "latitude": 42.35843, "longitude": -71.05977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06554717" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Metro Boston Clinical Partners", "city": "Brighton", "state_or_region": "Massachusetts", "postal_code": "02135", "country": "United States", "latitude": 42.3501, "longitude": -71.15644, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06548490", "study_title": "GLP-1R Agonist Treatment for Opioid Use Disorder", "lead_sponsor": "Milton S. Hershey Medical Center", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-28", "facility": "Stanley Street Treatment and Resources", "city": "Fall River", "state_or_region": "Massachusetts", "postal_code": "02720", "country": "United States", "latitude": 41.70149, "longitude": -71.15505, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06548490" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06727331", "study_title": "Study of Tirzepatide for Recovery and Alcohol Use Management", "lead_sponsor": "Brigham and Women's Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-09", "facility": "Brigham and Women's Faulkner Hospital", "city": "Jamaica Plain", "state_or_region": "Massachusetts", "postal_code": "02130", "country": "United States", "latitude": 42.30982, "longitude": -71.12033, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06727331" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Knownwell", "city": "Needham", "state_or_region": "Massachusetts", "postal_code": "02492", "country": "United States", "latitude": 42.28343, "longitude": -71.23283, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "ss-31", "nct_id": "NCT07531251", "study_title": "Clinical Trial in Patients With Barth Syndrome- 4TAZPower", "lead_sponsor": "Stealth BioTherapeutics Inc.", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-13", "facility": "Trial Not Offered in the U.S", "city": "Needham", "state_or_region": "Massachusetts", "postal_code": "02494", "country": "United States", "latitude": 42.28343, "longitude": -71.23283, "site_statuses": "TERMINATED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07531251" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Lucida Clinical Trials", "city": "New Bedford", "state_or_region": "Massachusetts", "postal_code": "02740", "country": "United States", "latitude": 41.63526, "longitude": -70.92701, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Lucida Clinical Trials", "city": "New Bedford", "state_or_region": "Massachusetts", "postal_code": "02740", "country": "United States", "latitude": 41.63526, "longitude": -70.92701, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Lucida Clinical Trials", "city": "New Bedford", "state_or_region": "Massachusetts", "postal_code": "02740", "country": "United States", "latitude": 41.63526, "longitude": -70.92701, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Lucida Clinical Trials", "city": "New Bedford", "state_or_region": "Massachusetts", "postal_code": "02740", "country": "United States", "latitude": 41.63526, "longitude": -70.92701, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "David Fivenson, MD, PLC", "city": "Ann Arbor", "state_or_region": "Michigan", "postal_code": "48103", "country": "United States", "latitude": 42.27756, "longitude": -83.74088, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07091734", "study_title": "Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024", "lead_sponsor": "University of Michigan", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-09", "last_update_post_date": "2025-09-09", "facility": "University of Michigan", "city": "Ann Arbor", "state_or_region": "Michigan", "postal_code": "48109", "country": "United States", "latitude": 42.27756, "longitude": -83.74088, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07091734" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA Ann Arbor Healthcare System, Ann Arbor, MI", "city": "Ann Arbor", "state_or_region": "Michigan", "postal_code": "48105-2303", "country": "United States", "latitude": 42.27756, "longitude": -83.74088, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Great Lakes Research Group, Inc.", "city": "Bay City", "state_or_region": "Michigan", "postal_code": "48706", "country": "United States", "latitude": 43.59447, "longitude": -83.88886, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Northern Pines Health Center - Buckley", "city": "Buckley", "state_or_region": "Michigan", "postal_code": "49620", "country": "United States", "latitude": 44.50445, "longitude": -85.67701, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Northern Pines Hlth Ctr, PC", "city": "Buckley", "state_or_region": "Michigan", "postal_code": "49620", "country": "United States", "latitude": 44.50445, "longitude": -85.67701, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "The Derm Institute of West Michigan", "city": "Caledonia", "state_or_region": "Michigan", "postal_code": "49316", "country": "United States", "latitude": 42.7892, "longitude": -85.51669, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research Institute of Michigan, LLC", "city": "Clinton Township", "state_or_region": "Michigan", "postal_code": "48038", "country": "United States", "latitude": 42.58698, "longitude": -82.91992, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research Institute of Michigan, LLC", "city": "Clinton Township", "state_or_region": "Michigan", "postal_code": "48038", "country": "United States", "latitude": 42.58698, "longitude": -82.91992, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research Institute of Michigan, LLC", "city": "Clinton Township", "state_or_region": "Michigan", "postal_code": "48038", "country": "United States", "latitude": 42.58698, "longitude": -82.91992, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Revival Research Institute, LLC - Dearborn", "city": "Dearborn", "state_or_region": "Michigan", "postal_code": "48126", "country": "United States", "latitude": 42.32226, "longitude": -83.17631, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Farmington Hills", "state_or_region": "Michigan", "postal_code": "48334", "country": "United States", "latitude": 42.48531, "longitude": -83.37716, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Elite Research Center", "city": "Flint", "state_or_region": "Michigan", "postal_code": "48532", "country": "United States", "latitude": 43.01253, "longitude": -83.68746, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Clinical Research Institute of Michigan, LLC", "city": "Saint Clair Shores", "state_or_region": "Michigan", "postal_code": "48081", "country": "United States", "latitude": 42.49698, "longitude": -82.88881, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Great Lakes Research Institute", "city": "Southfield", "state_or_region": "Michigan", "postal_code": "48075", "country": "United States", "latitude": 42.47337, "longitude": -83.22187, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Headlands Research - Detroit", "city": "Southfield", "state_or_region": "Michigan", "postal_code": "48034", "country": "United States", "latitude": 42.47337, "longitude": -83.22187, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Southfield", "state_or_region": "Michigan", "postal_code": "48076", "country": "United States", "latitude": 42.47337, "longitude": -83.22187, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Arcturus Healthcare - Troy Internal Medicine Research Division", "city": "Troy", "state_or_region": "Michigan", "postal_code": "48098", "country": "United States", "latitude": 42.60559, "longitude": -83.14993, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division", "city": "Troy", "state_or_region": "Michigan", "postal_code": "48098", "country": "United States", "latitude": 42.60559, "longitude": -83.14993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Arcturus Healthcare , PLC, Troy Internal Medicine Research Division", "city": "Troy", "state_or_region": "Michigan", "postal_code": "48098", "country": "United States", "latitude": 42.60559, "longitude": -83.14993, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "West Michigan Clinical Research Center", "city": "Wyoming", "state_or_region": "Michigan", "postal_code": "49519", "country": "United States", "latitude": 42.91336, "longitude": -85.70531, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "West Michigan Clinical Research Center", "city": "Wyoming", "state_or_region": "Michigan", "postal_code": "49519", "country": "United States", "latitude": 42.91336, "longitude": -85.70531, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07728383", "study_title": "A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity", "lead_sponsor": "Gila Therapeutics, Inc.", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-27", "facility": "Clinical Research Institute of Minnesota", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55402", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07728383" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "International Diabetes Center", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55416", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "International Diabetes Center", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55416", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Minneapolis VA Health Care System, Minneapolis, MN", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55417-2309", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MNGI Digestive Health, PA", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55413", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MNGI Digestive Health, PA", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55413", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "MNGI Digestive Health", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55413", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55416", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "University of Minnesota", "city": "Minneapolis", "state_or_region": "Minnesota", "postal_code": "55455", "country": "United States", "latitude": 44.97997, "longitude": -93.26384, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "AES Minneapolis DRS", "city": "Richfield", "state_or_region": "Minnesota", "postal_code": "55423", "country": "United States", "latitude": 44.8833, "longitude": -93.283, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "AES Minneapolis DRS", "city": "Richfield", "state_or_region": "Minnesota", "postal_code": "55423", "country": "United States", "latitude": 44.8833, "longitude": -93.283, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "liraglutide", "nct_id": "NCT06976619", "study_title": "The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes", "lead_sponsor": "Mayo Clinic", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-10", "last_update_post_date": "2025-10-14", "facility": "Mayo Clinic in Rochester", "city": "Rochester", "state_or_region": "Minnesota", "postal_code": "55905", "country": "United States", "latitude": 44.02163, "longitude": -92.4699, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06976619" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07213466", "study_title": "Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder", "lead_sponsor": "Mayo Clinic", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Mayo Clinic", "city": "Rochester", "state_or_region": "Minnesota", "postal_code": "55905", "country": "United States", "latitude": 44.02163, "longitude": -92.4699, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07213466" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06901245", "study_title": "Tirzepatide in PWS, HO and GNSO", "lead_sponsor": "Grace Kim", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-01", "last_update_post_date": "2025-09-16", "facility": "Children's Minnesota", "city": "Saint Paul", "state_or_region": "Minnesota", "postal_code": "55102", "country": "United States", "latitude": 44.94441, "longitude": -93.09327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06901245" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Belzoni Clinical Research", "city": "Belzoni", "state_or_region": "Mississippi", "postal_code": "39038", "country": "United States", "latitude": 33.18429, "longitude": -90.48926, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastrointestinal Associates, PA", "city": "Flowood", "state_or_region": "Mississippi", "postal_code": "39232", "country": "United States", "latitude": 32.30959, "longitude": -90.13898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Associates - GIA and Endoscopy Center - Flowood", "city": "Flowood", "state_or_region": "Mississippi", "postal_code": "39232", "country": "United States", "latitude": 32.30959, "longitude": -90.13898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Olive Branch Family Medical Center", "city": "Olive Branch", "state_or_region": "Mississippi", "postal_code": "38654", "country": "United States", "latitude": 34.96176, "longitude": -89.82953, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "SKY Clinical Research Network Group - Ridgeland", "city": "Ridgeland", "state_or_region": "Mississippi", "postal_code": "39157", "country": "United States", "latitude": 32.42848, "longitude": -90.13231, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "SKY Integrative Medical Center", "city": "Ridgeland", "state_or_region": "Mississippi", "postal_code": "39157", "country": "United States", "latitude": 32.42848, "longitude": -90.13231, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "The Gibson Center for Behavioral Change", "city": "Cape Girardeau", "state_or_region": "Missouri", "postal_code": "63703", "country": "United States", "latitude": 37.30588, "longitude": -89.51815, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research Professionals", "city": "Chesterfield", "state_or_region": "Missouri", "postal_code": "63005", "country": "United States", "latitude": 38.66311, "longitude": -90.57707, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Research Professionals", "city": "Chesterfield", "state_or_region": "Missouri", "postal_code": "63005", "country": "United States", "latitude": 38.66311, "longitude": -90.57707, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "StudyMetrix Research LLC", "city": "City of Saint Peters", "state_or_region": "Missouri", "postal_code": "63303", "country": "United States", "latitude": 38.80033, "longitude": -90.62651, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "StudyMetrix Research LLC", "city": "City of Saint Peters", "state_or_region": "Missouri", "postal_code": "63303", "country": "United States", "latitude": 38.80033, "longitude": -90.62651, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "StudyMetrix Research, LLC", "city": "City of Saint Peters", "state_or_region": "Missouri", "postal_code": "63303", "country": "United States", "latitude": 38.80033, "longitude": -90.62651, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "StudyMetrix Research", "city": "City of Saint Peters", "state_or_region": "Missouri", "postal_code": "63303", "country": "United States", "latitude": 38.80033, "longitude": -90.62651, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-GI Associates Research", "city": "Columbia", "state_or_region": "Missouri", "postal_code": "65201", "country": "United States", "latitude": 38.95171, "longitude": -92.33407, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-GI Associates Research", "city": "Columbia", "state_or_region": "Missouri", "postal_code": "65201", "country": "United States", "latitude": 38.95171, "longitude": -92.33407, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Jefferson City", "state_or_region": "Missouri", "postal_code": "65109", "country": "United States", "latitude": 38.5767, "longitude": -92.17352, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "AMR Clinical", "city": "Kansas City", "state_or_region": "Missouri", "postal_code": "64114", "country": "United States", "latitude": 39.09973, "longitude": -94.57857, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Clinical Research Consultants", "city": "Kansas City", "state_or_region": "Missouri", "postal_code": "64111-5964", "country": "United States", "latitude": 39.09973, "longitude": -94.57857, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kansas City Research Institute", "city": "Kansas City", "state_or_region": "Missouri", "postal_code": "64131", "country": "United States", "latitude": 39.09973, "longitude": -94.57857, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Kansas City Research Institute", "city": "Kansas City", "state_or_region": "Missouri", "postal_code": "64131", "country": "United States", "latitude": 39.09973, "longitude": -94.57857, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Kansas City", "state_or_region": "Missouri", "postal_code": "64114", "country": "United States", "latitude": 39.09973, "longitude": -94.57857, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Clinvest Headlands Llc", "city": "Springfield", "state_or_region": "Missouri", "postal_code": "65807", "country": "United States", "latitude": 37.21533, "longitude": -93.29824, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Headlands Research", "city": "Springfield", "state_or_region": "Missouri", "postal_code": "65807", "country": "United States", "latitude": 37.21533, "longitude": -93.29824, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Amicis Centers of Clinical Research", "city": "St Louis", "state_or_region": "Missouri", "postal_code": "63128", "country": "United States", "latitude": 38.62727, "longitude": -90.19789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Washington University School of Medicine", "city": "St Louis", "state_or_region": "Missouri", "postal_code": "63110", "country": "United States", "latitude": 38.62727, "longitude": -90.19789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Washington University School of Medicine", "city": "St Louis", "state_or_region": "Missouri", "postal_code": "63110", "country": "United States", "latitude": 38.62727, "longitude": -90.19789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06976853", "study_title": "Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease", "lead_sponsor": "Washington University School of Medicine", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-05", "facility": "Washington University School of Medicine", "city": "St Louis", "state_or_region": "Missouri", "postal_code": "63110", "country": "United States", "latitude": 38.62727, "longitude": -90.19789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06976853" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07091500", "study_title": "Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity", "lead_sponsor": "Washington University School of Medicine", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Washington University School of Medicine", "city": "St Louis", "state_or_region": "Missouri", "postal_code": "63110", "country": "United States", "latitude": 38.62727, "longitude": -90.19789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07091500" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Logan Health Research - Kalispell", "city": "Kalispell", "state_or_region": "Montana", "postal_code": "59901", "country": "United States", "latitude": 48.19579, "longitude": -114.31291, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Logan Health Rheumatology", "city": "Kalispell", "state_or_region": "Montana", "postal_code": "59901", "country": "United States", "latitude": 48.19579, "longitude": -114.31291, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Boeson Research - Missoula", "city": "Missoula", "state_or_region": "Montana", "postal_code": "59804", "country": "United States", "latitude": 46.87215, "longitude": -113.994, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Missoula", "state_or_region": "Montana", "postal_code": "59804", "country": "United States", "latitude": 46.87215, "longitude": -113.994, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Omaha", "state_or_region": "Nebraska", "postal_code": "68114", "country": "United States", "latitude": 41.25626, "longitude": -95.94043, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Nebraska Medical Center", "city": "Omaha", "state_or_region": "Nebraska", "postal_code": "68198", "country": "United States", "latitude": 41.25626, "longitude": -95.94043, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Nebraska Medical Center", "city": "Omaha", "state_or_region": "Nebraska", "postal_code": "68198", "country": "United States", "latitude": 41.25626, "longitude": -95.94043, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Henderson", "state_or_region": "Nevada", "postal_code": "89052", "country": "United States", "latitude": 36.0397, "longitude": -114.98194, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research of South Nevada", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89121", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research of South Nevada", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89121", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Excel Clinical Research, LLC", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89109", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Excel Clinical Research", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89109", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Excel Clinical Research", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89109", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jubilee Clinical Research NV. LLC", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89106", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Jubilee Clinical Research, Inc.", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89106", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jubilee Clinical Research, Inc", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89106", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Jubilee Clinical Research, Inc", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89106", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89148", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Las Vegas Medical Research", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89128", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Palm Research Center", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89128", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Las Vegas", "state_or_region": "Nevada", "postal_code": "89128", "country": "United States", "latitude": 36.17497, "longitude": -115.13722, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Skin Cancer and Dermatology Institute - Reno", "city": "Reno", "state_or_region": "Nevada", "postal_code": "89509", "country": "United States", "latitude": 39.52963, "longitude": -119.8138, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Dartmouth-Hitchcock Medical Center", "city": "Lebanon", "state_or_region": "New Hampshire", "postal_code": "03756", "country": "United States", "latitude": 43.64229, "longitude": -72.25176, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Dartmouth-Hitchcock Medical Center", "city": "Lebanon", "state_or_region": "New Hampshire", "postal_code": "03756", "country": "United States", "latitude": 43.64229, "longitude": -72.25176, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Stracskin", "city": "Portsmouth", "state_or_region": "New Hampshire", "postal_code": "03801", "country": "United States", "latitude": 43.07704, "longitude": -70.75766, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06751589", "study_title": "A Study of a Weight Loss Intervention in People With Endometrial Cancer", "lead_sponsor": "Memorial Sloan Kettering Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Memorial Sloan Kettering Basking Ridge", "city": "Basking Ridge", "state_or_region": "New Jersey", "postal_code": "07920", "country": "United States", "latitude": 40.70621, "longitude": -74.54932, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06751589" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Psoriasis Treatment Center of Central New Jersey", "city": "East Windsor", "state_or_region": "New Jersey", "postal_code": "08520", "country": "United States", "latitude": 40.268, "longitude": -74.54043, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06518837", "study_title": "Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "Trinitas Comprehensive Cancer Center", "city": "Elizabeth", "state_or_region": "New Jersey", "postal_code": "07202", "country": "United States", "latitude": 40.66399, "longitude": -74.2107, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06518837" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tandem Clinical Research - Freehold", "city": "Freehold", "state_or_region": "New Jersey", "postal_code": "07728", "country": "United States", "latitude": 40.26011, "longitude": -74.27376, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06518837", "study_title": "Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "RWJ Barnabas Health - Robert Wood Johnson University Hospital, Hamilton", "city": "Hamilton", "state_or_region": "New Jersey", "postal_code": "08690", "country": "United States", "latitude": 40.20706, "longitude": -74.08125, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06518837" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Care Access - Hoboken", "city": "Hoboken", "state_or_region": "New Jersey", "postal_code": "07030", "country": "United States", "latitude": 40.74399, "longitude": -74.03236, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06518837", "study_title": "Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "RWJBarnabas Health - Cooperman Barnabas, Livingston", "city": "Livingston", "state_or_region": "New Jersey", "postal_code": "07039", "country": "United States", "latitude": 40.79593, "longitude": -74.31487, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06518837" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06518837", "study_title": "Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "RWJBarnabas Health - Monmouth Medical Center", "city": "Long Branch", "state_or_region": "New Jersey", "postal_code": "07740", "country": "United States", "latitude": 40.30428, "longitude": -73.99236, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06518837" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06751589", "study_title": "A Study of a Weight Loss Intervention in People With Endometrial Cancer", "lead_sponsor": "Memorial Sloan Kettering Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Memorial Sloan Kettering Monmouth", "city": "Middletown", "state_or_region": "New Jersey", "postal_code": "07748", "country": "United States", "latitude": 40.39428, "longitude": -74.11709, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06751589" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06751589", "study_title": "A Study of a Weight Loss Intervention in People With Endometrial Cancer", "lead_sponsor": "Memorial Sloan Kettering Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Memorial Sloan Kettering Bergen", "city": "Montvale", "state_or_region": "New Jersey", "postal_code": "07645", "country": "United States", "latitude": 41.04676, "longitude": -74.02292, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06751589" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Atlantic Health System Morristown Medical Center", "city": "Morristown", "state_or_region": "New Jersey", "postal_code": "07960", "country": "United States", "latitude": 40.79677, "longitude": -74.48154, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06518837", "study_title": "Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "Rutgers Cancer Institute", "city": "New Brunswick", "state_or_region": "New Jersey", "postal_code": "08901", "country": "United States", "latitude": 40.48622, "longitude": -74.45182, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06518837" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06518837", "study_title": "Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "RWJBarnabas Health - Newark Beth Israel Medical Center", "city": "Newark", "state_or_region": "New Jersey", "postal_code": "07112", "country": "United States", "latitude": 40.73566, "longitude": -74.17237, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06518837" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research of Philadelphia", "city": "Pennington", "state_or_region": "New Jersey", "postal_code": "08534", "country": "United States", "latitude": 40.32844, "longitude": -74.79072, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Cognitive and Research Center of New Jersey - Ridgewood", "city": "Ridgewood", "state_or_region": "New Jersey", "postal_code": "07450", "country": "United States", "latitude": 40.97926, "longitude": -74.11653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07465965", "study_title": "A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults", "lead_sponsor": "Shanghai World Leader Pharmaceutical Co., Ltd.", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-12", "facility": "Frontage Clinical Services, Inc.", "city": "Secaucus", "state_or_region": "New Jersey", "postal_code": "07094", "country": "United States", "latitude": 40.78955, "longitude": -74.05653, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07465965" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06518837", "study_title": "Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer", "lead_sponsor": "Rutgers, The State University of New Jersey", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-21", "facility": "RWJ Barnabas Health - Robert Wood Johnson University Hospital, Somerset", "city": "Somerville", "state_or_region": "New Jersey", "postal_code": "08876", "country": "United States", "latitude": 40.57427, "longitude": -74.60988, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06518837" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research Warren", "city": "Warren Township", "state_or_region": "New Jersey", "postal_code": "07059", "country": "United States", "latitude": 40.60822, "longitude": -74.51803, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research-Warren-69742", "city": "Warren Township", "state_or_region": "New Jersey", "postal_code": "07059", "country": "United States", "latitude": 40.60822, "longitude": -74.51803, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research-Warren-69742", "city": "Warren Township", "state_or_region": "New Jersey", "postal_code": "07059", "country": "United States", "latitude": 40.60822, "longitude": -74.51803, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Albuquerque Clinical Trials", "city": "Albuquerque", "state_or_region": "New Mexico", "postal_code": "87102", "country": "United States", "latitude": 35.08449, "longitude": -106.65114, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Albuquerque", "state_or_region": "New Mexico", "postal_code": "87112", "country": "United States", "latitude": 35.08449, "longitude": -106.65114, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southwest Gastroenterology Associates", "city": "Albuquerque", "state_or_region": "New Mexico", "postal_code": "87109", "country": "United States", "latitude": 35.08449, "longitude": -106.65114, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06934642", "study_title": "Effect of Tirzepatide on Markers of MASLD in Patients With Obesity", "lead_sponsor": "University of New Mexico", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-15", "facility": "University of New Mexico Health Sciences Center", "city": "Albuquerque", "state_or_region": "New Mexico", "postal_code": "87131", "country": "United States", "latitude": 35.08449, "longitude": -106.65114, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06934642" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Albany Medical College", "city": "Albany", "state_or_region": "New York", "postal_code": "12203", "country": "United States", "latitude": 42.65258, "longitude": -73.75623, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Albany", "state_or_region": "New York", "postal_code": "12203", "country": "United States", "latitude": 42.65258, "longitude": -73.75623, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Dent Neurologic Institute", "city": "Amherst", "state_or_region": "New York", "postal_code": "14226", "country": "United States", "latitude": 42.97839, "longitude": -78.79976, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ellipsis Research Group - Brooklyn", "city": "Brooklyn", "state_or_region": "New York", "postal_code": "11215", "country": "United States", "latitude": 40.6501, "longitude": -73.94958, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NewYork-Presbyterian Brooklyn Methodist Hospital", "city": "Brooklyn", "state_or_region": "New York", "postal_code": "11215", "country": "United States", "latitude": 40.6501, "longitude": -73.94958, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NewYork-Presbyterian Brooklyn Methodist Hospital", "city": "Brooklyn", "state_or_region": "New York", "postal_code": "11215", "country": "United States", "latitude": 40.6501, "longitude": -73.94958, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Foundation of SUNY - University of Buffalo", "city": "Buffalo", "state_or_region": "New York", "postal_code": "14203", "country": "United States", "latitude": 42.88645, "longitude": -78.87837, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "UBMD Pediatrics", "city": "Buffalo", "state_or_region": "New York", "postal_code": "14203", "country": "United States", "latitude": 42.88645, "longitude": -78.87837, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "UBMD Physicians Group - Pediatrics - Conventus", "city": "Buffalo", "state_or_region": "New York", "postal_code": "14203", "country": "United States", "latitude": 42.88645, "longitude": -78.87837, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06751589", "study_title": "A Study of a Weight Loss Intervention in People With Endometrial Cancer", "lead_sponsor": "Memorial Sloan Kettering Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Memorial Sloan Kettering Commack", "city": "Commack", "state_or_region": "New York", "postal_code": "11725", "country": "United States", "latitude": 40.84288, "longitude": -73.29289, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06751589" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Velocity Clinical Research, Syracuse", "city": "East Syracuse", "state_or_region": "New York", "postal_code": "13057", "country": "United States", "latitude": 43.06534, "longitude": -76.07853, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06751589", "study_title": "A Study of a Weight Loss Intervention in People With Endometrial Cancer", "lead_sponsor": "Memorial Sloan Kettering Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Memorial Sloan Kettering Westchester", "city": "Harrison", "state_or_region": "New York", "postal_code": "10604", "country": "United States", "latitude": 40.96899, "longitude": -73.71263, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06751589" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Basil Clinical", "city": "Laurelton", "state_or_region": "New York", "postal_code": "11413", "country": "United States", "latitude": 40.67019, "longitude": -73.74659, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Basil Clinical", "city": "Laurelton", "state_or_region": "New York", "postal_code": "11413", "country": "United States", "latitude": 40.67019, "longitude": -73.74659, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "ALSA Research", "city": "New York", "state_or_region": "New York", "postal_code": "10016", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Equity Medical", "city": "New York", "state_or_region": "New York", "postal_code": "10023", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Icahn School of Medicine at Mount Sinai", "city": "New York", "state_or_region": "New York", "postal_code": "10029", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Icahn School of Medicine at Mount Sinai", "city": "New York", "state_or_region": "New York", "postal_code": "10029", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Icahn School of Medicine at Mount Sinai", "city": "New York", "state_or_region": "New York", "postal_code": "10029", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06976853", "study_title": "Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease", "lead_sponsor": "Washington University School of Medicine", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-05", "facility": "Icahn School of Medicine at Mount Sinai", "city": "New York", "state_or_region": "New York", "postal_code": "10029", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06976853" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research Manhattan", "city": "New York", "state_or_region": "New York", "postal_code": "10036", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06751589", "study_title": "A Study of a Weight Loss Intervention in People With Endometrial Cancer", "lead_sponsor": "Memorial Sloan Kettering Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Memorial Sloan Kettering Cancer Center", "city": "New York", "state_or_region": "New York", "postal_code": "10065", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06751589" }, { "compound_slugs": "liraglutide", "nct_id": "NCT05681299", "study_title": "Effects of GH and Lirglutide on AgRP", "lead_sponsor": "Columbia University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-04", "facility": "Neuroendocrine Unit and Pituitary Center, Columbia University Irving Medical Center", "city": "New York", "state_or_region": "New York", "postal_code": "10032", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05681299" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New York Gastroenterology Associates", "city": "New York", "state_or_region": "New York", "postal_code": "10075", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New York Gastroenterology Associates", "city": "New York", "state_or_region": "New York", "postal_code": "10075", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New York Gastroenterology Associates", "city": "New York", "state_or_region": "New York", "postal_code": "10075", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06548490", "study_title": "GLP-1R Agonist Treatment for Opioid Use Disorder", "lead_sponsor": "Milton S. Hershey Medical Center", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-28", "facility": "NYU Langone Health", "city": "New York", "state_or_region": "New York", "postal_code": "10016", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06548490" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "NYU Langone Health", "city": "New York", "state_or_region": "New York", "postal_code": "10016", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07257484", "study_title": "Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors", "lead_sponsor": "Weill Medical College of Cornell University", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Weill Cornell Medicine", "city": "New York", "state_or_region": "New York", "postal_code": "10021", "country": "United States", "latitude": 40.71427, "longitude": -74.00597, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07257484" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "North Suffolk Neurology", "city": "Port Jefferson Station", "state_or_region": "New York", "postal_code": "11776", "country": "United States", "latitude": 40.92538, "longitude": -73.04733, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Rochester Clinical Research, LLC", "city": "Rochester", "state_or_region": "New York", "postal_code": "14609", "country": "United States", "latitude": 43.15478, "longitude": -77.61556, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Rochester Medical Center", "city": "Rochester", "state_or_region": "New York", "postal_code": "14642", "country": "United States", "latitude": 43.15478, "longitude": -77.61556, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Rochester Medical Center", "city": "Rochester", "state_or_region": "New York", "postal_code": "14642", "country": "United States", "latitude": 43.15478, "longitude": -77.61556, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "University of Rochester Medical Center", "city": "Rochester", "state_or_region": "New York", "postal_code": "14642", "country": "United States", "latitude": 43.15478, "longitude": -77.61556, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "SUNY Upstate Medical Univ - Syracuse", "city": "Syracuse", "state_or_region": "New York", "postal_code": "13210", "country": "United States", "latitude": 43.04812, "longitude": -76.14742, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "SUNY Upstate Medical University", "city": "Syracuse", "state_or_region": "New York", "postal_code": "13210", "country": "United States", "latitude": 43.04812, "longitude": -76.14742, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Advantage Clinical Trials", "city": "The Bronx", "state_or_region": "New York", "postal_code": "10467", "country": "United States", "latitude": 40.84985, "longitude": -73.86641, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06751589", "study_title": "A Study of a Weight Loss Intervention in People With Endometrial Cancer", "lead_sponsor": "Memorial Sloan Kettering Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "Memorial Sloan Kettering Nassau", "city": "Uniondale", "state_or_region": "New York", "postal_code": "11553", "country": "United States", "latitude": 40.70038, "longitude": -73.59291, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06751589" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Southgate Medical Group, LLP", "city": "West Seneca", "state_or_region": "New York", "postal_code": "14224", "country": "United States", "latitude": 42.85006, "longitude": -78.79975, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Great Lakes Medical Research", "city": "Westfield", "state_or_region": "New York", "postal_code": "14787", "country": "United States", "latitude": 42.32228, "longitude": -79.5781, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - Yonkers", "city": "Yonkers", "state_or_region": "New York", "postal_code": "10701", "country": "United States", "latitude": 40.9304, "longitude": -73.89789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - Yonkers", "city": "Yonkers", "state_or_region": "New York", "postal_code": "10701", "country": "United States", "latitude": 40.9304, "longitude": -73.89789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - Yonkers", "city": "Yonkers", "state_or_region": "New York", "postal_code": "10701", "country": "United States", "latitude": 40.9304, "longitude": -73.89789, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Asheville VA Medical Center, Asheville, NC", "city": "Asheville", "state_or_region": "North Carolina", "postal_code": "28805-2576", "country": "United States", "latitude": 35.60095, "longitude": -82.55402, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Revival Research Institute, LLC", "city": "Cary", "state_or_region": "North Carolina", "postal_code": "27511", "country": "United States", "latitude": 35.79154, "longitude": -78.78112, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07065552", "study_title": "Tirzepatide in Obesity-Driven Endometrial Cancer", "lead_sponsor": "UNC Lineberger Comprehensive Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-28", "facility": "Lineberger Comprehensive Cancer Center", "city": "Chapel Hill", "state_or_region": "North Carolina", "postal_code": "27599", "country": "United States", "latitude": 35.9132, "longitude": -79.05584, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07065552" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06975111", "study_title": "Focusing on the Menopausal Transition to Improve Mid-Life Women's Health", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-21", "facility": "University of North Carolina, School of Medicine", "city": "Chapel Hill", "state_or_region": "North Carolina", "postal_code": "27599", "country": "United States", "latitude": 35.9132, "longitude": -79.05584, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06975111" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Duke University - Main Hospital and Clinics", "city": "Durham", "state_or_region": "North Carolina", "postal_code": "27710", "country": "United States", "latitude": 35.99403, "longitude": -78.89862, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Duke University Medical Center", "city": "Durham", "state_or_region": "North Carolina", "postal_code": "27710", "country": "United States", "latitude": 35.99403, "longitude": -78.89862, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Durham VA Medical Center, Durham, NC", "city": "Durham", "state_or_region": "North Carolina", "postal_code": "27705-3875", "country": "United States", "latitude": 35.99403, "longitude": -78.89862, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Durham", "state_or_region": "North Carolina", "postal_code": "27701", "country": "United States", "latitude": 35.99403, "longitude": -78.89862, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Cape Fear Valley Medical Center", "city": "Fayetteville", "state_or_region": "North Carolina", "postal_code": "28304", "country": "United States", "latitude": 35.05266, "longitude": -78.87836, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Coastal Research Institute - Fayetteville", "city": "Fayetteville", "state_or_region": "North Carolina", "postal_code": "28304", "country": "United States", "latitude": 35.05266, "longitude": -78.87836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Coastal Research Institute - Fayetteville", "city": "Fayetteville", "state_or_region": "North Carolina", "postal_code": "28304", "country": "United States", "latitude": 35.05266, "longitude": -78.87836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Coastal Research Institute, LLC", "city": "Fayetteville", "state_or_region": "North Carolina", "postal_code": "28304", "country": "United States", "latitude": 35.05266, "longitude": -78.87836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Coastal Research Institute, LLC", "city": "Fayetteville", "state_or_region": "North Carolina", "postal_code": "28304", "country": "United States", "latitude": 35.05266, "longitude": -78.87836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "Coastal Research Institute, LLC", "city": "Fayetteville", "state_or_region": "North Carolina", "postal_code": "28304", "country": "United States", "latitude": 35.05266, "longitude": -78.87836, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Medication Management", "city": "Greensboro", "state_or_region": "North Carolina", "postal_code": "27405", "country": "United States", "latitude": 36.07264, "longitude": -79.79198, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "PharmQuest Life Sciences LLC", "city": "Greensboro", "state_or_region": "North Carolina", "postal_code": "27408", "country": "United States", "latitude": 36.07264, "longitude": -79.79198, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "PharmQuest Life Sciences", "city": "Greensboro", "state_or_region": "North Carolina", "postal_code": "27408", "country": "United States", "latitude": 36.07264, "longitude": -79.79198, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "PharmQuest", "city": "Greensboro", "state_or_region": "North Carolina", "postal_code": "27408", "country": "United States", "latitude": 36.07264, "longitude": -79.79198, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "PharmQuest", "city": "Greensboro", "state_or_region": "North Carolina", "postal_code": "27408", "country": "United States", "latitude": 36.07264, "longitude": -79.79198, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Carolina Researche", "city": "Greenville", "state_or_region": "North Carolina", "postal_code": "27834", "country": "United States", "latitude": 35.61266, "longitude": -77.36635, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Carolina Researche", "city": "Greenville", "state_or_region": "North Carolina", "postal_code": "27834", "country": "United States", "latitude": 35.61266, "longitude": -77.36635, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Physician's East Endocrinology", "city": "Greenville", "state_or_region": "North Carolina", "postal_code": "27834", "country": "United States", "latitude": 35.61266, "longitude": -77.36635, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Onsite Clinical Solutions - Huntersville", "city": "Huntersville", "state_or_region": "North Carolina", "postal_code": "28078", "country": "United States", "latitude": 35.41069, "longitude": -80.84285, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Monroe Biomedical Research, LLC", "city": "Monroe", "state_or_region": "North Carolina", "postal_code": "28112", "country": "United States", "latitude": 34.98543, "longitude": -80.54951, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Monroe Biomedical Research", "city": "Monroe", "state_or_region": "North Carolina", "postal_code": "28112", "country": "United States", "latitude": 34.98543, "longitude": -80.54951, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Monroe Biomedical Research", "city": "Monroe", "state_or_region": "North Carolina", "postal_code": "28112", "country": "United States", "latitude": 34.98543, "longitude": -80.54951, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Carteret Medical Group", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Carteret Medical Group", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Carteret Medical Group", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centricity Research - Morehead City", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Centricity Rsrch MHCity Multi", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Lucas Research, Inc", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Morehead City", "state_or_region": "North Carolina", "postal_code": "28557", "country": "United States", "latitude": 34.72294, "longitude": -76.72604, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Morrisville", "state_or_region": "North Carolina", "postal_code": "27560", "country": "United States", "latitude": 35.82348, "longitude": -78.82556, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centricity Research (New Bern)", "city": "New Bern", "state_or_region": "North Carolina", "postal_code": "28562", "country": "United States", "latitude": 35.10849, "longitude": -77.04411, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Lucas Research, Inc.", "city": "New Bern", "state_or_region": "North Carolina", "postal_code": "28562", "country": "United States", "latitude": 35.10849, "longitude": -77.04411, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "M3 Wake Research, Inc.", "city": "Raleigh", "state_or_region": "North Carolina", "postal_code": "27612", "country": "United States", "latitude": 35.7721, "longitude": -78.63861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "M3 Wake Research, Inc.", "city": "Raleigh", "state_or_region": "North Carolina", "postal_code": "27612", "country": "United States", "latitude": 35.7721, "longitude": -78.63861, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Raleigh", "state_or_region": "North Carolina", "postal_code": "27612", "country": "United States", "latitude": 35.7721, "longitude": -78.63861, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Onsite Clinical Solutions, LLC - Brenner Ave", "city": "Salisbury", "state_or_region": "North Carolina", "postal_code": "28144", "country": "United States", "latitude": 35.67097, "longitude": -80.47423, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Piedmont Healthcare Statesville", "city": "Statesville", "state_or_region": "North Carolina", "postal_code": "28625", "country": "United States", "latitude": 35.78264, "longitude": -80.8873, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Piedmont Healthcare/Research", "city": "Statesville", "state_or_region": "North Carolina", "postal_code": "28625", "country": "United States", "latitude": 35.78264, "longitude": -80.8873, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Statesville", "state_or_region": "North Carolina", "postal_code": "28625", "country": "United States", "latitude": 35.78264, "longitude": -80.8873, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Accellacare Wilmington", "city": "Wilmington", "state_or_region": "North Carolina", "postal_code": "28401", "country": "United States", "latitude": 34.23556, "longitude": -77.94604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Accellacare", "city": "Wilmington", "state_or_region": "North Carolina", "postal_code": "28401", "country": "United States", "latitude": 34.23556, "longitude": -77.94604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "KDCILM, LLC & Accellacare US, Inc.", "city": "Wilmington", "state_or_region": "North Carolina", "postal_code": "28401", "country": "United States", "latitude": 34.23556, "longitude": -77.94604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "KDCILM, LLC & Accellacare US, Inc.", "city": "Wilmington", "state_or_region": "North Carolina", "postal_code": "28401", "country": "United States", "latitude": 34.23556, "longitude": -77.94604, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Wilmington", "state_or_region": "North Carolina", "postal_code": "28403", "country": "United States", "latitude": 34.23556, "longitude": -77.94604, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Brookview Hills Research Associates, LLC", "city": "Winston-Salem", "state_or_region": "North Carolina", "postal_code": "27103", "country": "United States", "latitude": 36.09986, "longitude": -80.24422, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Lillestol Research LLC", "city": "Fargo", "state_or_region": "North Dakota", "postal_code": "58104", "country": "United States", "latitude": 46.87719, "longitude": -96.7898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Plains Clinical Research Center, LLC_Fargo", "city": "Fargo", "state_or_region": "North Dakota", "postal_code": "58104", "country": "United States", "latitude": 46.87719, "longitude": -96.7898, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Plains Clinical Research Center, LLC", "city": "Fargo", "state_or_region": "North Dakota", "postal_code": "58104", "country": "United States", "latitude": 46.87719, "longitude": -96.7898, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Valley Weight Loss Clinic", "city": "Fargo", "state_or_region": "North Dakota", "postal_code": "58104", "country": "United States", "latitude": 46.87719, "longitude": -96.7898, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Akron Gastro Research", "city": "Akron", "state_or_region": "Ohio", "postal_code": "44320", "country": "United States", "latitude": 41.08144, "longitude": -81.51901, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Dayton Gastroenterology - Beavercreek", "city": "Beavercreek", "state_or_region": "Ohio", "postal_code": "45440", "country": "United States", "latitude": 39.70923, "longitude": -84.06327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Optima Research - Boardman", "city": "Boardman", "state_or_region": "Ohio", "postal_code": "44512", "country": "United States", "latitude": 41.02423, "longitude": -80.66285, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Research Institute of Ohio - Brooklyn", "city": "Brooklyn", "state_or_region": "Ohio", "postal_code": "44144", "country": "United States", "latitude": 41.43977, "longitude": -81.73541, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Diabetes & Endocrinology Associates of Stark County", "city": "Canton", "state_or_region": "Ohio", "postal_code": "44718", "country": "United States", "latitude": 40.79895, "longitude": -81.37845, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "liraglutide", "nct_id": "NCT07029009", "study_title": "Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)", "lead_sponsor": "Mansa", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2024-12", "last_update_post_date": "2025-12-17", "facility": "Cincinnati Children's Hospital Medical Center", "city": "Cincinnati", "state_or_region": "Ohio", "postal_code": "45229", "country": "United States", "latitude": 39.12711, "longitude": -84.51439, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07029009" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "CTI Clinical Research Center", "city": "Cincinnati", "state_or_region": "Ohio", "postal_code": "45212", "country": "United States", "latitude": 39.12711, "longitude": -84.51439, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06802081", "study_title": "TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation", "lead_sponsor": "The Cleveland Clinic", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-01-13", "facility": "Cleveland Clinic", "city": "Cleveland", "state_or_region": "Ohio", "postal_code": "44195", "country": "United States", "latitude": 41.4995, "longitude": -81.69541, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06802081" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Louis Stokes VA Medical Center, Cleveland, OH", "city": "Cleveland", "state_or_region": "Ohio", "postal_code": "44106-1702", "country": "United States", "latitude": 41.4995, "longitude": -81.69541, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Centricity Research - Ohio", "city": "Columbus", "state_or_region": "Ohio", "postal_code": "43213", "country": "United States", "latitude": 39.96118, "longitude": -82.99879, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Columbus", "state_or_region": "Ohio", "postal_code": "43215", "country": "United States", "latitude": 39.96118, "longitude": -82.99879, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Ohio State University Wexner Medical Center", "city": "Columbus", "state_or_region": "Ohio", "postal_code": "43210", "country": "United States", "latitude": 39.96118, "longitude": -82.99879, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "The Ohio State University Wexner Medical Center", "city": "Columbus", "state_or_region": "Ohio", "postal_code": "43210", "country": "United States", "latitude": 39.96118, "longitude": -82.99879, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "PriMed Clinical Research", "city": "Dayton", "state_or_region": "Ohio", "postal_code": "45429", "country": "United States", "latitude": 39.75895, "longitude": -84.19161, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Providence Center for Clinical Research", "city": "Dayton", "state_or_region": "Ohio", "postal_code": "45439", "country": "United States", "latitude": 39.75895, "longitude": -84.19161, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Advanced Medical Research - Maumee", "city": "Maumee", "state_or_region": "Ohio", "postal_code": "43537", "country": "United States", "latitude": 41.56283, "longitude": -83.65382, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Advanced Medical Research", "city": "Maumee", "state_or_region": "Ohio", "postal_code": "43537", "country": "United States", "latitude": 41.56283, "longitude": -83.65382, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Great Lakes Gastroenterology", "city": "Mentor", "state_or_region": "Ohio", "postal_code": "44060", "country": "United States", "latitude": 41.66616, "longitude": -81.33955, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Great Lakes Gastroenterology", "city": "Mentor", "state_or_region": "Ohio", "postal_code": "44060", "country": "United States", "latitude": 41.66616, "longitude": -81.33955, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Paramount Medical Research & Consulting, LLC", "city": "Middleburg Heights", "state_or_region": "Ohio", "postal_code": "44130", "country": "United States", "latitude": 41.36144, "longitude": -81.81291, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-DSI Research - Springboro, LLC", "city": "Springboro", "state_or_region": "Ohio", "postal_code": "45066", "country": "United States", "latitude": 39.55228, "longitude": -84.23327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-DSI Research - Springboro, LLC", "city": "Springboro", "state_or_region": "Ohio", "postal_code": "45066", "country": "United States", "latitude": 39.55228, "longitude": -84.23327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Family Practice Center of Wadsworth Inc.", "city": "Wadsworth", "state_or_region": "Ohio", "postal_code": "44281-9236", "country": "United States", "latitude": 41.02561, "longitude": -81.72985, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "New Venture Medical Research", "city": "Wadsworth", "state_or_region": "Ohio", "postal_code": "44281", "country": "United States", "latitude": 41.02561, "longitude": -81.72985, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CRIOH", "city": "Westlake", "state_or_region": "Ohio", "postal_code": "44145", "country": "United States", "latitude": 41.45532, "longitude": -81.91792, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro Intestinal Research Institute of Northern Ohio, LLC", "city": "Westlake", "state_or_region": "Ohio", "postal_code": "44145", "country": "United States", "latitude": 41.45532, "longitude": -81.91792, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro Intestinal Research Institute of Northern Ohio, LLC", "city": "Westlake", "state_or_region": "Ohio", "postal_code": "44145", "country": "United States", "latitude": 41.45532, "longitude": -81.91792, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Northshore Gastroenterology Research", "city": "Westlake", "state_or_region": "Ohio", "postal_code": "44145", "country": "United States", "latitude": 41.45532, "longitude": -81.91792, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Northshore Gastroenterology Research", "city": "Westlake", "state_or_region": "Ohio", "postal_code": "44145", "country": "United States", "latitude": 41.45532, "longitude": -81.91792, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tekton Research-Edmond-68875", "city": "Edmond", "state_or_region": "Oklahoma", "postal_code": "73013", "country": "United States", "latitude": 35.65283, "longitude": -97.4781, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Alliance for Multispecialty Research", "city": "Norman", "state_or_region": "Oklahoma", "postal_code": "73069", "country": "United States", "latitude": 35.22257, "longitude": -97.43948, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Norman", "state_or_region": "Oklahoma", "postal_code": "73069", "country": "United States", "latitude": 35.22257, "longitude": -97.43948, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Lynn Institute of Norman", "city": "Norman", "state_or_region": "Oklahoma", "postal_code": "73072", "country": "United States", "latitude": 35.22257, "longitude": -97.43948, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Children's Physicians OU", "city": "Oklahoma City", "state_or_region": "Oklahoma", "postal_code": "73104", "country": "United States", "latitude": 35.46756, "longitude": -97.51643, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06986993", "study_title": "Impact of Semaglutide on Tobacco Use and Related Health Behaviors", "lead_sponsor": "University of Oklahoma", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-08", "last_update_post_date": "2025-08-27", "facility": "Health Promotion Research Center", "city": "Oklahoma City", "state_or_region": "Oklahoma", "postal_code": "73104", "country": "United States", "latitude": 35.46756, "longitude": -97.51643, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06986993" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Essential Medical Research", "city": "Tulsa", "state_or_region": "Oklahoma", "postal_code": "74137", "country": "United States", "latitude": 36.15398, "longitude": -95.99277, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Options Health Research", "city": "Tulsa", "state_or_region": "Oklahoma", "postal_code": "74104", "country": "United States", "latitude": 36.15398, "longitude": -95.99277, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Options Health Research", "city": "Tulsa", "state_or_region": "Oklahoma", "postal_code": "74104", "country": "United States", "latitude": 36.15398, "longitude": -95.99277, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Yukon", "state_or_region": "Oklahoma", "postal_code": "73099", "country": "United States", "latitude": 35.50672, "longitude": -97.76254, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Corvallis Clinic PC Clinical Research Department", "city": "Corvallis", "state_or_region": "Oregon", "postal_code": "97330-3737", "country": "United States", "latitude": 44.56457, "longitude": -123.26204, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Oregon Dermatology and Research Center", "city": "Portland", "state_or_region": "Oregon", "postal_code": "97210", "country": "United States", "latitude": 45.52345, "longitude": -122.67621, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA Portland Health Care System, Portland, OR", "city": "Portland", "state_or_region": "Oregon", "postal_code": "97207-2964", "country": "United States", "latitude": 45.52345, "longitude": -122.67621, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Heritage Valley Medical Group", "city": "Beaver", "state_or_region": "Pennsylvania", "postal_code": "15009", "country": "United States", "latitude": 40.69534, "longitude": -80.30478, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Heritage Valley Medical Group", "city": "Beaver", "state_or_region": "Pennsylvania", "postal_code": "15009", "country": "United States", "latitude": 40.69534, "longitude": -80.30478, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Feasterville-Trevose", "state_or_region": "Pennsylvania", "postal_code": "19053", "country": "United States", "latitude": 40.15242, "longitude": -74.98655, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health - Flourtown", "city": "Flourtown", "state_or_region": "Pennsylvania", "postal_code": "19031", "country": "United States", "latitude": 40.10344, "longitude": -75.2124, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health", "city": "Flourtown", "state_or_region": "Pennsylvania", "postal_code": "19031", "country": "United States", "latitude": 40.10344, "longitude": -75.2124, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health", "city": "Flourtown", "state_or_region": "Pennsylvania", "postal_code": "19031", "country": "United States", "latitude": 40.10344, "longitude": -75.2124, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06548490", "study_title": "GLP-1R Agonist Treatment for Opioid Use Disorder", "lead_sponsor": "Milton S. Hershey Medical Center", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-28", "facility": "Pennsylvania Psychiatric Institute", "city": "Harrisburg", "state_or_region": "Pennsylvania", "postal_code": "17110", "country": "United States", "latitude": 40.2737, "longitude": -76.88442, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06548490" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Hatboro Med Associates", "city": "Hatboro", "state_or_region": "Pennsylvania", "postal_code": "19040", "country": "United States", "latitude": 40.17428, "longitude": -75.10684, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Penn State Milton S. Hershey Medical Center", "city": "Hershey", "state_or_region": "Pennsylvania", "postal_code": "17033", "country": "United States", "latitude": 40.28592, "longitude": -76.65025, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Penn State Milton S. Hershey Medical Center", "city": "Hershey", "state_or_region": "Pennsylvania", "postal_code": "17033", "country": "United States", "latitude": 40.28592, "longitude": -76.65025, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05071898", "study_title": "Pharmacogenetics of Response to GLP1R Agonists", "lead_sponsor": "University of Maryland, Baltimore", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-27", "facility": "Amish Research Clinic", "city": "Lancaster", "state_or_region": "Pennsylvania", "postal_code": "17602", "country": "United States", "latitude": 40.03788, "longitude": -76.30551, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05071898" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health", "city": "Lancaster", "state_or_region": "Pennsylvania", "postal_code": "17601", "country": "United States", "latitude": 40.03788, "longitude": -76.30551, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health", "city": "Lancaster", "state_or_region": "Pennsylvania", "postal_code": "17601", "country": "United States", "latitude": 40.03788, "longitude": -76.30551, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19104-4551", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Corporal Michael J. Crescenz VA Medical Center", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19104", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Northeast Endocrine Metabolic Associates", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19114", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Penn Medicine: University of Pennsylvania Health System", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19104", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19114", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Thomas Jefferson University - Medicine/GI and Hepatology", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19107", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Thomas Jefferson University - Medicine/GI and Hepatology", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19107", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05746039", "study_title": "Feasibility of Semaglutide in Advanced Lung Disease", "lead_sponsor": "University of Pennsylvania", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-21", "facility": "University of Pennsylvania Perelman School of Medicine", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19104", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05746039" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "UPA Ctr Weight and Eating Dis", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19104", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "UPA Ctr Weight and Eating Dis", "city": "Philadelphia", "state_or_region": "Pennsylvania", "postal_code": "19104", "country": "United States", "latitude": 39.95238, "longitude": -75.16362, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Preferred Primary Care Physicians-Pittsburgh-63932", "city": "Pittsburgh", "state_or_region": "Pennsylvania", "postal_code": "15236", "country": "United States", "latitude": 40.44062, "longitude": -79.99589, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Preferred Primary Care Physicians", "city": "Pittsburgh", "state_or_region": "Pennsylvania", "postal_code": "15243", "country": "United States", "latitude": 40.44062, "longitude": -79.99589, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07573163", "study_title": "Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion", "lead_sponsor": "Alaa Sada", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "University of Pittsburgh Medical Center", "city": "Pittsburgh", "state_or_region": "Pennsylvania", "postal_code": "15213", "country": "United States", "latitude": 40.44062, "longitude": -79.99589, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07573163" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "UPMC Child Hosp-Pittsburgh", "city": "Pittsburgh", "state_or_region": "Pennsylvania", "postal_code": "15224", "country": "United States", "latitude": 40.44062, "longitude": -79.99589, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Dermatology Associates of Plymouth Meeting", "city": "Plymouth Meeting", "state_or_region": "Pennsylvania", "postal_code": "19462", "country": "United States", "latitude": 40.10233, "longitude": -75.27435, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Geisinger Scenery Park", "city": "State College", "state_or_region": "Pennsylvania", "postal_code": "16801", "country": "United States", "latitude": 40.79339, "longitude": -77.86, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Preferred Primary Care Physicians - Matthew Drive", "city": "Uniontown", "state_or_region": "Pennsylvania", "postal_code": "15401", "country": "United States", "latitude": 39.90008, "longitude": -79.71643, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Preferred Primary Care Physicians, Inc.", "city": "Uniontown", "state_or_region": "Pennsylvania", "postal_code": "15401", "country": "United States", "latitude": 39.90008, "longitude": -79.71643, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health - Wyomissing", "city": "Wyomissing", "state_or_region": "Pennsylvania", "postal_code": "19610", "country": "United States", "latitude": 40.32954, "longitude": -75.96521, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health", "city": "Wyomissing", "state_or_region": "Pennsylvania", "postal_code": "19610", "country": "United States", "latitude": 40.32954, "longitude": -75.96521, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "US Digestive Health", "city": "Wyomissing", "state_or_region": "Pennsylvania", "postal_code": "19610", "country": "United States", "latitude": 40.32954, "longitude": -75.96521, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Res Collaborative", "city": "Cumberland", "state_or_region": "Rhode Island", "postal_code": "02864", "country": "United States", "latitude": 41.96677, "longitude": -71.43284, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Clinical Res Collaborative", "city": "Cumberland", "state_or_region": "Rhode Island", "postal_code": "02864", "country": "United States", "latitude": 41.96677, "longitude": -71.43284, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "East Greenwich", "state_or_region": "Rhode Island", "postal_code": "02818", "country": "United States", "latitude": 41.66038, "longitude": -71.45589, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Gastroenterology", "city": "Providence", "state_or_region": "Rhode Island", "postal_code": "02905", "country": "United States", "latitude": 41.82399, "longitude": -71.41283, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Gastroenterology", "city": "Providence", "state_or_region": "Rhode Island", "postal_code": "02905", "country": "United States", "latitude": 41.82399, "longitude": -71.41283, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Gastroenterology", "city": "Providence", "state_or_region": "Rhode Island", "postal_code": "02905", "country": "United States", "latitude": 41.82399, "longitude": -71.41283, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "PanAmerican Clinical Research - Bluffton", "city": "Bluffton", "state_or_region": "South Carolina", "postal_code": "29910", "country": "United States", "latitude": 32.23715, "longitude": -80.86039, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medical University of South Carolina", "city": "Charleston", "state_or_region": "South Carolina", "postal_code": "29425", "country": "United States", "latitude": 32.77632, "longitude": -79.93275, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Columbia Dermatology & Aesthetics", "city": "Columbia", "state_or_region": "South Carolina", "postal_code": "29212", "country": "United States", "latitude": 34.00071, "longitude": -81.03481, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Columbia Digestive Health Research", "city": "Columbia", "state_or_region": "South Carolina", "postal_code": "29204", "country": "United States", "latitude": 34.00071, "longitude": -81.03481, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-Columbia Digestive Health Research", "city": "Columbia", "state_or_region": "South Carolina", "postal_code": "29204", "country": "United States", "latitude": 34.00071, "longitude": -81.03481, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-Columbia Digestive Health Research", "city": "Columbia", "state_or_region": "South Carolina", "postal_code": "29204", "country": "United States", "latitude": 34.00071, "longitude": -81.03481, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Velocity Clinical Research-Gaffney", "city": "Gaffney", "state_or_region": "South Carolina", "postal_code": "29340", "country": "United States", "latitude": 35.07179, "longitude": -81.64982, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Associates - Patewood", "city": "Greenville", "state_or_region": "South Carolina", "postal_code": "29607", "country": "United States", "latitude": 34.85262, "longitude": -82.39401, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Associates - Patewood", "city": "Greenville", "state_or_region": "South Carolina", "postal_code": "29607", "country": "United States", "latitude": 34.85262, "longitude": -82.39401, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Prisma Health-Ped Endo", "city": "Greenville", "state_or_region": "South Carolina", "postal_code": "29615", "country": "United States", "latitude": 34.85262, "longitude": -82.39401, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "Prisma Health", "city": "Greenville", "state_or_region": "South Carolina", "postal_code": "29605", "country": "United States", "latitude": 34.85262, "longitude": -82.39401, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Tribe Clinical Research, LLC", "city": "Greenville", "state_or_region": "South Carolina", "postal_code": "29607", "country": "United States", "latitude": 34.85262, "longitude": -82.39401, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Myrtle Beach", "state_or_region": "South Carolina", "postal_code": "29572", "country": "United States", "latitude": 33.68906, "longitude": -78.88669, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Coastal Carolina Research Ctr", "city": "North Charleston", "state_or_region": "South Carolina", "postal_code": "29405", "country": "United States", "latitude": 32.85462, "longitude": -79.97481, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Coastal Carolina Research Ctr", "city": "North Charleston", "state_or_region": "South Carolina", "postal_code": "29405", "country": "United States", "latitude": 32.85462, "longitude": -79.97481, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "North Charleston", "state_or_region": "South Carolina", "postal_code": "29405", "country": "United States", "latitude": 32.85462, "longitude": -79.97481, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Monroe Biomedical Research, LLC", "city": "North Charleston", "state_or_region": "South Carolina", "postal_code": "29406", "country": "United States", "latitude": 32.85462, "longitude": -79.97481, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "North Charleston", "state_or_region": "South Carolina", "postal_code": "29405", "country": "United States", "latitude": 32.85462, "longitude": -79.97481, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Spartanburg", "state_or_region": "South Carolina", "postal_code": "29303", "country": "United States", "latitude": 34.94957, "longitude": -81.93205, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Spartanburg Medical Research", "city": "Spartanburg", "state_or_region": "South Carolina", "postal_code": "29303", "country": "United States", "latitude": 34.94957, "longitude": -81.93205, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Spartanburg Medical Research", "city": "Spartanburg", "state_or_region": "South Carolina", "postal_code": "29303", "country": "United States", "latitude": 34.94957, "longitude": -81.93205, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Spartanburg Medical Research", "city": "Spartanburg", "state_or_region": "South Carolina", "postal_code": "29303", "country": "United States", "latitude": 34.94957, "longitude": -81.93205, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Palmetto Clinical Research", "city": "Summerville", "state_or_region": "South Carolina", "postal_code": "29485", "country": "United States", "latitude": 33.0185, "longitude": -80.17565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Palmetto Clinical Research", "city": "Summerville", "state_or_region": "South Carolina", "postal_code": "29485", "country": "United States", "latitude": 33.0185, "longitude": -80.17565, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Monument Health Clinical Rsrch", "city": "Rapid City", "state_or_region": "South Dakota", "postal_code": "57701", "country": "United States", "latitude": 44.08054, "longitude": -103.23101, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Holston Medical Group_Bristol", "city": "Bristol", "state_or_region": "Tennessee", "postal_code": "37620", "country": "United States", "latitude": 36.59511, "longitude": -82.18874, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Holston Medical Group_Bristol", "city": "Bristol", "state_or_region": "Tennessee", "postal_code": "37620", "country": "United States", "latitude": 36.59511, "longitude": -82.18874, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ClinSearch, LLC", "city": "Chattanooga", "state_or_region": "Tennessee", "postal_code": "37421", "country": "United States", "latitude": 35.04563, "longitude": -85.30968, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ClinSearch, LLC", "city": "Chattanooga", "state_or_region": "Tennessee", "postal_code": "37421", "country": "United States", "latitude": 35.04563, "longitude": -85.30968, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Galen Medical Group - Galen Hepatology", "city": "Chattanooga", "state_or_region": "Tennessee", "postal_code": "37421", "country": "United States", "latitude": 35.04563, "longitude": -85.30968, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University Diabetes & Endocrine Consultants", "city": "Chattanooga", "state_or_region": "Tennessee", "postal_code": "37411", "country": "United States", "latitude": 35.04563, "longitude": -85.30968, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Innovative Clinical Research", "city": "Clarksville", "state_or_region": "Tennessee", "postal_code": "37040", "country": "United States", "latitude": 36.52977, "longitude": -87.35945, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Innovative Clinical Research", "city": "Clarksville", "state_or_region": "Tennessee", "postal_code": "37040", "country": "United States", "latitude": 36.52977, "longitude": -87.35945, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastro One (Walnut Run Road)", "city": "Cordova", "state_or_region": "Tennessee", "postal_code": "38018", "country": "United States", "latitude": 35.15565, "longitude": -89.7762, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Center Of The Midsouth", "city": "Cordova", "state_or_region": "Tennessee", "postal_code": "38018", "country": "United States", "latitude": 35.15565, "longitude": -89.7762, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Center Of The Midsouth", "city": "Cordova", "state_or_region": "Tennessee", "postal_code": "38018", "country": "United States", "latitude": 35.15565, "longitude": -89.7762, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Jackson Clinic", "city": "Jackson", "state_or_region": "Tennessee", "postal_code": "38305", "country": "United States", "latitude": 35.61452, "longitude": -88.81395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "West Tennessee Research Institute", "city": "Jackson", "state_or_region": "Tennessee", "postal_code": "38305", "country": "United States", "latitude": 35.61452, "longitude": -88.81395, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Holston Medical Group", "city": "Kingsport", "state_or_region": "Tennessee", "postal_code": "37660", "country": "United States", "latitude": 36.54843, "longitude": -82.56182, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Holston Medical Group", "city": "Kingsport", "state_or_region": "Tennessee", "postal_code": "37660", "country": "United States", "latitude": 36.54843, "longitude": -82.56182, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "CNS Healthcare", "city": "Memphis", "state_or_region": "Tennessee", "postal_code": "38119", "country": "United States", "latitude": 35.14953, "longitude": -90.04898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "CNS Healthcare", "city": "Memphis", "state_or_region": "Tennessee", "postal_code": "38119", "country": "United States", "latitude": 35.14953, "longitude": -90.04898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "LifeDoc Health", "city": "Memphis", "state_or_region": "Tennessee", "postal_code": "38115", "country": "United States", "latitude": 35.14953, "longitude": -90.04898, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "LifeDoc Health", "city": "Memphis", "state_or_region": "Tennessee", "postal_code": "38115", "country": "United States", "latitude": 35.14953, "longitude": -90.04898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "LifeDoc Research, PLLC", "city": "Memphis", "state_or_region": "Tennessee", "postal_code": "38115", "country": "United States", "latitude": 35.14953, "longitude": -90.04898, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Memphis", "state_or_region": "Tennessee", "postal_code": "38119", "country": "United States", "latitude": 35.14953, "longitude": -90.04898, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07228741", "study_title": "Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity", "lead_sponsor": "St. Jude Children's Research Hospital", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-04", "facility": "St. Jude Children's Research Hospital", "city": "Memphis", "state_or_region": "Tennessee", "postal_code": "38105", "country": "United States", "latitude": 35.14953, "longitude": -90.04898, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07228741" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "HealthStar Physicians, PC", "city": "Morristown", "state_or_region": "Tennessee", "postal_code": "37813", "country": "United States", "latitude": 36.21398, "longitude": -83.29489, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Morristown", "state_or_region": "Tennessee", "postal_code": "37813", "country": "United States", "latitude": 36.21398, "longitude": -83.29489, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Murfreesboro Medical Clinic", "city": "Murfreesboro", "state_or_region": "Tennessee", "postal_code": "37128", "country": "United States", "latitude": 35.84562, "longitude": -86.39027, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Clinical Research Associates", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37203", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Clinical Research Associates", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37203", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Quality Medical Research", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37211", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06901245", "study_title": "Tirzepatide in PWS, HO and GNSO", "lead_sponsor": "Grace Kim", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-01", "last_update_post_date": "2025-09-16", "facility": "Vanderbilt University Medical Center", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37203", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06901245" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06338553", "study_title": "GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab", "lead_sponsor": "Vanderbilt University Medical Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2025-12-18", "facility": "Vanderbilt University Medical Center", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37232", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06338553" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vanderbilt University Medical Center", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37232", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Vanderbilt University Medical Center", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37232", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "Vanderbilt University Medical Center", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37232", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07221214", "study_title": "GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV", "lead_sponsor": "Vanderbilt University Medical Center", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-26", "facility": "Vanderbilt University Medical Center", "city": "Nashville", "state_or_region": "Tennessee", "postal_code": "37232", "country": "United States", "latitude": 36.16589, "longitude": -86.78444, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07221214" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "DelRicht Research - Thompson's Station", "city": "Smyrna", "state_or_region": "Tennessee", "postal_code": "37167", "country": "United States", "latitude": 35.98284, "longitude": -86.5186, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Amarillo Med Spec LLP", "city": "Amarillo", "state_or_region": "Texas", "postal_code": "79124", "country": "United States", "latitude": 35.222, "longitude": -101.8313, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Amarillo Medical Specialists", "city": "Amarillo", "state_or_region": "Texas", "postal_code": "79124", "country": "United States", "latitude": 35.222, "longitude": -101.8313, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Texas Clinical Research Institute, LLC", "city": "Arlington", "state_or_region": "Texas", "postal_code": "76012", "country": "United States", "latitude": 32.73569, "longitude": -97.10807, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Texas Clinical Research Institute, LLC", "city": "Arlington", "state_or_region": "Texas", "postal_code": "76012", "country": "United States", "latitude": 32.73569, "longitude": -97.10807, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "American Research Corporation - Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78757", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "American Research Corporation - Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78757", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "American Research Corporation", "city": "Austin", "state_or_region": "Texas", "postal_code": "78757", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07527910", "study_title": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "lead_sponsor": "Regeneron Pharmaceuticals", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "American Research Corporation", "city": "Austin", "state_or_region": "Texas", "postal_code": "78757", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07527910" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT07607587", "study_title": "Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-25", "facility": "Elligo Clin Res Centre", "city": "Austin", "state_or_region": "Texas", "postal_code": "78704", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07607587" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "IMA Clinical Research Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78745", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78745", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78745", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78745", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "IMA Clinical Research", "city": "Austin", "state_or_region": "Texas", "postal_code": "78745", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research - Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78757", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research - Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78757", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research", "city": "Austin", "state_or_region": "Texas", "postal_code": "78757", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Texas Diab & Endo, P.A.", "city": "Austin", "state_or_region": "Texas", "postal_code": "78731", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Texas Diabetes and Endocrinology", "city": "Austin", "state_or_region": "Texas", "postal_code": "78731", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06173778", "study_title": "Semaglutide for Post-Smoking Cessation Weight Management", "lead_sponsor": "The University of Texas Health Science Center, Houston", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-11", "facility": "The University of Texas at Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78723", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06173778" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Velocity Clinical Research Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78759", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78759", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Austin", "city": "Austin", "state_or_region": "Texas", "postal_code": "78759", "country": "United States", "latitude": 30.26715, "longitude": -97.74306, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bellaire Clinical Research, LLC", "city": "Bellaire", "state_or_region": "Texas", "postal_code": "77401", "country": "United States", "latitude": 29.70579, "longitude": -95.45883, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Bellaire Clinical Research", "city": "Bellaire", "state_or_region": "Texas", "postal_code": "77401", "country": "United States", "latitude": 29.70579, "longitude": -95.45883, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Bellaire Dermatology Associates", "city": "Bellaire", "state_or_region": "Texas", "postal_code": "77401", "country": "United States", "latitude": 29.70579, "longitude": -95.45883, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research, LLC", "city": "Bellaire", "state_or_region": "Texas", "postal_code": "77401", "country": "United States", "latitude": 29.70579, "longitude": -95.45883, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Headlands Horizons, LLC dba Headlands Research-Brownsville", "city": "Brownsville", "state_or_region": "Texas", "postal_code": "78526", "country": "United States", "latitude": 25.90175, "longitude": -97.49748, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Brownsville", "state_or_region": "Texas", "postal_code": "78526", "country": "United States", "latitude": 25.90175, "longitude": -97.49748, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Texas Research Institute - Brownsville", "city": "Brownsville", "state_or_region": "Texas", "postal_code": "78520", "country": "United States", "latitude": 25.90175, "longitude": -97.49748, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Texas Research Institute - Brownsville", "city": "Brownsville", "state_or_region": "Texas", "postal_code": "78520", "country": "United States", "latitude": 25.90175, "longitude": -97.49748, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Texas Research Institute - Brownsville", "city": "Brownsville", "state_or_region": "Texas", "postal_code": "78520", "country": "United States", "latitude": 25.90175, "longitude": -97.49748, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Texas Research Institute - Brownsville", "city": "Brownsville", "state_or_region": "Texas", "postal_code": "78520", "country": "United States", "latitude": 25.90175, "longitude": -97.49748, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05119179", "study_title": "Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes", "lead_sponsor": "The University of Texas Health Science Center, Houston", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-17", "facility": "UTHealth Clinical Research Unit (CRU) at UT Brownsville", "city": "Brownsville", "state_or_region": "Texas", "postal_code": "78520", "country": "United States", "latitude": 25.90175, "longitude": -97.49748, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05119179" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Medical Research - Carrollton", "city": "Carrollton", "state_or_region": "Texas", "postal_code": "75006", "country": "United States", "latitude": 32.95373, "longitude": -96.89028, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Precision Comprehensive Clinical Research Solutions - Colleyville", "city": "Colleyville", "state_or_region": "Texas", "postal_code": "76034", "country": "United States", "latitude": 32.88096, "longitude": -97.15501, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Privia Medical Group Gulf Coast, PLLC", "city": "Conroe", "state_or_region": "Texas", "postal_code": "77384", "country": "United States", "latitude": 30.31188, "longitude": -95.45605, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Driscoll Children's Hospital", "city": "Corpus Christi", "state_or_region": "Texas", "postal_code": "78411", "country": "United States", "latitude": 27.80058, "longitude": -97.39638, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research - Corpus Christi", "city": "Corpus Christi", "state_or_region": "Texas", "postal_code": "78404", "country": "United States", "latitude": 27.80058, "longitude": -97.39638, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06517212", "study_title": "Tirzepatide Weight Loss for MRD+ Early Breast Cancer", "lead_sponsor": "Baylor Research Institute", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-12", "facility": "Baylor University Medical Center, Baylor Charles A Sammons Cancer Center", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75246", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06517212" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Cedar Health Research", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75251", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07387796", "study_title": "Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation", "lead_sponsor": "The University of Texas at Dallas", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-26", "facility": "Center for BrainHealth", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75235", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07387796" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "FutureSearch Trials of Dallas", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75251", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Alliance Research - Dallas", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75246", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Alliance Research - Dallas", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75246", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Modern Research Associates, PLLC", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75231", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "North Texas Endocrine Center", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75231", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "North Texas Research Institute - Dallas", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75150", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "North Texas Research Institute - Dallas", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75150", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75390", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "University of Texas Southwestern Medical Center", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75390-8837", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "University of Texas Southwestern Medical Center", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75390-9302", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07361874", "study_title": "IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion", "lead_sponsor": "University of Texas Southwestern Medical Center", "phases": "NA", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-27", "facility": "University of Texas Southwestern Medical Center", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75390", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07361874" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75216-7167", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Velocity Clin Res, Dallas", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75230", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Dallas-69170", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75230", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Velocity Clinical Research, Dallas", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75230", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Zenos Clinical Research", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75230", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Zenos Clinical Research", "city": "Dallas", "state_or_region": "Texas", "postal_code": "75230", "country": "United States", "latitude": 32.78306, "longitude": -96.80667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Soma Clinical Trials", "city": "Denison", "state_or_region": "Texas", "postal_code": "75020", "country": "United States", "latitude": 33.75566, "longitude": -96.53666, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Soma Clinical Trials", "city": "Denison", "state_or_region": "Texas", "postal_code": "75020", "country": "United States", "latitude": 33.75566, "longitude": -96.53666, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Soma Clinical Trials", "city": "Denison", "state_or_region": "Texas", "postal_code": "75020", "country": "United States", "latitude": 33.75566, "longitude": -96.53666, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Epic Medical Research - DeSoto", "city": "DeSoto", "state_or_region": "Texas", "postal_code": "75115", "country": "United States", "latitude": 32.58986, "longitude": -96.85695, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Medical Research - DeSoto", "city": "DeSoto", "state_or_region": "Texas", "postal_code": "75115", "country": "United States", "latitude": 32.58986, "longitude": -96.85695, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Medical Research - DeSoto", "city": "DeSoto", "state_or_region": "Texas", "postal_code": "75115", "country": "United States", "latitude": 32.58986, "longitude": -96.85695, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Texas Research Institute-Edinburg-67012", "city": "Edinburg", "state_or_region": "Texas", "postal_code": "78539", "country": "United States", "latitude": 26.30174, "longitude": -98.16334, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "South Texas Research Institute", "city": "Edinburg", "state_or_region": "Texas", "postal_code": "78539", "country": "United States", "latitude": 26.30174, "longitude": -98.16334, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Davita Clinical Research", "city": "El Paso", "state_or_region": "Texas", "postal_code": "79902", "country": "United States", "latitude": 31.75872, "longitude": -106.48693, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Cedar Health Research", "city": "Euless", "state_or_region": "Texas", "postal_code": "76040", "country": "United States", "latitude": 32.83707, "longitude": -97.08195, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Dallas Research Institute", "city": "Farmers Branch", "state_or_region": "Texas", "postal_code": "75234", "country": "United States", "latitude": 32.92651, "longitude": -96.89612, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care United Research, LLC", "city": "Forney", "state_or_region": "Texas", "postal_code": "75126", "country": "United States", "latitude": 32.74818, "longitude": -96.47193, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care United Research", "city": "Forney", "state_or_region": "Texas", "postal_code": "75126", "country": "United States", "latitude": 32.74818, "longitude": -96.47193, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Fort Worth", "city": "Fort Worth", "state_or_region": "Texas", "postal_code": "76109", "country": "United States", "latitude": 32.72541, "longitude": -97.32085, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Alliance - Fort Worth", "city": "Fort Worth", "state_or_region": "Texas", "postal_code": "76104", "country": "United States", "latitude": 32.72541, "longitude": -97.32085, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Valley Institute of Research - Fort Worth", "city": "Fort Worth", "state_or_region": "Texas", "postal_code": "76164", "country": "United States", "latitude": 32.72541, "longitude": -97.32085, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07220473", "study_title": "Tirzepatide to Slow Biological Aging", "lead_sponsor": "The University of Texas Medical Branch, Galveston", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-24", "facility": "University of Texas Medical Branch", "city": "Galveston", "state_or_region": "Texas", "postal_code": "77555", "country": "United States", "latitude": 29.30135, "longitude": -94.7977, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07220473" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EmVenio Research Center at Prime Healthcare - Farmers Branch", "city": "Garden City", "state_or_region": "Texas", "postal_code": "48135", "country": "United States", "latitude": 31.86402, "longitude": -101.48123, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "EmVenio Research Center at Prime Healthcare - Farmers Branch", "city": "Garden City", "state_or_region": "Texas", "postal_code": "48135", "country": "United States", "latitude": 31.86402, "longitude": -101.48123, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "DHAT Reseach Institute", "city": "Garland", "state_or_region": "Texas", "postal_code": "75044", "country": "United States", "latitude": 32.91262, "longitude": -96.63888, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Medical Research - Garland", "city": "Garland", "state_or_region": "Texas", "postal_code": "75043", "country": "United States", "latitude": 32.91262, "longitude": -96.63888, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07527910", "study_title": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "lead_sponsor": "Regeneron Pharmaceuticals", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Advanced Medical Trials", "city": "Georgetown", "state_or_region": "Texas", "postal_code": "78628", "country": "United States", "latitude": 30.63269, "longitude": -97.67723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07527910" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research - Georgetown", "city": "Georgetown", "state_or_region": "Texas", "postal_code": "78626", "country": "United States", "latitude": 30.63269, "longitude": -97.67723, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research, LLC", "city": "Georgetown", "state_or_region": "Texas", "postal_code": "78626", "country": "United States", "latitude": 30.63269, "longitude": -97.67723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research, LLC", "city": "Georgetown", "state_or_region": "Texas", "postal_code": "78626", "country": "United States", "latitude": 30.63269, "longitude": -97.67723, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Accurate Clinical Research, Inc", "city": "Houston", "state_or_region": "Texas", "postal_code": "77089", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ben Taub General Hospital", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030-1608", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Ben Taub General Hospital", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030-1608", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Biopharma Informatic, Inc. Research Center", "city": "Houston", "state_or_region": "Texas", "postal_code": "77084", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Biopharma Informatic, Inc. Research Center", "city": "Houston", "state_or_region": "Texas", "postal_code": "77084", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Biopharma Informatic, Inc. Research Center", "city": "Houston", "state_or_region": "Texas", "postal_code": "77084", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Biopharma Informatic, LLC", "city": "Houston", "state_or_region": "Texas", "postal_code": "77084", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - Houston", "city": "Houston", "state_or_region": "Texas", "postal_code": "77054", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Center for Clinical Studies", "city": "Houston", "state_or_region": "Texas", "postal_code": "77004", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "DM Clinical", "city": "Houston", "state_or_region": "Texas", "postal_code": "77065", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "thymosin-alpha-1", "nct_id": "NCT06821100", "study_title": "Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine", "lead_sponsor": "The Methodist Hospital Research Institute", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-16", "facility": "Houston Methodist Hospital", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06821100" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07651319", "study_title": "Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease", "lead_sponsor": "The Methodist Hospital Research Institute", "phases": "PHASE1; PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-16", "facility": "Houston Methodist Research Institute", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07651319" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Houston Research Institute", "city": "Houston", "state_or_region": "Texas", "postal_code": "77079", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "HRI Medical Center", "city": "Houston", "state_or_region": "Texas", "postal_code": "77004", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "HRI- Medical Center", "city": "Houston", "state_or_region": "Texas", "postal_code": "77004", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "JCCT- Juno NW Houston", "city": "Houston", "state_or_region": "Texas", "postal_code": "77040", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "JCCT- Juno NW Houston", "city": "Houston", "state_or_region": "Texas", "postal_code": "77040", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Juno Research, LLC", "city": "Houston", "state_or_region": "Texas", "postal_code": "77040", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "Michael E. DeBakey VA Medical Center, Houston, TX", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030-4211", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "PlanIt Research, PLLC", "city": "Houston", "state_or_region": "Texas", "postal_code": "77079", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "PlanIt Research, PLLC", "city": "Houston", "state_or_region": "Texas", "postal_code": "77079", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Private Practice - Dr. Laila A. Hassan", "city": "Houston", "state_or_region": "Texas", "postal_code": "77089", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Research Physicians Network, LLC", "city": "Houston", "state_or_region": "Texas", "postal_code": "77089", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Physicians Network, LLC", "city": "Houston", "state_or_region": "Texas", "postal_code": "77089", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Physicians Network", "city": "Houston", "state_or_region": "Texas", "postal_code": "77089", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Physicians Network", "city": "Houston", "state_or_region": "Texas", "postal_code": "77089", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Research Physicians Network", "city": "Houston", "state_or_region": "Texas", "postal_code": "77089", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Houston", "state_or_region": "Texas", "postal_code": "77004", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Houston", "state_or_region": "Texas", "postal_code": "77040", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Houston", "state_or_region": "Texas", "postal_code": "77079", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "The Endocrine Center", "city": "Houston", "state_or_region": "Texas", "postal_code": "77079", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07227948", "study_title": "Repurposing Semaglutide for the Treatment of Cocaine Use Disorder", "lead_sponsor": "The University of Texas Health Science Center, Houston", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-19", "facility": "The University of Texas Health Science Center at Houston", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07227948" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07325500", "study_title": "Incretin Microdosing for Cardiometabolic Health in People With HIV", "lead_sponsor": "The University of Texas Health Science Center, Houston", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-18", "facility": "The University of Texas Health Science Center at Houston", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07325500" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06173778", "study_title": "Semaglutide for Post-Smoking Cessation Weight Management", "lead_sponsor": "The University of Texas Health Science Center, Houston", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-11", "facility": "The University of Texas Health Science Center at Houston", "city": "Houston", "state_or_region": "Texas", "postal_code": "77054", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06173778" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06759701", "study_title": "Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study", "lead_sponsor": "M.D. Anderson Cancer Center", "phases": "EARLY_PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2026-02", "last_update_post_date": "2026-02-27", "facility": "The University of Texas M. D. Anderson Cancer Center", "city": "Houston", "state_or_region": "Texas", "postal_code": "77030", "country": "United States", "latitude": 29.76328, "longitude": -95.36327, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06759701" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving", "city": "Irving", "state_or_region": "Texas", "postal_code": "75039", "country": "United States", "latitude": 32.81402, "longitude": -96.94889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "DM Clinical - Dallas", "city": "Irving", "state_or_region": "Texas", "postal_code": "75061", "country": "United States", "latitude": 32.81402, "longitude": -96.94889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Biopharma Informatic, LLC", "city": "Katy", "state_or_region": "Texas", "postal_code": "77494", "country": "United States", "latitude": 29.78579, "longitude": -95.8244, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Medical Colleagues-Texas LLP", "city": "Katy", "state_or_region": "Texas", "postal_code": "77450", "country": "United States", "latitude": 29.78579, "longitude": -95.8244, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Katy", "state_or_region": "Texas", "postal_code": "77450", "country": "United States", "latitude": 29.78579, "longitude": -95.8244, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Sante Clinical Research", "city": "Kerrville", "state_or_region": "Texas", "postal_code": "78028", "country": "United States", "latitude": 30.04743, "longitude": -99.14032, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Radiance Clinical Research", "city": "Lampasas", "state_or_region": "Texas", "postal_code": "76550", "country": "United States", "latitude": 31.06378, "longitude": -98.1817, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Radiance Clinical Research", "city": "Lampasas", "state_or_region": "Texas", "postal_code": "76550", "country": "United States", "latitude": 31.06378, "longitude": -98.1817, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Aeres Clinical Research", "city": "Laredo", "state_or_region": "Texas", "postal_code": "78041", "country": "United States", "latitude": 27.50641, "longitude": -99.50754, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Clinical Research", "city": "Lewisville", "state_or_region": "Texas", "postal_code": "75057", "country": "United States", "latitude": 33.04623, "longitude": -96.99417, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Clinical Research", "city": "Lewisville", "state_or_region": "Texas", "postal_code": "75057", "country": "United States", "latitude": 33.04623, "longitude": -96.99417, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "DCOL Ctr for Clin Res", "city": "Longview", "state_or_region": "Texas", "postal_code": "75605", "country": "United States", "latitude": 32.5007, "longitude": -94.74049, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Alliance Research - Mansfield", "city": "Mansfield", "state_or_region": "Texas", "postal_code": "76063", "country": "United States", "latitude": 32.56319, "longitude": -97.14168, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Alliance Research - Mansfield", "city": "Mansfield", "state_or_region": "Texas", "postal_code": "76063", "country": "United States", "latitude": 32.56319, "longitude": -97.14168, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Biopharma Informatic LLC", "city": "McAllen", "state_or_region": "Texas", "postal_code": "78503", "country": "United States", "latitude": 26.20341, "longitude": -98.23001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Biopharma Informatic LLC", "city": "McAllen", "state_or_region": "Texas", "postal_code": "78503", "country": "United States", "latitude": 26.20341, "longitude": -98.23001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Biopharma Informatic, LLC", "city": "McAllen", "state_or_region": "Texas", "postal_code": "78503", "country": "United States", "latitude": 26.20341, "longitude": -98.23001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centex Studies, Inc.", "city": "McAllen", "state_or_region": "Texas", "postal_code": "78504", "country": "United States", "latitude": 26.20341, "longitude": -98.23001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Centex Studies, Inc.", "city": "McAllen", "state_or_region": "Texas", "postal_code": "78504", "country": "United States", "latitude": 26.20341, "longitude": -98.23001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "DHR Health Institute for Research and Development (Administrative Office & Laboratory)", "city": "McAllen", "state_or_region": "Texas", "postal_code": "78504", "country": "United States", "latitude": 26.20341, "longitude": -98.23001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "RGV Endocrine Center", "city": "McAllen", "state_or_region": "Texas", "postal_code": "78503", "country": "United States", "latitude": 26.20341, "longitude": -98.23001, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern Endocrinology Associates", "city": "Mesquite", "state_or_region": "Texas", "postal_code": "75149", "country": "United States", "latitude": 32.7668, "longitude": -96.59916, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern Endocrinology Associates", "city": "Mesquite", "state_or_region": "Texas", "postal_code": "75149", "country": "United States", "latitude": 32.7668, "longitude": -96.59916, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "HRI Pasadena", "city": "Pasadena", "state_or_region": "Texas", "postal_code": "77505", "country": "United States", "latitude": 29.69106, "longitude": -95.2091, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Austin Institute for Clinical Research", "city": "Pflugerville", "state_or_region": "Texas", "postal_code": "78660", "country": "United States", "latitude": 30.43937, "longitude": -97.62, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Epic Medical Research - Plano", "city": "Plano", "state_or_region": "Texas", "postal_code": "75093", "country": "United States", "latitude": 33.01984, "longitude": -96.69889, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "AES San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "American Research Corporation at Texas Liver Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78215", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "American Research Corporation at the Texas Liver Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78215", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "American Research Corporation at the Texas Liver Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78215", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT07527910", "study_title": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "lead_sponsor": "Regeneron Pharmaceuticals", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "American Research Corporation at The Texas Liver Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78215", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07527910" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Brooke Army Medical Center", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78219", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Brooke Army Medical Center", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78219", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Clinical Advancement Center", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78212", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Trials of Texas, LLC dba Flourish Research", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Trials of Texas, LLC", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "DM Clinical", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78207", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Endeavor Clinical Trials", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78240", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Research of San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Research of San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "HASresearch", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78240", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "HASresearch", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78240", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT06719011", "study_title": "A Study on How NNC0174-1213 Works in People With Overweight or Obesity.", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2025-05", "last_update_post_date": "2025-05-25", "facility": "ICON Early Phase Services, LLC", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78209", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06719011" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "IMA Clinical Research San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Northeast Clinical Research of San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78233", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research - San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78222", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research - San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78222", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research, LLC", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Pinnacle Clinical Research, LLC", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Pinnacle Clinical Research", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78222", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Pinnacle Clinical Research", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78222", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Quality Research Inc", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78209", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Quality Research Inc", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78209", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern Star Research Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Southern Star Research Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Tekton Research - Fredericksburg Road", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78258", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Tekton Research Inc", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78258", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Tekton Research", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78251", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Texas Dermatology and Laser Specialists", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78218", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "The Texas Liver Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78215", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06706284", "study_title": "Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes", "lead_sponsor": "Marzieh Salehi", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "University Health - Texas Diabetic Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78207", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06706284" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06246799", "study_title": "Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes", "lead_sponsor": "The University of Texas Health Science Center at San Antonio", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-10", "facility": "University Health System Texas Diabetic Institute", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78207", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06246799" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06446531", "study_title": "Prevention of Progression of Prediabetes, Obesity and CV Risk", "lead_sponsor": "The University of Texas Health Science Center at San Antonio", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2025-11", "last_update_post_date": "2025-11-12", "facility": "University of Texas Health Science Center at San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06446531" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06706284", "study_title": "Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes", "lead_sponsor": "Marzieh Salehi", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-04", "last_update_post_date": "2026-04-13", "facility": "University of Texas Health Science Center at San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06706284" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06811324", "study_title": "Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults", "lead_sponsor": "The University of Texas Health Science Center at San Antonio", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-01", "last_update_post_date": "2026-04-15", "facility": "University of Texas Health Science Center at San Antonio", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06811324" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06246799", "study_title": "Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes", "lead_sponsor": "The University of Texas Health Science Center at San Antonio", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-10", "facility": "UT Health Science Center", "city": "San Antonio", "state_or_region": "Texas", "postal_code": "78229", "country": "United States", "latitude": 29.42412, "longitude": -98.49363, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06246799" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Consano Clin Res-Shavano Park", "city": "Shavano Park", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.58495, "longitude": -98.55252, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Consano Clin Res-Shavano Park", "city": "Shavano Park", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.58495, "longitude": -98.55252, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Consano Clinical Research, LLC", "city": "Shavano Park", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.58495, "longitude": -98.55252, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Consano Clinical Research, LLC", "city": "Shavano Park", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.58495, "longitude": -98.55252, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Consano Clinical Research, LLC", "city": "Shavano Park", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.58495, "longitude": -98.55252, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Consano Clinical Research, LLC", "city": "Shavano Park", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.58495, "longitude": -98.55252, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Consano Clinical Research", "city": "Shavano Park", "state_or_region": "Texas", "postal_code": "78231", "country": "United States", "latitude": 29.58495, "longitude": -98.55252, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Alliance - Southlake", "city": "Southlake", "state_or_region": "Texas", "postal_code": "76092", "country": "United States", "latitude": 32.94124, "longitude": -97.13418, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Houston Research Institute (HRI) - Sugar Land", "city": "Sugar Land", "state_or_region": "Texas", "postal_code": "77479", "country": "United States", "latitude": 29.61968, "longitude": -95.63495, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Mt Olympus Medical Research, LLC", "city": "Sugar Land", "state_or_region": "Texas", "postal_code": "77478", "country": "United States", "latitude": 29.61968, "longitude": -95.63495, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Sugar Land", "state_or_region": "Texas", "postal_code": "77478", "country": "United States", "latitude": 29.61968, "longitude": -95.63495, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Advanced Rheumatology of Houston - Woodlands", "city": "The Woodlands", "state_or_region": "Texas", "postal_code": "77382", "country": "United States", "latitude": 30.15799, "longitude": -95.48938, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "DM Clinical Research - TRA", "city": "Tomball", "state_or_region": "Texas", "postal_code": "77375", "country": "United States", "latitude": 30.09716, "longitude": -95.61605, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tyler Research Institute", "city": "Tyler", "state_or_region": "Texas", "postal_code": "75701", "country": "United States", "latitude": 32.35126, "longitude": -95.30106, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tyler Research Institute", "city": "Tyler", "state_or_region": "Texas", "postal_code": "75701", "country": "United States", "latitude": 32.35126, "longitude": -95.30106, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Objective Health-Digestive Research of Central Texas", "city": "Waco", "state_or_region": "Texas", "postal_code": "76712", "country": "United States", "latitude": 31.54933, "longitude": -97.14667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Objective Health-Digestive Research of Central Texas", "city": "Waco", "state_or_region": "Texas", "postal_code": "76712", "country": "United States", "latitude": 31.54933, "longitude": -97.14667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Waco", "city": "Waco", "state_or_region": "Texas", "postal_code": "76710", "country": "United States", "latitude": 31.54933, "longitude": -97.14667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Waco", "city": "Waco", "state_or_region": "Texas", "postal_code": "76710", "country": "United States", "latitude": 31.54933, "longitude": -97.14667, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Center for Clinical Studies", "city": "Webster", "state_or_region": "Texas", "postal_code": "77598", "country": "United States", "latitude": 29.53773, "longitude": -95.11826, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Weslaco", "state_or_region": "Texas", "postal_code": "78596", "country": "United States", "latitude": 26.15952, "longitude": -97.99084, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Texas Valley Clinical Research", "city": "Weslaco", "state_or_region": "Texas", "postal_code": "78596", "country": "United States", "latitude": 26.15952, "longitude": -97.99084, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Texas Valley Clinical Research", "city": "Weslaco", "state_or_region": "Texas", "postal_code": "78596", "country": "United States", "latitude": 26.15952, "longitude": -97.99084, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Texas Valley Clinical Research", "city": "Weslaco", "state_or_region": "Texas", "postal_code": "78596", "country": "United States", "latitude": 26.15952, "longitude": -97.99084, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "Texas Valley Clinical Research", "city": "Weslaco", "state_or_region": "Texas", "postal_code": "78596", "country": "United States", "latitude": 26.15952, "longitude": -97.99084, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Texas Valley Clinical Research", "city": "Weslaco", "state_or_region": "Texas", "postal_code": "78596", "country": "United States", "latitude": 26.15952, "longitude": -97.99084, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-Digestive Health Research of North Texas", "city": "Wichita Falls", "state_or_region": "Texas", "postal_code": "76301", "country": "United States", "latitude": 33.91371, "longitude": -98.49339, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ObjectiveHealth-Digestive Health Research of North Texas", "city": "Wichita Falls", "state_or_region": "Texas", "postal_code": "76301", "country": "United States", "latitude": 33.91371, "longitude": -98.49339, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Medrasa Clinical Research", "city": "Wylie", "state_or_region": "Texas", "postal_code": "75098", "country": "United States", "latitude": 33.01512, "longitude": -96.53888, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Bountiful", "state_or_region": "Utah", "postal_code": "84010", "country": "United States", "latitude": 40.88939, "longitude": -111.88077, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06439277", "study_title": "A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-07", "facility": "Alliance for Multispecialty Research, LLC", "city": "Layton", "state_or_region": "Utah", "postal_code": "84041", "country": "United States", "latitude": 41.06022, "longitude": -111.97105, "site_statuses": "COMPLETED", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06439277" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07253285", "study_title": "A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-17", "facility": "AMR Clinical", "city": "Layton", "state_or_region": "Utah", "postal_code": "84041", "country": "United States", "latitude": 41.06022, "longitude": -111.97105, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07253285" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Tanner Clinic", "city": "Layton", "state_or_region": "Utah", "postal_code": "84041", "country": "United States", "latitude": 41.06022, "longitude": -111.97105, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Care Access - Ogden", "city": "Ogden", "state_or_region": "Utah", "postal_code": "84403", "country": "United States", "latitude": 41.223, "longitude": -111.97383, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide", "nct_id": "NCT06719011", "study_title": "A Study on How NNC0174-1213 Works in People With Overweight or Obesity.", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE1", "overall_status": "RECRUITING", "status_verified_date": "2025-05", "last_update_post_date": "2025-05-25", "facility": "ICON Early Phase Services, LLC", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84124", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06719011" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "J.Lewis Research Inc", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84109", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "J.Lewis Research Inc", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84121", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Olympus Family Medicine", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84117", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84124", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05173714", "study_title": "Sit Less, Interact and Move More (SLIMM) 2 Study", "lead_sponsor": "Srinvasan Beddhu", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-27", "facility": "University of Utah", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84108", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05173714" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "University of Utah", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84108", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA Salt Lake City Health Care System, Salt Lake City, UT", "city": "Salt Lake City", "state_or_region": "Utah", "postal_code": "84148-0001", "country": "United States", "latitude": 40.76078, "longitude": -111.89105, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Advanced Research Institute - Sandy", "city": "Sandy City", "state_or_region": "Utah", "postal_code": "84070", "country": "United States", "latitude": 40.59161, "longitude": -111.8841, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Diabetes & Endo Tx Specialists", "city": "Sandy City", "state_or_region": "Utah", "postal_code": "84093", "country": "United States", "latitude": 40.59161, "longitude": -111.8841, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "J.Lewis Research Inc", "city": "South Jordan", "state_or_region": "Utah", "postal_code": "84095", "country": "United States", "latitude": 40.56217, "longitude": -111.92966, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Chrysalis Clinical Research", "city": "St. George", "state_or_region": "Utah", "postal_code": "84790", "country": "United States", "latitude": 37.10415, "longitude": -113.58412, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "liraglutide", "nct_id": "NCT03883412", "study_title": "Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)", "lead_sponsor": "University of Virginia", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "University of Virginia", "city": "Charlottesville", "state_or_region": "Virginia", "postal_code": "22906", "country": "United States", "latitude": 38.02931, "longitude": -78.47668, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT03883412" }, { "compound_slugs": "liraglutide", "nct_id": "NCT04575844", "study_title": "Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome", "lead_sponsor": "University of Virginia", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-05-06", "facility": "University of Virginia", "city": "Charlottesville", "state_or_region": "Virginia", "postal_code": "22906", "country": "United States", "latitude": 38.02931, "longitude": -78.47668, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT04575844" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Sovah Clinical Research-River District", "city": "Danville", "state_or_region": "Virginia", "postal_code": "24541", "country": "United States", "latitude": 36.58597, "longitude": -79.39502, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Leesburg", "state_or_region": "Virginia", "postal_code": "20176", "country": "United States", "latitude": 39.11566, "longitude": -77.5636, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Manassas", "state_or_region": "Virginia", "postal_code": "20110", "country": "United States", "latitude": 38.75095, "longitude": -77.47527, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Health Res of Hampton Roads", "city": "Newport News", "state_or_region": "Virginia", "postal_code": "23606", "country": "United States", "latitude": 36.98038, "longitude": -76.42975, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Liver Institute of Virginia-Bremo", "city": "Newport News", "state_or_region": "Virginia", "postal_code": "23601", "country": "United States", "latitude": 36.98038, "longitude": -76.42975, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Tidewater Physicians Multispecialty Group", "city": "Newport News", "state_or_region": "Virginia", "postal_code": "23606", "country": "United States", "latitude": 36.98038, "longitude": -76.42975, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Tidewater Physicians Multispecialty Group", "city": "Newport News", "state_or_region": "Virginia", "postal_code": "23606", "country": "United States", "latitude": 36.98038, "longitude": -76.42975, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Eximia Research - Norfolk", "city": "Norfolk", "state_or_region": "Virginia", "postal_code": "23502", "country": "United States", "latitude": 36.84681, "longitude": -76.28522, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Norfolk", "state_or_region": "Virginia", "postal_code": "23502", "country": "United States", "latitude": 36.84681, "longitude": -76.28522, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Select Health Research, LLC", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23236", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "GI Select Health Research, LLC", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23236", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07284979", "study_title": "Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes", "lead_sponsor": "Kailera", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-22", "facility": "Kailera Clinical Site", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23236", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07284979" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "National Clin Res Inc.", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23294", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "National Clin Res Inc.", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23294", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Richmond Veterans Affairs Medical Center (Richmond VA Medical Center)", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23249", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "VCU Medical Center West Hospital", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23298", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "VCU Medical Center West Hospital", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23298", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Virginia Commonwealth University (VCU) Medical Center", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23298", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05424003", "study_title": "Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant", "lead_sponsor": "University of Virginia", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-04", "facility": "Virginia Commonwealth University", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23298", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05424003" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06975111", "study_title": "Focusing on the Menopausal Transition to Improve Mid-Life Women's Health", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE2; PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-21", "facility": "Virginia Commonwealth University", "city": "Richmond", "state_or_region": "Virginia", "postal_code": "23298", "country": "United States", "latitude": 37.55376, "longitude": -77.46026, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06975111" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Consultants of Southwest Virginia", "city": "Roanoke", "state_or_region": "Virginia", "postal_code": "24014", "country": "United States", "latitude": 37.27097, "longitude": -79.94143, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Gastroenterology Consultants of Southwest Virginia", "city": "Roanoke", "state_or_region": "Virginia", "postal_code": "24014", "country": "United States", "latitude": 37.27097, "longitude": -79.94143, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07770841", "study_title": "Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-18", "facility": "Selma Medical Associates", "city": "Winchester", "state_or_region": "Virginia", "postal_code": "22601-3834", "country": "United States", "latitude": 39.18566, "longitude": -78.16333, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07770841" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Bellevue Dermatology Clinic", "city": "Bellevue", "state_or_region": "Washington", "postal_code": "98104", "country": "United States", "latitude": 47.61038, "longitude": -122.20068, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Washington Gastroenterology - Bellevue", "city": "Bellevue", "state_or_region": "Washington", "postal_code": "98004", "country": "United States", "latitude": 47.61038, "longitude": -122.20068, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06857942", "study_title": "A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-03", "facility": "Dermatology of Seattle", "city": "Burien", "state_or_region": "Washington", "postal_code": "98168", "country": "United States", "latitude": 47.47038, "longitude": -122.34679, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06857942" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "ERA Health Research - Redmond", "city": "Redmond", "state_or_region": "Washington", "postal_code": "98052", "country": "United States", "latitude": 47.67399, "longitude": -122.12151, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07639021", "study_title": "A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-10", "facility": "Rainier Clin Res Ctr Inc", "city": "Renton", "state_or_region": "Washington", "postal_code": "98057", "country": "United States", "latitude": 47.48288, "longitude": -122.21707, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07639021" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Renton", "state_or_region": "Washington", "postal_code": "98057", "country": "United States", "latitude": 47.48288, "longitude": -122.21707, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07446998", "study_title": "Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss", "lead_sponsor": "Veru Inc.", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-07-01", "facility": "DM Clinical - Seattle", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98122", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07446998" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98104", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98105", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06901245", "study_title": "Tirzepatide in PWS, HO and GNSO", "lead_sponsor": "Grace Kim", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2025-01", "last_update_post_date": "2025-09-16", "facility": "Seattle Children's Hospital", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98105", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06901245" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Seattle Rheumatology Associates PLLC", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98104", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05780905", "study_title": "Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes", "lead_sponsor": "University of Washington", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2024-05", "last_update_post_date": "2024-06-05", "facility": "University of Washington - Harborview Medical Center", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98104", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05780905" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05819138", "study_title": "Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes", "lead_sponsor": "University of Colorado, Denver", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-04", "facility": "University of Washington Medicine Diabetes Institute (UWMDI)", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98109", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05819138" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05822609", "study_title": "Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes", "lead_sponsor": "University of Washington", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-06-02", "facility": "University of Washington", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98104", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05822609" }, { "compound_slugs": "ss-31", "nct_id": "NCT07275424", "study_title": "Study of Healthy Aging and Physical Function With Elamipretide", "lead_sponsor": "David Marcinek", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2025-12", "last_update_post_date": "2025-12-10", "facility": "University of Washington", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98109", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07275424" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "UW Medicine Diabetes Institute", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98109", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Seattle", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98105", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research, Seattle", "city": "Seattle", "state_or_region": "Washington", "postal_code": "98105", "country": "United States", "latitude": 47.60621, "longitude": -122.33207, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06864026", "study_title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE4", "overall_status": "RECRUITING", "status_verified_date": "2026-06", "last_update_post_date": "2026-06-11", "facility": "Arthritis Northwest, PLLC", "city": "Spokane Valley", "state_or_region": "Washington", "postal_code": "99216", "country": "United States", "latitude": 47.67323, "longitude": -117.23937, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "compound_slugs": "semaglutide", "nct_id": "NCT06717698", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-03", "last_update_post_date": "2026-03-11", "facility": "Providence Medical Research Center", "city": "Spokane", "state_or_region": "Washington", "postal_code": "99204", "country": "United States", "latitude": 47.65966, "longitude": -117.42908, "site_statuses": "ACTIVE_NOT_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT06717698" }, { "compound_slugs": "semaglutide", "nct_id": "NCT05822609", "study_title": "Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes", "lead_sponsor": "University of Washington", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-06-02", "facility": "Providence Sacred Heart Medical Center", "city": "Spokane", "state_or_region": "Washington", "postal_code": "99204", "country": "United States", "latitude": 47.65966, "longitude": -117.42908, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT05822609" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632444", "study_title": "LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Spokane-69716", "city": "Spokane", "state_or_region": "Washington", "postal_code": "99218", "country": "United States", "latitude": 47.65966, "longitude": -117.42908, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632444" }, { "compound_slugs": "survodutide", "nct_id": "NCT06632457", "study_title": "LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Velocity Clinical Research-Spokane-69716", "city": "Spokane", "state_or_region": "Washington", "postal_code": "99218", "country": "United States", "latitude": 47.65966, "longitude": -117.42908, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06632457" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "VA Puget Sound HCS - Seattle and Tacoma", "city": "Tacoma", "state_or_region": "Washington", "postal_code": "98493", "country": "United States", "latitude": 47.25288, "longitude": -122.44429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Washington Gastroenterology - Tacoma", "city": "Tacoma", "state_or_region": "Washington", "postal_code": "98405", "country": "United States", "latitude": 47.25288, "longitude": -122.44429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Washington Gastroenterology - Tacoma", "city": "Tacoma", "state_or_region": "Washington", "postal_code": "98405", "country": "United States", "latitude": 47.25288, "longitude": -122.44429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Washington Gastroenterology - Tacoma", "city": "Tacoma", "state_or_region": "Washington", "postal_code": "98405", "country": "United States", "latitude": 47.25288, "longitude": -122.44429, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07668388", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "The Vancouver Clinic", "city": "Vancouver", "state_or_region": "Washington", "postal_code": "98664", "country": "United States", "latitude": 45.63873, "longitude": -122.66149, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07668388" }, { "compound_slugs": "mazdutide; tirzepatide", "nct_id": "NCT06143956", "study_title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-06", "facility": "Central Washington Health Services Association d/b/a Confluence Health", "city": "Wenatchee", "state_or_region": "Washington", "postal_code": "98801", "country": "United States", "latitude": 47.42346, "longitude": -120.31035, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "compound_slugs": "retatrutide; tirzepatide", "nct_id": "NCT07165028", "study_title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "CAMC Health Education and Research Institute Inc", "city": "Charleston", "state_or_region": "West Virginia", "postal_code": "25304", "country": "United States", "latitude": 38.34982, "longitude": -81.63262, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT07165028" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "Marshall Health", "city": "Huntington", "state_or_region": "West Virginia", "postal_code": "25701", "country": "United States", "latitude": 38.41925, "longitude": -82.44515, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07415954", "study_title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-10", "facility": "Frontier Clinical Research - Kingwood", "city": "Kingwood", "state_or_region": "West Virginia", "postal_code": "26537", "country": "United States", "latitude": 39.47176, "longitude": -79.68339, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06651177", "study_title": "Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder", "lead_sponsor": "T. John Winhusen, PhD", "phases": "PHASE2", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-08-11", "facility": "Healthy Minds/Chestnut Ridge", "city": "Morgantown", "state_or_region": "West Virginia", "postal_code": "26505", "country": "United States", "latitude": 39.62953, "longitude": -79.9559, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06651177" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07662213", "study_title": "A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus", "lead_sponsor": "AstraZeneca", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-05", "last_update_post_date": "2026-07-14", "facility": "Research Site", "city": "Morgantown", "state_or_region": "West Virginia", "postal_code": "26505", "country": "United States", "latitude": 39.62953, "longitude": -79.9559, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07662213" }, { "compound_slugs": "cagrilintide; semaglutide", "nct_id": "NCT07564414", "study_title": "A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight", "lead_sponsor": "Novo Nordisk A/S", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-07", "last_update_post_date": "2026-07-30", "facility": "Prevea Health", "city": "Green Bay", "state_or_region": "Wisconsin", "postal_code": "54303", "country": "United States", "latitude": 44.51916, "longitude": -88.01983, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07564414" }, { "compound_slugs": "survodutide", "nct_id": "NCT07754461", "study_title": "A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar", "lead_sponsor": "Boehringer Ingelheim", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Clinical Investigation Specialists, Inc.-Kenosha-69111", "city": "Kenosha", "state_or_region": "Wisconsin", "postal_code": "53144", "country": "United States", "latitude": 42.58474, "longitude": -87.82119, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07754461" }, { "compound_slugs": "semaglutide", "nct_id": "NCT07218354", "study_title": "Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)", "lead_sponsor": "VA Office of Research and Development", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-12", "facility": "William S. Middleton Memorial Veterans Hospital, Madison, WI", "city": "Madison", "state_or_region": "Wisconsin", "postal_code": "53705-2254", "country": "United States", "latitude": 43.07305, "longitude": -89.40123, "site_statuses": "NOT_YET_RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": false, "official_record_url": "https://clinicaltrials.gov/study/NCT07218354" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937086", "study_title": "Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Wisconsin Center for Advanced Research", "city": "Milwaukee", "state_or_region": "Wisconsin", "postal_code": "53215", "country": "United States", "latitude": 43.0389, "longitude": -87.90647, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937086" }, { "compound_slugs": "tirzepatide", "nct_id": "NCT06937099", "study_title": "Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight", "lead_sponsor": "Eli Lilly and Company", "phases": "PHASE3", "overall_status": "RECRUITING", "status_verified_date": "2026-08", "last_update_post_date": "2026-08-21", "facility": "Wisconsin Center for Advanced Research", "city": "Milwaukee", "state_or_region": "Wisconsin", "postal_code": "53215", "country": "United States", "latitude": 43.0389, "longitude": -87.90647, "site_statuses": "RECRUITING", "status_conflict": false, "source_location_rows": 1, "registered_as_recruiting": true, "official_record_url": "https://clinicaltrials.gov/study/NCT06937099" } ] }